<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE PubmedArticleSet SYSTEM "http://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31418820</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>08</Month>
        <Day>18</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>08</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1558-5646</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>73</Volume>
            <Issue>9</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>09</Month>
            </PubDate>
          </JournalIssue>
          <Title>Evolution; international journal of organic evolution</Title>
          <ISOAbbreviation>Evolution</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Out of the testis, into the ovary: biased outcomes of gene duplication and deletion in Drosophila.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1850-1862</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/evo.13820</ELocationID>
        <Abstract>
          <AbstractText>Gene turnover is a key source of adaptive variation. Yet most evolutionary studies have focused on gene duplication, dismissing gene deletion as a mechanism that simply eradicates redundancy. Here, I use genome-scale sequence and multi-tissue expression data from Drosophila melanogaster and Drosophila pseudoobscura to simultaneously assess the evolutionary outcomes of gene duplication and deletion in Drosophila. I find that gene duplication is more frequent than gene deletion in both species, indicating that it may play a more important role in Drosophila evolution. However, examination of several genic properties reveals that genes likely possess distinct functions after duplication that diverge further before deletion, suggesting that loss of redundancy cannot explain a majority of gene deletion events in Drosophila. Moreover, in addition to providing support for the well-known "out of the testis" origin of young duplicate genes, analyses of gene expression profiles uncover a preferential bias against deletion of old ovary-expressed genes. Therefore, I propose a novel "into the ovary" hypothesis for gene deletion in Drosophila, in which gene deletion may promote adaptation by salvaging genes that contribute to the evolution of female reproductive phenotypes. Under this combined "out of the testis, into the ovary" evolutionary model, gene duplication and deletion work in concert to generate and maintain a balanced repertoire of genes that promote sex-specific adaptation in Drosophila.</AbstractText>
          <CopyrightInformation>© 2019 The Author(s). Evolution © 2019 The Society for the Study of Evolution.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Assis</LastName>
            <ForeName>Raquel</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology, Pennsylvania State University, University Park, Pennsylvania, 16801.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <DataBankList CompleteYN="Y">
          <DataBank>
            <DataBankName>Dryad</DataBankName>
            <AccessionNumberList>
              <AccessionNumber>10.5061/dryad.742564m</AccessionNumber>
            </AccessionNumberList>
          </DataBank>
        </DataBankList>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>DEB-1555981</GrantID>
            <Agency>National Science Foundation</Agency>
            <Country>International</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Evolution</MedlineTA>
        <NlmUniqueID>0373224</NlmUniqueID>
        <ISSNLinking>0014-3820</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004330" MajorTopicYN="N">Drosophila</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004331" MajorTopicYN="N">Drosophila melanogaster</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019143" MajorTopicYN="N">Evolution, Molecular</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017353" MajorTopicYN="Y">Gene Deletion</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020440" MajorTopicYN="Y">Gene Duplication</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017344" MajorTopicYN="N">Genes, Insect</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010053" MajorTopicYN="N">Ovary</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012641" MajorTopicYN="N">Selection, Genetic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013737" MajorTopicYN="N">Testis</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Gene turnover</Keyword>
        <Keyword MajorTopicYN="Y">gene deletion</Keyword>
        <Keyword MajorTopicYN="Y">gene duplication</Keyword>
        <Keyword MajorTopicYN="Y">out of the testis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>02</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>06</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>03</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>8</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418820</ArticleId>
        <ArticleId IdType="doi">10.1111/evo.13820</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>LITERATURE CITED</Title>
        <Reference>
          <Citation>Albalat, R., and C. Cañestro. 2016. Evolution by gene loss. Nat. Rev. Genet. 17:379-391.</Citation>
        </Reference>
        <Reference>
          <Citation>Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.</Citation>
        </Reference>
        <Reference>
          <Citation>Assis, R. 2014. Drosophila duplicate genes evolve new functions on the fly. Fly. 8:91-94.</Citation>
        </Reference>
        <Reference>
          <Citation>Assis, R., and D. Bachtrog. 2013. Neofunctionalization of young duplicate genes in Drosophila. Proc. Natl. Acad. Sci. USA 110:17409-17414.</Citation>
        </Reference>
        <Reference>
          <Citation>Assis, R., and D. Bachtrog. 2015. Rapid divergence and diversification of mammalian duplicate gene functions. BMC Evol. Biol. 15:138.</Citation>
        </Reference>
        <Reference>
          <Citation>Beckenbach, A. T., Y. W. Wei, and H. Liu. 1993. Relationships in the Drosophila obscura species group, inferred from mitochondrial cytochrome oxidase II sequences. Mol. Biol. Evol. 10:619-634.</Citation>
        </Reference>
        <Reference>
          <Citation>Betrán, E., K. Thornton, and M. Long. 2002. Retroposed new genes out of the X in Drosophila. Genome Res. 12:1854-1859.</Citation>
        </Reference>
        <Reference>
          <Citation>Blanc, G., and K. H. Wolfe. 2004. Functional divergence of duplicated genes formed by polyploidy during Arabidopsis evolution. Plant Cell 16:1679-1691.</Citation>
        </Reference>
        <Reference>
          <Citation>Brookfield, J. 1992. Can genes be truly redundant? Curr. Biol. 2:553- 554.</Citation>
        </Reference>
        <Reference>
          <Citation>Brookfield, J. F. Y. 1997. Genetic redundancy. Adv. Genet. 36:137-155.</Citation>
        </Reference>
        <Reference>
          <Citation>Casneuf, T., S. De Bodt, J. Raes, S. Maere, and Y. Van de Peer. 2006. Nonrandom divergence of gene expression following gene and genome duplications in the flowering plant Arabidopsis thaliana. Genome Biol. 7: R13.</Citation>
        </Reference>
        <Reference>
          <Citation>Celniker, S. E., L. A. Dillon, M. B. Gerstein, K. C. Gunsalus, S. Henikoff, G. H. Karpen, M. Kellis, E. C. Lai, J. D. Lieb, D. M. MacAlpine, et al. 2009. Unlocking the secrets of the genome. Nature 459:927-930.</Citation>
        </Reference>
        <Reference>
          <Citation>Csurӧs, M. 2008. Ancestral reconstruction by asymmetric Wagner parsimony over continuous characters and squared parsimony over distributions. Proceedings of the Sixth RECOMB Comparative Genomics Satellite Workshop 5267:72-86.</Citation>
        </Reference>
        <Reference>
          <Citation>Csurӧs, M. 2010. Count: evolutionary analysis of phylogenetic profiles with parsimony and likelihood. Bioinformatics 36:1910-1912.</Citation>
        </Reference>
        <Reference>
          <Citation>Chen, S., Y. E. Zhang, and M. Long. 2010. New genes in Drosophila quickly become essential. Science 330:1682-1685.</Citation>
        </Reference>
        <Reference>
          <Citation>Conant, G. C., and A. Wagner. 2003. Asymmetric sequence divergence of duplicate genes. Genome Res. 13:2052-2058.</Citation>
        </Reference>
        <Reference>
          <Citation>Dai, H., T. F. Yoshimatsu, and M. Long. 2006. Retrogene movement within- and between-chromosomes in the evolution of Drosophila genomes. Gene 385:96-102.</Citation>
        </Reference>
        <Reference>
          <Citation>Dean, M., M. Carrington, C. Winkler, G. A. Huttley, M. W. Smith, R. Allikmets, J. J. Goedert, S. P. Buchbinder, E. Vittinhoff, E. Gomperts, et al. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273:1856-1862.</Citation>
        </Reference>
        <Reference>
          <Citation>Drosophila 12 Genomes Consortium. 2007. Evolution of genes and genomes on the Drosophila phylogeny. Nature 450:203-218.</Citation>
        </Reference>
        <Reference>
          <Citation>Emerson, J. J., M. Cardoso-Moreira, J. O. Borevitz, and M. Long. 2008. Natural selection shapes genome-wide patterns of copy-number polymorphism in Drosophila melanogaster. Science 320:1629-1631.</Citation>
        </Reference>
        <Reference>
          <Citation>Emms, D. M., and S. Kelly. 2015. OrthoFinder: solving fundamental biases in whole genome comparisons dramatically improves orthogroups inference accuracy. Genome Biol. 16:157.</Citation>
        </Reference>
        <Reference>
          <Citation>Farré, D., and M. M. Albà. 2010. Heterogeneous patterns of gene-expression diversification in mammalian gene duplicates. Mol. Biol. Evol. 27:325-335.</Citation>
        </Reference>
        <Reference>
          <Citation>Farris, J. S. 1970. Methods for computing Wagner trees. Syst. Zool. 19:83-92.</Citation>
        </Reference>
        <Reference>
          <Citation>Ganko, E. W., B. C. Meyers, and T. J. Vision. 2007. Divergence in expression between duplicated genes in Arabidopsis. Mol. Biol. Evol. 24:2298-2309.</Citation>
        </Reference>
        <Reference>
          <Citation>Gramates, L. S., S. J. Marygold, G. D. Santos, J. M. Urbano, G. Antonazzo, B. B. Matthews, A. J. Rey, C. J. Tabone, M. A. Crosby, D. B. Emmert, et al. 2017. FlyBase at 25: looking to the future. Nucleic Acids Res. 45:D663-D671.</Citation>
        </Reference>
        <Reference>
          <Citation>Gu, X., Z. Zhang, and W. Huang. 2005. Rapid evolution of expression and regulatory divergence after yeast gene duplication. Proc. Natl. Acad. Sci. USA 102:707-712.</Citation>
        </Reference>
        <Reference>
          <Citation>Gu, Z., D. Nicolae, H. H. Lu, and W. H. Li. 2002. Rapid divergence in expression between duplicate genes inferred from microarray data. Trends Genet. 18:609-613.</Citation>
        </Reference>
        <Reference>
          <Citation>Gu, Z., S. A. Rifkin, K. P. White, and W. H. Li. 2004. Duplicate genes increase gene expression diversity within and between species. Nat. Genet. 36:577-579.</Citation>
        </Reference>
        <Reference>
          <Citation>Gu, Z., L. M. Steinmetz, X. Gu, C. Scharfe, R. W. Davis, and W. H. Li. 2003. Role of duplicate genes in genetic robustness against null mutations. Nature 421:63-66.</Citation>
        </Reference>
        <Reference>
          <Citation>Hahn, M. W., J. P. Demuth, and S. G. Han. 2007a. Accelerated rate of gene gain and loss in primates. Genetics 177:1941-1949.</Citation>
        </Reference>
        <Reference>
          <Citation>Hahn, M. W., M. V. Van, and S. G. Han. 2007b. Gene family evolution across 12 Drosophila genomes. PLoS Genet. 3:e197.</Citation>
        </Reference>
        <Reference>
          <Citation>Han, M. V., and M. W. Hahn. 2009. Identifying parent-daughter relationships among duplicated genes. Pac. Sym. Biocomput. 14:114-125.</Citation>
        </Reference>
        <Reference>
          <Citation>Hoballah, M. E., T. Gübitz, J. Stuurman, L. Broger, M. Barone, T. Mandel, A. Dell'Olivo, M. Arnold, and C. Kuhlemeier. 2007. Single gene-mediated shift in pollinator attraction in Petunia. Plant Cell. 19:779-790.</Citation>
        </Reference>
        <Reference>
          <Citation>Holland, P. W., J. Garcia Fernández, N. A. Williams, and A. Sidow. 1994. Gene duplications and the origins of vertebrate development. Development 1994:125-133.</Citation>
        </Reference>
        <Reference>
          <Citation>Hoskins, R. A., J. W. Carlson, K. H. Wan, S. Park, I. Mendez, S. E. Galle, B. W. Booth, B. D. Pfeiffer, R. A. George, R. Svirskas, et al. 2015. The release 6 reference sequence of the Drosophila melanogaster genome. Genome Res. 25:445-458.</Citation>
        </Reference>
        <Reference>
          <Citation>Hottes, A. K., P. L. Freddolino, A. Khare, Z. N. Donnell, J. C. Liu, and S. Tavazoie. 2013. Bacterial adaptation through loss of function. PLoS Genet. 9:e1003617.</Citation>
        </Reference>
        <Reference>
          <Citation>Ihmels, J., S. R. Collins, K. N. J. Schuldiner, and J. S. Weissman. 2007. Backup without redundancy: genetic interactions reveal the cost of duplicate gene loss. Mol. Syst. Biol. 3:86.</Citation>
        </Reference>
        <Reference>
          <Citation>Gautier, L., L. Cope, B. M. Bolstad, and R. A. Irizarry. 2004. affy-analysis of Affymetrix GeneChip data at the probe level. Bioinf. 20:307-315.</Citation>
        </Reference>
        <Reference>
          <Citation>Jiang, X., and R. Assis. 2017. Natural selection drives rapid functional evolution of young Drosophila duplicate genes. Mol. Biol. Evol. 34:3089-3098.</Citation>
        </Reference>
        <Reference>
          <Citation>Jiang, X., and R. Assis. 2019. Rapid functional divergence of grass duplicate genes. BMC Evol. Biol. 19:97.</Citation>
        </Reference>
        <Reference>
          <Citation>Kaessmann, H. 2010. Origins, evolution, and phenotypic impact of new genes. Genome Res. 20:1313-1326.</Citation>
        </Reference>
        <Reference>
          <Citation>Kaiser, V. B., Q. Zhou, and D. Bachtrog. 2011. Nonrandom gene loss from the Drosophila miranda neo-Y chromosome. Genome Biol. Evol. 3:1329-1337.</Citation>
        </Reference>
        <Reference>
          <Citation>Kellis, M., B. W. Birren, and E. S. Lander. 2004. Proof and evolutionary analysis of ancient genome duplication in the yeast Saccharomyces cerevisiae. Nature 4286983:617-624.</Citation>
        </Reference>
        <Reference>
          <Citation>Kondo, S., J. Vedanayagam, J. Mohammed, S. Eizadshenass, L. Kan, N. Pang, R. Aradhya, A. Siepel, J. Steinhauer, and E. C. Lai. 2017. New genes often acquire male-specific functions but rarely become essential in Drosophila. Genes. Dev. 31:1841-1846.</Citation>
        </Reference>
        <Reference>
          <Citation>Kondrashov, F. A., I. B. Rogozin, Y. I. Wolf, and E. V. Koonin. 2002. Selection in the evolution of gene duplications. Genome Biol. 3:RESEARCH0008.</Citation>
        </Reference>
        <Reference>
          <Citation>Langmead, B., C. Trapnell, M. Pop, and S. L. Salzberg. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10:R25.</Citation>
        </Reference>
        <Reference>
          <Citation>Li, W. H., J. Yang, and X. Gu. 2005. Expression divergence between duplicate genes. Trends Genet. 21:602-607.</Citation>
        </Reference>
        <Reference>
          <Citation>Liao, B. Y., and J. Zhang. 2007. Mouse duplicate genes are as essential as singletons. Trends Genet. 23:378-381.</Citation>
        </Reference>
        <Reference>
          <Citation>Lynch, M., and J. S. Conery. 2000. The evolutionary fate and consequences of duplicate genes. Science 290:1151-1155.</Citation>
        </Reference>
        <Reference>
          <Citation>Lynch, M., and J. S. Conery. 2003. The origins of genome complexity. Science 302:1401-1404.</Citation>
        </Reference>
        <Reference>
          <Citation>Makova, K. D., and W. H. Li. 2003. Divergence in the spatial pattern of gene expression between human duplicate genes. Genome Res. 13:1638-1645.</Citation>
        </Reference>
        <Reference>
          <Citation>Marques, A. C., I. Doupanloup, N. Vinckenbosch, A. Reymond, and H. Kaessmann. 2005. Emergence of young human genes after a burst of retroposition in primates. PLoS Biol. 3:e357.</Citation>
        </Reference>
        <Reference>
          <Citation>Millard, S. P. 2013. EnvStats: an R package for environmental statistics. Springer, New York, NY.</Citation>
        </Reference>
        <Reference>
          <Citation>Nadeau, J. H., and D. Sankoff. 1997. Comparable rates of gene loss and functional divergence after genome duplications early in vertebrate evolution. Genetics 147:1259-1266.</Citation>
        </Reference>
        <Reference>
          <Citation>Ng, M.-P., I. A. Vergara, C. Frech, Q. Chen, X. Zeng, J. Pei, and N. Chen. 2009. OrthoClusterDB: an online platform for synteny block. BMC Bioinf. 10:192.</Citation>
        </Reference>
        <Reference>
          <Citation>Ohno, S. 1970. Evolution by gene duplication. Springer-Verlag, Berlin, Germany.</Citation>
        </Reference>
        <Reference>
          <Citation>Olson, M. V. 1999. When less is more: gene loss as an engine of evolutionary change. Am. J. Hum. Genet. 64:18-23.</Citation>
        </Reference>
        <Reference>
          <Citation>Papp, B., C. Pál, and L. D. Hurst. 2004. Metabolic network analysis of the causes and evolution of enzyme dispensability in yeast. Nature 429:661-664.</Citation>
        </Reference>
        <Reference>
          <Citation>Petrov, D. A. 2002. DNA loss and evolution of genome size in Drosophila. Genetica 115:81-91.</Citation>
        </Reference>
        <Reference>
          <Citation>Postlethwait, J. H., Y. L. Yan, M. Gates, S. Horne, A. Amores, A. Brownlie, A. Donovan, E. S. Egan, A. Force, Z. Gong, et al. 1998. Vertebrate genome evolution and the zebrafish gene map. Nat. Genet. 18:345-349.</Citation>
        </Reference>
        <Reference>
          <Citation>R Core Team. 2013. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.</Citation>
        </Reference>
        <Reference>
          <Citation>Ranwez, V., E. J. P. Douzery, C. Cambon, N. Chantret, and F. Delsuc. 2018. MACSE v2: Toolkit for the alignment of coding sequences accounting for frameshifts and stop codons. Mol. Biol. Evol. 35:2582-2584.</Citation>
        </Reference>
        <Reference>
          <Citation>Revelle, W. 2018. psych: procedures for personality and psychological research, Northwestern University, Evanston, Illinois, USA, https://CRAN.R-project.org/package=psych. Version = 1.8.12.</Citation>
        </Reference>
        <Reference>
          <Citation>Richards, S., Y. Liu, B. R. Bettencourt, P. Hradecky, S. Letovsky, R. Nielsen, K. Thornton, M. J. Hubisz, R. Chen, R. P. Meisel, et al. 2005. Comparative genome sequencing of Drosophila pseudoobscura: chromosomal, gene, and cis-element evolution. Genome Res. 15:1-8.</Citation>
        </Reference>
        <Reference>
          <Citation>Roberts, A., and L. Pachter. 2013. Streaming fragment assignment for real-time analysis of sequencing experiments. Nat. Methods 10:71-73.</Citation>
        </Reference>
        <Reference>
          <Citation>Rogers, R. L., L. Shao, and K. R. Thornton. 2017. Tandem duplications lead to novel expression patterns through exon shuffling in Drosophila yakuba. PLoS Genet. 13:e1006795.</Citation>
        </Reference>
        <Reference>
          <Citation>Taylor, J. S., and J. Raes. 2004. Duplication and divergence: the evolution of new genes and old ideas. Annu. Rev. Genet. 38:615-643.</Citation>
        </Reference>
        <Reference>
          <Citation>Trapnell, C., B. A. Williams, G. Pertea, A. Mortazavi, G. Kwan, M. J. van Baren, S. L. Salzberg, B. J. Wold, and L. Pachter 2010. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28:511-515.</Citation>
        </Reference>
        <Reference>
          <Citation>Vinckenbosch, N., I. Dupanloup, and H. Kaessmann. 2006. Evolutionary fate of retroposed gene copies in the human genome. Proc. Natl. Acad. Sci. USA 103:3220-3225.</Citation>
        </Reference>
        <Reference>
          <Citation>Wagner, A. 2002. Asymmetric functional divergence of duplicate genes in yeast. Mol. Biol. Evol. 19:1760-1768.</Citation>
        </Reference>
        <Reference>
          <Citation>Will, J. L., H. S. Kim, J. Clarke, J. C. Painter, J. C. Fay, and A. P. Gasch. 2010. Incipient balancing selection through adaptive loss of aquaporins in natural Saccharomyces cerevisiae populations. PLoS Genet. 6(4):e1000893.</Citation>
        </Reference>
        <Reference>
          <Citation>Yanai, I., H. Benjamin, M. Shmoish, V. Chalifa-Caspi, M. Shklar, R. Ophir, A. Bar-Even, S. Horn-Saban, M. Safran, E. Domany, et al. 2005. Genome-wide midrange transcription profiles reveal expression level relationships in human tissue specification. Bioinformatics 21:650-659.</Citation>
        </Reference>
        <Reference>
          <Citation>Yang, Z. 2007. PAML 4: phylogenetic analysis by maximum likelihood. Mol. Biol. Evol. 24:1586-1591.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang, J. 2003. Evolution by gene duplication: an update. Trends Ecol. Evol. 18:292-298.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhao, L., P. Saelao, C. D. Jones, and D. J. Begun. 2014. Origin and spread of de novo genes in Drosophila melanogaster populations. Science 343:769-772.</Citation>
        </Reference>
        <Reference>
          <Citation>Zufall, R. A., and M. D. Rausher 2004. Genetic changes associated with floral adaptation restrict future evolutionary potential. Nature 428:847-850.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM">
      <PMID Version="1">31418821</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>11</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>11</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1097-0142</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>125</Volume>
            <Issue>22</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>11</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cancer</Title>
          <ISOAbbreviation>Cancer</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Improving chemotherapy consent in underserved patients.</ArticleTitle>
        <Pagination>
          <MedlinePgn>3921-3923</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/cncr.32418</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kilbridge</LastName>
            <ForeName>Kerry L</ForeName>
            <Initials>KL</Initials>
            <Identifier Source="ORCID">0000-0001-7460-6273</Identifier>
            <AffiliationInfo>
              <Affiliation>Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
          <PublicationType UI="D016420">Comment</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Cancer</MedlineTA>
        <NlmUniqueID>0374236</NlmUniqueID>
        <ISSNLinking>0008-543X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>AIM</CitationSubset>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentOn">
          <RefSource>Cancer. 2019 Nov 15;125(22):4011-4018</RefSource>
          <PMID Version="1">31418849</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D032882" MajorTopicYN="Y">Comprehension</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007258" MajorTopicYN="N">Informed Consent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D035862" MajorTopicYN="Y">Vulnerable Populations</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">health disparities</Keyword>
        <Keyword MajorTopicYN="Y">health literacy</Keyword>
        <Keyword MajorTopicYN="Y">informed consent</Keyword>
        <Keyword MajorTopicYN="Y">quality improvement</Keyword>
        <Keyword MajorTopicYN="Y">quality standards</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>05</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>01</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418821</ArticleId>
        <ArticleId IdType="doi">10.1002/cncr.32418</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Storm C, Casillas J, Grunwald H, Howard DS, McNiff K, Neuss MM. Informed consent for chemotherapy: ASCO member resources. J Oncol Pract. 2008;4:289-295.</Citation>
        </Reference>
        <Reference>
          <Citation>Neuss MN, Gilmore TR, Belderson KM, et al. 2016 Updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards, including standards for pediatric oncology. Oncol Nurs Forum. 2017;44:31-43.</Citation>
        </Reference>
        <Reference>
          <Citation>American Society of Clinical Oncology. QOPI Certification Program Standards Manual. Published June 2018. Accessed May 23, 2019. https://practice.asco.org/sites/default/files/drupalfiles/QOPI%20Certification%20Standards%20Manual%206.1.18.pdf.</Citation>
        </Reference>
        <Reference>
          <Citation>American Society of Clinical Oncology. Consent to Chemotherapy. Published November 2008. Accessed May 23, 2019. https://practice.asco.org/sites/default/files/drupalfiles/ASCO%20Informed%20Consent%20Form.pdf.</Citation>
        </Reference>
        <Reference>
          <Citation>Pentz RD, Lohani M, Hayban M, et al. Videos improve patient understanding of misunderstood chemotherapy terminology. Cancer. 2019;125:4011-4018.</Citation>
        </Reference>
        <Reference>
          <Citation>Farrell C. Learning to talk like a doctor. In: Gilbert S, editor. Bioethics Forum Essay. Hastings Bioethics Forum. Garrison, NY: The Hastings Center; 2013.</Citation>
        </Reference>
        <Reference>
          <Citation>Hafferty FW, Franks R. The hidden curriculum, ethics teaching, and the structure of medical education. Acad Med. 1994;69:861-871.</Citation>
        </Reference>
        <Reference>
          <Citation>National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Bethesda, MD: National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research; 1978.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
      <PMID Version="1">31418822</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>16</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1095-8649</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>95</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Nov</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of fish biology</Title>
          <ISOAbbreviation>J Fish Biol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Genetic and historical evidence of common sawsharks Pristiophorus cirratus in the waters of southern Queensland.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1342-1345</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jfb.14122</ELocationID>
        <Abstract>
          <AbstractText>In 2011, a male pristiophorid was caught by a prawn trawler north east of Cape Moreton, Queensland, Australia. Molecular analyses confirmed the specimen to be the common sawshark Pristiophorus cirratus. Historical catch data indicate the occurrence of the species in the region but this is the first verified record of P. cirratus occurring in the waters of southern Queensland. Together, these records extend the recognised northern limit of P. cirratus by c. 500 km, which suggests that further investigation of its distribution is warranted.</AbstractText>
          <CopyrightInformation>© 2019 The Fisheries Society of the British Isles.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Nevatte</LastName>
            <ForeName>Ryan J</ForeName>
            <Initials>RJ</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-1019-0544</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biological Sciences, Faculty of Science and Engineering, Macquarie University, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wueringer</LastName>
            <ForeName>Barbara E</ForeName>
            <Initials>BE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biological Sciences, Faculty of Science and Engineering, Macquarie University, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sharks And Rays Australia, Bungalow, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gillings</LastName>
            <ForeName>Michael R</ForeName>
            <Initials>MR</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-4043-4351</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biological Sciences, Faculty of Science and Engineering, Macquarie University, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Williamson</LastName>
            <ForeName>Jane E</ForeName>
            <Initials>JE</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0003-3627-4508</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biological Sciences, Faculty of Science and Engineering, Macquarie University, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <Agency>Department of Biological Sciences at Macquarie University</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>09</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Fish Biol</MedlineTA>
        <NlmUniqueID>0214055</NlmUniqueID>
        <ISSNLinking>0022-1112</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D063147" MajorTopicYN="N">Animal Distribution</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001522" MajorTopicYN="N">Behavior, Animal</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018940" MajorTopicYN="N">Elasmobranchii</DescriptorName>
          <QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011793" MajorTopicYN="N" Type="Geographic">Queensland</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Australia</Keyword>
        <Keyword MajorTopicYN="N">Pristiophoridae</Keyword>
        <Keyword MajorTopicYN="N">benthic elasmobranch</Keyword>
        <Keyword MajorTopicYN="N">new record</Keyword>
        <Keyword MajorTopicYN="N">range extension</Keyword>
        <Keyword MajorTopicYN="N">species distribution</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418822</ArticleId>
        <ArticleId IdType="doi">10.1111/jfb.14122</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Benson, D. A., Cavanaugh, M., Clark, K., Karsch-Mizrachi, I., Lipman, D. J., Ostell, J., &amp; Sayers, E. W. (2013). GenBank. Nucleic Acids Research, 41(D1), D36-D42.</Citation>
        </Reference>
        <Reference>
          <Citation>Bice, C. M., Wedderburn, S. D., Hammer, M. P., Ye, Q., &amp; Zampatti, B. P. (2018). Fishes of the lower lakes and Coorong: A summary of life-history, population dynamics and management. In L. Mosley, Q. Ye, S. Shepherd, S. Hemming, &amp; R. Fitzpatrick (Eds.), Natural history of the Coorong, lower lakes, and Murray mouth region (Yarluwar-Ruwe) (pp. 371-399). Adelaide, South Australia: University of Adelaide Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Braccini, M., Van Rijn, J., &amp; Frick, L. (2012). High post-capture survival for sharks, rays and chimaeras discarded in the main shark fishery of Australia? PLoS One, 7(2), e32547. https://doi.org/10.1371/journal.pone.0032547.</Citation>
        </Reference>
        <Reference>
          <Citation>Campbell, M. J., McLennan, M. F., Courtney, A. J., &amp; Simpfendorfer, C. A. (2018). Post-release survival of two elasmobranchs, the eastern shovelnose ray (Aptychotrema rostrata) and the common stingaree (Trygonoptera testacea), discarded from a prawn trawl fishery in southern Queensland, Australia. Marine and Freshwater Research, 69(4), 551-561.</Citation>
        </Reference>
        <Reference>
          <Citation>Compagno, L. J. V., Dando, M., &amp; Fowler, S. L. (2005). A field guide to the sharks of the world. London: Harper Collins Publishing Limited.</Citation>
        </Reference>
        <Reference>
          <Citation>Darriba, D., Taboada, G. L., Doallo, R., &amp; Posada, D. (2012). jModelTest 2: More models, new heuristics and parallel computing. Nature Methods, 9, 772. https://doi.org/10.1038/nmeth.2109</Citation>
        </Reference>
        <Reference>
          <Citation>Edgar, R. C. (2004). MUSCLE: Multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Research, 32(5), 1792-1797.</Citation>
        </Reference>
        <Reference>
          <Citation>Felsenstein, J. (1985). Confidence limits on phylogenies: An approach using the bootstrap. Evolution, 39(4), 783-791.</Citation>
        </Reference>
        <Reference>
          <Citation>Geraghty, P. T., Williamson, J. E., Macbeth, W. G., Wintner, S. P., Harry, A. V., Ovenden, J. R., &amp; Gillings, M. R. (2013). Population expansion and genetic structure in Carcharhinus brevipinna in the southern Indo-Pacific. PLoS One, 8(9), e75169. https://doi.org/10.1371/journal.pone.0075169.</Citation>
        </Reference>
        <Reference>
          <Citation>Graham, K. (2014). NSW Kapala Survey Data (1975-2008). CSIRO Oceans and Atmosphere. Retrieved from https://www.cmar.csiro.au/data/trawler//project_details.cfm?project_id=2390.</Citation>
        </Reference>
        <Reference>
          <Citation>Guindon, S., &amp; Gascuel, O. (2003). A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Systematic Biology, 52(5), 696-704.</Citation>
        </Reference>
        <Reference>
          <Citation>Hasegawa, M., Kishino, H., &amp; Yano, T. (1985). Dating of the human-ape splitting by a molecular clock of mitochondrial DNA. Journal of Molecular Evolution, 22(2), 160-174.</Citation>
        </Reference>
        <Reference>
          <Citation>Holmes, B. J., Sumpton, W. D., Mayer, D. G., Tibbetts, I. R., Neil, D. T., &amp; Bennett, M. B. (2012). Declining trends in annual catch rates of the tiger shark (Galeocerdo cuvier) in Queensland, Australia. Fisheries Research, 129-130, 38-45.</Citation>
        </Reference>
        <Reference>
          <Citation>Kearse, M., Moir, R., Wilson, A., Stones-Havas, S., Cheung, M., Sturrock, S., … Drummond, A. (2012). Geneious basic: An integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics, 28(12), 1647-1649.</Citation>
        </Reference>
        <Reference>
          <Citation>Kumar, S., Stecher, G., &amp; Tamura, K. (2016). MEGA7: Molecular evolutionary genetics analysis version 7.0 for bigger datasets. Molecular Biology and Evolution, 33(7), 1870-1874.</Citation>
        </Reference>
        <Reference>
          <Citation>Last, P. R., &amp; Stevens, J. D. (2009). Sharks and rays of Australia (Second ed.). Collingwood, Victoria: CSIRO Publishing.</Citation>
        </Reference>
        <Reference>
          <Citation>Nevatte, R. J., Williamson, J. E., Vella, N. G. F., Raoult, V., &amp; Wueringer, B. E. (2017a). Morphometry and microanatomy of the barbels of the common sawshark Pristiophorus cirratus (Pristiophoridae): Implications for pristiophorid behaviour. Journal of Fish Biology, 90(5), 1906-1925.</Citation>
        </Reference>
        <Reference>
          <Citation>Nevatte, R. J., Wueringer, B. E., Jacob, D. E., Park, J. M., &amp; Williamson, J. E. (2017b). First insights into the function of the sawshark rostrum through examination of rostral tooth microwear. Journal of Fish Biology, 91(6), 1582-1602.</Citation>
        </Reference>
        <Reference>
          <Citation>Raoult, V., Gaston, T. F., &amp; Williamson, J. E. (2015). Not all sawsharks are equal: Species of co-existing sawsharks show plasticity in trophic consumption both within and between species. Canadian Journal of Fisheries and Aquatic Sciences, 72(11), 1769-1775.</Citation>
        </Reference>
        <Reference>
          <Citation>Raoult, V., Peddemors, V., &amp; Williamson, J. E. (2017). Biology of angel sharks (Squatina sp.) and sawsharks (Pristiophorus sp.) caught in south-eastern Australian trawl fisheries and the New South Wales shark-meshing (bather-protection) program. Marine and Freshwater Research, 68, 207-212.</Citation>
        </Reference>
        <Reference>
          <Citation>Rigby, C. L. &amp; Heupel, M. R. (2015). Pristiophorus delicatus. The IUCN red list of threatened species, 2015, e.T42720A68641067, https://doi.org/10.2305/IUCN.UK.2015-4.RLTS.T42720A68641067.en. Downloaded on April 15, 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>Rigby, C. L., White, W. T., &amp; Simpfendorfer, C. A. (2016). Deepwater chondrichthyan bycatch of the eastern king prawn fishery in the southern Great Barrier Reef, Australia. PLoS One, 11(5), e0156036. https://doi.org/10.1371/journal.pone.0156036.</Citation>
        </Reference>
        <Reference>
          <Citation>Stead, D. G. (1963). Sharks and rays of Australian seas. Sydney: Angus and Robertson.</Citation>
        </Reference>
        <Reference>
          <Citation>Sumpton, W. D., Taylor, S. M., Gribble, N. A., McPherson, G., &amp; Ham, T. (2011). Gear selectivity of large-mesh nets and drumlines used to catch sharks in the Queensland Shark Control Program. African Journal of Marine Science, 33(1), 37-43.</Citation>
        </Reference>
        <Reference>
          <Citation>Sunnucks, P., &amp; Hales, D. F. (1996). Numerous transposed sequences of mitochondrial cytochrome oxidase I-II in aphids of the genus Sitobion (Hemiptera: Aphididae). Molecular Biology and Evolution, 13(3), 510-524.</Citation>
        </Reference>
        <Reference>
          <Citation>Walker, T.I. (2016). Pristiophorus cirratus. The IUCN red list of threatened species, 2016, e.T39327A68640973, https://doi.org/10.2305/IUCN.UK.2016-1.RLTS.T39327A68640973.en. Downloaded on April 15, 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>Ward, R. D., Zemlak, T. S., Innes, B. H., Last, P. R., &amp; Hebert, P. D. N. (2005). DNA barcoding Australia's fish species. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 360(1462), 1847-1857.</Citation>
        </Reference>
        <Reference>
          <Citation>Wueringer, B. E. (2017). Sawfish captures in the Queensland Shark Control Program, 1962 to 2016. Endangered Species Research, 34, 293-300.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31418823</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>27</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>12</Month>
        <Day>02</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1532-5415</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>67</Volume>
            <Issue>12</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>12</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of the American Geriatrics Society</Title>
          <ISOAbbreviation>J Am Geriatr Soc</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Associations between Skeletal Muscle and Myocardium in Aging: A Syndrome of "Cardio-Sarcopenia"?</ArticleTitle>
        <Pagination>
          <MedlinePgn>2568-2573</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jgs.16132</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES">The link between skeletal muscle and heart disease remains intriguing. It is unknown how skeletal muscle may be associated with aspects of myocardial structure and function, particularly in the presence of aging-related sarcopenia. We hypothesize that among aging adults with sarcopenia, alterations in myocardial structure and/or function may exist, resulting in a syndrome of "cardio-sarcopenia."</AbstractText>
          <AbstractText Label="METHODS">Participants derived from a community cohort study underwent same-day bioimpedance body composition analysis that measured skeletal muscle in sites such as the trunk, upper limb, and lower limb, and echocardiography for assessment of myocardial structure and function. Sarcopenia was diagnosed using the Asian Working Group for Sarcopenia criteria.</AbstractText>
          <AbstractText Label="RESULTS">We studied a total of 378 participants, of whom 88 (23.3%) had sarcopenia. Participants with sarcopenia had smaller left ventricular (LV) sizes (lower LV internal diameter end diastole (4.1 ± .7 vs 4.5 ± .6 cm; P &lt; .0001), lower LV internal diameter end systole (2.3 ± .5 vs 2.5 ± .4 cm; P = .010), lower LV posterior wall end diastole (.7 ± .1 vs .8 ± .1 cm; P = .0036), and lower LV posterior wall end systole (1.4 ± .3 vs 1.5 ± .2 cm; P = .0031). Sarcopenic participants also had lower LV mass (106 ± 35 vs 126 ± 53; P = .0014) and lower left atrial (LA) volume (33 ± 13 vs 36 ± 13; P = .033). Adjusting for age and diabetes mellitus, skeletal muscle mass was associated with LV diameter (β = .06; 95% confidence interval [CI] = .03-.09; P &lt; .0001), LV mass (β = 4.04; 95% CI = 1.78-6.29; P = .001), LA diameter (β = .05; 95% CI = .01-.09; P = .007), and LA volume (β = 1.26; 95% CI = .38-2.13; P = .005). A positive linear correlation was observed between LV mass and handgrip strength (r = .25; P &lt; .0001).</AbstractText>
          <AbstractText Label="CONCLUSION">Among a community sample of older adults with preserved heart function, sarcopenia is associated with reductions in LV and LA sizes. Skeletal muscle mass was independently associated with specific indices of myocardial structure. J Am Geriatr Soc 67:2568-2573, 2019.</AbstractText>
          <CopyrightInformation>© 2019 The American Geriatrics Society.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Keng</LastName>
            <ForeName>Bryan M H</ForeName>
            <Initials>BMH</Initials>
            <AffiliationInfo>
              <Affiliation>National Heart Centre Singapore, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gao</LastName>
            <ForeName>Fei</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>National Heart Centre Singapore, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Duke-NUS Medical School, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Teo</LastName>
            <ForeName>Louis L Y</ForeName>
            <Initials>LLY</Initials>
            <AffiliationInfo>
              <Affiliation>National Heart Centre Singapore, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Duke-NUS Medical School, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lim</LastName>
            <ForeName>Wee Shiong</ForeName>
            <Initials>WS</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Geriatrics and Active Aging, Tan Tock Seng Hospital, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tan</LastName>
            <ForeName>Ru San</ForeName>
            <Initials>RS</Initials>
            <AffiliationInfo>
              <Affiliation>National Heart Centre Singapore, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Duke-NUS Medical School, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ruan</LastName>
            <ForeName>Wen</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>National Heart Centre Singapore, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Duke-NUS Medical School, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ewe</LastName>
            <ForeName>See Hooi</ForeName>
            <Initials>SH</Initials>
            <AffiliationInfo>
              <Affiliation>National Heart Centre Singapore, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Duke-NUS Medical School, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Koh</LastName>
            <ForeName>Woon-Puay</ForeName>
            <Initials>WP</Initials>
            <AffiliationInfo>
              <Affiliation>Duke-NUS Medical School, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Koh</LastName>
            <ForeName>Angela S</ForeName>
            <Initials>AS</Initials>
            <Identifier Source="ORCID">0000-0001-5629-9732</Identifier>
            <AffiliationInfo>
              <Affiliation>National Heart Centre Singapore, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Duke-NUS Medical School, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>NIH R01 CA144034</GrantID>
            <Acronym>NH</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>MOH-000153</GrantID>
            <Agency>National Medical Research Council</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <GrantID>R01 CA144034</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 CA043092</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 CA080205</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>NMRC/TA/0031/2015</GrantID>
            <Agency>National Medical Research Council</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <GrantID>UM1 CA182876</GrantID>
            <Acronym>NH</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>UM1 CA182876</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Am Geriatr Soc</MedlineTA>
        <NlmUniqueID>7503062</NlmUniqueID>
        <ISSNLinking>0002-8614</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006352" MajorTopicYN="N">Heart Ventricles</DescriptorName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009206" MajorTopicYN="Y">Myocardium</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055948" MajorTopicYN="N">Sarcopenia</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">aging</Keyword>
        <Keyword MajorTopicYN="Y">cardiovascular</Keyword>
        <Keyword MajorTopicYN="Y">sarcopenia</Keyword>
        <Keyword MajorTopicYN="Y">skeletal muscle mass</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>05</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>06</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418823</ArticleId>
        <ArticleId IdType="doi">10.1111/jgs.16132</ArticleId>
        <ArticleId IdType="pmc">PMC6898740</ArticleId>
        <ArticleId IdType="mid">NIHMS1045673</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Circ Heart Fail. 2016 Sep;9(9):</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27609832</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Cardiol. 1989 Nov 1;64(16):1066-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2530879</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ. 2018 May 8;361:k1651</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29739772</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sci Rep. 2018 May 25;8(1):8138</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29802321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Cardiol. 2014 Sep 20;176(2):444-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25127973</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur Heart J. 2013 Feb;34(7):512-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23178647</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Future Cardiol. 2013 Nov;9(6):767-70</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24180533</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Nutr. 1997 May;127(5 Suppl):998S-1003S</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9164283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Am Med Dir Assoc. 2014 Feb;15(2):95-101</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24461239</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Cachexia Sarcopenia Muscle. 2014 Dec;5(4):253-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25425503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Cardiol. 2016 Oct 1;220:483-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27390974</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Heart Fail. 2016 Aug;18(8):891-975</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27207191</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coron Artery Dis. 2013 Dec;24(8):705-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24201087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Cardiol. 2013 Jan 10;162(2):77-85</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21982619</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur Heart J. 2017 Nov 14;38(43):3232-3240</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29020281</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Circulation. 2003 Jan 7;107(1):139-46</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12515756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Physiol Rev. 1993 Apr;73(2):413-67</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8475195</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nutr Cancer. 2001;39(2):187-95</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11759279</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Circulation. 1995 Mar 15;91(6):1739-48</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7882482</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Hum Biol. 2003 Jul-Aug;30(4):380-91</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12881138</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Nutr. 1997 May;127(5 Suppl):990S-991S</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9164280</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31418824</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>08</Month>
        <Day>06</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>08</Month>
        <Day>06</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1558-5646</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>73</Volume>
            <Issue>10</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>10</Month>
            </PubDate>
          </JournalIssue>
          <Title>Evolution; international journal of organic evolution</Title>
          <ISOAbbreviation>Evolution</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Evolution of a soft-tissue foraging adaptation in African cichlids: Roles for novelty, convergence, and constraint.</ArticleTitle>
        <Pagination>
          <MedlinePgn>2072-2084</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/evo.13824</ELocationID>
        <Abstract>
          <AbstractText>Understanding the origins of biodiversity demands consideration of both extrinsic (e.g., ecological opportunity) and intrinsic (e.g., developmental constraint) factors. Here, we use a combination of phylogenetic and genetic tools to address the origin of novelty in African cichlids. In particular, we focus on an extreme hypertrophied snout that is structurally integrated with the upper jaw. We show that this bizarre trait has evolved independently in at least two distinct and ecologically successful cichlid clades. We find that snout dimensions are decoupled both phenotypically and genetically, which has enabled it to evolve independently in multiple directions. Further, patterns of variation among species and within a genetic mapping pedigree suggest that relative to snout length, depth is under greater genetic and/or developmental constraint. Models of evolution suggest that snout shape is under selection for feeding behavior, with snout depth being important for algae scraping and snout length for sand sifting. Indeed, the deep snout of some algivores is achieved via an expansion of the intermaxillary ligament, which is important for jaw stability and may increase feeding performance. Overall, our data imply that the evolution of exaggerated snout depth required overcoming a genetic/developmental constraint, which led to expanded ecological opportunity via foraging adaptation.</AbstractText>
          <CopyrightInformation>© 2019 The Author(s). Evolution © 2019 The Society for the Study of Evolution.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Conith</LastName>
            <ForeName>Moira R</ForeName>
            <Initials>MR</Initials>
            <AffiliationInfo>
              <Affiliation>Graduate Program in Organismic and Evolutionary Biology, University of Massachusetts, Amherst, Massachusetts, 01003.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Conith</LastName>
            <ForeName>Andrew J</ForeName>
            <Initials>AJ</Initials>
            <Identifier Source="ORCID">0000-0001-9357-6620</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biology, University of Massachusetts, Amherst, Massachusetts, 01003.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Albertson</LastName>
            <ForeName>R Craig</ForeName>
            <Initials>RC</Initials>
            <Identifier Source="ORCID">0000-0002-4120-1840</Identifier>
            <AffiliationInfo>
              <Affiliation>Graduate Program in Organismic and Evolutionary Biology, University of Massachusetts, Amherst, Massachusetts, 01003.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Biology, University of Massachusetts, Amherst, Massachusetts, 01003.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <DataBankList CompleteYN="Y">
          <DataBank>
            <DataBankName>Dryad</DataBankName>
            <AccessionNumberList>
              <AccessionNumber>10.5061/dryad.2df6h8k</AccessionNumber>
            </AccessionNumberList>
          </DataBank>
        </DataBankList>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>IOS-1054909</GrantID>
            <Agency>National Science Foundation</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <GrantID>DEB-1501385</GrantID>
            <Agency>National Science Foundation</Agency>
            <Country>International</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>02</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Evolution</MedlineTA>
        <NlmUniqueID>0373224</NlmUniqueID>
        <ISSNLinking>0014-3820</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005075" MajorTopicYN="Y">Biological Evolution</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D023681" MajorTopicYN="N">Cichlids</DescriptorName>
          <QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005247" MajorTopicYN="Y">Feeding Behavior</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009666" MajorTopicYN="N">Nose</DescriptorName>
          <QualifierName UI="Q000033" MajorTopicYN="Y">anatomy &amp; histology</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Cichlid</Keyword>
        <Keyword MajorTopicYN="Y">constraint</Keyword>
        <Keyword MajorTopicYN="Y">convergence</Keyword>
        <Keyword MajorTopicYN="Y">ligament</Keyword>
        <Keyword MajorTopicYN="Y">novelty</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>08</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>06</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>05</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>8</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418824</ArticleId>
        <ArticleId IdType="doi">10.1111/evo.13824</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>LITERATURE CITED</Title>
        <Reference>
          <Citation>Albertson, R. C., and T. D. Kocher. 2001. Assessing morphological differences in an adaptive trait: a landmark-based morphometric approach. J. Exp. Zool. 289:385-403.</Citation>
        </Reference>
        <Reference>
          <Citation>Albertson, R. C., J. T. Streelman, T. D. Kocher, and P. C. Yelick. 2005. Integration and evolution of the cichlid mandible: the molecular basis of alternate feeding strategies. Proc. Natl. Acad. Sci. 102:16287-16292.</Citation>
        </Reference>
        <Reference>
          <Citation>Albertson, R. C., K. E. Powder, Y. Hu, K. P. Coyle, R. B. Roberts, and K. J. Parsons. 2014. Genetic basis of continuous variation in the levels and modular inheritance of pigmentation in cichlid fishes. Mol. Ecol. 23:5135-5150.</Citation>
        </Reference>
        <Reference>
          <Citation>Albertson, R., J. Markert, P. Danley, and T. Kocher. 1999. Phylogeny of a rapidly evolving clade: the cichlid fishes of Lake Malawi, East Africa. Proc. Natl. Acad. Sci. 96:5107-5110.</Citation>
        </Reference>
        <Reference>
          <Citation>Beaulieu, J. M., D. Jhwueng, C. Boettiger, and B. C. O'Meara. 2012. Modeling stabilizing selection: expanding the Ornstein-Uhlenbeck model of adaptive evolution. Evolution 66:2369-2383.</Citation>
        </Reference>
        <Reference>
          <Citation>Boettiger, C., G. Coop, and P. Ralph. 2012. Is your phylogeny informative? Measuring the power of comparative methods. Evolution 66:2240-2251.</Citation>
        </Reference>
        <Reference>
          <Citation>Bollback, J. P. 2006. SIMMAP: stochastic character mapping of discrete traits on phylogenies. BMC Bioinformatics 7:1-7.</Citation>
        </Reference>
        <Reference>
          <Citation>Bouckaert, R., J. Heled, D. Kühnert, T. Vaughan, C. H. Wu, D. Xie, M. A. Suchard, A. Rambaut, and A. J. Drummond. 2014. BEAST 2: a software platform for Bayesian evolutionary analysis. PLoS Comput. Biol. 10:1-7.</Citation>
        </Reference>
        <Reference>
          <Citation>Brawand, D., C. E. Wagner, Y. I. Li, M. Malinsky, I. Keller, S. Fan, O. Simakov, A. Y. Ng, Z. W. Lim, E. Bezault, et al. 2014. The genomic substrate for adaptive radiation in African cichlid fish. Nature 513:375-381.</Citation>
        </Reference>
        <Reference>
          <Citation>Burnham, K. P., and D. R. Anderson. 2002. Model selection and miltimodel inference: a practical information-theoretic approach. 2nd ed. Springer-Verlag, New York.</Citation>
        </Reference>
        <Reference>
          <Citation>Butler, M. A., and A. A. King. 2004. Phylogenetic comparative analysis: a modeling approach for adaptive evolution. Am. Nat. 164:683-695.</Citation>
        </Reference>
        <Reference>
          <Citation>Carnevale, G., C. Sorbini, and W. Landini. 2003. Oreochromis lorenzoi, a new species of tilapiine cichlid from the late miocene of central Italy. J. Vertebr. Paleontol. 23:508-516.</Citation>
        </Reference>
        <Reference>
          <Citation>Colombo, M., E. T. Diepeveen, M. Muschick, M. E. Santos, A. Indermaur, N. Boileau, M. Barluenga, and W. Salzburger. 2013. The ecological and genetic basis of convergent thick-lipped phenotypes in cichlid fishes. Mol. Ecol. 22:670-684.</Citation>
        </Reference>
        <Reference>
          <Citation>Colosimo, P. F., K. E. Hosemann, S. Balabhadra, G. Villarreal Jr., M. Dickson, J. Grimwood, J. Schmutz, R. M. Myers, D. Schluter, and D. M. Kingsley. 2005. Widespread parallel evolution in sticklebacks by repeated fixation of Ectodysplasin alleles. Science 307:1928-1933.</Citation>
        </Reference>
        <Reference>
          <Citation>Concannon, M. R., and R. C. Albertson. 2015. The genetic and developmental basis of an exaggerated craniofacial trait in East African cichlids. J. Exp. Zool. Part B Mol. Dev. Evol. 324:662-670.</Citation>
        </Reference>
        <Reference>
          <Citation>Conith, A. J., M. A. Meagher, and E. R. Dumont. 2018a. The influence of climatic variability on morphological integration, evolutionary rates, and disparity in the Carnivora. Am. Nat. 191:704-715.</Citation>
        </Reference>
        <Reference>
          <Citation>Conith, M. R., Y. Hu, A. J. Conith, M. A. Maginnis, J. F. Webb, and R. C. Albertson. 2018b. Genetic and developmental origins of a unique foraging adaptation in a Lake Malawi cichlid genus. Proc. Natl. Acad. Sci. 115:7063-7068.</Citation>
        </Reference>
        <Reference>
          <Citation>Cooper, N., G. H. Thomas, C. Venditti, A. Meade, and R. P. Freckleton. 2016. A cautionary note on the use of Ornstein-Uhlenbeck models in macroevolutionary studies. Biol. J. Linn. Soc. 118:64-77.</Citation>
        </Reference>
        <Reference>
          <Citation>Day, J. J., J. A. Cotton, and T. G. Barraclough. 2008. Tempo and mode of diversification of Lake Tanganyika cichlid fishes. PLoS One 3:e1730.</Citation>
        </Reference>
        <Reference>
          <Citation>Dumont, E. R., L. M. Davalos, A. Goldberg, S. E. Santana, K. Rex, and C. C. Voigt. 2012. Morphological innovation, diversification and invasion of a new adaptive zone. Proc. R. Soc. B Biol. Sci. 279:1797-1805.</Citation>
        </Reference>
        <Reference>
          <Citation>Elmer, K. R., and A. Meyer. 2011. Adaptation in the age of ecological genomics: insights from parallelism and convergence. Trends Ecol. Evol. 26:298-306.</Citation>
        </Reference>
        <Reference>
          <Citation>Fraser, G. J., R. F. Bloomquist, and J. T. Streelman. 2013. Common developmental pathways link tooth shape to regeneration. Dev. Biol. 377:399-414.</Citation>
        </Reference>
        <Reference>
          <Citation>Genner, M. J., and G. F. Turner. 2012. Ancient hybridization and phenotypic novelty within Lake Malawi's cichlid fish radiation. Mol. Biol. Evol. 29:195-206.</Citation>
        </Reference>
        <Reference>
          <Citation>Goolsby, E. W., J. Bruggeman, and C. Ané. 2017. Rphylopars: fast multivariate phylogenetic comparative methods for missing data and within-species variation. Methods Ecol. Evol. 8:22-27.</Citation>
        </Reference>
        <Reference>
          <Citation>Gysels, E., L. Janssens De Bisthoven, L. De Vos, and F. Ollevier. 1997. Food and habitat of four Xenotilapia species (Teleostei, Cichlidae) in a sandy bay of northern Lake Tanganyika (Burundi). J. Fish Biol. 50:254-266.</Citation>
        </Reference>
        <Reference>
          <Citation>Hall, B. K. 1986. The role of movement and tissue interactions in the development and growth of bone and secondary cartilage in the clavicle of the embryonic chick. J. Embryol. Exp. Morphol. 93:133-152.</Citation>
        </Reference>
        <Reference>
          <Citation>Hanssens, M., J. Snoeks, and E. Verheyen. 1999. A morphometric revision of the genus Ophthalmotilapia (Teleostei, Cichlidae) from Lake Tanganyika (East Africa). Zool. J. Linn. Soc. 125:487-512.</Citation>
        </Reference>
        <Reference>
          <Citation>Holzman, R., and C. D. Hulsey. 2017. Mechanical transgressive segregation and the rapid origin of trophic novelty. Sci. Rep. 7:1-15.</Citation>
        </Reference>
        <Reference>
          <Citation>Hulsey, C., M. Mims, and J. Streelman. 2007. Do constructional constraints influence cichlid craniofacial diversification? Proc. R. Soc. B Biol. Sci. 274:1867-1875.</Citation>
        </Reference>
        <Reference>
          <Citation>Hulsey, C. D., P. R. Hollingsworth, and R. Holzman. 2010. Co-evolution of the premaxilla and jaw protrusion in cichlid fishes (Heroine: Cichlidae). Biol. J. Linn. Soc. 100:619-629.</Citation>
        </Reference>
        <Reference>
          <Citation>Jonsson, K. A., P. -H. Fabre, S. A. Fritz, R. S. Etienne, R. E. Ricklefs, T. B. Jorgensen, J. Fjeldsa, C. Rahbek, P. G. P. Ericson, F. Woog, et al. 2012. Ecological and evolutionary determinants for the adaptive radiation of the Madagascan vangas. Proc. Natl. Acad. Sci. 109:6620-6625.</Citation>
        </Reference>
        <Reference>
          <Citation>Joyce, D. A., D. H. Lunt, M. J. Genner, G. F. Turner, R. Bills, and O. Seehausen. 2011. Repeated colonization and hybridization in Lake Malawi cichlids. Curr. Biol. 21:R109-R109.</Citation>
        </Reference>
        <Reference>
          <Citation>Klingenberg, C. P. 2010. Evolution and development of shape: integrating quantitative approaches. Nat. Rev. Genet. 11:623-635.</Citation>
        </Reference>
        <Reference>
          <Citation>Koblmüller, S., U. K. Schliewen, N. Duftner, K. M. Sefc, C. Katongo, and C. Sturmbauer. 2008. Age and spread of the haplochromine cichlid fishes in Africa. Mol. Phylogenet. Evol. 49:153-169.</Citation>
        </Reference>
        <Reference>
          <Citation>Kocher, T. D., J. A. Conroy, K. R. McKaye, and J. R. Stauffer. 1993. Similar morphologies of cichlid fish in lakes Tanganyika and Malawi are due to convergence. Mol. Phylogenet. Evol. 2:158-165.</Citation>
        </Reference>
        <Reference>
          <Citation>Konings, A. 1998. Tanganyika cichlids in their natural habitat. 1st ed. Cichlid Press, El Paso, TX.</Citation>
        </Reference>
        <Reference>
          <Citation>Konings, A. 2007. Malawi cichlids in their natural habitat. 4th ed. Cichlid Press, El Paso, TX.</Citation>
        </Reference>
        <Reference>
          <Citation>Koshikawa, S. 2015. Enhancer modularity and the evolution of new traits. Fly 9:155-159.</Citation>
        </Reference>
        <Reference>
          <Citation>Kuratani, S. 2012. Evolution of the vertebrate jaw from developmental perspectives. Evol. Dev. 14:76-92.</Citation>
        </Reference>
        <Reference>
          <Citation>Liem, K. F. 1973. Evolutionary strategies and morphological innovations: cichlid pharyngeal jaws. Syst. Zool. 22:425-441.</Citation>
        </Reference>
        <Reference>
          <Citation>Lyons, R. P., C. A. Scholz, A. S. Cohen, J. W. King, E. T. Brown, S. J. Ivory, T. C. Johnson, A. L. Deino, P. N. Reinthal, M. M. McGlue, et al. 2015. Continuous 1.3-million-year record of East African hydroclimate, and implications for patterns of evolution and biodiversity. Proc. Natl. Acad. Sci. 112:201512864.</Citation>
        </Reference>
        <Reference>
          <Citation>Maia, R., D. R. Rubenstein, and M. D. Shawkey. 2013. Key ornamental innovations facilitate diversification in an avian radiation. Proc. Natl. Acad. Sci. 110:10687-10692.</Citation>
        </Reference>
        <Reference>
          <Citation>Malinsky, M., H. Svardal, A. M. Tyers, E. A. Miska, M. J. Genner, G. F. Turner, and R. Durbin. 2018. Whole-genome sequences of Malawi cichlids reveal multiple radiations interconnected by gene flow. Nat. Ecol. Evol. 2:1940-1955.</Citation>
        </Reference>
        <Reference>
          <Citation>Manceau, M., V. S. Domingues, C. R. Linnen, E. B. Rosenblum, and H. E. Hoekstra. 2010. Convergence in pigmentation at multiple levels: mutations, genes and function. Philos. Trans. R. Soc. B Biol. Sci. 365:2439-2450.</Citation>
        </Reference>
        <Reference>
          <Citation>Martin, C. H., and P. C. Wainwright. 2011. Trophic novelty is linked to exceptional rates of morphological diversification in two adaptive radiations of cyprinodon pupfish. Evolution 65:2197-2212.</Citation>
        </Reference>
        <Reference>
          <Citation>Martins, E. P., and T. F. Hansen. 1997. Phylogenies and the comparative method: a general approach to incorporating phylogenetic information into the analysis of interspecific data. Am. Nat. 149:646-667.</Citation>
        </Reference>
        <Reference>
          <Citation>Matschiner, M., R. Hanel, and W. Salzburger. 2011. On the origin and trigger of the notothenioid adaptive radiation. PLoS One 6:e18911.</Citation>
        </Reference>
        <Reference>
          <Citation>Matthews, D. G., and R. C. Albertson. 2017. Effect of craniofacial genotype on the relationship between morphology and feeding performance in cichlid fishes. Evolution 71:2050-2061.</Citation>
        </Reference>
        <Reference>
          <Citation>Mcgee, M. D., B. C. Faircloth, S. R. Borstein, J. Zheng, C. D. Hulsey, P. C. Wainwright, and M. E. Alfaro. 2016. Replicated divergence in cichlid radiations mirrors a major vertebrate innovation. Proc. R. Soc. B Biol. Sci. 283:20151413.</Citation>
        </Reference>
        <Reference>
          <Citation>Meier, J. I., D. A. Marques, S. Mwaiko, C. E. Wagner, L. Excoffier, and O. Seehausen. 2017. Ancient hybridization fuels rapid cichlid fish adaptive radiations. Nat. Commun. 8:1-11.</Citation>
        </Reference>
        <Reference>
          <Citation>Mims, M. C., D. C. Hulsey, B. M. Fitzpatrick, and J. T. Streelman. 2010. Geography disentangles introgression from ancestral polymorphism in Lake Malawi cichlids. Mol. Ecol. 19:940-51.</Citation>
        </Reference>
        <Reference>
          <Citation>Muschick, M., A. Indermaur, and W. Salzburger. 2012. Convergent evolution within an adaptive radiation of cichlid fishes. Curr. Biol. 22:2362-2368.</Citation>
        </Reference>
        <Reference>
          <Citation>Paaby, A. B., and M. V. Rockman. 2014. Cryptic genetic variation: evolution's hidden substrate. Nat. Rev. Genet. 15:247-258.</Citation>
        </Reference>
        <Reference>
          <Citation>Paradis, E., J. Claude, and K. Strimmer. 2004. APE: analyses of phylogenetics and evolution in R language. Bioinformatics 20:289-290.</Citation>
        </Reference>
        <Reference>
          <Citation>Parnell, N. F., C. D. Hulsey, and J. T. Streelman. 2012. The genetic basis of a complex functional system. Evolution 66:3352-3366.</Citation>
        </Reference>
        <Reference>
          <Citation>Parsons, K. J., W. J. Cooper, and R. C. Albertson. 2011. Modularity of the oral jaws is linked to repeated changes in the craniofacial shape of African cichlids. Int. J. Evol. Biol. 2011:1-10.</Citation>
        </Reference>
        <Reference>
          <Citation>Pigliucci, M. 2008. Is evolvability evolvable? Nat. Rev. Genet. 9:75-82.</Citation>
        </Reference>
        <Reference>
          <Citation>Revell, L. J. 2010. Phylogenetic signal and linear regression on species data. Methods Ecol. Evol. 1:319-329.</Citation>
        </Reference>
        <Reference>
          <Citation>Revell, L. J. 2012. phytools: an R package for phylogenetic comparative biology (and other things). Methods Ecol. Evol. 3:217-223.</Citation>
        </Reference>
        <Reference>
          <Citation>Roberts, R. B., Y. Hu, R. C. Albertson, and T. D. Kocher. 2011. Craniofacial divergence and ongoing adaptation via the hedgehog pathway. Proc. Natl. Acad. Sci. 108:13194-13199.</Citation>
        </Reference>
        <Reference>
          <Citation>Rohner, N., M. Bercsényi, L. Orbán, M. E. Kolanczyk, D. Linke, M. Brand, C. Nüsslein-Volhard, and M. P. Harris. 2009. Duplication of fgfr1 permits Fgf signaling to serve as a target for selection during domestication. Curr. Biol. 19:1642-1647.</Citation>
        </Reference>
        <Reference>
          <Citation>Ruber, L., and D. C. Adams. 2001. Evolutionary convergence of body shape and trophic morphology in cichlids from Lake Tanganyika. J. Evol. Biol. 14:325-332.</Citation>
        </Reference>
        <Reference>
          <Citation>Salzburger, W., T. Mack, E. Verheyen, and A. Meyer. 2005. Out of Tanganyika: genesis, explosive speciation, key-innovations and phylogeography of the haplochromine cichlid fishes. BMC Evol. Biol. 5:17.</Citation>
        </Reference>
        <Reference>
          <Citation>Santos, M. E., I. Braasch, N. Boileau, B. S. Meyer, L. Sauteur, A. Böhne, H. -G. Belting, M. Affolter, and W. Salzburger. 2014. The evolution of cichlid fish egg-spots is linked with a cis-regulatory change. Nat. Commun. 5:5149.</Citation>
        </Reference>
        <Reference>
          <Citation>Schwarzer, J., B. Misof, D. Tautz, and U. K. Schliewen. 2009. The root of the East African cichlid radiations. BMC Evol. Biol. 9:1-11.</Citation>
        </Reference>
        <Reference>
          <Citation>Schwarzer, J., B. Misof, S. N. Ifuta, and U. K. Schliewen. 2011. Time and origin of cichlid colonization of the lower Congo rapids. PLoS One 6.</Citation>
        </Reference>
        <Reference>
          <Citation>Seehausen, O. 2015. Process and pattern in cichlid radiations: inferences for understanding unusually high rates of evolutionary diversification. New Phytol. 207:304-312.</Citation>
        </Reference>
        <Reference>
          <Citation>Seehausen, O., Y. Terai, I. S. Magalhaes, K. L. Carleton, H. D. J. Mrosso, R. Miyagi, I. Van Der Sluijs, M. V. Schneider, M. E. Maan, H. Tachida, et al. 2008. Speciation through sensory drive in cichlid fish. Nature 455:620-626.</Citation>
        </Reference>
        <Reference>
          <Citation>Shapiro, M. D., M. A. Bell, and D. M. Kingsley. 2006. Parallel genetic origins of pelvic reduction in vertebrates. Proc. Natl. Acad. Sci. 103:13753-13758.</Citation>
        </Reference>
        <Reference>
          <Citation>Stayton, C. T. 2015. The definition, recognition, and interpretation of convergent evolution, and two new measures for quantifying and assessing the significance of convergence. Evolution 69:2140-2153.</Citation>
        </Reference>
        <Reference>
          <Citation>Stewart, T. A., and R. C. Albertson. 2010. Evolution of a unique predatory feeding apparatus: functional anatomy, development and a genetic locus for jaw laterality in Lake Tanganyika scale-eating cichlids. BMC Biol. 8:8.</Citation>
        </Reference>
        <Reference>
          <Citation>Sturmbauer, C., W. Salzburger, N. Duftner, R. Schelly, and S. Koblmüller. 2010. Evolutionary history of the Lake Tanganyika cichlid tribe Lamprologini (Teleostei: Perciformes) derived from mitochondrial and nuclear DNA data. Mol. Phylogenet. Evol. 57:266-284.</Citation>
        </Reference>
        <Reference>
          <Citation>Suzuki, T. K. 2013. Modularity of a leaf moth-wing pattern and a versatile characteristic of the wing-pattern ground plan. BMC Evol. Biol. 13:1-2.</Citation>
        </Reference>
        <Reference>
          <Citation>Takahashi, R., K. Watanabe, M. Nishida, and M. Hori. 2007. Evolution of feeding specialization in Tanganyikan scale-eating cichlids: a molecular phylogenetic approach. BMC Evol. Biol. 7:1-11.</Citation>
        </Reference>
        <Reference>
          <Citation>Uy, J. A. C., E. A. Cooper, S. Cutie, M. R. Concannon, J. W. Poelstra, R. G. Moyle, and C. E. Filardi. 2016. Mutations in different pigmentation genes are associated with parallel melanism in island flycatchers. Proc. R. Soc. B Biol. Sci. 283:20160731.</Citation>
        </Reference>
        <Reference>
          <Citation>Vickrey, A. I., E. T. Domyan, M. P. Horvath, and M. D. Shapiro. 2015. Convergent evolution of head crests in two domesticated columbids is associated with different missense mutations in EphB2. Mol. Biol. Evol. 32:2657-2664.</Citation>
        </Reference>
        <Reference>
          <Citation>Waltzek, T. B., and P. C. Wainwright. 2003. Functional morphology of extreme jaw protrusion in neotropical cichlids. J. Morphol. 257:96-106.</Citation>
        </Reference>
        <Reference>
          <Citation>Westneat, M. W. 2005. Skull biomechanics and suction feeding in fishes. Fish Physiol. 23:29-75.</Citation>
        </Reference>
        <Reference>
          <Citation>Yamaoka, K. 1990. Feeding behavior of Asprotilapia leptura, an epilithic algal feeding cichlid fish in Lake Tanganyika. Japanese J. Ichthyol. 37:80-82.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31418825</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>06</Month>
        <Day>15</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>06</Month>
        <Day>15</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1471-4159</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>151</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>12</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of neurochemistry</Title>
          <ISOAbbreviation>J Neurochem</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Involvement of purinergic 2X<sub>4</sub> receptor in glycoprotein 120-induced pyroptosis in dorsal root ganglia.</ArticleTitle>
        <Pagination>
          <MedlinePgn>584-594</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jnc.14850</ELocationID>
        <Abstract>
          <AbstractText>Pyroptosis is a type of programmed cell death, displaying caspase-1-dependent and pro-inflammatory features. Purinergic 2X<sub>4</sub> (P2X<sub>4</sub> ) receptor activation in response to high-adenosine triphosphate release can induce inflammation. Envelope glycoprotein 120 (gp120) of human immunodeficiency virus type 1 is considered one of the primary pathogens leading to neuronal injury. In this study, we investigated the possible role of P2X<sub>4</sub> receptor activation in gp120-triggered pyroptosis in cultured satellite glial cells (SGCs) of rat dorsal root ganglia (DRG). MTS assay, TdT-mediated dUTP Nick-end labeling assay, real-time RT-PCR, and western blotting et al. methods were used. The results indicated that the expression of P2X<sub>4</sub> receptor in SGCs of DRG was up-regulated upon cultured with gp120 for 24 h. The highest decrease in viability of SGCs due to gp120 treatment was accompanied by marked increases of positive pyroptosis cells and cellular lactate dehydrogenase release, elevated levels of interleukin-1β, interleukin-18, active caspase-1 and NOD-like receptor family, pyrin domain containing 1, and enhanced phosphorylation of p38MAPK. These abnormal changes because of gp120 were significantly inhibited and cell viability was markedly improved when SGCs of DRG were treated with short hairpin RNAs targeting P2X<sub>4</sub> receptor. Our data suggest that silencing of P2X<sub>4</sub> receptor may act effectively against gp120-induced pyroptosis mediated by the activation of NOD-like receptor family, pyrin domain containing 1 inflammasome and caspase-1 signaling in SGCs of DRG.</AbstractText>
          <CopyrightInformation>© 2019 International Society for Neurochemistry.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Shanhong</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Neuropharmacology Laboratory of Physiology Department, Basic Medical College of Nanchang University, Nanchang, Jiangxi, P.R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Jiangxi Provincial Key Laboratory of autonomic nervous function and disease, Nanchang, Jiangxi, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Yanhong</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Undergraduate student of Medical College of Nanchang University, Nanchang, Jiangxi, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fan</LastName>
            <ForeName>Yang</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Undergraduate student of Medical College of Nanchang University, Nanchang, Jiangxi, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gong</LastName>
            <ForeName>Yingxin</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Undergraduate student of Medical College of Nanchang University, Nanchang, Jiangxi, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Jingjian</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Undergraduate student of Medical College of Nanchang University, Nanchang, Jiangxi, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Runan</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Neuropharmacology Laboratory of Physiology Department, Basic Medical College of Nanchang University, Nanchang, Jiangxi, P.R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Jiangxi Provincial Key Laboratory of autonomic nervous function and disease, Nanchang, Jiangxi, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Lin</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Neuropharmacology Laboratory of Physiology Department, Basic Medical College of Nanchang University, Nanchang, Jiangxi, P.R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Jiangxi Provincial Key Laboratory of autonomic nervous function and disease, Nanchang, Jiangxi, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zou</LastName>
            <ForeName>Lifang</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Neuropharmacology Laboratory of Physiology Department, Basic Medical College of Nanchang University, Nanchang, Jiangxi, P.R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Jiangxi Provincial Key Laboratory of autonomic nervous function and disease, Nanchang, Jiangxi, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Xiumei</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Neuropharmacology Laboratory of Physiology Department, Basic Medical College of Nanchang University, Nanchang, Jiangxi, P.R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Jiangxi Provincial Key Laboratory of autonomic nervous function and disease, Nanchang, Jiangxi, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Guilin</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Neuropharmacology Laboratory of Physiology Department, Basic Medical College of Nanchang University, Nanchang, Jiangxi, P.R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Jiangxi Provincial Key Laboratory of autonomic nervous function and disease, Nanchang, Jiangxi, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Shuangmei</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Neuropharmacology Laboratory of Physiology Department, Basic Medical College of Nanchang University, Nanchang, Jiangxi, P.R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Jiangxi Provincial Key Laboratory of autonomic nervous function and disease, Nanchang, Jiangxi, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Chunping</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Neuropharmacology Laboratory of Physiology Department, Basic Medical College of Nanchang University, Nanchang, Jiangxi, P.R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Cell Biology, Medical School of Nanchang University, Nanchang, Jiangxi, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Guodong</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Neuropharmacology Laboratory of Physiology Department, Basic Medical College of Nanchang University, Nanchang, Jiangxi, P.R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Jiangxi Provincial Key Laboratory of autonomic nervous function and disease, Nanchang, Jiangxi, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liang</LastName>
            <ForeName>Shangdong</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0003-0903-3004</Identifier>
            <AffiliationInfo>
              <Affiliation>Neuropharmacology Laboratory of Physiology Department, Basic Medical College of Nanchang University, Nanchang, Jiangxi, P.R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Jiangxi Provincial Key Laboratory of autonomic nervous function and disease, Nanchang, Jiangxi, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Neurochem</MedlineTA>
        <NlmUniqueID>2985190R</NlmUniqueID>
        <ISSNLinking>0022-3042</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D015699">HIV Envelope Protein gp120</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D058848">Receptors, Purinergic P2X4</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C514793">gp120 protein, Human immunodeficiency virus 1</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005727" MajorTopicYN="N">Ganglia, Spinal</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015699" MajorTopicYN="N">HIV Envelope Protein gp120</DescriptorName>
          <QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009457" MajorTopicYN="N">Neuroglia</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000069292" MajorTopicYN="N">Pyroptosis</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058848" MajorTopicYN="N">Receptors, Purinergic P2X4</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">P2X4 receptor</Keyword>
        <Keyword MajorTopicYN="Y">dorsal root ganglia</Keyword>
        <Keyword MajorTopicYN="Y">gp120</Keyword>
        <Keyword MajorTopicYN="Y">pyroptosis</Keyword>
        <Keyword MajorTopicYN="Y">satellite glial cells</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>09</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>08</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418825</ArticleId>
        <ArticleId IdType="doi">10.1111/jnc.14850</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Antinori A., Arendt G., Becker J. T., et al. (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69, 1789-1799.</Citation>
        </Reference>
        <Reference>
          <Citation>Bergsbaken T., Fink S. L. and Cookson B. T. (2009) Pyroptosis: host cell death and inflammation. Nat. Rev. Microbiol. 7, 99-109.</Citation>
        </Reference>
        <Reference>
          <Citation>Burnstock G. (2007) Physiology and pathophysiology of purinergic neurotransmission. Physiol. Rev. 87, 659-797.</Citation>
        </Reference>
        <Reference>
          <Citation>Burnstock G. (2017) Purinergic signalling: therapeutic developments. Front. Pharmacol. 8, 661.</Citation>
        </Reference>
        <Reference>
          <Citation>Burnstock G. and Knight G. E. (2004) Cellular distribution and functions of P2 receptor subtypes in different systems. Int. Rev. Cytol. 240, 31-304.</Citation>
        </Reference>
        <Reference>
          <Citation>Chen Q., Hu J., Qin S., et al. (2016) Protective effects of naringin against gp120-induced injury mediated by P2X7 receptors in BV2 microglial cells. Genet. Mol. Res. 15, gmr.15028649.</Citation>
        </Reference>
        <Reference>
          <Citation>Costa F. A. L. and Neto F. L. M. (2015) Satellite glial cells in sensory ganglia: its role in pain. Braz. J. Anesthesiol. 65, 73-81.</Citation>
        </Reference>
        <Reference>
          <Citation>Fan C., Zhao X., Guo X., Cao X. and Cai J. (2014) P2X4 promotes interleukin1beta production in osteoarthritis via NLRP1. Mol. Med. Rep. 9, 340-344.</Citation>
        </Reference>
        <Reference>
          <Citation>Fink S. L. and Cookson B. T. (2005) Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect. Immun. 73, 1907-1916.</Citation>
        </Reference>
        <Reference>
          <Citation>Hanani M. (2005) Satellite glial cells in sensory ganglia: from form to function. Brain Res. Rev. 48, 457-476.</Citation>
        </Reference>
        <Reference>
          <Citation>Hung S. C., Choi C. H., Said-Sadier N., Johnson L., Atanasova K. R., Sellami H., Yilmaz O. and Ojcius D. M. (2013) P2X4 assembles with P2X7 and pannexin-1 in gingival epithelial cells and modulates ATP-induced reactive oxygen species production and inflammasome activation. PLoS ONE 7, e70210.</Citation>
        </Reference>
        <Reference>
          <Citation>Jorgensen I. and Miao E. A. (2015) Pyroptotic cell death defends against intracellular pathogens. Immunol. Rev. 265, 130-142.</Citation>
        </Reference>
        <Reference>
          <Citation>Kobayashi K., Yamanaka H. and Noguchi K. (2013) Expression of ATP receptors in the rat dorsal root ganglion and spinal cord. Anat. Sci. Int. 88, 10-16.</Citation>
        </Reference>
        <Reference>
          <Citation>Kushnir R., Cherkas P. S. and Hanani M. (2011) Peripheral inflammation upregulates P2X receptor expression in satellite glial cells of mouse trigeminal ganglia: a calcium imaging study. Neuropharmacology 61, 739-746.</Citation>
        </Reference>
        <Reference>
          <Citation>Magni G. and Ceruti S. (2014) The purinergic system and glial cells: emerging costars in nociception. Biomed Res. Int. 2014, 1-13.</Citation>
        </Reference>
        <Reference>
          <Citation>Major E. O., Rausch D., Marra C. and Clifford D. (2000) HIV-associated dementia. Science 288, 440-442.</Citation>
        </Reference>
        <Reference>
          <Citation>Masters S. L., Gerlic M., Metcalf D., et al. (2012) NLRP1 inflammasome activation induces pyroptosis of hematopoietic progenitor cells. Immunity 37, 1009-1023.</Citation>
        </Reference>
        <Reference>
          <Citation>Miao E. A., Rajan J. V. and Aderem A. (2011) Caspase-1-induced pyroptotic cell death. Immunol. Rev. 243, 206-214.</Citation>
        </Reference>
        <Reference>
          <Citation>Ng K. Y., Wong Y. H. and Wise H. (2011) Glial cells isolated from dorsal root ganglia express prostaglandin E(2) (EP(4)) and prostacyclin (IP) receptors. Eur. J. Pharmacol. 661, 42-48.</Citation>
        </Reference>
        <Reference>
          <Citation>Portegies P., Cinque P., Chaudhuri A., Begovac J., Everall I., Weber T., Bojar M., Martinez-Martin P. and Kennedy P. G. E. (2011) Neurological complications of HIV infection. Aids 1, 373-381.</Citation>
        </Reference>
        <Reference>
          <Citation>Poulsen J. N., Larsen F., Duroux M. and Gazerani P. (2014) Primary culture of trigeminal satellite glial cells: a cell-based platform to study morphology and function of peripheral glia. Int. J. Physiol. Pathophysiol. Pharmacol. 6, 1-12.</Citation>
        </Reference>
        <Reference>
          <Citation>Rao V. R., Ruiz A. P. and Prasad V. R. (2014) Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND). AIDS Res. Ther. 11, 13.</Citation>
        </Reference>
        <Reference>
          <Citation>de Rivero Vaccari J. P., Bastien D., Yurcisin G., Pineau I., Dietrich W. D., Koninck Y. D., Keane R. W. and Lacroix S. (2012) P2X4 receptors influence inflammasome activation after spinal cord injury. J. Neurosci. 32, 3058-3066.</Citation>
        </Reference>
        <Reference>
          <Citation>Sakaki H., Fujiwaki T., Tsukimoto M., Kawano A., Harada H. and Kojima S. (2013) P2X4 receptor regulates P2X7 receptor-dependent IL-1beta and IL-18 release in mouse bone marrow-derived dendritic cells. Biochem. Biophys. Res. Commun. 432, 406-411.</Citation>
        </Reference>
        <Reference>
          <Citation>Salzer I., Gantumur E. and Stefan Boehm A. Y. (2016) Control of sensory neuron excitability by serotonin involves 5HT2C receptors and Ca2t-activated chloride channels. Neuropharmacology 110, 277-286.</Citation>
        </Reference>
        <Reference>
          <Citation>Samali A., Zhivotovsky B., Jones D., Nagata S. and Orrenius S. (1999) Apoptosis: cell death defined by caspase activation. Cell Death Differ. 6, 495-496.</Citation>
        </Reference>
        <Reference>
          <Citation>Stokes L., Layhadi J. A., Bibic L., Dhuna K. and Fountain S. J. (2017) P2X4 Receptor function in the nervous system and current breakthroughs in pharmacology. Front. Pharmacol. 8, 291.</Citation>
        </Reference>
        <Reference>
          <Citation>Surprenant A. and North R. A. (2009) Signaling at purinergic P2X receptors. Annu. Rev. Physiol. 71, 333-359.</Citation>
        </Reference>
        <Reference>
          <Citation>Suurväli J., Boudinot P., Kanellopoulos J. and Rüütel Boudinot S. (2017) P2X4: a fast and sensitive purinergic receptor. Biomed. J. 40, 245-256.</Citation>
        </Reference>
        <Reference>
          <Citation>Tan M., Tan L., Jiang T., Zhu X., Wang H., Jia C. and Yu J. (2014) Amyloid-beta induces NLRP1-dependent neuronal pyroptosis in models of Alzheimer's disease. Cell Death Dis. 5, e1382.</Citation>
        </Reference>
        <Reference>
          <Citation>Tsuda M., Shigemoto-Mogami Y., Koizumi S., Mizokoshi A., Kohsaka S., Salter M. W. and Inoue K. (2003) P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424, 778-783.</Citation>
        </Reference>
        <Reference>
          <Citation>Tsuda M., Masuda T., Tozaki-Saitoh H. and Inoue K. (2013) P2X4 receptors and neuropathic pain. Front. Cell. Neurosci. 7, 191.</Citation>
        </Reference>
        <Reference>
          <Citation>Ulmann L., Hatcher J. P., Hughes J. P., Chaumont S., Green P. J., Conquet F., Buell G. N., Reeve A. J., Chessell I. P. and Rassendren F. (2008) Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J. Neurosci. 28, 11263-11268.</Citation>
        </Reference>
        <Reference>
          <Citation>Ulmann L., Hirbec H. and Rassendren F. (2010) P2X4 receptors mediate PGE2 release by tissue-resident macrophages and initiate inflammatory pain. EMBO J. 29, 2290-2300.</Citation>
        </Reference>
        <Reference>
          <Citation>Walle L. V. and Lamkanfi M. (2016) Pyroptosis. Curr. Bio. 26, R568-R572.</Citation>
        </Reference>
        <Reference>
          <Citation>Xia C., Cai Y., Li S., Yang J. and Xiao G. (2015) Curcumin increases HSP70 expression in primary rat cortical neuronal apoptosis induced by gp120 V3 loop peptide. Neurochem. Res. 40, 1996-2005.</Citation>
        </Reference>
        <Reference>
          <Citation>Yi Z., Rao S., Ouyang S., et al. (2017) A317491 relieved HIV gp120-associated neuropathic pain involved in P2X3 receptor in dorsal root ganglia. Brain Res. Bull. 130, 81-89.</Citation>
        </Reference>
        <Reference>
          <Citation>Yi Z., Xie L., Zhou C., et al. (2018) P2Y12 receptor upregulation in satellite glial cells is involved in neuropathic pain induced by HIV glycoprotein 120 and 2',3'-dideoxycytidine. Purinergic Signal. 14, 47-58.</Citation>
        </Reference>
        <Reference>
          <Citation>Yuan H., Ouyang S., Yang R., et al. (2018) Osthole alleviated diabetic neuropathic pain mediated by the P2X4 receptor in dorsal root ganglia. Brain Res. Bull. 142, 289-296.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhu Q., Song X., Zhou J., Wang Y., Xia J., Qian W., Zhu J., Gao R., Wang J. and Xiao H. (2015) Target of HIV-1 envelope glycoprotein gp120-induced hippocampal neuron damage: role of voltage-gated K(+) channel Kv2.1. Viral Immunol. 28, 495-503.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31418826</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>06</Month>
        <Day>03</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>12</Month>
        <Day>01</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1097-0142</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>125</Volume>
            <Issue>23</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>12</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cancer</Title>
          <ISOAbbreviation>Cancer</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Effects of cancer history on functional age and mortality.</ArticleTitle>
        <Pagination>
          <MedlinePgn>4303-4309</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/cncr.32449</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">Cancer, its treatment, and associated adverse effects may accelerate the functional aging of cancer survivors. In the current study, the authors used geriatric assessment (GA) to compare the functional age of long-term cancer survivors with that of similarly aged women without a cancer history, and to examine whether functional age influences all-cause mortality differently between these 2 groups.</AbstractText>
          <AbstractText Label="METHODS">Participants included 1723 cancer survivors and 11,145 age-matched, cancer-free women enrolled in the Iowa Women's Health Study in 1986 who completed the 2004 questionnaire (at ages 73-88 years). GA domain deficits included ≥2 physical function limitations, ≥2 comorbidities, poor general health, poor mental health, and underweight. The risk of all-cause mortality was estimated for deficits in each GA domain between 4 groups based on the cross-classification of the presence and/or absence of cancer history and GA domain deficit (the referent group was cancer-free women without a GA deficit).</AbstractText>
          <AbstractText Label="RESULTS">Both cancer history and GA domain deficits significantly predicted 10-year mortality for all GA domains. Cancer survivors without deficits had a 1.3-fold to 1.4-fold risk of mortality, similar to the 1.1-fold to 1.7-fold risk noted among cancer-free women with deficits (all P &lt; .05). Cancer survivors with deficits were found to have the highest mortality risk for 4 of 5 domains (hazard ratio range, 1.6-2.0). Mortality risk increased with the increasing number of GA deficits, which was greater in cancer survivors compared with cancer-free women.</AbstractText>
          <AbstractText Label="CONCLUSIONS">Even without GA deficits, cancer survivors appear to have an excess risk of death compared with women without cancer, and these deficits add to mortality risk. Interventions are needed to maintain or improve functional/physiological capacity as women age, especially in cancer survivors.</AbstractText>
          <CopyrightInformation>© 2019 American Cancer Society.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Blair</LastName>
            <ForeName>Cindy K</ForeName>
            <Initials>CK</Initials>
            <Identifier Source="ORCID">0000-0001-6698-678X</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, University of New Mexico, Albuquerque, New Mexico.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Cancer Control and Population Sciences, University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jacobs</LastName>
            <ForeName>David R</ForeName>
            <Initials>DR</Initials>
            <Suffix>Jr</Suffix>
            <AffiliationInfo>
              <Affiliation>Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Demark-Wahnefried</LastName>
            <ForeName>Wendy</ForeName>
            <Initials>W</Initials>
            <Identifier Source="ORCID">0000-0001-5241-932X</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, Alabama.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Cancer Prevention and Control, O'Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, Birmingham, Alabama.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cohen</LastName>
            <ForeName>Harvey J</ForeName>
            <Initials>HJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Duke University Medical Center, Durham, North Carolina.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Claude D. Pepper Older Americans Independence Center/Center for the Study of Aging and Human Development, Duke University School of Medicine, Durham, North Carolina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Morey</LastName>
            <ForeName>Miriam C</ForeName>
            <Initials>MC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Duke University Medical Center, Durham, North Carolina.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Claude D. Pepper Older Americans Independence Center/Center for the Study of Aging and Human Development, Duke University School of Medicine, Durham, North Carolina.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Geriatric Research, Education, and Clinical Care, VA Medical Center, Durham, North Carolina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Robien</LastName>
            <ForeName>Kim</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Exercise and Nutrition Sciences, Milken Institute School of Public Health, The George Washington University, Washington, DC.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lazovich</LastName>
            <ForeName>DeAnn</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>K07 CA215937</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>P30 AG028716</GrantID>
            <Acronym>AG</Acronym>
            <Agency>NIA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>P30 CA118100</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 CA039742</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Cancer</MedlineTA>
        <NlmUniqueID>0374236</NlmUniqueID>
        <ISSNLinking>0008-543X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>AIM</CitationSubset>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000073116" MajorTopicYN="N">Cancer Survivors</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
          <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">cancer history</Keyword>
        <Keyword MajorTopicYN="Y">cancer survivorship</Keyword>
        <Keyword MajorTopicYN="Y">functional age</Keyword>
        <Keyword MajorTopicYN="Y">geriatric assessment</Keyword>
        <Keyword MajorTopicYN="Y">mortality</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>04</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418826</ArticleId>
        <ArticleId IdType="doi">10.1002/cncr.32449</ArticleId>
        <ArticleId IdType="pmc">PMC6856392</ArticleId>
        <ArticleId IdType="mid">NIHMS1043461</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Lancet Oncol. 2018 Jun;19(6):e305-e316</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29893262</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Geriatr Oncol. 2012 Apr 1;3(2):82-89</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22707996</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Oncol. 2017 Jan 10;35(2):149-156</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27893337</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Semin Oncol. 2004 Apr;31(2):149-59</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15112146</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Oncol. 2013 Dec 20;31(36):4496-503</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24248696</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am Soc Clin Oncol Educ Book. 2014;:e423-30</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24857133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Oncol Pract. 2016 Dec;12(12):e1025-e1034</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27624950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Oncol. 2002 Feb 1;20(3):770-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11821460</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cancer. 2009 Sep 15;115(18 Suppl):4283-97</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19731348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):2108-17</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23112268</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Natl Cancer Inst. 2012 Apr 18;104(8):581-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22457474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Acta Oncol. 2013 Feb;52(2):233-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23320771</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Oncol. 2010 Jan 20;28(3):380-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20008637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Oncol. 2013 Oct 1;31(28):3540-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23980087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Oncol. 2011 Apr 1;29(10):1290-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21357782</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Gerontol A Biol Sci Med Sci. 2003 Jan;58(1):82-91</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12560417</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Epidemiol. 1990 May;131(5):794-803</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2138863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Cancer. 2012 Apr;48(6):805-12</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21741826</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cancer. 2012 Jul 1;118(13):3377-86</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22072065</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Med Care. 1992 Jun;30(6):473-83</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1593914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Oncol. 2018 Aug 1;36(22):2326-2347</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29782209</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Gerontol A Biol Sci Med Sci. 2003 Dec;58(12):M1119-24</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14684709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Oncol. 2011 Sep 20;29(27):3636-42</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21709194</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Health Soc Care Community. 2010 Jul;18(4):396-406</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20491969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1029-36</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27371756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Oncol. 2011 Jul;22(7):1520-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21252061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cancer. 2003 Feb 1;97(3):674-81</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12548610</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crit Rev Oncol Hematol. 2010 Dec;76(3):208-17</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20005123</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am Soc Clin Oncol Educ Book. 2016;35:e516-22</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27249761</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Oncol. 2011 Sep 1;29(25):3457-65</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21810685</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Cancer Surviv. 2016 Feb;10(1):103-12</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26008207</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Natl Cancer Inst. 2004 Sep 1;96(17):1322-30</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15339970</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oncologist. 2014 Dec;19(12):1268-75</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25355846</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cancer. 2016 Aug 15;122(16):2459-568</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27172129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Natl Compr Canc Netw. 2012 Feb;10(2):286-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22308521</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31418827</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>06</Month>
        <Day>08</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>10</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-2141</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>187</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>10</Month>
            </PubDate>
          </JournalIssue>
          <Title>British journal of haematology</Title>
          <ISOAbbreviation>Br J Haematol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Therapeutic use of regulatory T cells for graft-versus-host disease.</ArticleTitle>
        <Pagination>
          <MedlinePgn>25-38</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/bjh.16157</ELocationID>
        <Abstract>
          <AbstractText>Regulatory T cells (Treg cells) represent a CD4<sup>+</sup> T-cell lineage that plays a critical role in restraining immune responses to self and foreign antigens and associated inflammation. Due to the suppressive function of Treg cells, inhibition or ablation of these cells can be used to boost the immunity against malignant cells. On the other hand, augmenting the activity of Treg cells can be employed for the treatment of inflammatory or autoimmune diseases and allogeneic conflicts associated with transplantation. Graft-versus-host disease (GvHD) is a leading cause of morbidity and mortality after haematopoietic stem cell transplantation (HSCT). In this review, we describe basic biological properties of Treg cells and their role in GvHD. We focus on the application of adoptive transfer of Treg cells and the therapeutic modulation of their activity for the prevention and treatment of GvHD in pre-clinical models and in clinical settings. We also discuss the main obstacles to applying Treg cell-based therapies for GvHD in clinical practice.</AbstractText>
          <CopyrightInformation>© 2019 British Society for Haematology and John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Elias</LastName>
            <ForeName>Shlomo</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0002-5055-5317</Identifier>
            <AffiliationInfo>
              <Affiliation>Howard Hughes Medical Institute and Immunology Program and Ludwig Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rudensky</LastName>
            <ForeName>Alexander Y</ForeName>
            <Initials>AY</Initials>
            <Identifier Source="ORCID">0000-0003-1280-2898</Identifier>
            <AffiliationInfo>
              <Affiliation>Howard Hughes Medical Institute and Immunology Program and Ludwig Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Br J Haematol</MedlineTA>
        <NlmUniqueID>0372544</NlmUniqueID>
        <ISSNLinking>0007-1048</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001327" MajorTopicYN="N">Autoimmune Diseases</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006086" MajorTopicYN="N">Graft vs Host Disease</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016219" MajorTopicYN="N">Immunotherapy, Adoptive</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008213" MajorTopicYN="N">Lymphocyte Activation</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017710" MajorTopicYN="N">Lymphocyte Transfusion</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D050378" MajorTopicYN="N">T-Lymphocytes, Regulatory</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000637" MajorTopicYN="Y">transplantation</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">IL-2</Keyword>
        <Keyword MajorTopicYN="Y">graft-versus-host disease</Keyword>
        <Keyword MajorTopicYN="Y">immunotherapy</Keyword>
        <Keyword MajorTopicYN="Y">rapamycin</Keyword>
        <Keyword MajorTopicYN="Y">treg cells</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418827</ArticleId>
        <ArticleId IdType="doi">10.1111/bjh.16157</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Agle, K., Vincent, B.G., Piper, C., Belle, L., Zhou, V., Shlomchik, W., Serody, J.S. &amp; Drobyski, W.R. (2018) Bim regulates the survival and suppressive capability of CD8(+) FOXP3(+) regulatory T cells during murine GVHD. Blood, 132, 435-447.</Citation>
        </Reference>
        <Reference>
          <Citation>Anderson, B.E., McNiff, J.M., Matte, C., Athanasiadis, I., Shlomchik, W.D. &amp; Shlomchik, M.J. (2004) Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease. Blood, 104, 1565-1573.</Citation>
        </Reference>
        <Reference>
          <Citation>Appelbaum, F.R. (2007) Hematopoietic-cell transplantation at 50. New England Journal of Medicine, 357, 1472-1475.</Citation>
        </Reference>
        <Reference>
          <Citation>Arimoto, K., Kadowaki, N., Ishikawa, T., Ichinohe, T. &amp; Uchiyama, T. (2007) FOXP3 expression in peripheral blood rapidly recovers and lacks correlation with the occurrence of graft-versus-host disease after allogeneic stem cell transplantation. International Journal of Hematology, 85, 154-162.</Citation>
        </Reference>
        <Reference>
          <Citation>Battaglia, M., Stabilini, A. &amp; Roncarolo, M.G. (2005) Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood, 105, 4743-4748.</Citation>
        </Reference>
        <Reference>
          <Citation>Bennett, C.L., Christie, J., Ramsdell, F., Brunkow, M.E., Ferguson, P.J., Whitesell, L., Kelly, T.E., Saulsbury, F.T., Chance, P.F. &amp; Ochs, H.D. (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nature Genetics, 27, 20-21.</Citation>
        </Reference>
        <Reference>
          <Citation>Beres, A., Komorowski, R., Mihara, M. &amp; Drobyski, W.R. (2011) Instability of Foxp3 expression limits the ability of induced regulatory T cells to mitigate graft versus host disease. Clinical Cancer Research, 17, 3969-3983.</Citation>
        </Reference>
        <Reference>
          <Citation>Betts, B.C., Pidala, J., Kim, J., Mishra, A., Nishihori, T., Perez, L., Ochoa-Bayona, J.L., Khimani, F., Walton, K., Bookout, R., Nieder, M., Khaira, D.K., Davila, M., Alsina, M., Field, T., Ayala, E., Locke, F.L., Riches, M., Kharfan-Dabaja, M., Fernandez, H. &amp; Anasetti, C. (2017) IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation. Haematologica, 102, 948-957.</Citation>
        </Reference>
        <Reference>
          <Citation>Blache, C., Chauvin, J.M., Marie-Cardine, A., Contentin, N., Pommier, P., Dedreux, I., Francois, S., Jacquot, S., Bastit, D. &amp; Boyer, O. (2010) Reduced frequency of regulatory T cells in peripheral blood stem cell compared to bone marrow transplantations. Biology of Blood and Marrow Transplantation, 16, 430-434.</Citation>
        </Reference>
        <Reference>
          <Citation>Bluestone, J.A. &amp; Tang, Q. (2018) Treg cells-the next frontier of cell therapy. Science, 362, 154-155.</Citation>
        </Reference>
        <Reference>
          <Citation>Bluestone, J.A., Buckner, J.H., Fitch, M., Gitelman, S.E., Gupta, S., Hellerstein, M.K., Herold, K.C., Lares, A., Lee, M.R., Li, K., Liu, W., Long, S.A., Masiello, L.M., Nguyen, V., Putnam, A.L., Rieck, M., Sayre, P.H. &amp; Tang, Q. (2015) Type 1 diabetes immunotherapy using polyclonal regulatory T cells. Science Translational Medicine, 7, 315ra189.</Citation>
        </Reference>
        <Reference>
          <Citation>Brunkow, M.E., Jeffery, E.W., Hjerrild, K.A., Paeper, B., Clark, L.B., Yasayko, S.A., Wilkinson, J.E., Galas, D., Ziegler, S.F. &amp; Ramsdell, F. (2001) Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nature Genetics, 27, 68-73.</Citation>
        </Reference>
        <Reference>
          <Citation>Brunstein, C.G., Miller, J.S., Cao, Q., McKenna, D.H., Hippen, K.L., Curtsinger, J., Defor, T., Levine, B.L., June, C.H., Rubinstein, P., McGlave, P.B., Blazar, B.R. &amp; Wagner, J.E. (2011) Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood, 117, 1061-1070.</Citation>
        </Reference>
        <Reference>
          <Citation>Brunstein, C.G., Blazar, B.R., Miller, J.S., Cao, Q., Hippen, K.L., McKenna, D.H., Curtsinger, J., McGlave, P.B. &amp; Wagner, J.E. (2013) Adoptive transfer of umbilical cord blood-derived regulatory T cells and early viral reactivation. Biology of Blood and Marrow Transplantation, 19, 1271-1273.</Citation>
        </Reference>
        <Reference>
          <Citation>Brunstein, C.G., Miller, J.S., McKenna, D.H., Hippen, K.L., DeFor, T.E., Sumstad, D., Curtsinger, J., Verneris, M.R., MacMillan, M.L., Levine, B.L., Riley, J.L., June, C.H., Le, C., Weisdorf, D.J., McGlave, P.B., Blazar, B.R. &amp; Wagner, J.E. (2016) Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect. Blood, 127, 1044-1051.</Citation>
        </Reference>
        <Reference>
          <Citation>Chen, X., Das, R., Komorowski, R., Beres, A., Hessner, M.J., Mihara, M. &amp; Drobyski, W.R. (2009) Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease. Blood, 114, 891-900.</Citation>
        </Reference>
        <Reference>
          <Citation>Chen, Y.B., Efebera, Y.A., Johnston, L., Ball, E.D., Avigan, D., Lekakis, L.J., Bachier, C.R., Martin, P., Duramad, O., Ishii, Y., Han, S., Jung, Y.J., Lee, D., Kunkel, L., Negrin, R.S. &amp; Bui, J.D. (2017) Increased Foxp3(+)Helios(+) regulatory T cells and decreased acute graft-versus-host disease after allogeneic bone marrow transplantation in patients receiving sirolimus and RGI-2001, an activator of invariant natural killer T cells. Biology of Blood and Marrow Transplantation, 23, 625-634.</Citation>
        </Reference>
        <Reference>
          <Citation>Choi, J., Ritchey, J., Prior, J.L., Holt, M., Shannon, W.D., Deych, E., Piwnica-Worms, D.R. &amp; DiPersio, J.F. (2010) In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia. Blood, 116, 129-139.</Citation>
        </Reference>
        <Reference>
          <Citation>Chopra, M., Biehl, M., Steinfatt, T., Brandl, A., Kums, J., Amich, J., Vaeth, M., Kuen, J., Holtappels, R., Podlech, J., Mottok, A., Kraus, S., Jordan-Garrote, A.L., Bauerlein, C.A., Brede, C., Ribechini, E., Fick, A., Seher, A., Polz, J., Ottmuller, K.J., Baker, J., Nishikii, H., Ritz, M., Mattenheimer, K., Schwinn, S., Winter, T., Schafer, V., Krappmann, S., Einsele, H., Muller, T.D., Reddehase, M.J., Lutz, M.B., Mannel, D.N., Berberich-Siebelt, F., Wajant, H. &amp; Beilhack, A. (2016) Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion. Journal of Experimental Medicine, 213, 1881-1900.</Citation>
        </Reference>
        <Reference>
          <Citation>Clark, F.J., Gregg, R., Piper, K., Dunnion, D., Freeman, L., Griffiths, M., Begum, G., Mahendra, P., Craddock, C., Moss, P. &amp; Chakraverty, R. (2004) Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25 high regulatory T cells. Blood, 103, 2410-2416.</Citation>
        </Reference>
        <Reference>
          <Citation>Cohen, J.L., Trenado, A., Vasey, D., Klatzmann, D. &amp; Salomon, B.L. (2002) CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease. Journal of Experimental Medicine, 196, 401-406.</Citation>
        </Reference>
        <Reference>
          <Citation>Duramad, O., Laysang, A., Li, J., Ishii, Y. &amp; Namikawa, R. (2011) Pharmacologic expansion of donor-derived, naturally occurring CD4(+)Foxp3(+) regulatory T cells reduces acute graft-versus-host disease lethality without abrogating the graft-versus-leukemia effect in murine models. Biology of Blood and Marrow Transplantation, 17, 1154-1168.</Citation>
        </Reference>
        <Reference>
          <Citation>Edinger, M., Hoffmann, P., Ermann, J., Drago, K., Fathman, C.G., Strober, S. &amp; Negrin, R.S. (2003) CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nature Medicine, 9, 1144-1150.</Citation>
        </Reference>
        <Reference>
          <Citation>Ehx, G., Fransolet, G., de Leval, L., D'Hondt, S., Lucas, S., Hannon, M., Delens, L., Dubois, S., Drion, P., Beguin, Y., Humblet-Baron, S. &amp; Baron, F. (2017) Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effects. Oncoimmunology, 6, e1314425.</Citation>
        </Reference>
        <Reference>
          <Citation>Ermann, J., Hoffmann, P., Edinger, M., Dutt, S., Blankenberg, F.G., Higgins, J.P., Negrin, R.S., Fathman, C.G. &amp; Strober, S. (2005) Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD. Blood, 105, 2220-2226.</Citation>
        </Reference>
        <Reference>
          <Citation>Florek, M., Schneidawind, D., Pierini, A., Baker, J., Armstrong, R., Pan, Y., Leveson-Gower, D., Negrin, R. &amp; Meyer, E. (2015) Freeze and thaw of CD4+CD25+Foxp3+ regulatory T cells results in loss of CD62L expression and a reduced capacity to protect against graft-versus-host disease. PLoS One, 10, e0145763.</Citation>
        </Reference>
        <Reference>
          <Citation>Fondi, C., Nozzoli, C., Benemei, S., Baroni, G., Saccardi, R., Guidi, S., Nicoletti, P., Bartolozzi, B., Pimpinelli, N., Santucci, M., Bosi, A. &amp; Massi, D. (2009) Increase in FOXP3+ regulatory T cells in GVHD skin biopsies is associated with lower disease severity and treatment response. Biology of Blood and Marrow Transplantation, 15, 938-947.</Citation>
        </Reference>
        <Reference>
          <Citation>Fontenot, J.D., Gavin, M.A. &amp; Rudensky, A.Y. (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nature Immunology, 4, 330-336.</Citation>
        </Reference>
        <Reference>
          <Citation>Fujimaki, W., Takahashi, N., Ohnuma, K., Nagatsu, M., Kurosawa, H., Yoshida, S., Dang, N.H., Uchiyama, T. &amp; Morimoto, C. (2008) Comparative study of regulatory T cell function of human CD25CD4 T cells from thymocytes, cord blood, and adult peripheral blood. Clinical and Developmental Immunology, 2008, 305859.</Citation>
        </Reference>
        <Reference>
          <Citation>Fujioka, T., Tamaki, H., Ikegame, K., Yoshihara, S., Taniguchi, K., Kaida, K., Kato, R., Inoue, T., Nakata, J., Ishii, S., Soma, T., Okada, M. &amp; Ogawa, H. (2013) Frequency of CD4(+)FOXP3(+) regulatory T-cells at early stages after HLA-mismatched allogeneic hematopoietic SCT predicts the incidence of acute GVHD. Bone Marrow Transplantation, 48, 859-864.</Citation>
        </Reference>
        <Reference>
          <Citation>Ganguly, S., Ross, D.B., Panoskaltsis-Mortari, A., Kanakry, C.G., Blazar, B.R., Levy, R.B. &amp; Luznik, L. (2014) Donor CD4+ Foxp3+ regulatory T cells are necessary for posttransplantation cyclophosphamide-mediated protection against GVHD in mice. Blood, 124, 2131-2141.</Citation>
        </Reference>
        <Reference>
          <Citation>Godfrey, W.R., Ge, Y.G., Spoden, D.J., Levine, B.L., June, C.H., Blazar, B.R. &amp; Porter, S.B. (2004) In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. Blood, 104, 453-461.</Citation>
        </Reference>
        <Reference>
          <Citation>Godfrey, W.R., Spoden, D.J., Ge, Y.G., Baker, S.R., Liu, B., Levine, B.L., June, C.H., Blazar, B.R. &amp; Porter, S.B. (2005) Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood, 105, 750-758.</Citation>
        </Reference>
        <Reference>
          <Citation>Goodyear, O.C., Dennis, M., Jilani, N.Y., Loke, J., Siddique, S., Ryan, G., Nunnick, J., Khanum, R., Raghavan, M., Cook, M., Snowden, J.A., Griffiths, M., Russell, N., Yin, J., Crawley, C., Cook, G., Vyas, P., Moss, P., Malladi, R. &amp; Craddock, C.F. (2012) Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML). Blood, 119, 3361-3369.</Citation>
        </Reference>
        <Reference>
          <Citation>Grant, C.R., Liberal, R., Mieli-Vergani, G., Vergani, D. &amp; Longhi, M.S. (2015) Regulatory T-cells in autoimmune diseases: challenges, controversies and-yet-unanswered questions. Autoimmunity Reviews, 14, 105-116.</Citation>
        </Reference>
        <Reference>
          <Citation>Hanash, A.M. &amp; Levy, R.B. (2005) Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation. Blood, 105, 1828-1836.</Citation>
        </Reference>
        <Reference>
          <Citation>Hasegawa, H., Inoue, A., Kohno, M., Lei, J., Miyazaki, T., Yoshie, O., Nose, M. &amp; Yasukawa, M. (2008) Therapeutic effect of CXCR39-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model. Gene Therapy, 15, 171-182.</Citation>
        </Reference>
        <Reference>
          <Citation>Hippen, K.L., Harker-Murray, P., Porter, S.B., Merkel, S.C., Londer, A., Taylor, D.K., Bina, M., Panoskaltsis-Mortari, A., Rubinstein, P., Van Rooijen, N., Golovina, T.N., Suhoski, M.M., Miller, J.S., Wagner, J.E., June, C.H., Riley, J.L. &amp; Blazar, B.R. (2008) Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells. Blood, 112, 2847-2857.</Citation>
        </Reference>
        <Reference>
          <Citation>Hippen, K.L., Merkel, S.C., Schirm, D.K., Sieben, C.M., Sumstad, D., Kadidlo, D.M., McKenna, D.H., Bromberg, J.S., Levine, B.L., Riley, J.L., June, C.H., Scheinberg, P., Douek, D.C., Miller, J.S., Wagner, J.E. &amp; Blazar, B.R. (2011) Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity. Science Translational Medicine, 3, 83ra41.</Citation>
        </Reference>
        <Reference>
          <Citation>Hippen, K.L., O'Connor, R.S., Lemire, A.M., Saha, A., Hanse, E.A., Tennis, N.C., Merkel, S.C., Kelekar, A., Riley, J.L., Levine, B.L., June, C.H., Turka, L.A., Kean, L.S., MacMillan, M.L., Miller, J.S., Wagner, J.E., Munn, D.H. &amp; Blazar, B.R. (2017) In vitro induction of human regulatory T cells using conditions of low tryptophan plus kynurenines. American Journal of Transplantation, 17, 3098-3113.</Citation>
        </Reference>
        <Reference>
          <Citation>Hoffmann, P., Ermann, J., Edinger, M., Fathman, C.G. &amp; Strober, S. (2002) Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. Journal of Experimental Medicine, 196, 389-399.</Citation>
        </Reference>
        <Reference>
          <Citation>Hori, S., Nomura, T. &amp; Sakaguchi, S. (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science, 299, 1057-1061.</Citation>
        </Reference>
        <Reference>
          <Citation>Iamsawat, S., Daenthanasanmak, A., Voss, J.H., Nguyen, H., Bastian, D., Liu, C. &amp; Yu, X.Z. (2018) Stabilization of Foxp3 by targeting JAK2 enhances efficacy of CD8 induced regulatory T cells in the prevention of graft-versus-host disease. The Journal of Immunology, 201, 2812-2823.</Citation>
        </Reference>
        <Reference>
          <Citation>Di Ianni, M., Del Papa, B., Cecchini, D., Bonifacio, E., Moretti, L., Zei, T., Ostini, R.I., Falzetti, F., Fontana, L., Tagliapietra, G., Maldini, C., Martelli, M.F. &amp; Tabilio, A. (2009) Immunomagnetic isolation of CD4+CD25+FoxP3+ natural T regulatory lymphocytes for clinical applications. Clinical and Experimental Immunology, 156, 246-253.</Citation>
        </Reference>
        <Reference>
          <Citation>Di Ianni, M., Falzetti, F., Carotti, A., Terenzi, A., Castellino, F., Bonifacio, E., Del Papa, B., Zei, T., Ostini, R.I., Cecchini, D., Aloisi, T., Perruccio, K., Ruggeri, L., Balucani, C., Pierini, A., Sportoletti, P., Aristei, C., Falini, B., Reisner, Y., Velardi, A., Aversa, F. &amp; Martelli, M.F. (2011) Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood, 117, 3921-3928.</Citation>
        </Reference>
        <Reference>
          <Citation>Joffre, O., Gorsse, N., Romagnoli, P., Hudrisier, D. &amp; van Meerwijk, J.P. (2004) Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes. Blood, 103, 4216-4221.</Citation>
        </Reference>
        <Reference>
          <Citation>Jones, S.C., Murphy, G.F. &amp; Korngold, R. (2003) Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response. Biology of Blood and Marrow Transplantation, 9, 243-256.</Citation>
        </Reference>
        <Reference>
          <Citation>Josefowicz, S.Z., Lu, L.F. &amp; Rudensky, A.Y. (2012) Regulatory T cells: mechanisms of differentiation and function. Annual Review of Immunology, 30, 531-564.</Citation>
        </Reference>
        <Reference>
          <Citation>Kanakry, C.G., Ganguly, S., Zahurak, M., Bolanos-Meade, J., Thoburn, C., Perkins, B., Fuchs, E.J., Jones, R.J., Hess, A.D. &amp; Luznik, L. (2013) Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide. Science Translational Medicine, 5, 211ra157.</Citation>
        </Reference>
        <Reference>
          <Citation>Kanamori, M., Nakatsukasa, H., Okada, M., Lu, Q. &amp; Yoshimura, A. (2016) Induced regulatory T cells: their development, stability, and applications. Trends in Immunology, 37, 803-811.</Citation>
        </Reference>
        <Reference>
          <Citation>Koenecke, C., Czeloth, N., Bubke, A., Schmitz, S., Kissenpfennig, A., Malissen, B., Huehn, J., Ganser, A., Forster, R. &amp; Prinz, I. (2009) Alloantigen-specific de novo-induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD. European Journal of Immunology, 39, 3091-3096.</Citation>
        </Reference>
        <Reference>
          <Citation>Komanduri, K.V. &amp; Champlin, R.E. (2011) Can Treg therapy prevent GVHD? Blood, 117, 751-752.</Citation>
        </Reference>
        <Reference>
          <Citation>Koreth, J., Matsuoka, K., Kim, H.T., McDonough, S.M., Bindra, B., Alyea, E.P. 3rd, Armand, P., Cutler, C., Ho, V.T., Treister, N.S., Bienfang, D.C., Prasad, S., Tzachanis, D., Joyce, R.M., Avigan, D.E., Antin, J.H., Ritz, J. &amp; Soiffer, R.J. (2011) Interleukin-2 and regulatory T cells in graft-versus-host disease. New England Journal of Medicine, 365, 2055-2066.</Citation>
        </Reference>
        <Reference>
          <Citation>Koreth, J., Kim, H.T., Jones, K.T., Lange, P.B., Reynolds, C.G., Chammas, M.J., Dusenbury, K., Whangbo, J., Nikiforow, S., Alyea, E.P. 3rd, Armand, P., Cutler, C.S., Ho, V.T., Chen, Y.B., Avigan, D., Blazar, B.R., Antin, J.H., Ritz, J. &amp; Soiffer, R.J. (2016) Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease. Blood, 128, 130-137.</Citation>
        </Reference>
        <Reference>
          <Citation>Lal, G., Zhang, N., van der Touw, W., Ding, Y., Ju, W., Bottinger, E.P., Reid, S.P., Levy, D.E. &amp; Bromberg, J.S. (2009) Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. The Journal of Immunology, 182, 259-273.</Citation>
        </Reference>
        <Reference>
          <Citation>Levine, A.G., Mendoza, A., Hemmers, S., Moltedo, B., Niec, R.E., Schizas, M., Hoyos, B.E., Putintseva, E.V., Chaudhry, A., Dikiy, S., Fujisawa, S., Chudakov, D.M., Treuting, P.M. &amp; Rudensky, A.Y. (2017) Stability and function of regulatory T cells expressing the transcription factor T-bet. Nature, 546, 421-425.</Citation>
        </Reference>
        <Reference>
          <Citation>Li, Q., Zhai, Z., Xu, X., Shen, Y., Zhang, A., Sun, Z., Liu, H., Geng, L. &amp; Wang, Y. (2010) Decrease of CD4(+)CD25(+) regulatory T cells and TGF-beta at early immune reconstitution is associated to the onset and severity of graft-versus-host disease following allogeneic haematogenesis stem cell transplantation. Leukemia Research, 34, 1158-1168.</Citation>
        </Reference>
        <Reference>
          <Citation>Li, C., DiSpirito, J.R., Zemmour, D., Spallanzani, R.G., Kuswanto, W., Benoist, C. &amp; Mathis, D. (2018) TCR transgenic mice reveal stepwise, multi-site acquisition of the distinctive fat-treg phenotype. Cell, 174, e212.</Citation>
        </Reference>
        <Reference>
          <Citation>Lord, J.D., Hackman, R.C., Gooley, T.A., Wood, B.L., Moklebust, A.C., Hockenbery, D.M., Steinbach, G., Ziegler, S.F. &amp; McDonald, G.B. (2011) Blood and gastric FOXP3+ T cells are not decreased in human gastric graft-versus-host disease. Biology of Blood and Marrow Transplantation, 17, 486-496.</Citation>
        </Reference>
        <Reference>
          <Citation>Lu, S.Y., Liu, K.Y., Liu, D.H., Xu, L.P. &amp; Huang, X.J. (2011) High frequencies of CD62L(+) naive regulatory T cells in allografts are associated with a low risk of acute graft-versus-host disease following unmanipulated allogeneic haematopoietic stem cell transplantation. Clinical and Experimental Immunology, 165, 264-277.</Citation>
        </Reference>
        <Reference>
          <Citation>MacDonald, K.G., Hoeppli, R.E., Huang, Q., Gillies, J., Luciani, D.S., Orban, P.C., Broady, R. &amp; Levings, M.K. (2016) Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor. J Clin Invest, 126, 1413-1424.</Citation>
        </Reference>
        <Reference>
          <Citation>Magenau, J.M., Qin, X., Tawara, I., Rogers, C.E., Kitko, C., Schlough, M., Bickley, D., Braun, T.M., Jang, P.S., Lowler, K.P., Jones, D.M., Choi, S.W., Reddy, P., Mineishi, S., Levine, J.E., Ferrara, J.L. &amp; Paczesny, S. (2010) Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-disease. Biology of Blood and Marrow Transplantation, 16, 907-914.</Citation>
        </Reference>
        <Reference>
          <Citation>Martelli, M.F., Di Ianni, M., Ruggeri, L., Falzetti, F., Carotti, A., Terenzi, A., Pierini, A., Massei, M.S., Amico, L., Urbani, E., Del Papa, B., Zei, T., Iacucci Ostini, R., Cecchini, D., Tognellini, R., Reisner, Y., Aversa, F., Falini, B. &amp; Velardi, A. (2014) HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse. Blood, 124, 638-644.</Citation>
        </Reference>
        <Reference>
          <Citation>Martin, G.H., Gregoire, S., Landau, D.A., Pilon, C., Grinberg-Bleyer, Y., Charlotte, F., Mege, J.P., Chatenoud, L., Salomon, B.L. &amp; Cohen, J.L. (2013) In vivo activation of transferred regulatory T cells specific for third-party exogenous antigen controls GVH disease in mice. European Journal of Immunology, 43, 2263-2272.</Citation>
        </Reference>
        <Reference>
          <Citation>Matsuoka, K., Koreth, J., Kim, H.T., Bascug, G., McDonough, S., Kawano, Y., Murase, K., Cutler, C., Ho, V.T., Alyea, E.P., Armand, P., Blazar, B.R., Antin, J.H., Soiffer, R.J. &amp; Ritz, J. (2013) Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease. Science Translational Medicine, 5, 179ra143.</Citation>
        </Reference>
        <Reference>
          <Citation>McDonald-Hyman, C., Muller, J.T., Loschi, M., Thangavelu, G., Saha, A., Kumari, S., Reichenbach, D.K., Smith, M.J., Zhang, G., Koehn, B.H., Lin, J., Mitchell, J.S., Fife, B.T., Panoskaltsis-Mortari, A., Feser, C.J., Kirchmeier, A.K., Osborn, M.J., Hippen, K.L., Kelekar, A., Serody, J.S., Turka, L.A., Munn, D.H., Chi, H., Neubert, T.A., Dustin, M.L. &amp; Blazar, B.R. (2018) The vimentin intermediate filament network restrains regulatory T cell suppression of graft-versus-host disease. Journal of Clinical Investigation, 128, 4604-4621.</Citation>
        </Reference>
        <Reference>
          <Citation>McIver, Z., Melenhorst, J.J., Wu, C., Grim, A., Ito, S., Cho, I., Hensel, N., Battiwalla, M. &amp; Barrett, A.J. (2013) Donor lymphocyte count and thymic activity predict lymphocyte recovery and outcomes after matched-sibling hematopoietic stem cell transplant. Haematologica, 98, 346-352.</Citation>
        </Reference>
        <Reference>
          <Citation>Mutis, T., van Rijn, R.S., Simonetti, E.R., Aarts-Riemens, T., Emmelot, M.E., van Bloois, L., Martens, A., Verdonck, L.F. &amp; Ebeling, S.B. (2006) Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2-/-gammac-/- immunodeficient mice. Clinical Cancer Research, 12, 5520-5525.</Citation>
        </Reference>
        <Reference>
          <Citation>Nguyen, V.H., Zeiser, R., Dasilva, D.L., Chang, D.S., Beilhack, A., Contag, C.H. &amp; Negrin, R.S. (2007) In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation. Blood, 109, 2649-2656.</Citation>
        </Reference>
        <Reference>
          <Citation>Noel, G., Bruniquel, D., Birebent, B., DeGuibert, S., Grosset, J.M., Bernard, M., Dauriac, C., Chevallier, P., Lamy-de-la-Chapelle, T., Semana, G. &amp; Brinster, C. (2008) Patients suffering from acute graft-versus-host disease after bone-marrow transplantation have functional CD4+CD25hiFoxp3+ regulatory T cells. Clinical Immunology, 129, 241-248.</Citation>
        </Reference>
        <Reference>
          <Citation>Okubo, Y., Mera, T., Wang, L. &amp; Faustman, D.L. (2013) Homogeneous expansion of human T-regulatory cells via tumor necrosis factor receptor 2. Scientific Reports, 3, 3153.</Citation>
        </Reference>
        <Reference>
          <Citation>Pabst, C., Schirutschke, H., Ehninger, G., Bornhauser, M. &amp; Platzbecker, U. (2007) The graft content of donor T cells expressing gamma delta TCR+ and CD4+foxp3+ predicts the risk of acute graft versus host disease after transplantation of allogeneic peripheral blood stem cells from unrelated donors. Clinical Cancer Research, 13, 2916-2922.</Citation>
        </Reference>
        <Reference>
          <Citation>Parmar, S., Liu, X., Najjar, A., Shah, N., Yang, H., Yvon, E., Rezvani, K., McNiece, I., Zweidler-McKay, P., Miller, L., Wolpe, S., Blazar, B.R. &amp; Shpall, E.J. (2015) Ex vivo fucosylation of third-party human regulatory T cells enhances anti-graft-versus-host disease potency in vivo. Blood, 125, 1502-1506.</Citation>
        </Reference>
        <Reference>
          <Citation>Peters, J.H., Preijers, F.W., Woestenenk, R., Hilbrands, L.B., Koenen, H.J. &amp; Joosten, I. (2008) Clinical grade Treg: GMP isolation, improvement of purity by CD127 Depletion, Treg expansion, and Treg cryopreservation. PLoS ONE, 3, e3161.</Citation>
        </Reference>
        <Reference>
          <Citation>Pierini, A., Colonna, L., Alvarez, M., Schneidawind, D., Nishikii, H., Baker, J., Pan, Y., Florek, M., Kim, B.S. &amp; Negrin, R.S. (2015) Donor requirements for regulatory T cell suppression of murine graft-versus-host disease. The Journal of Immunology, 195, 347-355.</Citation>
        </Reference>
        <Reference>
          <Citation>Pierini, A., Strober, W., Moffett, C., Baker, J., Nishikii, H., Alvarez, M., Pan, Y., Schneidawind, D., Meyer, E. &amp; Negrin, R.S. (2016) TNF-alpha priming enhances CD4+FoxP3+ regulatory T-cell suppressive function in murine GVHD prevention and treatment. Blood, 128, 866-871.</Citation>
        </Reference>
        <Reference>
          <Citation>Polansky, J.K., Kretschmer, K., Freyer, J., Floess, S., Garbe, A., Baron, U., Olek, S., Hamann, A., von Boehmer, H. &amp; Huehn, J. (2008) DNA methylation controls Foxp3 gene expression. European Journal of Immunology, 38, 1654-1663.</Citation>
        </Reference>
        <Reference>
          <Citation>Putnam, A.L., Brusko, T.M., Lee, M.R., Liu, W., Szot, G.L., Ghosh, T., Atkinson, M.A. &amp; Bluestone, J.A. (2009) Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes, 58, 652-662.</Citation>
        </Reference>
        <Reference>
          <Citation>Rezvani, K., Mielke, S., Ahmadzadeh, M., Kilical, Y., Savani, B.N., Zeilah, J., Keyvanfar, K., Montero, A., Hensel, N., Kurlander, R. &amp; Barrett, A.J. (2006) High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood, 108, 1291-1297.</Citation>
        </Reference>
        <Reference>
          <Citation>Rieger, K., Loddenkemper, C., Maul, J., Fietz, T., Wolff, D., Terpe, H., Steiner, B., Berg, E., Miehlke, S., Bornhauser, M., Schneider, T., Zeitz, M., Stein, H., Thiel, E., Duchmann, R. &amp; Uharek, L. (2006) Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD. Blood, 107, 1717-1723.</Citation>
        </Reference>
        <Reference>
          <Citation>Riley, J.L., June, C.H. &amp; Blazar, B.R. (2009) Human T regulatory cell therapy: take a billion or so and call me in the morning. Immunity, 30, 656-665.</Citation>
        </Reference>
        <Reference>
          <Citation>Robb, R.J., Lineburg, K.E., Kuns, R.D., Wilson, Y.A., Raffelt, N.C., Olver, S.D., Varelias, A., Alexander, K.A., Teal, B.E., Sparwasser, T., Hammerling, G.J., Markey, K.A., Koyama, M., Clouston, A.D., Engwerda, C.R., Hill, G.R. &amp; MacDonald, K.P. (2012) Identification and expansion of highly suppressive CD8(+)FoxP3(+) regulatory T cells after experimental allogeneic bone marrow transplantation. Blood, 119, 5898-5908.</Citation>
        </Reference>
        <Reference>
          <Citation>Sakaguchi, S. (2011) Regulatory T cells: history and perspective. Methods in Molecular Biology, 707, 3-17.</Citation>
        </Reference>
        <Reference>
          <Citation>Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. &amp; Toda, M. (2011) Pillars article: immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995. The Journal of Immunology, 186, 3808-3821.</Citation>
        </Reference>
        <Reference>
          <Citation>Sanchez, J., Casano, J., Alvarez, M.A., Roman-Gomez, J., Martin, C., Martinez, F., Gomez, P., Serrano, J., Herrera, C. &amp; Torres, A. (2004) Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation. British Journal of Haematology, 126, 697-703.</Citation>
        </Reference>
        <Reference>
          <Citation>Sawamukai, N., Satake, A., Schmidt, A.M., Lamborn, I.T., Ojha, P., Tanaka, Y. &amp; Kambayashi, T. (2012) Cell-autonomous role of TGFbeta and IL-2 receptors in CD4+ and CD8+ inducible regulatory T-cell generation during GVHD. Blood, 119, 5575-5583.</Citation>
        </Reference>
        <Reference>
          <Citation>Shin, H.J., Baker, J., Leveson-Gower, D.B., Smith, A.T., Sega, E.I. &amp; Negrin, R.S. (2011) Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells. Blood, 118, 2342-2350.</Citation>
        </Reference>
        <Reference>
          <Citation>Singh, K., Stempora, L., Harvey, R.D., Kirk, A.D., Larsen, C.P., Blazar, B.R. &amp; Kean, L.S. (2014) Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer. American Journal of Transplantation, 14, 2691-2703.</Citation>
        </Reference>
        <Reference>
          <Citation>Stanzani, M., Martins, S.L., Saliba, R.M., St John, L.S., Bryan, S., Couriel, D., McMannis, J., Champlin, R.E., Molldrem, J.J. &amp; Komanduri, K.V. (2004) CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humans. Blood, 103, 1140-1146.</Citation>
        </Reference>
        <Reference>
          <Citation>Steiner, D., Brunicki, N., Bachar-Lustig, E., Taylor, P.A., Blazar, B.R. &amp; Reisner, Y. (2006) Overcoming T cell-mediated rejection of bone marrow allografts by T-regulatory cells: synergism with veto cells and rapamycin. Experimental Hematology, 34, 802-808.</Citation>
        </Reference>
        <Reference>
          <Citation>Taylor, P.A., Lees, C.J. &amp; Blazar, B.R. (2002) The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood, 99, 3493-3499.</Citation>
        </Reference>
        <Reference>
          <Citation>Taylor, P.A., Panoskaltsis-Mortari, A., Swedin, J.M., Lucas, P.J., Gress, R.E., Levine, B.L., June, C.H., Serody, J.S. &amp; Blazar, B.R. (2004) L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood, 104, 3804-3812.</Citation>
        </Reference>
        <Reference>
          <Citation>Theil, A., Tuve, S., Oelschlagel, U., Maiwald, A., Dohler, D., Ossmann, D., Zenkel, A., Wilhelm, C., Middeke, J.M., Shayegi, N., Trautmann-Grill, K., von Bonin, M., Platzbecker, U., Ehninger, G., Bonifacio, E. &amp; Bornhauser, M. (2015) Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease. Cytotherapy, 17, 473-486.</Citation>
        </Reference>
        <Reference>
          <Citation>Tkachev, V., Furlan, S.N., Watkins, B., Hunt, D.J., Zheng, H.B., Panoskaltsis-Mortari, A., Betz, K., Brown, M., Schell, J.B., Zeleski, K., Yu, A., Kirby, I., Cooley, S., Miller, J.S., Blazar, B.R., Casson, D., Bland-Ward, P. &amp; Kean, L.S. (2017) Combined OX40L and mTOR blockade controls effector T cell activation while preserving Treg reconstitution after transplant. Science Translational Medicine, 9, pii: eaan3085.</Citation>
        </Reference>
        <Reference>
          <Citation>Trenado, A., Charlotte, F., Fisson, S., Yagello, M., Klatzmann, D., Salomon, B.L. &amp; Cohen, J.L. (2003) Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. Journal of Clinical Investigation, 112, 1688-1696.</Citation>
        </Reference>
        <Reference>
          <Citation>Trotta, E., Bessette, P.H., Silveria, S.L., Ely, L.K., Jude, K.M., Le, D.T., Holst, C.R., Coyle, A., Potempa, M., Lanier, L.L., Garcia, K.C., Crellin, N.K., Rondon, I.J. &amp; Bluestone, J.A. (2018) A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanism. Nature Medicine, 24, 1005-1014.</Citation>
        </Reference>
        <Reference>
          <Citation>Trzonkowski, P., Bieniaszewska, M., Juscinska, J., Dobyszuk, A., Krzystyniak, A., Marek, N., Mysliwska, J. &amp; Hellmann, A. (2009) First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells. Clinical Immunology, 133, 22-26.</Citation>
        </Reference>
        <Reference>
          <Citation>Ukena, S.N., Grosse, J., Mischak-Weissinger, E., Buchholz, S., Stadler, M., Ganser, A. &amp; Franzke, A. (2011) Acute but not chronic graft-versus-host disease is associated with a reduction of circulating CD4(+)CD25 (high)CD127 (low/-) regulatory T cells. Annals of Hematology, 90, 213-218.</Citation>
        </Reference>
        <Reference>
          <Citation>Veerapathran, A., Pidala, J., Beato, F., Yu, X.Z. &amp; Anasetti, C. (2011) Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly. Blood, 118, 5671-5680.</Citation>
        </Reference>
        <Reference>
          <Citation>Vogtenhuber, C., Bucher, C., Highfill, S.L., Koch, L.K., Goren, E., Panoskaltsis-Mortari, A., Taylor, P.A., Farrar, M.A. &amp; Blazar, B.R. (2010) Constitutively active Stat5b in CD4+ T cells inhibits graft-versus-host disease lethality associated with increased regulatory T-cell potency and decreased T effector cell responses. Blood, 116, 466-474.</Citation>
        </Reference>
        <Reference>
          <Citation>Wysocki, C.A., Jiang, Q., Panoskaltsis-Mortari, A., Taylor, P.A., McKinnon, K.P., Su, L., Blazar, B.R. &amp; Serody, J.S. (2005) Critical role for CCR101 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease. Blood, 106, 3300-3307.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang, P., Tey, S.K., Koyama, M., Kuns, R.D., Olver, S.D., Lineburg, K.E., Lor, M., Teal, B.E., Raffelt, N.C., Raju, J., Leveque, L., Markey, K.A., Varelias, A., Clouston, A.D., Lane, S.W., MacDonald, K.P. &amp; Hill, G.R. (2013) Induced regulatory T cells promote tolerance when stabilized by rapamycin and IL-2 in vivo. The Journal of Immunology, 191, 5291-5303.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhao, D., Zhang, C., Yi, T., Lin, C.L., Todorov, I., Kandeel, F., Forman, S. &amp; Zeng, D. (2008) In vivo-activated CD103+CD4+ regulatory T cells ameliorate ongoing chronic graft-versus-host disease. Blood, 112, 2129-2138.</Citation>
        </Reference>
        <Reference>
          <Citation>Zheng, J., Liu, Y., Liu, Y., Liu, M., Xiang, Z., Lam, K.T., Lewis, D.B., Lau, Y.L. &amp; Tu, W. (2013) Human CD8+ regulatory T cells inhibit GVHD and preserve general immunity in humanized mice. Science Translational Medicine, 5, 168ra169.</Citation>
        </Reference>
        <Reference>
          <Citation>Zorn, E., Kim, H.T., Lee, S.J., Floyd, B.H., Litsa, D., Arumugarajah, S., Bellucci, R., Alyea, E.P., Antin, J.H., Soiffer, R.J. &amp; Ritz, J. (2005) Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease. Blood, 106, 2903-2911.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">31418829</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1468-5922</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>64</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>09</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of analytical psychology</Title>
          <ISOAbbreviation>J Anal Psychol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Lev G. (2018) 'Poetics of reconcilement: psychoanalysis and the dilemmas of faith.' Psychoanalytic Psychology, vol. 35, no. 1: 38-45.</ArticleTitle>
        <Pagination>
          <MedlinePgn>629-632</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/1468-5922.12532</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>White</LastName>
            <ForeName>John</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Inter-Regional Society of Jungian Analysts.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Anal Psychol</MedlineTA>
        <NlmUniqueID>0376573</NlmUniqueID>
        <ISSNLinking>0021-8774</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418829</ArticleId>
        <ArticleId IdType="doi">10.1111/1468-5922.12532</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Binswanger, L. (1957). Sigmund Freud: Reminiscences of a Friendship (N. Guterman, Trans.). London, United Kingdom: Grune &amp; Stratton.</Citation>
        </Reference>
        <Reference>
          <Citation>Flynn Campbell, E. (2005). ‘Psychotherapy and the sacred’. In B. Marcella &amp; C. Barbre (Eds.), Psychotherapy and Religion: Many Paths, One Journey (pp. 57-76). Lanham, MD: Aronson.</Citation>
        </Reference>
        <Reference>
          <Citation>Freud, S. (1957). ‘Leonardo Da Vinci and a memory of his childhood’. In J. Strachey (Ed. &amp; Trans.), The Standard Edition of the Complete Psychological Works of Sigmund Freud (Vol. 11, pp. 57-138). London, United Kingdom: Hogarth Press and Institute of Psycho-Analysis. (Original work published 1910).</Citation>
        </Reference>
        <Reference>
          <Citation>Sorenson, R. L. (2004). Minding Spirituality. Hillsdale, NJ: Analytic Press.</Citation>
        </Reference>
        <Reference>
          <Citation>White, J. (2019). ‘Jung, the numinous, and the philosophers: on immanence and transcendence in religious experience’. In: J. Mills (Ed.) Jung and Philosophy New York: Routledge.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">31418831</PMID>
      <DateRevised>
        <Year>2019</Year>
        <Month>11</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1468-5922</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>64</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>09</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of analytical psychology</Title>
          <ISOAbbreviation>J Anal Psychol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Vacancy: North American Editor of the Journal of Analytical Psychology.</ArticleTitle>
        <Pagination>
          <MedlinePgn>646-647</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/1468-5922.12536</ELocationID>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Anal Psychol</MedlineTA>
        <NlmUniqueID>0376573</NlmUniqueID>
        <ISSNLinking>0021-8774</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418831</ArticleId>
        <ArticleId IdType="doi">10.1111/1468-5922.12536</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31418828</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>16</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1468-5922</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>64</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of analytical psychology</Title>
          <ISOAbbreviation>J Anal Psychol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Disquiet in the consulting room: everything/nothing that is said here is confidential.</ArticleTitle>
        <Pagination>
          <MedlinePgn>565-586</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/1468-5922.12521</ELocationID>
        <Abstract>
          <AbstractText>Writing from experiences in the consulting room in private practice in Australia, the author refers to the layered complexity of a conflict of ethical duty which has legal and social implications. The paper explores how the ethics that are congruent with creating a safe vas bene claustrum can be diametrically opposed to the social and legal structures and processes on which we all rely. It is suggested that within the vas, analysts and analysands engage in a shared process of emotionally connected, layered, symbolic thinking. Subpoenas directed at analysts are seeking concrete evidence that will stand up in court. The paper argues that this is a category error based on ignorance and misconceptions of what analytic work entails. The intrusion of a subpoena into the vas has the potential to cause havoc in the mental health and the lives of already vulnerable, possibly traumatized and isolated individuals. It can undermine a fundamental human right and undermine the profession of psychotherapy as a whole. The paper proposes that analysts have an ethical obligation to protect the work contained within the vas from these category errors and to educate other professionals as to why we cannot provide the kind of evidence that the courts require.</AbstractText>
          <CopyrightInformation>© 2019, The Society of Analytical Psychology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Meyerowitz-Katz</LastName>
            <ForeName>Julia</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Sydney, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Anal Psychol</MedlineTA>
        <NlmUniqueID>0376573</NlmUniqueID>
        <ISSNLinking>0021-8774</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003219" MajorTopicYN="Y">Confidentiality</DescriptorName>
          <QualifierName UI="Q000941" MajorTopicYN="N">ethics</QualifierName>
          <QualifierName UI="Q000331" MajorTopicYN="N">legislation &amp; jurisprudence</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006282" MajorTopicYN="Y">Health Personnel</DescriptorName>
          <QualifierName UI="Q000941" MajorTopicYN="N">ethics</QualifierName>
          <QualifierName UI="Q000331" MajorTopicYN="N">legislation &amp; jurisprudence</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007603" MajorTopicYN="Y">Jurisprudence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011369" MajorTopicYN="Y">Professional-Patient Relations</DescriptorName>
          <QualifierName UI="Q000941" MajorTopicYN="N">ethics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011575" MajorTopicYN="Y">Psychoanalytic Therapy</DescriptorName>
          <QualifierName UI="Q000941" MajorTopicYN="N">ethics</QualifierName>
          <QualifierName UI="Q000331" MajorTopicYN="N">legislation &amp; jurisprudence</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000067073" MajorTopicYN="N">Psychological Trauma</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <OtherAbstract Type="Publisher" Language="fre">
        <AbstractText>Ecrivant à partir d’expériences de sa pratique avec sa patientèle privée, en Australie, l’auteur souligne la complexité s’étageant sur plusieurs niveaux d’un conflit concernant un devoir éthique qui a des implications légales et sociales. L’article étudie comment l’éthique congruente avec la création d’un bon vas bene claustrum peut être diamétralement opposée aux structures et processus légaux et sociaux sur lesquels nous nous appuyons tous. Il est suggéré qu’à l’intérieur du vas, les analystes et les analysants sont impliqués dans un processus partagé de pensée symbolique, à plusieurs niveaux, et reliée aux émotions. Les assignations adressées à des analystes demandent des preuves concrètes qui tiendraient lors d’un procès. L’article argumente qu’il s’agit là d’une erreur de catégorie provenant de l’ignorance et de l’incompréhension sur ce que le travail analytique implique. L’intrusion d’une assignation dans le vas risque potentiellement de faire des ravages dans la santé psychique et la vie de personnes déjà vulnérables, et peut-être traumatisées ou isolées. Cela peut porter atteinte à un droit humain fondamental et saper la profession de psychothérapie dans son ensemble. L’article suggère que les analystes ont une obligation éthique de protéger le travail contenu dans le vas de ces erreurs de catégorie et d’éduquer les autres professions sur la question de pourquoi nous ne pouvons pas fournir la sorte de preuve dont les tribunaux ont besoin.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="ger">
        <AbstractText>Ausgehend von den Erfahrungen im Sprechzimmer einer Privatpraxis in Australien verweist die Autorin auf die vielschichtige Komplexität eines Konfliktes ethischer Pflichten, der rechtliche und soziale Auswirkungen hat. Der Beitrag untersucht, wie die Ethik, die mit der Schaffung eines sicheren vas bene claustrum übereinstimmt, den sozialen und rechtlichen Strukturen und Prozessen, auf die wir uns alle verlassen, diametral entgegenstehen kann. Es wird davon ausgegangen, daß sich Analytiker und Analysanden innerhalb des vas auf einen gemeinsamen Prozeß des emotional verbundenen, geschichteten, symbolischen Denkens einlassen. An Analytiker ergehende juristische Vorladungen zielen auf konkrete Beweise, die vor Gericht standhalten können. Es wird dahingehend argumentiert, daß dies ein kategorialer Fehler ist, der auf Unwissenheit und falschen Vorstellungen darüber beruht, was analytische Arbeit beinhaltet. Das Eindringen einer Vorladung in das vas kann Chaos in die psychische Gesundheit und das Leben bereits schutzbedürftiger, möglicherweise traumatisierter und isolierter Personen bringen. Es kann ein grundlegendes Menschenrecht untergraben und die Psychotherapie als Beruf im ganzen unterminieren. Der Beitrag vertritt die Auffassung, daß Analytiker eine ethische Verpflichtung haben, die Arbeit, die im vas contained ist, vor diesen kategorialen Fehlern zu schützen und andere Fachrichtungen darüber aufzuklären, warum wir nicht die Art von Beweisen vorlegen können, die die Gerichte verlangen.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="ita">
        <AbstractText>Partendo dalle esperienze nella stanza di consultazione del suo studio privato in Australia, l’Autrice fa riferimento alla stratificata complessità di un conflitto etico, che ha implicazioni legali e sociali. L’articolo esplora come l’etica congruente con la creazione di un sicuro vas bene claustrum possa essere diametralmente opposta alle strutture sociali e legali ed ai processi su cui noi tutti facciamo affidamento. Si suggerisce che all’interno del vas, analisti ed analizzandi prendono parte ad un processo condiviso di un pensiero simbolico, emozionalmente connesso e stratificato. Le citazioni in giudizio che coinvolgono gli analisti richiedono evidenze concrete che possano reggere in un’aula di tribunale. L’articolo sostiene che questo sia un errore basato sull’ignoranza e sul fraintendimento di cosa il lavoro analitico comporti. L’intrusione di una citazione in giudizio nel vas può causare confusione nello stato mentale e nelle vite di individui già vulnerabili, potenzialmente traumatizzati ed isolati. Può compromettere un fondamentale diritto umano e intaccare l’intera professione psicoterapeutica. L’articolo suggerisce che gli analisti abbiano l’obbligo etico di proteggere il lavoro contenuto all’interno del vas da questi errori e di aiutare altri professionisti a comprendere perché non sia possibile fornire il tipo di prove che un tribunale richiede.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="rus">
        <AbstractText>Автор, работая в частной практике в Австралии, говорит о многоуровневой сложности конфликта этических обязательств, которые имеют юридические и социальные значения. В статье исследуется, как этика, конкруэнтная созданию безопасной vas bene claustrum, может быть диаметрально противоположна социальным и юридическим структурам и процессам, на которые мы полагаемся. Предполагается, что внутри vas аналитики и анализанды вовлечены в общий процесс эмоционально связанного, многослойного, символического мышления. Вызовы в суд, которые приходят аналитикам, ищут конкретных доказательств, которые можно предъявить в суде. В статье обосновывается точка зрения, что эта ошибка категории является результатом незнания и неверного понимания аналитической работы. Вторжение повестки в аналитический сосуд (vas) может вызвать хаос в душевном здоровье и жизнях и без того уязвимых, возможно, травматизированных и изолированных людей. Вызов в суд может подорвать фундаментальное человеческое право и профессию психотерапевта в целом. В статье предлагается, что у аналитиков есть этическое обязательство защитить работу внутри аналитического сосуда от таких ошибок категории и информировать других профессионалов, что аналитики не могут давать показания в суде.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="spa">
        <AbstractText>A partir de experiencias en su práctica privada en Australia, la autora hace referencia a los distintos niveles de complejidad de un conflicto de deber ético que tiene implicancias sociales y legales. El trabajo explora como la ética congruente con la noción de crear un vas bene claustrum seguro puede ser diametralmente opuesta a las estructuras sociales y legales y a los procesos sobre los cuales todos nos apoyamos. Se sugiere que al interior del vas, analistas y analizandos se comprometen en un proceso compartido de pensamientos simbólico, emocionalmente conectado. Las citaciones dirigidas a analistas buscan evidencia concreta que se sostendrá en la corte. El presente trabajo argumenta que este es un error de categoría basado en la ignorancia y la incomprensión de lo que implica el trabajo analítico. La intrusión de una citación dentro del vas tiene el potencial de hacer estragos en la salud mental y en las vidas de individuos ya vulnerables, y posiblemente aislados y traumatizados. Puede debilitar un derecho humano fundamental y la profesión de psicoterapia en su totalidad. El artículo propone que analistas tienen una obligación ética de proteger el trabajo contenido al interior del vas de estos errores categóricos, así como de educar a otros profesionales respecto a porqué no es posible proveer esta clase de evidencia que la corte requiere.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="chi">
        <AbstractText>作者基于在澳洲个人执业的咨询室中的经验写了这篇文章, 其中作者谈论了一个涉及法律和社会意义的、与伦理义务相关的冲突中, 那些多层次的复杂性。文章讨论了与伦理等同的“创造密闭容器”的过程, 这一过程可能与社会和法律架构、以及我们所赖以生存的程序完全相悖。文章提出, 在容器之内, 分析师与受分析者共同参与到一个情感联系、分层和象征化思考的过程中。人们在找寻在法庭上传召分析师的确凿证据支持。文章指出这是源于对分析工作必要方面的忽视和错误认识而产生的分类错误。侵入到容器中的传票对于心理健康以及原本已十分脆弱的生命有着潜在的巨大损害, 可能会让个体受创或是隔离。这会侵蚀基本的人权, 侵蚀心理治疗整体的专业性。文章提出分析师有伦理的责任, 去保护分析工作在容器之中, 不受这种分类错误的侵入, 并教育其他的专业人士为什么我们不能够依照法庭所要求的提供证据。.</AbstractText>
      </OtherAbstract>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Analyse</Keyword>
        <Keyword MajorTopicYN="N">Ethik</Keyword>
        <Keyword MajorTopicYN="N">Schweigepflicht</Keyword>
        <Keyword MajorTopicYN="N">Symbolisches</Keyword>
        <Keyword MajorTopicYN="N">Trauma</Keyword>
        <Keyword MajorTopicYN="N">Vorladung</Keyword>
        <Keyword MajorTopicYN="N">analisi</Keyword>
        <Keyword MajorTopicYN="N">analyse</Keyword>
        <Keyword MajorTopicYN="N">analysis</Keyword>
        <Keyword MajorTopicYN="N">análisis</Keyword>
        <Keyword MajorTopicYN="N">assignation</Keyword>
        <Keyword MajorTopicYN="N">citación</Keyword>
        <Keyword MajorTopicYN="N">citazione in giudizio</Keyword>
        <Keyword MajorTopicYN="N">confidencialidad</Keyword>
        <Keyword MajorTopicYN="N">confidentiality</Keyword>
        <Keyword MajorTopicYN="N">confidentialité</Keyword>
        <Keyword MajorTopicYN="N">confidenzialità</Keyword>
        <Keyword MajorTopicYN="N">deber ético</Keyword>
        <Keyword MajorTopicYN="N">devoir éthique</Keyword>
        <Keyword MajorTopicYN="N">dovere morale</Keyword>
        <Keyword MajorTopicYN="N">ethical duty</Keyword>
        <Keyword MajorTopicYN="N">ethics</Keyword>
        <Keyword MajorTopicYN="N">ethische Pflicht</Keyword>
        <Keyword MajorTopicYN="N">etica</Keyword>
        <Keyword MajorTopicYN="N">simbolico</Keyword>
        <Keyword MajorTopicYN="N">simbólico</Keyword>
        <Keyword MajorTopicYN="N">subpoena</Keyword>
        <Keyword MajorTopicYN="N">symbolic</Keyword>
        <Keyword MajorTopicYN="N">symbolique</Keyword>
        <Keyword MajorTopicYN="N">trauma</Keyword>
        <Keyword MajorTopicYN="N">traumatisme</Keyword>
        <Keyword MajorTopicYN="N">éthique</Keyword>
        <Keyword MajorTopicYN="N">ética</Keyword>
        <Keyword MajorTopicYN="N">анализ</Keyword>
        <Keyword MajorTopicYN="N">вызов в суд</Keyword>
        <Keyword MajorTopicYN="N">конфиденциальность</Keyword>
        <Keyword MajorTopicYN="N">символическое</Keyword>
        <Keyword MajorTopicYN="N">травма</Keyword>
        <Keyword MajorTopicYN="N">этика</Keyword>
        <Keyword MajorTopicYN="N">этический долг</Keyword>
        <Keyword MajorTopicYN="N">传票</Keyword>
        <Keyword MajorTopicYN="N">伦理</Keyword>
        <Keyword MajorTopicYN="N">伦理义务</Keyword>
        <Keyword MajorTopicYN="N">保密</Keyword>
        <Keyword MajorTopicYN="N">分析</Keyword>
        <Keyword MajorTopicYN="N">创伤</Keyword>
        <Keyword MajorTopicYN="N">象征</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418828</ArticleId>
        <ArticleId IdType="doi">10.1111/1468-5922.12521</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Alderdice, J. (2003). Foreword. The Ethical Attitude in Analytic Practice. Eds. Solomon, H.M., &amp; Twyman, M. London, New York: Free Association Books.</Citation>
        </Reference>
        <Reference>
          <Citation>Bollas, C. (1987). Psychoanalysis of the Unthought Known. London: Free Association Books.</Citation>
        </Reference>
        <Reference>
          <Citation>Bollas, C. (2003). ‘Confidentiality and professionalism in psychoanalysis’. British Journal of Psychotherapy, 20, 2, 157-176.</Citation>
        </Reference>
        <Reference>
          <Citation>Bollas, C. &amp; Sundelson, D. (1997) The New Informants. Betrayal of Confidentiality in Psychoanalysis and Psychotherapy. London: Karnac.</Citation>
        </Reference>
        <Reference>
          <Citation>Clark, G. (1996). ‘The animating body: psychoid substance as a mutual experience of psychosomatic disorder’. Journal of Analytical Psychology, 41, 3, 353-368.</Citation>
        </Reference>
        <Reference>
          <Citation>Clark, G. (2006). ‘A Spinozan lens onto the confusions of borderline relations’. Journal of Analytical Psychology, 51, 1, 67-86.</Citation>
        </Reference>
        <Reference>
          <Citation>Clark, G. (2010). ‘The embodied countertransference and recycling the mad matter of symbolic equivalence’. In: Heuer, G. (Ed.) Sacral Revolutions. Reflecting on the work of Andrew Samuels - cutting edges in Psychoanalysis and Jungian Analysis. London: Routledge, Taylor and Francis Group.</Citation>
        </Reference>
        <Reference>
          <Citation>Connolly, A. (2011). ‘Healing the wounds of our fathers’. Journal of Analytical Psychology, 56, 5, 607-626.</Citation>
        </Reference>
        <Reference>
          <Citation>Etymology Online Dictionary https://www.etymonline.com/word/agape accessed 28.12.18</Citation>
        </Reference>
        <Reference>
          <Citation>Freud, S. (1914). 'Remembering, repeating and working through'. SE 12.</Citation>
        </Reference>
        <Reference>
          <Citation>Grotstein, J. S. (1997). ‘Mens sane in copore sano: The mind and body as an “odd couple” and as an oddly coupled unity’. Psychoanalytic Inquiry, 17, 2, 204-222.</Citation>
        </Reference>
        <Reference>
          <Citation>Jung, C.G. (1947). ‘On the nature of the psyche’ CW 8.</Citation>
        </Reference>
        <Reference>
          <Citation>Jung, C.G. (1953). Psychology and Alchemy. CW 12.</Citation>
        </Reference>
        <Reference>
          <Citation>Jung, C.G. (1954). The Practice of Psychotherapy. CW 16.</Citation>
        </Reference>
        <Reference>
          <Citation>Jung, C.G. (1963) Memories, Dreams, Reflections. Recorded and edited by Aniella Jaffe. London: Fontana Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Jung, C.G. (1973). Letters Volume 1: 1906-1950, ed. G. Adler, trans R. F. C. Hull. Princeton: Princeton University Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Lambert, K. (1981). Analysis, Repair and Individuation. The Library of Analytical Psychology, Volume V. London: Karnac.</Citation>
        </Reference>
        <Reference>
          <Citation>MacKenna, C. (2003). ‘Ethical pressures on the analytic alliance’. In The Ethical Attitude in Analytic Practice, eds. H.M. Solomon &amp; M. Twyman. London: Free Association Books, pp.51-64.</Citation>
        </Reference>
        <Reference>
          <Citation>Meyerowitz-Katz, J. (2010). ‘From anti-mourning to mourning: harnessing the potential in regressed psychoid experience’. Unpublished thesis. ANZSJA Training.</Citation>
        </Reference>
        <Reference>
          <Citation>Meyerowitz-Katz, J. (2011). ‘Putting the dis-ease of psychoid infection to good use: supporting individuation and developing an analytic bodymind’. Unpublished Long Case Study. ANZSJA Training.</Citation>
        </Reference>
        <Reference>
          <Citation>Meyerowitz-Katz, J. (2016). ‘Navigating ambivalent states of bodymind: working with intergenerationally transmitted holocaust trauma in couple therapy’. Couple and Family Psychoanalysis, 6, 1, 25-43.</Citation>
        </Reference>
        <Reference>
          <Citation>Meyerowitz-Katz, J. (2017). ‘The crisis of the cream cakes: an infant’s food refusal as a representation of intergenerational trauma’. In Art therapy in the early years. Therapeutic interventions with infants, toddlers and their families, eds. J. Meyerowitz-Katz &amp; D. Reddick. London: Routledge.</Citation>
        </Reference>
        <Reference>
          <Citation>Meyerowitz-Katz, J. (2018).‘Gathering fragments: steps in the evolution of a creative coupling’. In Working with Developmental Anxieties in Couple and Family Psychotherapy: the Family Within, eds. P. Jools, N. Byrne, J. Berg. London: Routledge.</Citation>
        </Reference>
        <Reference>
          <Citation>Phillips, P. (2011). Foreword in The Bollas Reader. London: Routledge Taylor and Francis Group.</Citation>
        </Reference>
        <Reference>
          <Citation>Pickering, J. (2008). Being in Love. Therapeutic Pathways Through Psychological Obstacles to Love. London: Routledge, Taylor and Francis Group.</Citation>
        </Reference>
        <Reference>
          <Citation>Pickering, J. (2012). ‘Bearing the unbearable: ancestral transmission through dreams and moving metaphors in the analytic field’. Journal of Analytical Psychology, 57, 5, 576-596.</Citation>
        </Reference>
        <Reference>
          <Citation>Richardson, E. (2003). ‘Birth of the ethical attitude in a clinical setting’. In The Ethical Attitude in Analytic Practice, eds. H.M. Solomon, &amp; M. Twyman. London: Free Association Books.</Citation>
        </Reference>
        <Reference>
          <Citation>Solomon, H.M., &amp; Twyman, M. (2003). ‘Introduction: the ethical attitude in analytic practice’. In The Ethical Attitude in Analytic Practice, eds. H.M. Solomon &amp; M. Twyman. London: Free Association Books.</Citation>
        </Reference>
        <Reference>
          <Citation>Solomon, H. M., (2007). ‘Ethics in the psyche: ethics in the consulting room’. The Self in Transformation. London: Karnac Books.</Citation>
        </Reference>
        <Reference>
          <Citation>Jaffee v. Redmond 518 U.S. 1 (1996) https://supreme.justia.com/cases/federal/us/518/1/case.html accessed 2.11.17</Citation>
        </Reference>
        <Reference>
          <Citation>The Royal Australian and New Zealand College of Psychiatrists (2017) Position statement 89. Patient-psychiatrist confidentiality: the issue of subpoenas. https://www.ranzcp.org/Files/Resources/College_Statements/Position_Statements/PS89-Access-to-clinical-records-without-patient-co.aspx</Citation>
        </Reference>
        <Reference>
          <Citation>Wharton, B. (2003). ‘The reporting of clinical material’. In The Ethical Attitude in Analytic Practice. Eds. H.M. Solomon &amp; M. Twyman. London, New York: Free Association Books.</Citation>
        </Reference>
        <Reference>
          <Citation>Weeks, K. (2017). SBS. Insight Episode 33, On Trial, 30 October.</Citation>
        </Reference>
        <Reference>
          <Citation>West, M. (2011). ‘Attachment, sensitivity and agency: the alchemy of analytic work’. Journal of Analytical Psychology, 56, 3, 354-361.</Citation>
        </Reference>
        <Reference>
          <Citation>West, M. (2013). ‘Trauma and the transference-countertransference: working with the bad object and the wounded self’. Journal of Analytical Psychology, 58, 1, 73-98.</Citation>
        </Reference>
        <Reference>
          <Citation>West, M. (2017). Into the Darkest Places. Early Relational Trauma and Borderline States of Mind. London: Karnac Books.</Citation>
        </Reference>
        <Reference>
          <Citation>Wiener, J. (2001a). Review of Raphael Leff, J. (Ed.) Ethics of psychoanalysis. in Journal of Analytical Psychology, 46, 2, 381-383.</Citation>
        </Reference>
        <Reference>
          <Citation>Wiener, J. (2001b). ‘Confidentiality and paradox: the location of ethical space’. Journal of Analytical Psychology, 46, 3, 431-442.</Citation>
        </Reference>
        <Reference>
          <Citation>Winnicott, D.W. (1962/1985). The aims of psycho-analytical treatment. The maturational processes and the facilitating environment. Studies in the theory of emotional development, pp.166-170. London: The Hogarth Press and the Institute of Psycho-analysis.</Citation>
        </Reference>
        <Reference>
          <Citation>Winnicott, D.W. (1962/1985). ‘The Maturational Processes and the Facilitating Environment’. Studies in the Theory of Emotional Development. London: The Hogarth Press and the Institute of Psychoanalysis.</Citation>
        </Reference>
        <Reference>
          <Citation>Winnicott D.W. (1956/1984). ‘Primary maternal preoccupation’. Through Paediatrics to Psychoanalysis: Collected Papers. London: Karnac Books.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31418830</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>16</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1468-5922</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>64</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of analytical psychology</Title>
          <ISOAbbreviation>J Anal Psychol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Inventing the enemy.</ArticleTitle>
        <Pagination>
          <MedlinePgn>462-474</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/1468-5922.12514</ELocationID>
        <Abstract>
          <AbstractText>The following article elaborates on the need for the Other in order to delineate the self and one's identity, and the eternal psychological process of turning the Other into an enemy. A parallel process, which can be observed nowadays, leads to a disregard for the otherness of the Other that results in the blurring of identity and an internal loss of the differentiation of intrapsychic structures. Both psychological processes share a dehumanizing approach which leads to neurosis and alienation. In order to withstand these tendencies, a revision of analytical psychology's view of the psyche and of the practice of Jungian analysis is warranted: an alternative to the 'Fear of the Feminine' described by Erich Neumann in 1959. It is suggested that consciousness and unconsciousness intertwine but from a position of equality and reciprocity. Such an attitude does not inspire fear. Rather, it recognizes the need of one for the Other and the inevitability of this situation. Moreover, this need and interdependence on equal grounds nourish the wish to know the Other, to be aware of the differences, and yet, at the same time, to acknowledge how close the Other really is. Analytical psychological therapy based on this model stresses the power of the ego while also strengthening its capacity for introspection.</AbstractText>
          <CopyrightInformation>© 2019, The Society of Analytical Psychology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Abramovitch</LastName>
            <ForeName>Yehuda</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Tel Aviv, Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Anal Psychol</MedlineTA>
        <NlmUniqueID>0376573</NlmUniqueID>
        <ISSNLinking>0021-8774</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004532" MajorTopicYN="Y">Ego</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007398" MajorTopicYN="Y">Interpersonal Relations</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011572" MajorTopicYN="Y">Psychoanalysis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012933" MajorTopicYN="Y">Social Identification</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <OtherAbstract Type="Publisher" Language="fre">
        <AbstractText>L’article suivant développe le thème du besoin de l’Autre pour délimiter le soi et son identité, et l’éternel processus psychologique consistant à faire de l’Autre un ennemi. Un processus parallèle, que l’on peut observer de nos jours, amène à une indifférence concernant l’altérité de l’Autre, ce qui aboutit à l’estompement de l’identité et la perte intérieure de la différentiation des structures intrapsychiques. Ces deux processus psychologiques partagent une approche déshumanisante qui conduit à la névrose et l’aliénation. Afin de résister à ces tendances, une révision de la perspective de la psychologie analytique sur la psyché et sur la pratique de l’analyse Jungienne est justifiée: une alternative à la « Peur du Féminin » décrite par Erich Neumann en 1959. Nous suggérons que la conscience et l’inconscience s’entremêlent, mais ceci à partir d’une position d’égalité et de réciprocité. Une telle attitude n’inspire pas la peur. Plutôt, elle reconnait le besoin de l’Autre et l’inévitabilité de cette situation. De plus, ce besoin et cette interdépendance sur un terrain d’égalité nourrit le souhait de connaitre l’Autre, d’être conscient des différences, et cependant, en même temps, de reconnaitre combien l’Autre est en fait si proche. La thérapie issue de la psychologie analytique et fondée sur ce modèle souligne la puissance de l’égo tout en renforçant aussi sa capacité à l’introspection.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="ger">
        <AbstractText>Der folgende Artikel behandelt die Notwendigkeit eines Anderen, um das Selbst und die eigene Identität darzustellen und desweiteren den ewigen psychischen Prozeß, in dem der Andere zum Feind gemacht wird. Ein paralleler Prozeß, der heutzutage beobachtet werden kann, führt dazu, daß das Anderssein des Anderen mißachtet wird, was zu einer Verschwommenheit der Identität und einem internen Verlust der Differenzierung intrapsychischer Strukturen führt. Beide psychologischen Prozesse vereinen einen entmenschlichenden Ansatz, der zu Neurose und Entfremdung führt. Um diesen Tendenzen zu widerstehen ist eine Überarbeitung der Sichtweise der Analytischen Psychologie auf die Psyche und die Praxis der Jungschen Analyse angezeigt: eine Alternative zu der von Erich Neumann 1959 beschriebenen 'Angst vor dem Weiblichen'. Es wird davon ausgegangen, daß sich Bewußtes und Unbewußtes nur von einer Position der Gleichheit und Gegenseitigkeit aus verflechten. Eine solche Haltung weckt keine Angst. Vielmehr erkennt es die Notwendigkeit des einen für das Andere und die Unvermeidlichkeit dieser Situation. Darüber hinaus nähren dieses Bedürfnis und diese gegenseitige Abhängigkeit auf dem gleichen Hintergrund den Wunsch, den Anderen zu kennen, sich der Unterschiede bewußt zu sein und gleichzeitig anzuerkennen, wie nahe der Andere wirklich ist. Die auf diesem Modell basierende analytische psychologische Therapie betont die Macht des Ichs und stärkt gleichzeitig seine Fähigkeit zur Introspektion.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="ita">
        <AbstractText>Il seguente articolo elabora il bisogno dell’Altro allo scopo di delineare se stessi e la propria identità, e l’eterno processo psicologico che porta a trasformare l’Altro in un nemico. Un processo parallelo, che può essere osservato oggigiorno, porta ad un disprezzo per l’estraneità dell’Altro che provoca un offuscamento dell’identità e la perdita della differenziazione tra strutture intrapsichiche. Entrambi questi processi psicologici condividono un approccio disumanizzante che porta a nevrosi ed alienazione. Al fine di contrastare queste tendenze, una rivisitazione della visione della psiche nella psicologia analitica e nella pratica dell’analisi junghiana è auspicabile: una alternativa alla ‘Paura del Femminile’ descritta da Eric Neumann nel 1959. Si ipotizza che conscio ed inconscio si intersechino, ma da una posizione di uguaglianza e reciprocità. Tale atteggiamento non suscita paura. Piuttosto, riconosce il bisogno dell’uno per l’Altro e l’inevitabilità di questa situazione. Inoltre, questo bisogno e l’interdipendenza nutrono egualmente il desiderio di conoscere l’Altro, di essere consapevoli delle differenze, e tuttavia, allo stesso tempo, di riconoscere quanto l’Altro sia realmente vicino. Una terapia psicoanalitica basata su questo modello sottolinea il potere dell’Io e allo stesso tempo rafforza la sua capacità di introspezione.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="rus">
        <AbstractText>В статье анализируется потребность в Другом как в средстве определения себя и своей идентичности и как вечный психологический процесс превращения Другого во врага. Параллельный процесс, который мы можем наблюдать сегодня, ведет к игнорированию инаковости в Другом, что ведет к размыванию идентичности и внутренней утрате дифференцированности интрапсихических структур. Обоим психолоническим процессам свойственен дегуманизирующий подход, результатом которого являются неврозы и отчуждение. Чтобы противостоять этим тенденциям, необходимо пересмотреть взгляд аналитической психологии на психику и практику юнгианского анализа. Это альтернатива “Страху фемининного”, описанного Эрихом Нойманном в 1959 году. Предполагается, что сознание и бессознательное переплетены, но с позиции равенства и взаимности. Такая установка не возбуждает страх. Напротив, она признает потребность одного в Другом и неизбежность этой ситуации. Более того, эта потребность и взаимозависимость на равных основаниях питает желание познать Другого, осознать различия, и в то же время признать, что Другой очень близок. Аналитическая психотерапия, основанная на этой модели, подчеркивает мощь эго и укрепляет его способность к интроспекции.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="spa">
        <AbstractText>El siguiente artículo elabora sobre la necesidad del Otro para delinear el sí mismo, y la propia identidad, y el eterno proceso psicológico de convertir al Otro en un enemigo. Un proceso paralelo, el cual puede ser observado en la actualidad, conduce a un desprecio por la otredad del Otro que resulta en un borramiento de la identidad y a una pérdida interna de la diferenciación de estructuras intrapsíquicas. Ambos procesos psicológicos comparten un abordaje deshumanizado el cual conduce a la neurosis y la alienación. Para poder resistir estas tendencias, es requerida una revisión de la perspectiva de la psicología analítica sobre la psique, y de la práctica del análisis Junguiano: una alternativa al “Miedo de lo Femenino” descripto por Erich Neumann en 1959. Se sugiere que consciente e inconsciente se entrelazan pero desde una posición de igualdad y reciprocidad. Una actitud semejante no inspira miedo. Sino, que reconoce la necesidad de uno para el Otro y la inevitabilidad de esta situación. Además, esta necesidad e interdependencia sobre bases equitativas nutre el deseo de conocer al Otro, de ser consciente de las diferencias, y al mismo tiempo, dar cuenta de cuan cerca el Otro está realmente. La terapia analítica basada en este modelo subraya el poder del ego al mismo tiempo que fortalece su capacidad de introspección.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="chi">
        <AbstractText>这篇文章描绘了为了要描绘自己和自己的身份而对他人提出的需要, 以及把他者变为敌人的永恒心理过程。当下可以观察到一个与此平行的过程, 它忽视他人的他者性, 这会引起身份的模糊, 并在内在失去内部心理结构的区分性。两个心理过程都具备去人性的取向, 而这导致了神经症和疏离。为了承受这些倾向, 文章指出一个修正的分析心理学关于心灵的观点, 以及关于荣格分析实践的观点:这是一个与埃里西-诺伊曼1959年提出的“对女性化的恐惧”不一样的观点。其中建议, 意识和无意识缠结, 但是这一缠结是出自一个公平和互惠的角度进行的。这一态度不会激发恐惧, 而是会让个体意识到自己需要他者, 以及意识到这一情境的必然性。此外, 这一需要, 以及在平等基础上的独立, 滋养了去了解他者的希望, 去意识到不同, 与此同时, 承认他者离得有多近。基于这一模型的分析心理学的治疗强调了自我的力量, 同时也加强了它内省的能力。.</AbstractText>
      </OtherAbstract>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Ego</Keyword>
        <Keyword MajorTopicYN="N">El Otro</Keyword>
        <Keyword MajorTopicYN="N">Gleichheit und Reziprozität</Keyword>
        <Keyword MajorTopicYN="N">Io</Keyword>
        <Keyword MajorTopicYN="N">L’Autre</Keyword>
        <Keyword MajorTopicYN="N">Neurosentheorie</Keyword>
        <Keyword MajorTopicYN="N">Revisionen</Keyword>
        <Keyword MajorTopicYN="N">The Other</Keyword>
        <Keyword MajorTopicYN="N">der Andere</Keyword>
        <Keyword MajorTopicYN="N">ego</Keyword>
        <Keyword MajorTopicYN="N">equality and reciprocity</Keyword>
        <Keyword MajorTopicYN="N">igualdad y reciprocidad</Keyword>
        <Keyword MajorTopicYN="N">la théorie des névroses</Keyword>
        <Keyword MajorTopicYN="N">l’Altro</Keyword>
        <Keyword MajorTopicYN="N">l’égo</Keyword>
        <Keyword MajorTopicYN="N">revisiones</Keyword>
        <Keyword MajorTopicYN="N">revisioni</Keyword>
        <Keyword MajorTopicYN="N">revisions</Keyword>
        <Keyword MajorTopicYN="N">révisions</Keyword>
        <Keyword MajorTopicYN="N">teoria delle nevrosi</Keyword>
        <Keyword MajorTopicYN="N">teoría de las neurosis</Keyword>
        <Keyword MajorTopicYN="N">theory of neurosis</Keyword>
        <Keyword MajorTopicYN="N">uguaglianza e reciprocità</Keyword>
        <Keyword MajorTopicYN="N">égalité et réciproci</Keyword>
        <Keyword MajorTopicYN="N">Другой</Keyword>
        <Keyword MajorTopicYN="N">его</Keyword>
        <Keyword MajorTopicYN="N">пересмотр</Keyword>
        <Keyword MajorTopicYN="N">равенство и взаимность</Keyword>
        <Keyword MajorTopicYN="N">теория невроза</Keyword>
        <Keyword MajorTopicYN="N">他者</Keyword>
        <Keyword MajorTopicYN="N">修正</Keyword>
        <Keyword MajorTopicYN="N">平等与互惠</Keyword>
        <Keyword MajorTopicYN="N">神经症理论</Keyword>
        <Keyword MajorTopicYN="N">自我</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418830</ArticleId>
        <ArticleId IdType="doi">10.1111/1468-5922.12514</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Eco, U. (2011). Costruire Il Nemico. Milan: Bompiani.</Citation>
        </Reference>
        <Reference>
          <Citation>Gordon Montagnon, R. (2005). ‘Do Be My Enemy For Friendship’s Sake’ (Blake). Journal of Analytical Psychology, 50, 27-34.</Citation>
        </Reference>
        <Reference>
          <Citation>Hillman, J. (1985). Anima - An Anatomy Of A Personified Notion. Dallas, Texas: Spring Publications.</Citation>
        </Reference>
        <Reference>
          <Citation>Jung, C.G. (1927). ‘Woman in Europe’. CW 10.</Citation>
        </Reference>
        <Reference>
          <Citation>Jung, C.G. (1942). ‘On The Psychology of the Unconscious’. CW 7.</Citation>
        </Reference>
        <Reference>
          <Citation>Littell, J. (2006). Les Bienveillantes. Paris: Gallimard.</Citation>
        </Reference>
        <Reference>
          <Citation>Lopez-Pedraza, R. (2003). Hermes and his Children. Switzerland: Daimon.</Citation>
        </Reference>
        <Reference>
          <Citation>Neumann, E. (1994). ‘The fear of the feminine’. In: The Fear Of The Feminine. New Jersey: Princeton University Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Oz, A. (2014). Judas. Israel: Keter Publishing House.</Citation>
        </Reference>
        <Reference>
          <Citation>Sartre, J.P. (1947). Huis Clos. Paris: Gallimard.</Citation>
        </Reference>
        <Reference>
          <Citation>Varoufakis, Y. (2017). My Battle with Europe’s Deep Establishment. UK: The Bodley Head.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">31418833</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1468-5922</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>64</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>09</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of analytical psychology</Title>
          <ISOAbbreviation>J Anal Psychol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Busch, F. (2018). 'Searching for the analyst's reveries'. International Journal of Psychoanalysis. Vol. 99 (3), 569-589.</ArticleTitle>
        <Pagination>
          <MedlinePgn>621-623</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/1468-5922.12529</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Solem</LastName>
            <ForeName>David</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Inter-Regional Society of Jungian Analysts and C.G. Jung Institute of Santa Fe.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Anal Psychol</MedlineTA>
        <NlmUniqueID>0376573</NlmUniqueID>
        <ISSNLinking>0021-8774</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418833</ArticleId>
        <ArticleId IdType="doi">10.1111/1468-5922.12529</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Cwik, August J. (2011). ‘Associative dreaming: reverie and active imagination’. Journal of Analytical Psychology 6, 14-36.</Citation>
        </Reference>
        <Reference>
          <Citation>Knoblach, Steven H. (2000). The Musical Edge of Therapeutic Dialogue. Hillsdale, NJ: The Analytic Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Lombardi, Riccardo (2008). ‘Time, music, and reverie.’ Journal of the American Psychoanalytic Association, 56:1191-1211.</Citation>
        </Reference>
        <Reference>
          <Citation>Winborn, Mark (2014). Shared Realities: Participation Mystique and Beyond. Sheridan, Wyoming: Fisher King Press.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">31418835</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1468-5922</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>64</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>09</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of analytical psychology</Title>
          <ISOAbbreviation>J Anal Psychol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Hartung, T. &amp; Steinbrecher, M. (2018) 'From somatic pain to psychic pain: The body in the psychoanalytic field'. International Journal of Psychoanalysis. Vol. 99 (1), pp. 159-180.</ArticleTitle>
        <Pagination>
          <MedlinePgn>626-629</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/1468-5922.12531</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Luft</LastName>
            <ForeName>Cynthia</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Inter-Regional Society of Jungian Analysts.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Anal Psychol</MedlineTA>
        <NlmUniqueID>0376573</NlmUniqueID>
        <ISSNLinking>0021-8774</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418835</ArticleId>
        <ArticleId IdType="doi">10.1111/1468-5922.12531</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Guntrip, H. (1968). Schizoid Phenomena: Object Relations and the Self. London, Karnac Books.</Citation>
        </Reference>
        <Reference>
          <Citation>Jung, C.G. (1946). The Psychology of the Transference, CW16, Princeton, NJ: Princeton University Press.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31418832</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>16</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1468-5922</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>64</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of analytical psychology</Title>
          <ISOAbbreviation>J Anal Psychol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Psychotherapy research: an interplay between inner and outer and a succession of meanings.</ArticleTitle>
        <Pagination>
          <MedlinePgn>512-529</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/1468-5922.12518</ELocationID>
        <Abstract>
          <AbstractText>Psychotherapy research is a rapidly developing area of study that aims to explore the integration of inner and outer conditions of an individual's experience, the interplay between subjective and objective, as well as between individual and collective. Questions regarding a more integrative view and qualitative research in psychotherapy are discussed in the paper. The author introduces some ideas from the studies on psychotherapy effectiveness that were done at Vilnius University by a group of researchers who work in the 'Centre for research on the psychodynamics of personality'. Clinical psychologists who hold a doctorate degree or who are in doctoral studies in the Department of Psychology at Vilnius University are members of this research group. The subjective understanding about healing episodes and the development of depth premises were the main tasks of these studies. Among other methods, the researchers used the drawing a picture of a healing moment and telling a psychotherapy story recalled by the client to collect data. Two examples of drawing a picture of a healing moment and one example of telling a therapy story are analyzed in the paper. The themes of subjective experience of renewal in psychotherapy as well as the multiplicity of experience and results in psychotherapy are discussed in the paper with case illustrations. This study showed that drawing a picture opens one more dimension of reflection and that it can be an appropriate tool for developing individual narratives as well. Authoring and re-authoring one's life narrative is accepted as part of a productive therapy as well as discovering one's inner authorship. The ability to follow a succession of meanings, as well as a connection to nature and culture could be one of the ways of actualizing an integrative view in psychotherapy research.</AbstractText>
          <CopyrightInformation>© 2019, The Society of Analytical Psychology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Gudaitė</LastName>
            <ForeName>Gražina</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Vilnius, Lithuania.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Anal Psychol</MedlineTA>
        <NlmUniqueID>0376573</NlmUniqueID>
        <ISSNLinking>0021-8774</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D035843" MajorTopicYN="Y">Biomedical Research</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001523" MajorTopicYN="N">Mental Disorders</DescriptorName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011613" MajorTopicYN="Y">Psychotherapy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D036301" MajorTopicYN="Y">Qualitative Research</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <OtherAbstract Type="Publisher" Language="fre">
        <AbstractText>La recherche dans le domaine de la psychothérapie est un domaine d’étude en croissance rapide qui vise à étudier l’intégration des conditions intérieures et extérieures dans l’expérience d’une personne, l’interaction entre le subjectif et l’objectif, ainsi qu’entre l’individuel et le collectif. L’article aborde des questions concernant une perspective plus intégrative et la recherche qualitative en psychothérapie. L’auteur introduit des idées provenant d’études faites par un groupe de chercheurs à l’université de Vilnius sur l’efficacité de la psychothérapie. Ces chercheurs travaillent au « Centre for research on the psychodynamics of personality » (Centre de recherche sur les psychodynamiques de la personnalité). Ils sont docteurs en psychologie clinique ou doctorants dans le département de Psychologie à l’université de Vilnius. L’objet principal de ces recherches est la compréhension subjective d’épisodes de guérison et la construction de postulats de profondeur. Parmi différentes méthodes pour obtenir des données, les chercheurs ont utilisé celle consistant à faire un dessin d’un moment de guérison et celle consistant à raconter une histoire de psychothérapie telle que le client se la rappelle. Deux exemples de faire un dessin d’un moment de guérison ainsi qu’un exemple de raconter une histoire de psychothérapie sont analysés dans l’article. Les thèmes de l’expérience subjective du renouveau en psychothérapie, ainsi que la multiplicité d’expérience et de résultats en psychothérapie sont traités dans l’article et illustrés par des cas. Cette étude montre que de faire un dessin ouvre une dimension de plus dans la réflexion et que cela peut être un outil approprié pour le développement des récits individuels. Etre l’auteur de son récit de vie, ainsi que de sa réécriture, est considéré comme étant un aspect d’une thérapie productive. De même que découvrir sa capacité intérieure à « être auteur ». La capacité à suivre une succession de significations, ainsi qu’un lien avec la nature et la culture pourraient être une des manières d’actualiser une perspective intégrative dans la recherche en psychothérapie.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="ger">
        <AbstractText>Psychotherapieforschung ist ein sich rasant entwickelndes Forschungsgebiet, das darauf abzielt, die Integration der inneren und äußeren Bedingungen einer individuellen Erfahrung, das Zusammenspiel von Subjektivem und Objektivem sowie von Individuellem und Kollektivem zu untersuchen. In diesem Beitrag werden Fragen diskutiert, die sowohl eine integrativere Sichtweise als auch qualitative Forschung in der Psychotherapie berücksichtigen. Die Autorin stellt einige Ideen aus Studien zur Wirksamkeit von Psychotherapie vor, die an der Universität Vilnius von einer Gruppe von Forschern durchgeführt wurden, die im 'Zentrum zur Erforschung der Psychodynamik der Persönlichkeit' arbeiten. Zu dieser Forschergruppe gehören promovierte klinische Psychologen oder solche, die gegenwärtig am Institut für Psychologie der Universität Vilnius promovieren. Das subjektive Verständnis von Heilungsepisoden und die Entwicklung von Tiefenprämissen stellten die Hauptthemen dieser Studien dar. Neben anderen Methoden verwendeten die Forscher das Zeichnen eines Bildes eines Heilungsmomentes und das Erzählen einer Psychotherapiegeschichte, wie sie von Klienten erinnert wurde, um Daten zu sammeln. In der Arbeit werden zwei Beispiele für das Zeichnen eines Bildes eines Heilungsmomentes und ein Beispiel für das Erzählen einer Therapiegeschichte analysiert. Anhand von Falldarstellungen werden in dem Beitrag die Themen der subjektiven Erfahrung von Erneuerung in der Psychotherapie und die Vielzahl der Erfahrungen mit sowie die Ergebnisse von Psychotherapie diskutiert. Diese Studie hat gezeigt, daß das Zeichnen eines Bildes eine weitere Dimension der Reflexion eröffnet und ein geeignetes Werkzeug für die Entwicklung individueller Erzählungen sein kann. Das Verfassen und Neuverfassen der eigenen Lebenserzählung wird dabei als Teil einer produktiven Therapie und als Entdeckung der inneren Urheberschaft angesehen. Die Fähigkeit, einer Sukzession von Bedeutungen zu folgen sowie eine Verbindung zu Natur und Kultur herzustellen könnte eine der Möglichkeiten sein, eine integrative Sichtweise in der Psychotherapieforschung zu verwirklichen.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="ita">
        <AbstractText>La ricerca in psicoterapia è un’area di studio in rapida evoluzione che tende ad esplorare l’integrazione tra le condizioni interne ed esterne dell’esperienza individuale, l’interazione tra soggettivo ed oggettivo tanto quanto tra individuale e collettivo. Nell’articolo vengono affrontate domande relative ad una visione più integrativa ed alla ricerca qualitativa in psicoterapia. L’Autrice introduce alcune idee prese dagli studi sull’efficacia della psicoterapia effettuati all’università di Vilnius da un gruppo di ricercatori, che lavorano nel ‘Center for Research on the psychodynamics of personality’. Psicologi clinici che hanno conseguito un dottorato o che lo stanno per conseguire presso il Dipartimento di Psicologia dell’Università di Vilnius fanno parte di questo gruppo di ricerca. La comprensione soggettiva degli episodi di guarigione e lo sviluppo di premesse profonde erano gli obiettivi principali di questi studi. Tra i tanti metodi utilizzati dai ricercatori per raccogliere informazioni vi è il disegno di un’immagine di un momento di guarigione e la narrazione di una storia terapeutica rammentata dal paziente. Due esempi del ‘disegno di un’immagine di un momento di guarigione’ e un esempio della ‘narrazione di una storia terapeutica’ sono analizzati nell’articolo. I temi dell’esperienza soggettiva del rinnovamento nella psicoterapia così come la molteplicità di esperienze e risultati vengono trattati nell’articolo con illustrazioni di casi. Questo studio ha mostrato che disegnare un’immagine apre un’ulteriore dimensione di riflessione e che può essere uno strumento appropriato per lo sviluppo di una narrazione individuale. Scrivere e riscrivere la narrazione della propria vita fa parte di una terapia produttiva tanto quanto la scoperta di esserne l’autore. L’abilità di seguire una successione di significati, così come una connessione con la natura e la cultura, potrebbe essere un modo per realizzare una prospettiva nella ricerca psicoterapeutica.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="rus">
        <AbstractText>Исследование в психотерапии - это быстро развивающая область знаний, задачи которой состоят в изучении интеграции внутренних и внешних условий индивидуального опыта, взаимодействия между субъективным и объективным, индивидуальным и коллективным. В статье обсуждаются вопросы, связанные с интегративным подходом и качественными исследованиями в психотерапии. Автор представляет читателю некоторые идеи из работ по эффективности психотерапии, которые были проведены в университете Вильнюса группой ученых, работавших в «Центре исследования по психодинамике личности». Клинические психологи, имеющие докторскую степень или пишущие докторскую диссертацию на факультете психологии в университете Вильнюса, являются членами этой группы. Субъективное понимание моментов исцеления, а также предпосылки развития глубины терапии были основными задачами исследования. Среди прочих методов докторанты использовали рисунки моментов исцеления и рассказ психотерапевтической истории клиентом, которого приглашали для сбора данных. В статье анализируется два рисунка момента исцеления и одна терапевтическая история. Темы субъективного опыта обновления в психотерапии, а также многогранность опыта и результаты в психотерапии обсуждаются в статье вместе с клиническими иллюстрациями. Исследование показало, что рисунок открывает несколько измерений рефлексии, он может быть использован как адекватное средство для развития индивидуального нарратива. Авторское творение повторное сотворение нарратива своей жизни принимает как часть продуктивной терапии, а также позволяет открыть внутреннего автора. Способность прослеживать преемственность смыслов, а также связь между природой и культурой может быть одним из способов актуализации интегративного взгляда в исследовании в психотерапии.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="spa">
        <AbstractText>La investigación en psicoterapia es un área de estudio en creciente desarrollo cuyo objetivo es explorar la integración entre las condiciones internas y externas de la experiencia de un individuo, el inter-juego entre lo subjetivo y lo objetivo, así como entre lo individual y lo colectivo. Se plantean consideraciones respecto a una perspectiva más integradora y a la investigación cualitativa. La autora introduce algunas ideas, a partir de estudios sobre la efectividad de la psicoterapia llevados a cabo en la Universidad de Vilnius, por un grupo de investigadores que trabajan en el ‘Centro de investigación en los procesos psicodinámicos de la personalidad’. Los miembros de este grupo de investigación son psicólogos clínicos que tienen un doctorado o están realizando un doctorado en el Departamento de Psicología en la Universidad de Vilnius. Las principales tareas de estos estudios fueron el desarrollo de premisas profundas y la comprensión subjetiva sobre los episodios de curación. Entre otros métodos, los investigadores para recoger data, utilizaban el dibujar un cuadro sobre un momento de curación y contar una historia de psicoterapia contada por el cliente. Dos ejemplos de dibujar un cuadro de un momento de curación y un ejemplo de contar una historia de terapia son analizados en el presente trabajo. Se da cuenta de la experiencia subjetiva de renovación en psicoterapia así como de la multiplicidad de experiencias y resultados a partir de la ilustración de casos. El estudio muestra que el dibujar un cuadro abre una nueva dimensión de reflexión y puede ser una herramienta apropiada para el desarrollo de narrativas individuales. Ser autor/a, y volver a ser autor/a de la propia narrativa de vida se acepta como parte de una terapia productiva así como del descubrimiento de la autoridad interna. La habilidad de dar cuenta de una sucesión de sentidos, así como una conexión con la naturaleza y la cultura podrían ser uno de los modos de actualizar una perspectiva integradora en la investigación en psicoterapia.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="chi">
        <AbstractText>心理治疗研究是一个快速发展的领域, 它的目标是探索个体经验内在和外在状况的整合、主体与客体间以及个体与集体间的相互作用。这篇文章讨论的问题涉及心理治疗中更加整合的观点及定性的研究。作者介绍了来自维尔纽斯大学“人格心理动力研究中心”的一群研究者在进行心理治疗有效性研究时所发展出来的一些概念。这一研究团队的成员为具有博士学位的临床心理学家或是在维尔纽斯大学心理系在读的博士生。对治愈情节的主观理解, 以及作为治愈前提的深度发展是这些研究的主要任务。在研究者采用的诸多方法中, 还包括画出治愈时刻的图画, 以及来访者通过回忆而讲一个心理治疗的故事, 这些都作为研究所收集的数据。文章分析了两幅关于治愈时刻的绘画的案例, 以及一个治疗故事讲述的案例。治疗中更新的主体经验主题, 以及心理治疗中多样化的经验与结局都被作者以个案的形式进行了描绘。这一研究显示, 绘画可以带来更多层面的反思, 它可以是一个合适的工具用于个体叙述的发展。编著及再编著个体的生命叙述被当作为一种有益的治疗, 与此同时, 也有益于个体发现自己内在的著作者。有能力去跟随意义的演替, 以及去联系自然与文化, 可以是一种实行心理治疗研究的整合视角的途径。.</AbstractText>
      </OtherAbstract>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Analyse von Zeichnungen</Keyword>
        <Keyword MajorTopicYN="N">Gegensätze</Keyword>
        <Keyword MajorTopicYN="N">Neuverfassen von Erzählung</Keyword>
        <Keyword MajorTopicYN="N">Wirksamkeit von Psychotherapie</Keyword>
        <Keyword MajorTopicYN="N">actitud integradora</Keyword>
        <Keyword MajorTopicYN="N">analisi dei disegni</Keyword>
        <Keyword MajorTopicYN="N">analyse de dessins</Keyword>
        <Keyword MajorTopicYN="N">analysis of drawings</Keyword>
        <Keyword MajorTopicYN="N">análisis de dibujos</Keyword>
        <Keyword MajorTopicYN="N">attitude intégrative</Keyword>
        <Keyword MajorTopicYN="N">attitudine integrativa</Keyword>
        <Keyword MajorTopicYN="N">efectividad en psicoterapia</Keyword>
        <Keyword MajorTopicYN="N">efficacia della psicoterapia</Keyword>
        <Keyword MajorTopicYN="N">efficacité de la psychothérapie</Keyword>
        <Keyword MajorTopicYN="N">integrative Haltung</Keyword>
        <Keyword MajorTopicYN="N">integrative attitude</Keyword>
        <Keyword MajorTopicYN="N">investigación cualitativa</Keyword>
        <Keyword MajorTopicYN="N">narrativa riscritta</Keyword>
        <Keyword MajorTopicYN="N">opposites</Keyword>
        <Keyword MajorTopicYN="N">opposti</Keyword>
        <Keyword MajorTopicYN="N">opposés</Keyword>
        <Keyword MajorTopicYN="N">opuestos</Keyword>
        <Keyword MajorTopicYN="N">psychotherapy effectiveness</Keyword>
        <Keyword MajorTopicYN="N">qualitative Forschung</Keyword>
        <Keyword MajorTopicYN="N">qualitative research</Keyword>
        <Keyword MajorTopicYN="N">re-authoring narrative</Keyword>
        <Keyword MajorTopicYN="N">recherche qualitative</Keyword>
        <Keyword MajorTopicYN="N">ricerca qualitativa</Keyword>
        <Keyword MajorTopicYN="N">être auteur de ses récits de vie</Keyword>
        <Keyword MajorTopicYN="N">анализ рисунков</Keyword>
        <Keyword MajorTopicYN="N">интегративная установка</Keyword>
        <Keyword MajorTopicYN="N">качественное исследование</Keyword>
        <Keyword MajorTopicYN="N">повторное сотворение авторского нарратива</Keyword>
        <Keyword MajorTopicYN="N">противоположности</Keyword>
        <Keyword MajorTopicYN="N">эффективность психотерапии</Keyword>
        <Keyword MajorTopicYN="N">定性研究</Keyword>
        <Keyword MajorTopicYN="N">对立</Keyword>
        <Keyword MajorTopicYN="N">心理治疗效果</Keyword>
        <Keyword MajorTopicYN="N">整合的态度</Keyword>
        <Keyword MajorTopicYN="N">绘画分析</Keyword>
        <Keyword MajorTopicYN="N">重新编著叙事</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418832</ArticleId>
        <ArticleId IdType="doi">10.1111/1468-5922.12518</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Abt T. (2005). Introduction to Picture Interpretation According to C.G. Jung. Zurich, Zurich, Switzerland: Living Human Heritage Publications.</Citation>
        </Reference>
        <Reference>
          <Citation>Angus, L.E., Lewin, J., Bouffard, B., Rotondi-Trevisan, D., (2004). ‘What’s the story. working with narrative in experiential psychotherapy’. In The Handbook of Narrative and Psychotherapy. Practice, Theory and Research, eds. Angus, L. E, McLeod, J. London, Thousand Oaks, New Delhi: Sage Publications.</Citation>
        </Reference>
        <Reference>
          <Citation>Arzt, T. (2017). ‘The way of what is to come: searching for soul under postmodern conditions’. In Jung’s Red Book for Our Time: Searching for Soul under Postmodern Conditions, eds. Stein, M. and Arzt, T.. Vol.1. Asheville, North Carolina: Chiron Publications.</Citation>
        </Reference>
        <Reference>
          <Citation>Botella L., Herrero O., Pacheco M., Corbela S. (2004). ‘Working with narrative in psychotherapy: a relational constructivist approach’. In The Handbook of Narrative and Psychotherapy. Practice, Theory and Research, eds. Angus L. E, McLeod, J. London, Thousand Oaks, New Delhi: Sage Publications.</Citation>
        </Reference>
        <Reference>
          <Citation>Bryman, A. (2011). Visual Methods in Psychology: Using and Interpreting Images in Qualitative Research. London: Routledge.</Citation>
        </Reference>
        <Reference>
          <Citation>Cambray, J. (2010). ‘Emergence of the Self’. In Jungian Psychoanalysis: Working in the Spirit of C. G. Jung, ed. Stein, M. Chicago and La Salle: Open Court.</Citation>
        </Reference>
        <Reference>
          <Citation>Gailienė, D. (ed). (2015). Lithuanian Faces after Transition: Psychological Consequences of Cultural Trauma. Vilnius: Eugrimas.</Citation>
        </Reference>
        <Reference>
          <Citation>Grigutytė, N. and Rukšaitė, G. (2016). ‘Lithuanian historical heritage: relationship with authority and psychological well-being’. The European Proceedings of Social and Behavioral Sciences, 274-284.</Citation>
        </Reference>
        <Reference>
          <Citation>Gudaitė, G. (2014). ‘Restoration of continuity: desperation or hope in facing the consequences of cultural trauma’. In Confronting Cultural Trauma: Jungian Approaches to Understanding and Healing ed. Gudaitė, G. and Stein, M. New Orleans: Spring Journal Books.</Citation>
        </Reference>
        <Reference>
          <Citation>Gudaitė, G. (2016). Relationship with Authority and Sense of Personal Power. Vilnius, Lithuania: Vilnius University Press (in Lithuanian).</Citation>
        </Reference>
        <Reference>
          <Citation>Gudaitė, G. (2018a). ‘Psychotherapy research in times of change’. In Research in Analytical Psychology ed. Cambray, J. and Sawin, L. London and New York: Routledge.</Citation>
        </Reference>
        <Reference>
          <Citation>Gudaitė, G. (2018b). ‘Integrating horizontal and vertical dimensions of experience under postmodern conditions’. In Jung’s Red Book for Our Time. Searching for Soul under Postmodern Conditions, Vol.2. eds. Stein, M. and Arzt, T. Asheville, North Carolina: Chiron Publications.</Citation>
        </Reference>
        <Reference>
          <Citation>Hardke, K. K. and Angus, L. E. (2004). ‘The narrative assessment interview: assessing self- change in psychotherapy’. In The Handbook of Narrative and Psychotherapy. Practice, Theory and Research, eds. Angus L. E, McLeod, J. London: Thousand Oaks, Deli: Sage Publications.</Citation>
        </Reference>
        <Reference>
          <Citation>Jung, C.G. (1954). ‘Image. Definitions’. CW 6.</Citation>
        </Reference>
        <Reference>
          <Citation>Jung, C.G. (1978). ‘Psychology and Literature’. CW 15.</Citation>
        </Reference>
        <Reference>
          <Citation>Jung, C.G. (2009). The Red Book. Liber Novus, ed. Shamdasani, S. New York &amp; London: W.W. Norton.</Citation>
        </Reference>
        <Reference>
          <Citation>Leibowitz, M. (1999). Interpreting Projective Drawings. A Self -Psychological Approach. New York and London: Routledge.</Citation>
        </Reference>
        <Reference>
          <Citation>Kast, V. (2009). ‘The cultural unconsciousness and the roots of identity’ (keynote address, First European Conference of Analytical Psychology, ‘Dialogue at the Threshold between East and West: Cultural Identity Past, Present, and Future’, Vilnius, Jun 25-27, 2009.</Citation>
        </Reference>
        <Reference>
          <Citation>Lozovska, J. (2014). Reflecting on Psychotherapeutic Changes: Therapeutic Factors and the Transformation of Anger Expression. Summary of Doctoral Dissertation. Vilnius University.</Citation>
        </Reference>
        <Reference>
          <Citation>Nelson, E. E. (2018). ‘Jungian research and postmodernism: an antinomial approach’. In Research in Analytical Psychology, eds. Cambray, J. and Sawin, L. London and New York: Routledge.</Citation>
        </Reference>
        <Reference>
          <Citation>Prince, G. (2014). ‘On contemporary narratology’. In: Man and the Word/Literary Criticism, LED, 2014, vol.16, No 2, pp.106-130. Printed in Lithuanian Language.</Citation>
        </Reference>
        <Reference>
          <Citation>Proser, J. (2005). Image-based Research - a Sourcebook for Qualitative Researchers. London and New York: Taylor and Francis Group.</Citation>
        </Reference>
        <Reference>
          <Citation>Račiūnaitė-Vyčinienė, D. (1999). ‘The Motif of “Lino mūka”in Lithuanian Folklore: a Semantic Insight’. In Folk Culture. Scientific Works/Liaudies kultūra. Mokslo darbai 1999/2 No 65.p 18-25 (in Lithuanian).</Citation>
        </Reference>
        <Reference>
          <Citation>Stone, M. (2018). ‘Who is my Jung? Memories, Reflections, Prospects’. Journal of Analytical Psychology, 63, 3, 280-294.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31418834</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>16</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1468-5922</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>64</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of analytical psychology</Title>
          <ISOAbbreviation>J Anal Psychol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Cultural identity in Siberia and in analytical practice.</ArticleTitle>
        <Pagination>
          <MedlinePgn>548-564</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/1468-5922.12520</ELocationID>
        <Abstract>
          <AbstractText>This paper discusses the main features of Siberian identity formed throughout the historical development of Siberia under the influence of social, economic, geographical, climatic, and other factors. Siberian cultural identity is closely connected with the mythology and ancient religion of the indigenous peoples of Siberia - shamanism, whose rituals, images, symbols, and motifs are often manifested in the clients' dreams. Following an in-depth study of Siberian history and culture, I formulate a complex of homelessness rooted in a deep collective trauma that left its imprint on people's psyche. Three clinical cases presented in the paper reveal a deep relationship between cultural complexes and collective traumas on the one hand, and individual complexes and traumas, on the other. My psychotherapeutic practice shows that a client's awareness of their history and culture brings them closer to the meaning and source of their suffering, which, in turn, helps them find their own way of individuation, rather than relive the transgenerational trauma of their ancestors.</AbstractText>
          <CopyrightInformation>© 2019, The Society of Analytical Psychology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zabelina</LastName>
            <ForeName>Vera</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Kemerovo, Russia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Anal Psychol</MedlineTA>
        <NlmUniqueID>0376573</NlmUniqueID>
        <ISSNLinking>0021-8774</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003469" MajorTopicYN="Y">Culture</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004325" MajorTopicYN="N">Dreams</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011573" MajorTopicYN="N">Psychoanalytic Interpretation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011575" MajorTopicYN="N">Psychoanalytic Therapy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000067073" MajorTopicYN="N">Psychological Trauma</DescriptorName>
          <QualifierName UI="Q000208" MajorTopicYN="Y">ethnology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019423" MajorTopicYN="Y">Shamanism</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012800" MajorTopicYN="N" Type="Geographic">Siberia</DescriptorName>
          <QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012933" MajorTopicYN="Y">Social Identification</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <OtherAbstract Type="Publisher" Language="fre">
        <AbstractText>Cet article étudie les caractéristiques principales de l’identité Sibérienne formée au cours du développement historique de la Sibérie sous l’influence de facteurs sociaux, économiques, géographiques, climatiques et autres. L’identité culturelle Sibérienne est intimement liée à la mythologie et la religion ancienne des peuples indigènes de Sibérie - le shamanisme, dont les rituels, les images, les symboles et les motifs apparaissent souvent dans les rêves des clients. Après une étude approfondie de l’histoire et de la culture sibérienne, j’élabore le complexe « d’être sans domicile » enraciné dans un traumatisme collectif profond qui a laissé sa marque sur la psyché des personnes. Trois cas cliniques sont présentés. Ils révèlent une relation profonde entre les complexes culturels et les traumatismes collectifs d’une part, et les complexes et traumatismes individuels d’autre part. Ma clientèle psychothérapeutique montre qu’un client qui a conscience de son histoire et de sa culture se rapproche plus de la source et du sens de sa souffrance, et que ceci l’aide à trouver son propre chemin d’individuation, plutôt que de revivre le traumatisme transgénérationnel de leurs ancêtres.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="ger">
        <AbstractText>In diesem Artikel werden die Hauptmerkmale der sibirischen Identität erörtert, wie sie sich während der historischen Entwicklung Sibiriens unter dem Einfluß sozialer, wirtschaftlicher, geographischer, klimatischer und anderer Faktoren gebildet hat. Die sibirische kulturelle Identität ist eng mit der Mythologie und der alten Religion der sibirischen Ureinwohner verbunden - dem Schamanismus, dessen Rituale, Bilder, Symbole und Motive sich häufig in den Träumen der Klienten manifestieren. Nach einer eingehenden Untersuchung der sibirischen Geschichte und Kultur skizziere ich einen Komplex von Obdachlosigkeit, der in einem tiefen kollektiven Trauma wurzelt und seine Spuren in der Psyche der Menschen hinterlassen hat. Drei in der Arbeit vorgestellte klinische Fälle enthüllen eine tiefe Beziehung zwischen kulturellen Komplexen und kollektiven Traumata einerseits und individuellen Komplexen und Traumata andererseits. Meine psychotherapeutische Praxis zeigt, daß das Bewußtsein eines Klienten für seine Geschichte und Kultur ihn näher an die Bedeutung und die Quelle seines Leidens heranbringt was ihm wiederum hilft, seinen eigenen Weg der Individuation zu finden, anstatt das generationsübergreifende Trauma seiner Vorfahren erneut zu erleben.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="ita">
        <AbstractText>Questo articolo esamina i principali aspetti dell’identità siberiana formatisi nel corso dello sviluppo della Siberia sotto l’influenza di fattori sociali, economici, geografici, climatici ed altri. L’identità culturale siberiana è strettamente correlata alla mitologia ed all’antica religione della popolazione indigena della Siberia - lo sciamanesimo, i cui rituali, immagini, simboli e temi si manifestano spesso nei sogni dei pazienti. A seguito di uno studio approfondito della storia e della cultura siberiana ho individuato un ‘complesso del senza fissa dimora’ radicato in un profondo trauma collettivo che ha lasciato la sua impronta nella psiche della popolazione. Tre casi clinici presentati nell’articolo rivelano un profondo legame tra complessi culturali e traumi collettivi da un lato, e complessi e traumi individuali dall’altro. La mia pratica psicoterapeutica mostra come la consapevolezza che i pazienti hanno della loro storia e cultura li porti più vicini al significato ed alla radice della loro sofferenza, che a sua a volta li aiuta a trovare la loro personale strada per l’individuazione, piuttosto che rivivere il trauma transgenerazionale dei loro antenati.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="rus">
        <AbstractText>В статье исследуются основные черты сибирской идентичности, сформировавшиеся в ходе исторического развития Сибири под влиянием социальных, экономических, географических, климатических и других факторов. Сибирская культурная идентичность тесно связана с мифологией и древними верованиями коренных жителей Сибири - шаманизмом, чьи ритуалы, образы, символы и мотивы часто проявляются в сновидениях клиентов. Глубинное изучение истории и культуры Сибири позволило мне сформулировать комплекс бездомности, укорененный в глубине коллективной травмы, которая оставила свой отпечаток в психике людей. Три клинических случая, представленные в статье, раскрывают глубокие отношения между культурными комплексами и коллективными травмами с одной стороны, и индивидуальными комплексами и травмами с другой. Моя психотерапевтическая практика показывает, что осознание клиентами их истории и культуры приближает их к смыслу и источнику страданий, что в свою очередь помогает найти путь индивидуации и избежать повторного проживания травмы их предков.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="spa">
        <AbstractText>El presente trabajo da cuenta de los rasgos principales de la identidad Siberiana formada a través del desarrollo histórico de Siberia bajo la influencia de factores sociales, económicos, geográficos, climáticos y otros. La identidad cultural Siberiana está conectada a la mitología y a la religión antigua de los pueblos originarios de Siberia - el chamanismo, cuyos rituales, imágenes, símbolos y motivos se manifiestan a menudo en los sueños de los clientes. A partir de un estudio profundo sobre la cultura y la historia de Siberia, he formulado un complejo de “sin hogar” enraizado en un profundo trauma colectivo que deja sus marcas en la psique de las personas. Los tres casos clínicos presentados revelan una profunda relación entre complejos culturales y traumas colectivos por un lado, y complejos individuales y traumas, por otro. Mi práctica psicoterapéutica muestra que el conocimiento por parte del cliente de su historia y su cultura, le posibilita un acercamiento al sentido y a la fuente de su sufrimiento, lo cual, a su turno, le permite encontrar su propio modo de individuación, en lugar de revivir el trauma transgeneracional de sus ancestros.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="chi">
        <AbstractText>这篇文章讨论了在西伯利亚在社会、经济、地域、气候和其它因素影响下的历史发展中, 所构建起来西伯利亚人身份认同的主要特征。西伯利亚人的文化身份密切联系着其神话和原著民的古老宗教--即萨满教, 其仪式、意象、象征和教义常在来访者的梦中呈现。作者对西伯利亚的历史与文化进行了深层研究之后, 阐述了一个无家可归情结, 它根植在一个深度的集体创伤中, 并在人们的心灵中留下了印记。文章呈现了三个案例, 一方面展示了文化情结和集体创伤间的关系, 另一方面展示了个体情结和个体创伤。作者的心理治疗实践显示, 来访者对其历史和文化的觉察让他们更明了他们伤痛的意义和来源, 因此帮助他们找到自己的自性化之路, 而不是活在来自他们祖先的代际创伤中。.</AbstractText>
      </OtherAbstract>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Individuation</Keyword>
        <Keyword MajorTopicYN="N">Siberian shamanism</Keyword>
        <Keyword MajorTopicYN="N">chamanismo Siberiano</Keyword>
        <Keyword MajorTopicYN="N">complejo cultural</Keyword>
        <Keyword MajorTopicYN="N">complesso culturale</Keyword>
        <Keyword MajorTopicYN="N">complexe culturel</Keyword>
        <Keyword MajorTopicYN="N">cultural complex</Keyword>
        <Keyword MajorTopicYN="N">cultural identity</Keyword>
        <Keyword MajorTopicYN="N">identidad cultural</Keyword>
        <Keyword MajorTopicYN="N">identità culturale</Keyword>
        <Keyword MajorTopicYN="N">identité culturelle</Keyword>
        <Keyword MajorTopicYN="N">individuación</Keyword>
        <Keyword MajorTopicYN="N">individuation</Keyword>
        <Keyword MajorTopicYN="N">individuazione</Keyword>
        <Keyword MajorTopicYN="N">kulturelle Identität</Keyword>
        <Keyword MajorTopicYN="N">kultureller Komplex</Keyword>
        <Keyword MajorTopicYN="N">sciamanesimo siberiano</Keyword>
        <Keyword MajorTopicYN="N">shamanisme Sibérien</Keyword>
        <Keyword MajorTopicYN="N">sibirischer Schamanismus</Keyword>
        <Keyword MajorTopicYN="N">индивидуация</Keyword>
        <Keyword MajorTopicYN="N">культурная идентичность</Keyword>
        <Keyword MajorTopicYN="N">культурный комплекс</Keyword>
        <Keyword MajorTopicYN="N">сибирский шаманизм</Keyword>
        <Keyword MajorTopicYN="N">文化情结</Keyword>
        <Keyword MajorTopicYN="N">文化身份</Keyword>
        <Keyword MajorTopicYN="N">自性化</Keyword>
        <Keyword MajorTopicYN="N">西伯利亚萨满教</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418834</ArticleId>
        <ArticleId IdType="doi">10.1111/1468-5922.12520</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Anisimova, A. A., Yechevskaya, O. G. (2012). Sibirskaya identichnost: predposylki formirovaniya, konteksty aktualizatsiyi [Siberian identity: the prerequisites of formation, the contexts of actualization]. Novosibirsk: NGU.</Citation>
        </Reference>
        <Reference>
          <Citation>Downton J. (1989). ‘Individuation and shamanism’. Journal of Analytical Psychology, 34, 1. 73-88.</Citation>
        </Reference>
        <Reference>
          <Citation>Eliade, M. (1964). Shamanism: Archaic Techniques of Ecstasy. London: Routledge &amp; K. Paul.</Citation>
        </Reference>
        <Reference>
          <Citation>Gudaite, G. (2015). ‘Issues of cultural identity and authorship when receiving training from other cultures,’ in From Tradition to Innovation. Jungian Analysts Working in Different Cultural Settings. Ed. C. Crowther &amp; J. Wiener. New Orleans: Spring Journal.</Citation>
        </Reference>
        <Reference>
          <Citation>Jung, C.G. (1954/1981a). ‘The visions of Zosimos.’ In Alchemical Studies. CW 13.</Citation>
        </Reference>
        <Reference>
          <Citation>Kimeyev, V.M. (1989). Shortsy. Kto oni? Etnograficheskiye ocherki [The Shors. Who are they? Ethnographic essays]. Kemerovskoye knizhnoye izdatelstvo. .</Citation>
        </Reference>
        <Reference>
          <Citation>Olekh, L. (2001). Istoriya Sibiri [The history of Siberia]. Moscow: INFRA-M; Novosibirsk: Sibirskoye soglasheniye.</Citation>
        </Reference>
        <Reference>
          <Citation>Rasputin, V. (1996). Siberia, Siberia. Evanston: Northwestern University Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Rasputin, V. (2000). Bol’ ‘zapasnoy’ zemli [The pain of the ‘spare’ land] Rodina. No. 5. Pp. 18-23.</Citation>
        </Reference>
        <Reference>
          <Citation>Singer, T. &amp; Kimbles, S.eds. (2004). The Cultural Complex: Contemporary Jungian Perspectives on Psyche and Society. Hove and New York: Brunner Routledge.</Citation>
        </Reference>
        <Reference>
          <Citation>Sauer, G. (2018). Sibirskiye lektsii po analiticheskoy psikhologii [Siberian lectures on analytical psychology]. Moscow: Cogito-Centrе.</Citation>
        </Reference>
        <Reference>
          <Citation>Zherebina, T. (2017). Sibirskiy shamanizm: etnokulturniy atlas [Siberian shamanism: an ethnocultural atlas]. Saint Petersburg: Palmira; Moscow: Kniga po trebovaniyu.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">31418839</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1468-5922</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>64</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>09</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of analytical psychology</Title>
          <ISOAbbreviation>J Anal Psychol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Brogan, C. (2018). 'Donald Winnicott's unique view of depression with particular reference to his 1963 paper on the value of depression'. British Journal of Psychotherapy, 34:358-375.</ArticleTitle>
        <Pagination>
          <MedlinePgn>619-620</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/1468-5922.12528</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Cochrane</LastName>
            <ForeName>M J</ForeName>
            <Initials>MJ</Initials>
            <AffiliationInfo>
              <Affiliation>British Association for Counselling and Psychotherapy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Anal Psychol</MedlineTA>
        <NlmUniqueID>0376573</NlmUniqueID>
        <ISSNLinking>0021-8774</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="ErratumIn">
          <RefSource>J Anal Psychol. 2020 Feb;65(1):252</RefSource>
          <PMID Version="1">31972889</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418839</ArticleId>
        <ArticleId IdType="doi">10.1111/1468-5922.12528</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Samuels A, Shorter B, &amp; Plaut F. (1986). A Critical Dictionary of Jungian Analysis. London and New York: Routledge</Citation>
        </Reference>
        <Reference>
          <Citation>Sedgwick D. (2008). ‘Winnicott’s Dream: Some reflections on D.W. Winnicott and C.G. Jung.’ Journal of Analytical Psychology Vol. 3, p. 543.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31418836</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>16</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1468-5922</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>64</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of analytical psychology</Title>
          <ISOAbbreviation>J Anal Psychol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Models for training in Developing Groups: importing the traditional into unfamiliar cultures.</ArticleTitle>
        <Pagination>
          <MedlinePgn>443-461</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/1468-5922.12513</ELocationID>
        <Abstract>
          <AbstractText>The paper's central focus is on the usefulness or not of taking established and well-tried and tested models of training into cultures with different social, political and clinical attitudes. Beginning with the author's description of necessary changes introduced to ensure the revival of her own institute, the Society of Analytical Psychology, the author goes on to explore issues relevant to different aspects of training in countries where the IAAP runs its own training, known as the 'Router Programmes'. Here, analysts, teachers and supervisors visiting other cultures to offer their expertise may experience clashes in their views about the nature of the analytic attitude, not only with those they train but also amongst themselves.</AbstractText>
          <CopyrightInformation>© 2019, The Society of Analytical Psychology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wiener</LastName>
            <ForeName>Jan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>London.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Anal Psychol</MedlineTA>
        <NlmUniqueID>0376573</NlmUniqueID>
        <ISSNLinking>0021-8774</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003469" MajorTopicYN="Y">Culture</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004500" MajorTopicYN="Y">Education, Graduate</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
          <QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName>
          <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007318" MajorTopicYN="N">Inservice Training</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
          <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011575" MajorTopicYN="N">Psychoanalytic Therapy</DescriptorName>
          <QualifierName UI="Q000193" MajorTopicYN="Y">education</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012952" MajorTopicYN="N">Societies</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <OtherAbstract Type="Publisher" Language="fre">
        <AbstractText>L’accent central de cet article est la question de savoir s’il est heureux ou non d’importer des modèles de formation établis et qui ont fait leurs preuves dans des cultures qui ont des attitudes cliniques, sociales et politiques différentes. Commençant par la description par l’auteur de changements nécessaires introduits pour assurer le renouveau de son propre institut, la Society of Analytical Psychology, l’auteur poursuit en explorant des questions concernant différents aspects de la formation dans des pays ou l’AIPA fournit sa propre formation, que l’on appelle le Programme Router. Ici, les analystes, enseignants et superviseurs qui sont en visite dans les autres cultures pour apporter leur expertise peuvent faire l’expérience de conflits dans leurs perspectives sur la nature de l’attitude analytique, non seulement avec ceux qu’ils forment mais entre formateurs.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="ger">
        <AbstractText>Das Hauptaugenmerk des Beitrages gilt der Zweckmäßigkeit oder Nichtzweckmäßigkeit etablierter und bewährter Ausbildungsmodelle in Kulturen mit unterschiedlichen sozialen, politischen und klinischen Einstellungen. Beginnend mit den Schilderung der notwendigen Veränderungen, die getroffen wurden, um die Wiederbelebung ihres eigenen Institutes, der Society of Analytical Psychology, zu bewirken, untersucht die Autorin anschließend Fragen, die für verschiedene Aspekte der Ausbildung in Ländern relevant sind, in denen die IAAP ihre eigene Ausbildung durchführt, bekannt als das sogenannte 'Router-Programme'. Hier besuchen Analytiker, Lehrer und Supervisoren andere Kulturen, um ihr Fachwissen zur Verfügung zu stellen und erleben dabei Zusammenstöße ihrer Ansichten über die Art der analytischen Haltung nicht nur mit denen jener, die sie ausbilden, sondern auch untereinander.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="ita">
        <AbstractText>L’articolo si focalizza sull’utilità o meno dell’importare modelli di formazione consolidati e testati all’interno di culture con diverse attitudini sociali, politiche e cliniche. Iniziando con la descrizione dell’Autrice dei necessari cambiamenti introdotti per garantire il rilancio del proprio istituto, la Società di Psicologia Analitica (SAP), l’Autrice prosegue esplorando temi relativi a diversi aspetti della formazione in Paesi dove la IAAP svolge la propria formazione, conosciuta come il Programma dei Routers. Qui, analisti, insegnanti e supervisori in visita ad altre culture per offrire la loro competenza, potrebbero avvertire conflitti nelle loro visioni sulla natura dell’attitudine analitica, non solo nei confronti di chi educano, ma anche tra loro stessi.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="rus">
        <AbstractText>Внимание статьи обращено на полезность (или бесполезность) использования существующих хорошо апробированных тренинговых моделей в культурах с иными социальными, политическими и клиническими установками. Автор начинает с описания необходимых изменений, которые были внесены и оживили ее собственный институт the Society of Analytical Psychology. Затем она исследует вопросы, относящиеся к разным аспектам тренинга в странах, IAAP проводит свои обучающие «Рутерские Программы». Аналитики, преподаватели, супервизоры, приезжающие в другую культуру, чтобы предложить свою экспертизу, могут переживать столкновения своих взглядов на природу аналитической установки не только с убеждениями тех, кого они обучают, но и с коллегами по программе.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="spa">
        <AbstractText>El foco central del artículo es sobre la utilidad o no, de llevar modelos de formación establecidos, y bien probados y testeados, a culturas con diferentes actitudes sociales, políticas y clínicas. Comenzando con la descripción de los cambios necesarios introducidos para asegurar la renovación de su propio instituto, la Sociedad de Psicología Analítica, la autora continúa explorando cuestiones relevantes a aspectos diferentes de la formación en países donde la IAAP conduce su propia formación, conocida como “Programas de Routers”. Aquí, analistas, docentes y supervisores que visitan otras culturas para ofrecer su experticia pueden experimentar confrontaciones con sus perspectivas sobre la naturaleza de la actitud analítica, no solamente con aquellos a quienes forman, sino también entre sí mismos.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="chi">
        <AbstractText>文章的核心关注点是:对不同社会、政治、临床态度的文化中输入训练时的获益之处, 或者说关注的是如何在输入训练时不去用已经建构好的, 被反复实践试验的训练模型。作者先描述了那些为了让她的机构 (即分析心理学学会)可以保有新生力而作出的必要改变, 然后探索了IAAP在多个国家独立运行的训练, 即“行者项目”, 多方面的相关问题。这个项目中, 当分析师、教师、督导到访其它国家, 并提供他们的专业时, 可能会经历到与他们分析性态度不一致的冲突, 这些冲突不仅仅来自于他们所训练的人, 也来自他们自己内在。.</AbstractText>
      </OtherAbstract>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Ausbildungsmodelle</Keyword>
        <Keyword MajorTopicYN="N">Kommunikation</Keyword>
        <Keyword MajorTopicYN="N">Kultur</Keyword>
        <Keyword MajorTopicYN="N">Standards</Keyword>
        <Keyword MajorTopicYN="N">apprendimento bi-direzionale</Keyword>
        <Keyword MajorTopicYN="N">apprentissage bi-directionnel</Keyword>
        <Keyword MajorTopicYN="N">aprendizaje bidireccional</Keyword>
        <Keyword MajorTopicYN="N">bi-directional learning</Keyword>
        <Keyword MajorTopicYN="N">communication</Keyword>
        <Keyword MajorTopicYN="N">comunicación</Keyword>
        <Keyword MajorTopicYN="N">comunicazione</Keyword>
        <Keyword MajorTopicYN="N">cultura</Keyword>
        <Keyword MajorTopicYN="N">culture</Keyword>
        <Keyword MajorTopicYN="N">developing groups</Keyword>
        <Keyword MajorTopicYN="N">estándares</Keyword>
        <Keyword MajorTopicYN="N">groupes en développement</Keyword>
        <Keyword MajorTopicYN="N">grupos en desarrollo</Keyword>
        <Keyword MajorTopicYN="N">gruppi in via di sviluppo</Keyword>
        <Keyword MajorTopicYN="N">modelli di formazione</Keyword>
        <Keyword MajorTopicYN="N">modelos de formación</Keyword>
        <Keyword MajorTopicYN="N">models of training</Keyword>
        <Keyword MajorTopicYN="N">modèles de formation</Keyword>
        <Keyword MajorTopicYN="N">normes</Keyword>
        <Keyword MajorTopicYN="N">routers</Keyword>
        <Keyword MajorTopicYN="N">standard</Keyword>
        <Keyword MajorTopicYN="N">standards</Keyword>
        <Keyword MajorTopicYN="N">zweidirektionales Lernen</Keyword>
        <Keyword MajorTopicYN="N">группы развития</Keyword>
        <Keyword MajorTopicYN="N">дву-направленное обучение</Keyword>
        <Keyword MajorTopicYN="N">коммуникация</Keyword>
        <Keyword MajorTopicYN="N">культура</Keyword>
        <Keyword MajorTopicYN="N">рутеры</Keyword>
        <Keyword MajorTopicYN="N">стандарты</Keyword>
        <Keyword MajorTopicYN="N">тренинговые модели</Keyword>
        <Keyword MajorTopicYN="N">交流</Keyword>
        <Keyword MajorTopicYN="N">双向学习</Keyword>
        <Keyword MajorTopicYN="N">发展小组</Keyword>
        <Keyword MajorTopicYN="N">文化</Keyword>
        <Keyword MajorTopicYN="N">标准</Keyword>
        <Keyword MajorTopicYN="N">行者</Keyword>
        <Keyword MajorTopicYN="N">训练模式</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418836</ArticleId>
        <ArticleId IdType="doi">10.1111/1468-5922.12513</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>Bibliography</Title>
        <Reference>
          <Citation>Bauman, Z. (2012). Liquid Modernity. Cambridge and Malden MA: Polity Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Bauman, Z. (2017). A Chronicle of Crisis 2011 to 2016. Collection of articles published by Social Europe between 2011 and 2016. London: Social Europe Edition.</Citation>
        </Reference>
        <Reference>
          <Citation>Cambray, J. (2015). ‘Reflections on the bi-directionality of influence in analytical work across cultures’. Chapter 2 in From Tradition to Innovation: Jungian Analysts working in Different Cultural Settings, ed. C. Crowther &amp; J. Wiener. Spring Journal Books</Citation>
        </Reference>
        <Reference>
          <Citation>Crowther, C. &amp; Wiener, J. (2015). ‘From tradition to innovation: what have we learned?’ Chapter 16 in From Tradition to Innovation: Jungian Analysts working in Different Cultural Settings, ed. C. Crowther and J. Wiener. Spring Journal Books.</Citation>
        </Reference>
        <Reference>
          <Citation>Eisold, K. (2017). ‘Psychoanalytic training: then and now’. Chapter 3 in The Future of Psychoanalysis: The Debate about the Training Analyst System, ed. P. Zagermann. London: Karnac.</Citation>
        </Reference>
        <Reference>
          <Citation>Everett, D.L. (2016). Dark Matters of the Mind. Chicago and London: The University of Chicago Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Fornari Spoto, G. (2017). ‘Current aspects and challenges of analytic training’. Chapter 4 in The Future of Psychoanalysis: The Debate about the Training Analyst System, ed. P. Zagermann. London: Karnac.</Citation>
        </Reference>
        <Reference>
          <Citation>Garza-Guerrero, C. (2017). ‘Psychoanalytic education: between marginalization and irrelevance’. Chapter 6 in The Future of Psychoanalysis: The Debate about the Training Analyst System, ed. P. Zagermann. London: Karnac.</Citation>
        </Reference>
        <Reference>
          <Citation>Gessen, M. (2017). The Future is History: How Totalitarianism Reclaims Russia. London: Granta Publications.</Citation>
        </Reference>
        <Reference>
          <Citation>Gramsci. A. (1971). Prison Notebook Selection. London: Lawrence and Wishart.</Citation>
        </Reference>
        <Reference>
          <Citation>Holmes, J. (2010). Exploring in Security. London: Routledge.</Citation>
        </Reference>
        <Reference>
          <Citation>Lemma, A. (2017). The Digital Age on the Couch. London: Routledge.</Citation>
        </Reference>
        <Reference>
          <Citation>McGuire, W. (1974). The Freud/Jung Letters: The Correspondence between Sigmund Freud and C.G. Jung. London: Hogarth Press and Routledge and Kegan Paul.</Citation>
        </Reference>
        <Reference>
          <Citation>Merchant, J. (2016). ‘The use of Skype in analysis and training: a research and literature review’, Journal of Analytical Psychology, 61, 3, 309-328.</Citation>
        </Reference>
        <Reference>
          <Citation>Perry, C. &amp; Wiener, J. (2006). ‘Fifty years on: a training for the 21st century, from couple to community’. Journal of Analytical Psychology, 51, 2, 227-251.</Citation>
        </Reference>
        <Reference>
          <Citation>Rasche, J. and Singer, T. (2016). Europe’s Many Souls: Exploring Cultural Complexes and Identities. Spring Journal Books.</Citation>
        </Reference>
        <Reference>
          <Citation>Russell, G. (2015). Screen Relations: The Limits of Computer-Mediated Psychoanalysis and Psychotherapy. London: Karnac.</Citation>
        </Reference>
        <Reference>
          <Citation>Samuels, A. (2011). ‘Pluralism and psychotherapy: what is a good training?’ In Implausible Professions: Arguments for Pluralism and Autonomy in Psychotherapy and Counselling, ed. R. House &amp; N. Totton. Ross on Wye: PCCS Books.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, Y-W. et al. (2003). ‘The scale of ethnocultural empathy: development, validation and reliability’. Journal of Counselling Psychology, 50, 2, 222.</Citation>
        </Reference>
        <Reference>
          <Citation>Wiener, J. (2007). ‘Evaluating progress in training: character or competence?’ Journal of Analytical Psychology, 52, 2, 171-185</Citation>
        </Reference>
        <Reference>
          <Citation>Wiener, J. (2017). ‘Bureaucracy and creativity: do they make companionable bedfellows?’ Journal of Analytical Psychology, 62, 5, 660-670.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">31418840</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1468-5922</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>64</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>09</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of analytical psychology</Title>
          <ISOAbbreviation>J Anal Psychol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Gulina, M. &amp; Dobralioubova, V. (2018) 'One language and two mother tongues in the consulting room: dilemmas of a bilingual psychotherapist', British Journal of Psychotherapy. 34:1, 3-24.</ArticleTitle>
        <Pagination>
          <MedlinePgn>623-626</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/1468-5922.12530</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Egli</LastName>
            <ForeName>Jacqueline</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>British Association for Counselling and Psychotherapy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Anal Psychol</MedlineTA>
        <NlmUniqueID>0376573</NlmUniqueID>
        <ISSNLinking>0021-8774</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="ErratumIn">
          <RefSource>J Anal Psychol. 2020 Feb;65(1):253</RefSource>
          <PMID Version="1">31972883</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418840</ArticleId>
        <ArticleId IdType="doi">10.1111/1468-5922.12530</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Akhtar, S. (1995), ‘A third individuation: immigration, identity, and the psychoanalytic process’. Journal of American Psycho-Analysis, 43, 1051-1084.</Citation>
        </Reference>
        <Reference>
          <Citation>Anzieu, D. (2016), The Skin-Ego. London: Karnac.</Citation>
        </Reference>
        <Reference>
          <Citation>Brewster, F. (2013), ‘Wheel of Fire: The African American dreamer and cultural consciousness’. Jung Journal, 71, 70-87.</Citation>
        </Reference>
        <Reference>
          <Citation>De Waal, E. (2010), The Hare with Amber Eyes. A Hidden Inheritance. London: Vintage Books.</Citation>
        </Reference>
        <Reference>
          <Citation>Jung, C.G.. Jung, Letters Vol. II, Pages 95-98, taken from the Carl Jung Depth Psychology Website, Quotations with Images and Sources IV.</Citation>
        </Reference>
        <Reference>
          <Citation>Morgan, H. (2018), ‘Living in Two Worlds. How Jungian Am I?’, Journal of Analytical Psychology, 63.3, 313-321.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31418841</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>16</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1468-5922</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>64</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>09</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of analytical psychology</Title>
          <ISOAbbreviation>J Anal Psychol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Editorial.</ArticleTitle>
        <Pagination>
          <MedlinePgn>439-442</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/1468-5922.12512</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kelly</LastName>
            <ForeName>Tom</ForeName>
            <Initials>T</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
          <PublicationType UI="D054711">Introductory Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Anal Psychol</MedlineTA>
        <NlmUniqueID>0376573</NlmUniqueID>
        <ISSNLinking>0021-8774</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003226" MajorTopicYN="N">Congresses as Topic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003469" MajorTopicYN="N">Culture</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011575" MajorTopicYN="Y">Psychoanalytic Therapy</DescriptorName>
          <QualifierName UI="Q000193" MajorTopicYN="N">education</QualifierName>
          <QualifierName UI="Q000331" MajorTopicYN="N">legislation &amp; jurisprudence</QualifierName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
          <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418841</ArticleId>
        <ArticleId IdType="doi">10.1111/1468-5922.12512</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31418838</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>16</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1468-5922</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>64</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of analytical psychology</Title>
          <ISOAbbreviation>J Anal Psychol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Primo Levi's bearing witness and the reinterpreted past: post-truth and the authoritarian other.</ArticleTitle>
        <Pagination>
          <MedlinePgn>498-511</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/1468-5922.12517</ELocationID>
        <Abstract>
          <AbstractText>The stark realism of Primo Levi's experiences of the Shoah is considered in light of the current political climate in which the authoritarian other induces a divergence between reality, a state of things as they actually exist or existed, and truth, that which to some extent accords to reality. In this paper I will consider how truth becomes divorced from reality by considering Giegerich's interpretation of Plato's Parable of the Cave, arguing that truth is affected by perception and belief. After addressing 'truth' in justice, analytic work and the family, the post-truth phenomenon is discussed and defined as a force erosive to reason and sensibility; its general purpose is to avoid doubt and anxiety. The past is interpreted and re-interpreted to advance multiple geopolitical interests. Levi warned, in 1976, that the authoritarian state considers it quite permissible to alter the perception of what is true.</AbstractText>
          <CopyrightInformation>© 2019, The Society of Analytical Psychology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Willemsen</LastName>
            <ForeName>Hessel</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>London.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Anal Psychol</MedlineTA>
        <NlmUniqueID>0376573</NlmUniqueID>
        <ISSNLinking>0021-8774</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011572" MajorTopicYN="Y">Psychoanalysis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011574" MajorTopicYN="Y">Psychoanalytic Theory</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <OtherAbstract Type="Publisher" Language="fre">
        <AbstractText>Le réalisme frappant des expériences de Primo Levi de la Shoah est étudié à la lumière du climat politique actuel dans lequel l’autre autoritariste provoque une divergence entre une vérité perçue et la réalité factuelle. Dans cet article je vais prendre en compte comment la vérité devient divorcée de la réalité. Pour cela, je considérerai l’interprétation que fait Giegerich de la parabole de la caverne de Platon, la vérité étant la perception d’une réalité factuelle qui fut jadis. Après une discussion de la « vérité » dans le domaine de la justice, du travail analytique et de la famille, le phénomène de la post-vérité est abordé et défini comme une force érosive de la raison et de la sensibilité afin de s’épargner le doute et l’angoisse. Le passé est réinterprété dans le but de promouvoir les intérêts personnels et géopolitiques. Levi a donné l’avertissement, en 1976, que l’état autoritariste considère qu’il est permis d’altérer la vérité. Le point central dans la pensée de Levi est que la Shoah ne peut pas être comprise et ne doit pas être comprise, parce que comprendre voudrait dire la contenir.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="ger">
        <AbstractText>Primo Levis krasse Realerfahrungen mit der Shoah werden im Lichte des gegenwärtigen politischen Klimas betrachtet, in welchem der autoritäre Andere eine Divergenz zwischen einer wahrgenommenen Wahrheit und der tatsächlichen Realität hervorruft. In diesem Artikel werde ich untersuchen, wie die Wahrheit von der Realität getrennt wird, wobei ich Giegerichs Interpretation von Platons Höhlengleichnis heranziehe, in der als Wahrheit die Wahrnehmung einer tatsächlichen Realität gilt, die einmal war. Nach einer Erörterung von 'Wahrheit' in Justiz, analytischer Arbeit und Familie wird das Post-Wahrheitsphänomen diskutiert und als erosive Kraft gegen Vernunft und Sensibilität definiert, eingesetzt, um Zweifel und Angst zu vermeiden. Die Vergangenheit wird dabei neu interpretiert, um eigennützige und geopolitische Interessen voranzutreiben. Levi warnte 1976 davor, daß es der autoritäre Staat als zulässig ansehe, die Wahrheit zu verändern. In Levis Denken steht an zentraler Stelle, daß die Shoah nicht verstanden werden kann und nicht verstanden werden sollte, weil zu verstehen bedeutet, sie in sich aufzunehmen.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="ita">
        <AbstractText>Il crudo realismo di Primo Levi sulla sua esperienza della Shoah viene considerato alla luce dell’attuale clima politico, in cui l’altro autoritario induce ad una discrepanza tra una verità percepita ed una realtà fattuale. In questo articolo esamino come la verità si separi dalla realtà, prendendo in considerazione l’interpretazione di Giegerich sulla parabola della caverna di Platone, con la verità come percezione di una realtà fattuale che è stata. Dopo un approfondimento sulla ‘verità’ nella giustizia, nel lavoro analitico e nella famiglia, il fenomeno del post-verità è discusso e definito come una forza erosiva della ragione e sensibilità per cercare di sfuggire a dubbi ed angoscia. Il passato è re-interpretato per promuovere interessi personali e geopolitici. Levi avvisava, nel 1976, che lo stato autoritario considera ammissibile alterare la verità. Centrale nel pensiero di Levi è il fatto che la Shoah non può essere compresa, e non dovrebbe esserlo, perché comprenderla vorrebbe dire contenerla.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="rus">
        <AbstractText>Абсолютный реализм Примо Леви о его опыте Шоа (Холокоста) рассматривается в свете современного политического климата, в котором авторитарный другой вызывает разделение между воспринимаемой истиной и фактической реальностью. В этой статье на примере интерпретации Гигерихом притчи Платона о пещере я рассмотрю, как истина расходится с реальностью. После дискуссии об «истине» в правосудии, аналитической работе и семье, обсуждается феномен пост-правды, который определяется как разрушительная сила для разума и как способность избегать сомнения и тревогу. Прошлое интерпретируется заново с целью укрепления собственных и геополитических интересов. В 1976 году Леви предупреждал, что авторитарное государство считает допустимым менять правду. Центральной линией в рассуждениях Леви является отношение к Холокосту (Шоа): его невозможно понять и не следует понимать, так как понять означает контейнировать.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="spa">
        <AbstractText>El fuerte realismo de Primo Levi en torno a sus experiencias en la Shoah es considerado a la luz del clima político actual, en el cual el otro autoritario induce una divergencia entre una verdad percibida y la realidad factual. En el presente trabajo, consideraré como la verdad se divorcia de la realidad, considerando la interpretación de Giegerich sobre la parábola de la caverna de Platón, siendo la verdad, la percepción de una realidad factual que alguna vez fue. Luego de plantear la ‘verdad’ en la justicia, el trabajo analítico y la familia, el fenómeno de la posverdad es discutido y definido como una fuerza erosiva de la razón y de la sensibilidad para evitar la duda y la ansiedad. El pasado es reinterpretado dando cuenta del interés personal y de los intereses geopolíticos. Levi advirtió, en 1976, que el estado autoritario considera permitida la alteración de la verdad. Central en el pensamiento de Levi es que la Shoah no puede ser comprendida y no debería ser comprendida, porque comprenderla significa contenerla.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="chi">
        <AbstractText>文章从从当前政治气候的角度探讨了普里莫·莱维多所描绘的大屠杀经验中那种赤裸裸的写实主义, 这一视角认为集权他者诱发了感知到的现实和真实的现实之间的分裂。这篇文章中, 作者通过分析格里希关于柏拉图的洞穴寓言的解释来探讨真实如何与现实分道扬镳, 此处, 真实是指曾经感知的真实的现实。在讨论了法制中、分析工作中、以及家庭中的“真实”之后, 文章讨论了后真实的现象, 并把它定义为对理性的侵蚀性力量, 以及对怀疑与焦虑回避的敏感性。过往被重新解释为符合自我兴趣和历史政治兴趣的版本。1976年莱维曾警告过, 集权状态认为改变现实是允许的。莱维最核心的想法是, 大屠杀是不可以被理解的, 不应该被理解的, 因为理解它意味着接纳它。.</AbstractText>
      </OtherAbstract>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Höhlengleichnis</Keyword>
        <Keyword MajorTopicYN="N">Narzißmus</Keyword>
        <Keyword MajorTopicYN="N">Parable of the Cave</Keyword>
        <Keyword MajorTopicYN="N">Plato</Keyword>
        <Keyword MajorTopicYN="N">Platone</Keyword>
        <Keyword MajorTopicYN="N">Platón</Keyword>
        <Keyword MajorTopicYN="N">Post-Wahrheit</Keyword>
        <Keyword MajorTopicYN="N">Primo Levi</Keyword>
        <Keyword MajorTopicYN="N">Realität</Keyword>
        <Keyword MajorTopicYN="N">Wahrheit</Keyword>
        <Keyword MajorTopicYN="N">altro autoritario</Keyword>
        <Keyword MajorTopicYN="N">authoritarian other</Keyword>
        <Keyword MajorTopicYN="N">autoritärer Anderer</Keyword>
        <Keyword MajorTopicYN="N">autre autoritariste</Keyword>
        <Keyword MajorTopicYN="N">narcisismo</Keyword>
        <Keyword MajorTopicYN="N">narcissism</Keyword>
        <Keyword MajorTopicYN="N">narcissisme</Keyword>
        <Keyword MajorTopicYN="N">otro autoritario</Keyword>
        <Keyword MajorTopicYN="N">parabola della caverna</Keyword>
        <Keyword MajorTopicYN="N">parabole de la caverne</Keyword>
        <Keyword MajorTopicYN="N">parábola de la caverna</Keyword>
        <Keyword MajorTopicYN="N">post-truth</Keyword>
        <Keyword MajorTopicYN="N">post-verità</Keyword>
        <Keyword MajorTopicYN="N">post-vérité</Keyword>
        <Keyword MajorTopicYN="N">posverdad</Keyword>
        <Keyword MajorTopicYN="N">realidad</Keyword>
        <Keyword MajorTopicYN="N">reality</Keyword>
        <Keyword MajorTopicYN="N">realtà</Keyword>
        <Keyword MajorTopicYN="N">réalité</Keyword>
        <Keyword MajorTopicYN="N">truth</Keyword>
        <Keyword MajorTopicYN="N">verdad</Keyword>
        <Keyword MajorTopicYN="N">verità</Keyword>
        <Keyword MajorTopicYN="N">vérité</Keyword>
        <Keyword MajorTopicYN="N">Платон</Keyword>
        <Keyword MajorTopicYN="N">Примо Леви</Keyword>
        <Keyword MajorTopicYN="N">авторитарный другой</Keyword>
        <Keyword MajorTopicYN="N">истина</Keyword>
        <Keyword MajorTopicYN="N">нарциссизм</Keyword>
        <Keyword MajorTopicYN="N">пост-правда</Keyword>
        <Keyword MajorTopicYN="N">притча о пещере</Keyword>
        <Keyword MajorTopicYN="N">реальность</Keyword>
        <Keyword MajorTopicYN="N">后真实</Keyword>
        <Keyword MajorTopicYN="N">普里莫</Keyword>
        <Keyword MajorTopicYN="N">柏拉图</Keyword>
        <Keyword MajorTopicYN="N">洞穴寓言</Keyword>
        <Keyword MajorTopicYN="N">现实</Keyword>
        <Keyword MajorTopicYN="N">真实</Keyword>
        <Keyword MajorTopicYN="N">自恋</Keyword>
        <Keyword MajorTopicYN="N">莱维</Keyword>
        <Keyword MajorTopicYN="N">集权他者</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418838</ArticleId>
        <ArticleId IdType="doi">10.1111/1468-5922.12517</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Abensour, M. (2007). ‘Against the sovereignty of philosophy over politics: Arendt’s reading of Plato’s cave allegory’. Social Research, 74, 4, 955-82.</Citation>
        </Reference>
        <Reference>
          <Citation>Aberbach, D. (1989). Surviving Trauma: Loss, Literature, and Psychoanalysis. New Haven: Yale University Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Civitarese, G. (2016). ‘Truth as immediacy and unison: A new common round in psychoanalysis? Commentary on essays addressing “Is Truth relevant”?’. The Psychoanalytic Quarterly, 85, 2, 449-501.</Citation>
        </Reference>
        <Reference>
          <Citation>Collins, S. (2008). The Hunger Games. New York: Scholastic Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Cooper, J.M. (ed.) (1997). Plato: Complete Works. Cambridge: Hackett Publishing Company.</Citation>
        </Reference>
        <Reference>
          <Citation>Covington, C. (2014). Shrinking the New: Headline stories on the Couch. London: Karnac.</Citation>
        </Reference>
        <Reference>
          <Citation>Erikson, Erik H. (1959). Identity and the Life Cycle. New York: International Universities Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Giegerich, W. (2007). Technology and the Soul: From the Nuclear Bomb to the World Wide Web. Vol. II. New Orleans, LO: Spring Journal Books.</Citation>
        </Reference>
        <Reference>
          <Citation>Glanzberg, M. (ed.) (2018). The Oxford Handbook of Truth. Oxford: Oxford University Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Golding, W. (1954). The Lord of the Flies. Chatham: Faber and Faber.</Citation>
        </Reference>
        <Reference>
          <Citation>Grotstein, J.S. (1997). ‘Bion, the Pariah of “O”’. British Journal of Psychotherapy, 14, 1, 77-90.</Citation>
        </Reference>
        <Reference>
          <Citation>Heidegger, M. (2002). The Essence of the Truth: On Plato's Parable of the Cave and the Theaetetus. Nottingham: Mansell Publishing.</Citation>
        </Reference>
        <Reference>
          <Citation>Hinton, A. (2018). ‘Justice, temporality and shame at the Khmer Rouge Tribunal’. In: W. Ladson Hinton &amp; Hessel Willemsen (eds.). Temporality and Shame: Perspectives from Psychoanalysis and Philosophy. London and New York: Routledge.</Citation>
        </Reference>
        <Reference>
          <Citation>Hinton, L. (2019). ‘Jung, time and ethics’. In: John Mills (ed.). Jung and Philosophy. London and New York: Routledge.</Citation>
        </Reference>
        <Reference>
          <Citation>Jung, C.G. (1991). ‘The Structure and Dynamics of the Psyche’. CW 8.</Citation>
        </Reference>
        <Reference>
          <Citation>Jung, C.G. (1963/1995). Memories, Dreams, Reflections. London: Fontana Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Levi, P. (2015). ‘If this is a Man’. In Ann Goldstein (Ed.), The Complete Works of Primo Levi. London: Penguin Classics.</Citation>
        </Reference>
        <Reference>
          <Citation>Lipstadt, D. (1993/2016). Denying the Holocaust. London: Penguin Books.</Citation>
        </Reference>
        <Reference>
          <Citation>McEwan, I. (1997). The Cement Garden. London: Vintage.</Citation>
        </Reference>
        <Reference>
          <Citation>Orwell, G. (1945/2000). Animal Farm. London: Penguin Books.</Citation>
        </Reference>
        <Reference>
          <Citation>Orwell, G. (1949/2000). Nineteen Eighty-Four. London: Penguin Books.</Citation>
        </Reference>
        <Reference>
          <Citation>Oxford Dictionaries. https://en.oxforddictionaries.com/definition/post-truth.</Citation>
        </Reference>
        <Reference>
          <Citation>Renik, O. (1994). ‘Publication of clinical facts’. International Journal of Psycho-Analysis, 75, 5, 1245-50.</Citation>
        </Reference>
        <Reference>
          <Citation>Stiegler, B. (1998). Technics and Time, 1: The Fault of Epimetheus. Stanford: Stanford University Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Wharton, B. (1998). ‘What comes out of the consulting-room? The reporting of clinical material’. Journal of Analytical Psychology, 43, 2, 205-23.</Citation>
        </Reference>
        <Reference>
          <Citation>Žižek, S. (2009). Violence. London: Profile Books.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">31418842</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1468-5922</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>64</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>09</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of analytical psychology</Title>
          <ISOAbbreviation>J Anal Psychol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Samuels, Andrew (2017) 'The 'Activist Client': social responsibility, the political self, and clinical practice in psychotherapy and psychoanalysis'. Psychoanalytic Dialogues, 27:6, 678-693.</ArticleTitle>
        <Pagination>
          <MedlinePgn>634-637</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/1468-5922.12534</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Carta</LastName>
            <ForeName>Stefano</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>University of Cagliari.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Anal Psychol</MedlineTA>
        <NlmUniqueID>0376573</NlmUniqueID>
        <ISSNLinking>0021-8774</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418842</ArticleId>
        <ArticleId IdType="doi">10.1111/1468-5922.12534</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>Reference</Title>
        <Reference>
          <Citation>Schweder, R. A. (1991). Thinking Through Cultures: Expeditions in Cultural Psychology. Cambridge, MA: Harvard University Press</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM">
      <PMID Version="1">31418845</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>11</Month>
        <Day>27</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1468-5922</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>64</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>09</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of analytical psychology</Title>
          <ISOAbbreviation>J Anal Psychol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Mizen, Richard. (2019). 'The affective basis of violence'. Infant Mental Health Journal, 2019, 1-14.</ArticleTitle>
        <Pagination>
          <MedlinePgn>632-634</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/1468-5922.12533</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Berg</LastName>
            <ForeName>Astrid</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>World Association for Infant Mental Health.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016420">Comment</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Anal Psychol</MedlineTA>
        <NlmUniqueID>0376573</NlmUniqueID>
        <ISSNLinking>0021-8774</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentOn">
          <RefSource>Infant Ment Health J. 2019 Jan;40(1):113-128</RefSource>
          <PMID Version="1">30602065</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008603" MajorTopicYN="Y">Mental Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014754" MajorTopicYN="Y">Violence</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418845</ArticleId>
        <ArticleId IdType="doi">10.1111/1468-5922.12533</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Beebe, B. &amp; Lachmann, F. M. (2014). The Origins of Attachment: Infant Research and Adult Treatment. New York: Routledge.</Citation>
        </Reference>
        <Reference>
          <Citation>Bion, W. (1962). Learning from Experience. London: Karnac.</Citation>
        </Reference>
        <Reference>
          <Citation>Bion, W. (1963). Elements of Psychoanalysis. London: Karnac.</Citation>
        </Reference>
        <Reference>
          <Citation>Damasio, A. (2000). The Feeling of What Happens. London: Vintage.</Citation>
        </Reference>
        <Reference>
          <Citation>Golding P. &amp; Fitzgerald H. (2019). The early biopsychosocial development of boys and the origins of violence in males. Infant Mental Health Journal, 1(40), 8-22.</Citation>
        </Reference>
        <Reference>
          <Citation>Jung, C. G. (1954). The Development of Personality. New York: Princeton University Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Jung, C. G. (1969). Answer to Job. New York: Princeton University Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Stern, D. (2010). Forms of Vitality - Exploring Dynamic Experience in Psychology, the Arts, Psychotherapy and Development. Oxford: Oxford University Press.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31418843</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>16</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1468-5922</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>64</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of analytical psychology</Title>
          <ISOAbbreviation>J Anal Psychol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>No one here gets out alive: the Bluebeard story in therapy and in the culture.</ArticleTitle>
        <Pagination>
          <MedlinePgn>485-497</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/1468-5922.12516</ELocationID>
        <Abstract>
          <AbstractText>In this paper, the Bluebeard story is used to highlight mechanisms underlying an individual analytic case and some cultural phenomena from a Jungian perspective. I describe a patient whose psyche was dissociated into a tormenting monstrous figure and a regressed childish self, which Kalsched explains as activation of the archetypal defence system. As her analyst, I had to survive attacks of the patient's persecuting inner object, which she related to Bluebeard as a representation of relentless murderousness. At the cultural level, Bluebeard pertains to the concept of the totalitarian object (Sebek 1996) and to the pole of grandiosity of the Russian cultural complex.</AbstractText>
          <CopyrightInformation>© 2019, The Society of Analytical Psychology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Tsivinsky</LastName>
            <ForeName>Vladimir</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>St Petersburg, Russia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Anal Psychol</MedlineTA>
        <NlmUniqueID>0376573</NlmUniqueID>
        <ISSNLinking>0021-8774</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003469" MajorTopicYN="Y">Culture</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003674" MajorTopicYN="Y">Defense Mechanisms</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005195" MajorTopicYN="Y">Family Relations</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007602" MajorTopicYN="Y">Jungian Theory</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011369" MajorTopicYN="Y">Professional-Patient Relations</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011575" MajorTopicYN="N">Psychoanalytic Therapy</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <OtherAbstract Type="Publisher" Language="fre">
        <AbstractText>Dans cet article, l’histoire de Barbe Bleue est utilisée afin de souligner les mécanismes à l’œuvre dans un cas analytique et quelques phénomènes culturels à partir d’une perspective Jungienne. Je décris un patient dont la psyché a été dissociée en un personnage monstrueux et torturant, et en un soi infantile régressé, ce que Kalsched explique en tant que l’activation du système défensif archétypal. En tant que son analyste, j’eus à survivre les attaques de l’objet intérieur persécuteur du patient, qu’elle rapprochait de Barbe Bleue en tant que représentation d’une envie de tuer irrépressible. Au niveau culturel, Barbe Bleue se rapporte au concept d’objet totalitaire (Sebek 1996) et au pôle grandiose dans le complexe culturel russe.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="ger">
        <AbstractText>In diesem Aufsatz wird aus einer Jungianischen Perspektive die Blaubartgeschichte dazu verwendet, Mechanismen aufzuzeigen, die einem individuellen analytischen Fall wie auch einigen kulturellen Phänomenen zugrunde liegen. Ich beschreibe einen Patienten, dessen Psyche in eine quälende monströse Gestalt und ein regrediertes kindliches Selbst zerlegt war, was Kalsched mit einer Aktivierung des archetypischen Abwehrsystems erklärt. Als ihr Analytiker mußte ich Angriffe des verfolgenden inneren Objektes der Patientin überleben, welches sie mit Blaubart als Repräsentanten unerbittlicher Mordlust in Verbindung brachte. Auf kultureller Ebene steht Blaubart in Verbindung mit dem Konzept des totalitären Objektes (Sebek 1996) und dem Pol der Grandiosität des russischen kulturellen Komplexes.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="ita">
        <AbstractText>In questo articolo, la storia di Barbablù è utilizzata per evidenziare meccanismi sottostanti un caso analitico e alcuni fenomeni culturali da una prospettiva junghiana. Descrivo una paziente la cui psiche era dissociata in una figura mostruosa e crudele ed in un sé infantile regredito, che Kalsched descrive come attivazione del sistema di difesa archetipico. Come suo analista, ho dovuto superare attacchi da parte dell’oggetto interno persecutorio della paziente, da lei collegato a Barbablù come rappresentazione di una implacabile furia omicida. A livello culturale, Barbablù riguarda il concetto dell’oggetto totalitario (Sebek 1996) ed è il polo di grandiosità del complesso culturale russo.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="rus">
        <AbstractText>В данной статье история Синей Бороды использована для того, чтобы осветить с юнгианской точки зрения механизмы, лежащие в основе индивидуального аналитического случая и некоторых культурных феноменов. Я описываю пациентку, чья психика раскололась на мучающего монстра и регрессировавшее детское я. Калшед объясняет подобный процесс как активацию архетипической системы защит. Будучи ее аналитиком, я должен был выжить под атаками преследующего внутреннего объекта пациентки, которого она называла Синей Бородой - репрезентацией неуемной жажды убивать. На культурном уровне Синюю Бороду можно соотнести с понятием тоталитарного объекта (Sebek 1996) и с полюсом грандиозности в русском культурном комплексе.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="spa">
        <AbstractText>En el presente trabajo, la historia de Barba Azul es utilizada para esclarecer los mecanismos que subyacen a un caso analítico individual, y ciertos fenómenos culturales desde una perspectiva Junguiana. Describo a un paciente cuya psique fue disociada entre una figura monstruosa y atormentadora, y un self infantil regresivo, lo cual Kalsched ha explicado como la activación del sistema arquetipal de defensa. Como su analista, he tenido que sobrevivir a los ataques de un objeto interno persecutorio de la paciente, el cual ella relacionó con Barba Azul como representación de un incesante impulso homicida. A nivel cultural, Barba Azul pertenece al concepto de objeto totalitario (Sebek 1996) y al polo de grandiosidad del complejo cultural Ruso.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="chi">
        <AbstractText>文中用蓝胡子的故事来强调在一个个体分析案例中发生的基本的心理机制, 以及从荣格学派的角度强调了一些文化现象。作者描述了一个病人, 其心灵分裂为一个折磨人的可怕人物和一个退行的孩子气的自我, 即卡尔斯切德所说的被激活的原型防御系统。作为她的分析师, 我必须要受得住这位病人迫害性的内在客体的攻击, 她把这个客体与蓝胡子联系起来, 代表了残酷的谋杀性。在文化层面, 蓝胡子属于极权主义客体的概念 (Sebek 1996), 是俄罗斯文化情结中自大狂的极点。.</AbstractText>
      </OtherAbstract>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Barba Azul</Keyword>
        <Keyword MajorTopicYN="N">Barbablù</Keyword>
        <Keyword MajorTopicYN="N">Barbe Bleue</Keyword>
        <Keyword MajorTopicYN="N">Blaubart</Keyword>
        <Keyword MajorTopicYN="N">Bluebeard</Keyword>
        <Keyword MajorTopicYN="N">Dissoziation</Keyword>
        <Keyword MajorTopicYN="N">Jungian analysis</Keyword>
        <Keyword MajorTopicYN="N">Jungianische Analyse</Keyword>
        <Keyword MajorTopicYN="N">analisi junghiana</Keyword>
        <Keyword MajorTopicYN="N">analyse Jungienne</Keyword>
        <Keyword MajorTopicYN="N">análisis Junguiano</Keyword>
        <Keyword MajorTopicYN="N">archetypisches Abwehrsystem</Keyword>
        <Keyword MajorTopicYN="N">complejo cultural Ruso</Keyword>
        <Keyword MajorTopicYN="N">complesso culturale russo</Keyword>
        <Keyword MajorTopicYN="N">der russische kulturelle Komplex</Keyword>
        <Keyword MajorTopicYN="N">disociación</Keyword>
        <Keyword MajorTopicYN="N">dissociation</Keyword>
        <Keyword MajorTopicYN="N">dissociazione</Keyword>
        <Keyword MajorTopicYN="N">el sistema arquetipal de defensa</Keyword>
        <Keyword MajorTopicYN="N">le complexe culturel russe</Keyword>
        <Keyword MajorTopicYN="N">le système défensif archétypal</Keyword>
        <Keyword MajorTopicYN="N">sistema di difesa archetipico</Keyword>
        <Keyword MajorTopicYN="N">the Russian cultural complex</Keyword>
        <Keyword MajorTopicYN="N">the archetypal defence system</Keyword>
        <Keyword MajorTopicYN="N">Синяя Борода</Keyword>
        <Keyword MajorTopicYN="N">архетипическая система защит</Keyword>
        <Keyword MajorTopicYN="N">диссоциация</Keyword>
        <Keyword MajorTopicYN="N">русский культурный комплекс</Keyword>
        <Keyword MajorTopicYN="N">юнгианский анализ</Keyword>
        <Keyword MajorTopicYN="N">俄罗斯文化情结</Keyword>
        <Keyword MajorTopicYN="N">分裂</Keyword>
        <Keyword MajorTopicYN="N">原型的防御系统</Keyword>
        <Keyword MajorTopicYN="N">荣格分析</Keyword>
        <Keyword MajorTopicYN="N">蓝胡子</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418843</ArticleId>
        <ArticleId IdType="doi">10.1111/1468-5922.12516</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Arendt, H. (1962). The Origins of Totalitarianism. Cleveland &amp; New York: Meridian Books.</Citation>
        </Reference>
        <Reference>
          <Citation>Ashley, T. (2004). ‘Bloody Chambers’. The Guardian, Aug 28, 2004. Available from: https://www.theguardian.com/music/2004/aug/28/classicalmusicandopera.stage</Citation>
        </Reference>
        <Reference>
          <Citation>Chernychev (1950). Skayki I LegendiPushkinskihMest (Fairy Tales and Legends of Pushkin's Places) Moscow, Leningrad: Publishing House of the USSR Academy of Science.</Citation>
        </Reference>
        <Reference>
          <Citation>Chukovsky, K. (1921). The Monster Cockroach (Tarakanische). Available from: https://www.behance.net/gallery/4406355/The-Monster-Cockroach-Kornei-Chukovsky</Citation>
        </Reference>
        <Reference>
          <Citation>Classic Fairy Tale: Bluebeard. (1997) Available from: http://childhoodreading.com/bluebeard/</Citation>
        </Reference>
        <Reference>
          <Citation>Estes, C. P. (1992). Women Who Run with the Wolves: Myths and Stories of the Wild Woman Archetype. New York: Ballantine Books.</Citation>
        </Reference>
        <Reference>
          <Citation>France, A. (1920). The Seven Wives of Bluebeard. Eds. James Lewis May and Bernard Miall. London and New York: John Lane Company.</Citation>
        </Reference>
        <Reference>
          <Citation>Grimm, J. &amp; Grimm, W. (1884). Household Tales. Margaret Hunt, translator. London: George Bell.</Citation>
        </Reference>
        <Reference>
          <Citation>Jónsdóttir, M.S. (2015). ‘Madam has a Word to Say: Power, Gender and Responsibility in Retellings of “Bluebeard”’. Available from: https://skemman.is/handle/1946/21033?locale=en</Citation>
        </Reference>
        <Reference>
          <Citation>Jung, C.G. (1958). ‘The Shadow’, CW 9ii.</Citation>
        </Reference>
        <Reference>
          <Citation>Jung, C.G. (1970). Mysterium Coniunctionis. CW 14.</Citation>
        </Reference>
        <Reference>
          <Citation>Kalsched, D. (1994). The Inner World of Trauma: Archetypal Defenses of the Spirit. New York: Routledge.</Citation>
        </Reference>
        <Reference>
          <Citation>Kalsched, D. (2013). Trauma and the Soul: A Psycho-Spiritual Approach to Human Development and its Interruption. New York: Routledge.</Citation>
        </Reference>
        <Reference>
          <Citation>Klein, M. (1952). Envy and Gratitude and Other Works 1946-1963. London: Hogarth Press and the Institute of Psycho-Analysis.</Citation>
        </Reference>
        <Reference>
          <Citation>Osborne, D.M. (2014). ‘Bluebeard and its multiple layers of meaning’. Revista Alpha, 15, pp. 128-137.</Citation>
        </Reference>
        <Reference>
          <Citation>Propp, V.Y. (2012). The Russian Folktale. Edited and translated by Sibelan Forrester. Detroit: Wayne State University Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Pushkin, A.S. (1825). The Bridegroom. English translation available from: http://hs.dibollisd.com/ourpages/auto/2014/2/24/41421532/The%20Bridegroom%20full%20text.pdf</Citation>
        </Reference>
        <Reference>
          <Citation>Sebek, M. (1996). ‘The fate of the totalitarian object’. International Forum of Psychoanalysis, 1996, 5, 289-294.</Citation>
        </Reference>
        <Reference>
          <Citation>Singer, T. &amp; Kimbles, S.L. (Ed.) (2004). The Cultural Complex: Contemporary Jungian Perspectives on Psyche and Society. Hove &amp; New York: Brunner-Routledge.</Citation>
        </Reference>
        <Reference>
          <Citation>Svendsen, L. F. H. (2010). A Philosophy of Evil. London: Dalkey Archive Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Tsivinsky, V. (2014). ‘The spatial metaphor of Utopia in the Russian culture and in analysis’. Journal of Analytical Psychology, 59, 1, 47-59.</Citation>
        </Reference>
        <Reference>
          <Citation>Very Blue Beard (OchenSinyayaBoroda). (1979). Available from https://www.youtube.com/watch?v=RtmrldwPVng</Citation>
        </Reference>
        <Reference>
          <Citation>Vonnegut, K. (1987). Bluebeard. New York: Delacorte Press.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31418844</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>16</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1468-5922</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>64</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of analytical psychology</Title>
          <ISOAbbreviation>J Anal Psychol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Trauma, resilience and healthy and unhealthy forms of dissociation.</ArticleTitle>
        <Pagination>
          <MedlinePgn>587-606</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/1468-5922.12522</ELocationID>
        <Abstract>
          <AbstractText>This paper outlines the difference between healthy and unhealthy forms of dissociation following, and in response to, traumatic experience, in particular the experience of refugees, calling on 30 years' experience in working with refugees in voluntary and public sectors, including 20 years at the Refugee Therapy Centre, London. It differentiates dissociation from repression, and looks at some of the specific traumatic experiences associated with refugees' displacement and situation, particularly relating to loss. Four key characteristics of resilience are described: 'psychic space', 'sense of self', and the use of a 'listening other' and 'healthy dissociation/resiliency'. Two vignettes are given to illustrate the difference between healthy and unhealthy dissociation.</AbstractText>
          <CopyrightInformation>© 2019, The Society of Analytical Psychology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Alayarian</LastName>
            <ForeName>Aida</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>London.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Anal Psychol</MedlineTA>
        <NlmUniqueID>0376573</NlmUniqueID>
        <ISSNLinking>0021-8774</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004213" MajorTopicYN="N">Dissociative Disorders</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004532" MajorTopicYN="Y">Ego</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007602" MajorTopicYN="N">Jungian Theory</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000067073" MajorTopicYN="N">Psychological Trauma</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012036" MajorTopicYN="N">Refugees</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055500" MajorTopicYN="Y">Resilience, Psychological</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <OtherAbstract Type="Publisher" Language="fre">
        <AbstractText>Cet article souligne la différence entre des formes saines et des formes pathologiques de dissociation, qui surviennent à la suite d’expériences traumatiques et en réponse à ces expériences. L’article s’appuie en particulier sur l’expérience de réfugiés ainsi que l’expérience de trente années de travail de l’auteur auprès de réfugiés dans le secteur public et privé, dont vingt années au Refugee Therapy Centre à Londres. L’article fait la différence entre dissociation et refoulement, et étudie les expériences traumatiques spécifiques des réfugiés, concernant le déplacement et le statut, et particulièrement l’expérience de la perte. Quatre caractéristiques de la résilience sont décrites: « l’espace psychique », « le sentiment de soi », l’accès à « quelqu’un qui écoute » et la « dissociation saine/la résilience ». Deux vignettes cliniques sont données pour illustrer cette différence entre dissociation saine et dissociation pathologique.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="ger">
        <AbstractText>In diesem Beitrag wird der Unterschied zwischen gesunden und ungesunden Formen der Dissoziation nach und als Reaktion auf traumatische Erfahrungen, insbesondere die Erfahrungen von Flüchtlingen, skizziert. Dabei wird auf 30 Jahre Erfahrung in der Arbeit mit Flüchtlingen im freiwilligen und öffentlichen Sektor zurückgegriffen, darunter 20 Jahre im EU Flüchtlingstherapiezentrum London. Es wird zwischen Dissoziation und Unterdrückung unterschieden und der Blick auf einige der spezifischen traumatischen Erfahrungen gerichtet, die mit der Vertreibung und der allgemeinen Lage von Flüchtlingen verbunden sind, insbesondere hinsichtlich Verlust. Es werden vier Schlüsselmerkmale der Resilienz beschrieben: ‘psychischer Raum', ‘Selbstgefühl' und die Bedeutung eines ‘zuhörenden Anderen' sowie ‘gesunde Dissoziation/Resilienz'. Zwei Vignetten veranschaulichen den Unterschied zwischen gesunder und ungesunder Dissoziation.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="ita">
        <AbstractText>Questo articolo delinea la differenza tra forme di dissociazione sane e malate a seguito, ed in risposta, a l’esperienza traumatica, in particolare l’esperienza dei rifugiati, facendo riferimento a 30 anni di esperienza di lavoro con essi, sia nel settore pubblico che nel volontariato, compresi 20 anni presso il Refugee Therapy Centre di Londra. In questo articolo si differenzia la dissociazione dalla repressione, e si guarda ad alcune specifiche esperienze traumatiche associate al dislocamento dei rifugiati ed alla loro situazione, in particolare in relazione alla perdita. Le quattro caratteristiche chiave della resilienza sono descritte come: ‘spazio psichico’, ‘senso di sé’, l’utilizzo di un ‘altro che ascolta’ ed una ‘sana dissociazione/resilienza’. Vengono presentate due vignette per illustrare questa differenza tra dissociazione sana e dissociazione malata.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="rus">
        <AbstractText>В статье описаны различия между здоровыми и нездоровыми формами диссоциации как ответной реакции на травматический опыт. Особое внимание уделено опыту беженцев, так как автор проработала 30 лет в добровольческих и общественных организациях помощи беженцам, в том числе в Терапевтическом Центре для беженцев в Лондоне. Проводится различие между диссоциацией и вытеснением, а также исследуются травматические переживания беженцев, связанные с перемещением и утратой. Описаны 4 главные характеристики устойчивости: «психическое пространство», «чувство я», использование «слушающего другого» и «здоровая диссоциация/устойчивость». Две виньетки иллюстрируют различия между здоровой и нездоровой диссоциацией.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="spa">
        <AbstractText>El presente trabajo da cuenta de la diferencia entre formas saludables y no saludables de disociación, en respuesta a experiencias traumáticas, en particular, la experiencia de los refugiados; a partir de 30 años de experiencia trabajando con refugiados en sectores públicos y privados, incluyendo 20 años en el Centro de Terapia para Refugiados, en Londres. Se diferencia la disociación de la represión, y se atiende a las experiencias traumáticas específicas asociadas a los desplazamientos de los refugiados, y a la situación particular relacionada con la pérdida. Se describen cuatro características de la resiliencia: ‘espacio psíquico’, ‘sentido del sí mismo’, ‘y el uso de ‘otro que escucha’ y ‘sana disociación/resiliencia’. Se presentan dos viñetas para ilustrar la diferencia entre la disociación saludable y no saludable.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="chi">
        <AbstractText>这篇文章结合了作者30年间作为志愿者和公共机关工作者与难民工作的经验, 以及20年来在伦敦难民治疗中心的经验, 来概述健康与不健康的隔离间的差别, 及其与创伤的关系, 文章特别关注了难民的经验。文章把隔离与压抑做了区分, 分析了难民的移置和其特别处境相关的创伤经验, 特别是与他们的丧失有关的经验。文章描述了四种关键的弹性特征:“心理空间”, “自我感”, 对“倾听的他人”的使用, “健康的隔离/弹性”。文章插叙了两个片段用来区分健康与不健康的隔离。.</AbstractText>
      </OtherAbstract>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Dissoziation</Keyword>
        <Keyword MajorTopicYN="N">Flüchtling</Keyword>
        <Keyword MajorTopicYN="N">Resilienz</Keyword>
        <Keyword MajorTopicYN="N">Selbstgefühl</Keyword>
        <Keyword MajorTopicYN="N">Trauma</Keyword>
        <Keyword MajorTopicYN="N">Verletzlichkeit</Keyword>
        <Keyword MajorTopicYN="N">altro che ascolta</Keyword>
        <Keyword MajorTopicYN="N">disociación</Keyword>
        <Keyword MajorTopicYN="N">dissociation</Keyword>
        <Keyword MajorTopicYN="N">dissociazione</Keyword>
        <Keyword MajorTopicYN="N">espace psychique</Keyword>
        <Keyword MajorTopicYN="N">espacio psíquico</Keyword>
        <Keyword MajorTopicYN="N">listening other</Keyword>
        <Keyword MajorTopicYN="N">otro que escucha</Keyword>
        <Keyword MajorTopicYN="N">psychic space</Keyword>
        <Keyword MajorTopicYN="N">psychischer Raum</Keyword>
        <Keyword MajorTopicYN="N">quelqu’un qui écoute</Keyword>
        <Keyword MajorTopicYN="N">refugee</Keyword>
        <Keyword MajorTopicYN="N">refugiado</Keyword>
        <Keyword MajorTopicYN="N">resilience</Keyword>
        <Keyword MajorTopicYN="N">resiliencia</Keyword>
        <Keyword MajorTopicYN="N">resilienza</Keyword>
        <Keyword MajorTopicYN="N">rifugiato</Keyword>
        <Keyword MajorTopicYN="N">réfugié</Keyword>
        <Keyword MajorTopicYN="N">résilience</Keyword>
        <Keyword MajorTopicYN="N">sense of self</Keyword>
        <Keyword MajorTopicYN="N">senso di sé</Keyword>
        <Keyword MajorTopicYN="N">sentido de sí mismo</Keyword>
        <Keyword MajorTopicYN="N">sentiment de soi</Keyword>
        <Keyword MajorTopicYN="N">spazio psichico</Keyword>
        <Keyword MajorTopicYN="N">trauma</Keyword>
        <Keyword MajorTopicYN="N">traumatisme</Keyword>
        <Keyword MajorTopicYN="N">vulnerabilidad</Keyword>
        <Keyword MajorTopicYN="N">vulnerability</Keyword>
        <Keyword MajorTopicYN="N">vulnerabilità</Keyword>
        <Keyword MajorTopicYN="N">vulnérabilité</Keyword>
        <Keyword MajorTopicYN="N">zuhörender Anderer</Keyword>
        <Keyword MajorTopicYN="N">беженцы</Keyword>
        <Keyword MajorTopicYN="N">диссоциация</Keyword>
        <Keyword MajorTopicYN="N">психического пространство</Keyword>
        <Keyword MajorTopicYN="N">слушающий другой</Keyword>
        <Keyword MajorTopicYN="N">травма</Keyword>
        <Keyword MajorTopicYN="N">устойчивость</Keyword>
        <Keyword MajorTopicYN="N">уязвимость</Keyword>
        <Keyword MajorTopicYN="N">чувство я</Keyword>
        <Keyword MajorTopicYN="N">倾听的他人</Keyword>
        <Keyword MajorTopicYN="N">创伤</Keyword>
        <Keyword MajorTopicYN="N">弹性</Keyword>
        <Keyword MajorTopicYN="N">心理空间</Keyword>
        <Keyword MajorTopicYN="N">脆弱</Keyword>
        <Keyword MajorTopicYN="N">自我感</Keyword>
        <Keyword MajorTopicYN="N">隔离</Keyword>
        <Keyword MajorTopicYN="N">难民</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418844</ArticleId>
        <ArticleId IdType="doi">10.1111/1468-5922.12522</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Alayarian, A. (2011). Trauma, Torture and Dissociation: A Psychoanalytic View. Karnac Books: London.</Citation>
        </Reference>
        <Reference>
          <Citation>Alayarian, A. (2015). Handbook of Working with Children, Trauma, and Resilience. Karnac Books: London.</Citation>
        </Reference>
        <Reference>
          <Citation>Barker, P. (1991). Regeneration. United Kingdom: Viking Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Cozolino L. (2002). ‘The impact of trauma on the brain’. In: The Neuroscience of Psychotherapy. Building and Rebuilding the Human Brain. (pp.257-288). New York: W.W. Norton.</Citation>
        </Reference>
        <Reference>
          <Citation>DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, 4th. Edition, the American Psychiatric Association</Citation>
        </Reference>
        <Reference>
          <Citation>Freud, S. (1896). ‘Further remarks on the neuro-psychoses of defence’. S.E., 3, 162-18.</Citation>
        </Reference>
        <Reference>
          <Citation>Freud, S. (1919) Introduction to Psychoanalysis and War Neuroses. S.E. 17, 205-211.</Citation>
        </Reference>
        <Reference>
          <Citation>Freud, S. (1920). ‘Beyond the pleasure principle’. S.E. 18.</Citation>
        </Reference>
        <Reference>
          <Citation>Fonagy, P. (1999) ‘Evidenced based medicine and its justifications’ in: Leuzinger-Bohleber, M and Target, M. (ed.) Outcomes of Psychoanalytic Treatment. London: Whurr.</Citation>
        </Reference>
        <Reference>
          <Citation>Freyd. J. J. (1996). Betrayal Trauma. London: Harvard University Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Hart, O., Nijenhuis, E. R. S., &amp; Steele, K. (2006). The Haunted Self: Structural Dissociation and the Treatment of Chronic Traumatization. New York: W.W. Norton.</Citation>
        </Reference>
        <Reference>
          <Citation>Howell, E. &amp; Itzkowitz, Sh. (2016), Eds. The Dissociative Mind in Psychoanalysis: Understanding and Working with Trauma. Hove: Routledge.</Citation>
        </Reference>
        <Reference>
          <Citation>Jung, C.G. (1934). ‘A review of complex theory’. C.W. 8.</Citation>
        </Reference>
        <Reference>
          <Citation>Jung, C.G. (1963). Memories, Dreams, Reflections. A. Jaffe (Ed.). London: Collins &amp; Routledge &amp; Keegan Paul.</Citation>
        </Reference>
        <Reference>
          <Citation>Kalsched, D. (2013). Trauma and the Soul: A Psycho-spiritual Approach to Human Development and its Interruption. New York, NY, US: Routledge/Taylor &amp; Francis Group.</Citation>
        </Reference>
        <Reference>
          <Citation>Kohli, R. &amp; Mather, R. (2003). ‘Report: Promoting psychosocial well-being in unaccompanied asylum seeking young people in the United Kingdom’in Child &amp; Family Social Work 8 (3), 201-212.</Citation>
        </Reference>
        <Reference>
          <Citation>Krakow, B., Haynes, P., Warner, T., et al. (2004). ‘Nightmares, insomnia, and sleep-disordered breathing in fire evacuees seeking treatment for posttraumatic sleep disturbance’. Journal of Traumatic Stress, 17, 3, 257-268.</Citation>
        </Reference>
        <Reference>
          <Citation>Krystal, H. (1978). ‘Trauma and affects’. Psychoanalytic Study of the Child, 33, 81-116.</Citation>
        </Reference>
        <Reference>
          <Citation>Luci. M. (2017). ‘Disintegration of the self and the regeneration of “Psychic Skin” in the treatment of traumatized refugees’. Journal of Analytical Psychology, 62, 2, 227-246</Citation>
        </Reference>
        <Reference>
          <Citation>Sinason, V. (2002). Attachment, Trauma and Multiplicity: Working with Dissociative Identity Disorder, Hove: Brunner-Routledge.</Citation>
        </Reference>
        <Reference>
          <Citation>van der Kolk, B., McFarlane, A., Weisaeth, L. (1996). Traumatic Stress, The Effects of Overwhelming Experience on Mind, Body, and Society. New York: Guilford Press.</Citation>
        </Reference>
        <Reference>
          <Citation>van der Kolk, B., Weisaeth, L. &amp; van der Hart, O. (1996). ‘History of trauma in psychiatry’. In: Traumatic Stress, The Effects of Overwhelming Experience on Mind, Body, and Society. New York: Guilford Press.</Citation>
        </Reference>
        <Reference>
          <Citation>van der Kolk, B. (2006). BA. Ann N Y Acad Sci. 2006 Jul;1071:27793. ‘Clinical implications of neuroscience research in PTSD’.</Citation>
        </Reference>
        <Reference>
          <Citation>Van Velsen, C., Gorst-Unsworth, C., &amp; Turner, S. (1996). ‘Survivors of torture and organized violence: demography and diagnosis’, Journal of Traumatic Stress, 9, 2, 181-193.</Citation>
        </Reference>
        <Reference>
          <Citation>Wilkinson, M. (2005). ‘Undoing dissociation. Affective neuroscience: A contemporary Jungian clinical perspective’. Journal of Analytical Psychology, 50, 4, 483-501.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31418846</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>16</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1468-5922</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>64</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of analytical psychology</Title>
          <ISOAbbreviation>J Anal Psychol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Confronting Bluebeard: totalitarian regimes in childhood and in the collective psyche.</ArticleTitle>
        <Pagination>
          <MedlinePgn>475-484</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/1468-5922.12515</ELocationID>
        <Abstract>
          <AbstractText>Beginning with the story of Bluebeard, the author considers how traumatic overwhelm can occur in everyday childhood situations of a psychically murderous quality; for example, a nanny's totalitarian regime may be invisible to parents ruled by collective social and cultural norms. A child who is remote from mother and idealises a father embodying a powerful patriarchal system may remain naïvely dependent in marriage and unable to cope with the realities of human aggression. The paper describes analytic work with a woman who had suffered repeated breakdowns and needed to relinquish a fragile, socially constructed identity in order to establish her own true orientation.</AbstractText>
          <CopyrightInformation>© 2019, The Society of Analytical Psychology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wright</LastName>
            <ForeName>Susanna</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>London.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Anal Psychol</MedlineTA>
        <NlmUniqueID>0376573</NlmUniqueID>
        <ISSNLinking>0021-8774</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005195" MajorTopicYN="N">Family Relations</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005783" MajorTopicYN="Y">Gender Identity</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010287" MajorTopicYN="N">Parent-Child Relations</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011575" MajorTopicYN="N">Psychoanalytic Therapy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000067073" MajorTopicYN="N">Psychological Trauma</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018454" MajorTopicYN="N">Spouses</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <OtherAbstract Type="Publisher" Language="fre">
        <AbstractText>Prenant pour point de départ l’histoire de Barbe Bleue, l’auteur examine comment le débordement traumatique peut se produire dans l’enfance dans des situations de tous les jours qui ont une qualité psychique meurtrière. Par exemple, le régime totalitaire d’une assistante maternelle (nourrice) peut être invisible aux yeux de parents régis par des normes collectives sociales et culturelles. Un enfant émotionnellement à distance de sa mère et qui idéalise un père incarnant un système patriarcal puissant peut rester dépendant d’une manière naïve étant marié et incapable de se débrouiller de la réalité de l’agressivité humaine. L’article décrit le travail analytique avec une femme qui a vécu des dépressions à répétition et qui devait renoncer à une identité fragile, construite selon des normes sociales, afin d’établir son orientation personnelle authentique.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="ger">
        <AbstractText>Ausgehend von der Geschichte von Blaubart betrachtet die Autorin, wie traumatische Überwältigungen von psychisch mörderischer Qualität in alltäglichen Situationen der Kindheit auftreten können. Zum Beispiel mag das totalitaristische Regime einer Kinderfrau für Eltern unsichtbar sein, die ihrerseits von kollektiven sozialen und kulturellen Normen bestimmt sind. Ein Kind, das fern der Mutter ist und einen Vater idealisiert, der ein mächtiges patriarchales System verkörpert, kann in der Ehe naiv abhängig bleiben und unfähig sein, mit den Realitäten menschlicher Aggression fertig zu werden. Der Aufsatz beschreibt die analytische Arbeit mit einer Frau, die wiederholt Zusammenbrüche erlitten hatte und eine fragile, sozial konstruierte Identität aufgeben mußte, um ihre eigene wahre Orientierung zu finden.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="ita">
        <AbstractText>Iniziando con la storia di Barbablù, l’autrice considera come una inondazione traumatica, con una qualità potenzialmente omicida, possa avvenire in situazioni quotidiane dell’infanzia; per esempio, il regime totalitario di una bambinaia può essere invisibile a genitori guidati da norme sociali e culturali. Un bambino distante dalla madre e che idealizza un padre che incarna un potente sistema patriarcale, può rimanere ingenuamente dipendente nel matrimonio e incapace di affrontare le realtà dell’aggressività umana. L’articolo descrive il lavoro analitico con una donna, che aveva sofferto ripetuti crolli ed aveva bisogno di rinunciare ad una identità fragile, costruita per la società, al fine di definire il proprio vero orientamento.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="rus">
        <AbstractText>Начиная со сказки про Синюю Бороду, автор рассматривает, как травматическая охваченность убийственного для психики качества может случиться в повседневной жизни ребенка. Например, тоталитарный режим, введенный няней и невидимый для родителей. Ребенок, который удален от матери и идеализирует отца - носителя мощной патриархальной системы, может оставаться наивно зависимым в браке и не уметь справляться с человеческой агрессией. В статье описана аналитическая работа с женщиной, которая страдала от повторяющихся эмоциональных срывов. Ей было необходимо отказаться от хрупкой, социально сконструированной идентичности, чтобы установить свои подлинные ориентиры.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="spa">
        <AbstractText>Comenzando con la historia de Barba Azul, la autora considera cómo una devastación traumática puede ocurrir en situaciones cotidianas de infancias con cualidades de asesinato psíquico; por ejemplo, el régimen totalitario de una abuelita puede resultar invisible a los padres regulados por normas colectivas sociales y culturales. Un niño controlado por la madre y que idealiza a un padre que representa un sistema profundamente patriarcal, puede permanecer ingenuamente dependiente del matrimonio e incapaz de hacerle frente a las realidades de la agresión humana. El artículo describe el trabajo analítico con una mujer que sufrió repetidas crisis y necesitó renunciar a una frágil identidad, socialmente construida para poder establecer su propia y verdadera orientación.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="chi">
        <AbstractText>文章以蓝胡子的故事作为开始, 作者讨论了创伤性的压制可以出现在童年日常情境中, 表现为心理谋杀的特性。比如, 在集体社会和文化规范统治之下的父母可能看不出保姆所持有的极权主义状态。远离母亲并把父亲理想化的孩子, 体现了一个有力的父权体系, 它会维持对婚姻天真的依赖, 无法应对人类攻击性的事实。文章描述了和一位女性的分析性工作, 她重复性地经历了崩溃的状态, 她需要放弃一个脆弱的、被社会建构的身份, 以便于建构她自己的真实取向。.</AbstractText>
      </OtherAbstract>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Barba Azul</Keyword>
        <Keyword MajorTopicYN="N">Barbablù</Keyword>
        <Keyword MajorTopicYN="N">Barbe Bleue</Keyword>
        <Keyword MajorTopicYN="N">Blaubart</Keyword>
        <Keyword MajorTopicYN="N">Bluebeard</Keyword>
        <Keyword MajorTopicYN="N">Kinderfrau</Keyword>
        <Keyword MajorTopicYN="N">Normen der Geschlechtsrollen</Keyword>
        <Keyword MajorTopicYN="N">Zusammenbruch</Keyword>
        <Keyword MajorTopicYN="N">abuelita</Keyword>
        <Keyword MajorTopicYN="N">assistante maternelle</Keyword>
        <Keyword MajorTopicYN="N">bambinaia</Keyword>
        <Keyword MajorTopicYN="N">breakdown</Keyword>
        <Keyword MajorTopicYN="N">crisis</Keyword>
        <Keyword MajorTopicYN="N">crollo</Keyword>
        <Keyword MajorTopicYN="N">depression</Keyword>
        <Keyword MajorTopicYN="N">devastación traumática</Keyword>
        <Keyword MajorTopicYN="N">débordement traumatique</Keyword>
        <Keyword MajorTopicYN="N">gender role norms</Keyword>
        <Keyword MajorTopicYN="N">inondazione traumatica</Keyword>
        <Keyword MajorTopicYN="N">nanny</Keyword>
        <Keyword MajorTopicYN="N">normas basadas en roles de género</Keyword>
        <Keyword MajorTopicYN="N">normes concernant les rôles liés au genre</Keyword>
        <Keyword MajorTopicYN="N">patriarcal</Keyword>
        <Keyword MajorTopicYN="N">patriarcale</Keyword>
        <Keyword MajorTopicYN="N">patriarchal</Keyword>
        <Keyword MajorTopicYN="N">ruoli gender</Keyword>
        <Keyword MajorTopicYN="N">traumatic overwhelm</Keyword>
        <Keyword MajorTopicYN="N">traumatische Überwältigung</Keyword>
        <Keyword MajorTopicYN="N">Синяя Борода</Keyword>
        <Keyword MajorTopicYN="N">гендерные ролевые нормы</Keyword>
        <Keyword MajorTopicYN="N">няня</Keyword>
        <Keyword MajorTopicYN="N">патриархальное</Keyword>
        <Keyword MajorTopicYN="N">срыв</Keyword>
        <Keyword MajorTopicYN="N">травматический захват</Keyword>
        <Keyword MajorTopicYN="N">保姆</Keyword>
        <Keyword MajorTopicYN="N">创伤性的压制</Keyword>
        <Keyword MajorTopicYN="N">崩溃</Keyword>
        <Keyword MajorTopicYN="N">性别角色规范</Keyword>
        <Keyword MajorTopicYN="N">父权</Keyword>
        <Keyword MajorTopicYN="N">蓝胡子</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418846</ArticleId>
        <ArticleId IdType="doi">10.1111/1468-5922.12515</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Bachmann, I. ([1978] 1999). The Book of Franza &amp; Requiem for Fanny Goldmann, trans. P. Filkins. Evanston, Ill: Hydra Books, Northwestern University Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Covington, C. (1989). ‘In search of the Heroine’, Journal of Analytical Psychology, 34, 3, 242-254.</Citation>
        </Reference>
        <Reference>
          <Citation>Fordham, M. (1985). Explorations into the Self. London: Routledge.</Citation>
        </Reference>
        <Reference>
          <Citation>Kalsched, D. E. (1998). ‘Archetypal defenses in the clinical situation: A vignette’, Journal of Analytical Psychology, 43, 1, 3-17.</Citation>
        </Reference>
        <Reference>
          <Citation>Stern, M. (1953). ‘Trauma and symptom formation’, International Journal of Psycho-Analysis, 34, 202-218.</Citation>
        </Reference>
        <Reference>
          <Citation>Wieland, C. (1991). ‘Beauty and the Beast: The Father's unconscious and the riddle of femininity’, British Journal of Psychotherapy, 8, 2, 131-143.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31418849</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>26</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>26</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1097-0142</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>125</Volume>
            <Issue>22</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>11</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cancer</Title>
          <ISOAbbreviation>Cancer</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Videos improve patient understanding of misunderstood chemotherapy terminology.</ArticleTitle>
        <Pagination>
          <MedlinePgn>4011-4018</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/cncr.32421</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">Chemotherapy is the backbone of many cancer therapies; however, the terminology used to describe chemotherapy may be difficult for patients to understand, particularly in underserved populations. Studies have shown that educational videos can improve patient understanding of cancer-related terms. The goal of this study was to identify chemotherapy terms that were difficult for an underserved population to understand and then develop and test educational videos describing these terms.</AbstractText>
          <AbstractText Label="METHODS">A word bank of 50 difficult-to-understand chemotherapy terms was developed by querying 15 providers and 50 patients at an underserved hospital. Twenty of these terms were then tested with 50 additional patients to determine rates of misunderstanding. Six pilot educational videos describing 6 important terms were created using VideoScribe and then assessed with 50 patients to see if they improved understanding.</AbstractText>
          <AbstractText Label="RESULTS">Fifteen of the 20 terms tested to establish rates of misunderstanding were misunderstood by more than one third of patients, with 98% unable to define maintenance, 74% unable to define cancer, and 58% unable to define chemotherapy. Patient understanding of all 6 terms improved by at least 20% after watching the videos. Notable improvement was reported for palliative chemotherapy, where before-and-after video understanding increased from 0% to 72%.</AbstractText>
          <AbstractText Label="CONCLUSION">Chemotherapy, a backbone of cancer treatment, is described with terms that are difficult to understand. Short, animated educational videos can significantly increase patient understanding of chemotherapy terminology.</AbstractText>
          <CopyrightInformation>© 2019 American Cancer Society.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pentz</LastName>
            <ForeName>Rebecca D</ForeName>
            <Initials>RD</Initials>
            <Identifier Source="ORCID">0000-0003-4338-6663</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Hematology and Oncology, Emory University School of Medicine, Atlanta, Georgia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Winship Cancer Institute, Atlanta, Georgia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lohani</LastName>
            <ForeName>Minisha</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Medical School, Philadelphia College of Osteopathic Medicine-Georgia, Suwanee, Georgia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hayban</LastName>
            <ForeName>Melissa</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematology and Oncology, Emory University School of Medicine, Atlanta, Georgia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Switchenko</LastName>
            <ForeName>Jeffrey M</ForeName>
            <Initials>JM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biostatistics and Bioinformatics, Emory University Rollins School of Public Health, Atlanta, Georgia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dixon</LastName>
            <ForeName>Margie D</ForeName>
            <Initials>MD</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematology and Oncology, Emory University School of Medicine, Atlanta, Georgia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>DeFeo</LastName>
            <ForeName>Richard J</ForeName>
            <Initials>RJ</Initials>
            <Suffix>Jr</Suffix>
            <AffiliationInfo>
              <Affiliation>Care and Counseling Center of Georgia, Inc, Decatur, Georgia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Orloff</LastName>
            <ForeName>Gregg M</ForeName>
            <Initials>GM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematology and Oncology, Emory University School of Medicine, Atlanta, Georgia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jani</LastName>
            <ForeName>Ashesh B</ForeName>
            <Initials>AB</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematology and Oncology, Emory University School of Medicine, Atlanta, Georgia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Winship Cancer Institute, Atlanta, Georgia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Master</LastName>
            <ForeName>Viraj A</ForeName>
            <Initials>VA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematology and Oncology, Emory University School of Medicine, Atlanta, Georgia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Winship Cancer Institute, Atlanta, Georgia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>P30 CA138292</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>P30CA138292</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Cancer</MedlineTA>
        <NlmUniqueID>0374236</NlmUniqueID>
        <ISSNLinking>0008-543X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>AIM</CitationSubset>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>Cancer. 2019 Nov 15;125(22):3921-3923</RefSource>
          <PMID Version="1">31418821</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D032882" MajorTopicYN="Y">Comprehension</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007722" MajorTopicYN="Y">Health Knowledge, Attitudes, Practice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057220" MajorTopicYN="Y">Health Literacy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014741" MajorTopicYN="Y">Video Recording</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">cancer</Keyword>
        <Keyword MajorTopicYN="Y">chemotherapy</Keyword>
        <Keyword MajorTopicYN="Y">educational tool</Keyword>
        <Keyword MajorTopicYN="Y">health literacy</Keyword>
        <Keyword MajorTopicYN="Y">underserved</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>02</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>04</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>04</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418849</ArticleId>
        <ArticleId IdType="doi">10.1002/cncr.32421</ArticleId>
        <ArticleId IdType="pmc">PMC6986301</ArticleId>
        <ArticleId IdType="mid">NIHMS1066490</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>South Med J. 2000 Mar;93(3):297-304</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10728518</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cancer. 1996 Nov 1;78(9):1912-20</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8909311</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fam Med. 1993 Jun;25(6):391-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8349060</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Intern Med. 2011 Jul 19;155(2):97-107</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21768583</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cancer. 2015 Mar 1;121(5):733-40</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25393416</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Health Commun. 2014;19 Suppl 2:205-24</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25315594</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cancer Invest. 2001;19(2):193-200</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11296623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cancer Control. 2015 Jan;22(1):95-101</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25504283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Orthop Nurs. 2004 Mar-Apr;23(2):150-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15103803</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Gen Intern Med. 1998 Apr;13(4):230-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9565385</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Oncol. 2009 Apr 20;27(12):2015-21</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19307512</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Gen Intern Med. 1995 Oct;10(10):537-41</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8576769</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Support Oncol. 2010 Mar-Apr;8(2):64-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20464884</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cancer. 2014 Oct 1;120(19):3066-73</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24962202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Public Health Genomics. 2011;14(4-5):279-89</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20407217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cancer Treat Rev. 2016 Mar;44:42-50</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26866673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cancer. 2013 Sep 1;119(17):3204-11</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23733135</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Psychooncology. 2013 May;22(5):1186-91</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22573405</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cancer Nurs. 1981 Aug;4(4):311-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6911058</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Intern Med. 1997 Dec 1;127(11):966-72</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9412301</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cancer. 1979 Apr;43(4):1549-56</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">445353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Psychooncology. 2003 Sep;12(6):557-66</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12923796</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31418850</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>14</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>14</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1528-1167</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>60</Volume>
            <Issue>9</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>09</Month>
            </PubDate>
          </JournalIssue>
          <Title>Epilepsia</Title>
          <ISOAbbreviation>Epilepsia</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Characteristics of KCNQ2 variants causing either benign neonatal epilepsy or developmental and epileptic encephalopathy.</ArticleTitle>
        <Pagination>
          <MedlinePgn>1870-1880</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/epi.16314</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE">Pathogenic variants of KCNQ2, which encode a potassium channel subunit, cause either benign (familial) neonatal epilepsy-B(F)NE)-or KCNQ2 encephalopathy (KCNQ2 DEE). We examined the characteristics of KCNQ2 variants.</AbstractText>
          <AbstractText Label="METHODS">KCNQ2 pathogenic variants were collected from in-house data and two large disease databases with their clinical phenotypes. Nonpathogenic KCNQ2 variants were collected from the Genome Aggregation Database (gnomAD). Pathogenicity of all variants was reevaluated with clinical information to exclude irrelevant variants. The cumulative distribution plots of B(F)NE, KCNQ2 DEE, and gnomAD KCNQ2 variants were compared. Several algorithms predicting genetic variant pathogenicity were evaluated.</AbstractText>
          <AbstractText Label="RESULTS">A total of 259 individuals or pedigrees with 216 different pathogenic KCNQ2 variants and 2967 individuals with 247 different nonpathogenic variants were deemed eligible for the study. Compared to the distribution of nonpathogenic variants, B(F)NE and KCNQ2 DEE missense variants occurred in five and three specific KCNQ2 regions, respectively. Comparison between B(F)NE and KCNQ2 DEE sets showed that B(F)NE missense variants frequently localized to the intracellular domain between S2 and S3, whereas those of KCNQ2 DEE were more frequent in S6, and its adjacent pore domain, as well as in the intracellular domain between S6 and helix A. The scores of Protein Variation Effect Analyzer (PROVEAN) and Percent Accepted Mutation (PAM) 30 prediction algorithms were associated with phenotypes of the variant loci.</AbstractText>
          <AbstractText Label="SIGNIFICANCE">Missense variants in the intracellular domain between S2 and S3 are likely to cause B(F)NE, whereas those in S6 and its adjacent regions are more likely to cause KCNQ2 DEE. With such regional specificities of variants, PAM30 is a helpful tool to examine the possibility that a novel KCNQ2 variant is a B(F)NE or KCNQ2 DEE variant in genetic analysis.</AbstractText>
          <CopyrightInformation>Wiley Periodicals, Inc. © 2019 International League Against Epilepsy.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Goto</LastName>
            <ForeName>Ayako</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-6485-0528</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, School of Medicine, Fukuoka University, Fukuoka, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ishii</LastName>
            <ForeName>Atsushi</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-4423-2810</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, School of Medicine, Fukuoka University, Fukuoka, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shibata</LastName>
            <ForeName>Mami</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Central Research Institute for the Molecular Pathomechanisms of Epilepsy, Fukuoka University, Fukuoka, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ihara</LastName>
            <ForeName>Yukiko</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, School of Medicine, Fukuoka University, Fukuoka, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cooper</LastName>
            <ForeName>Edward C</ForeName>
            <Initials>EC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Baylor College of Medicine, Houston, Texas.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hirose</LastName>
            <ForeName>Shinichi</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, School of Medicine, Fukuoka University, Fukuoka, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Central Research Institute for the Molecular Pathomechanisms of Epilepsy, Fukuoka University, Fukuoka, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>15H02548</GrantID>
            <Agency>Japan Agency for Medical Research and Development</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <GrantID>19K17381</GrantID>
            <Agency>Japan Agency for Medical Research and Development</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <GrantID>25670481</GrantID>
            <Agency>Japan Agency for Medical Research and Development</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <GrantID>16ek0109038h</GrantID>
            <Agency>Japan Agency for Medical Research and Development</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <GrantID>H29-Nanji-Ippan-010</GrantID>
            <Agency>Ministry of Health, Labor and Welfare</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <GrantID>H30- Nanji-Ippan-007</GrantID>
            <Agency>Ministry of Health, Labor and Welfare</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <GrantID>R01 NS49119</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>U54 NS108874</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <Agency>The Jack Pribaz Foundation</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <Agency>KCNQ2 Cure Alliance</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <Agency>Miles Family Fund</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <Agency>U.S.-Japan Brain Research Cooperative Program</Agency>
            <Country>International</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Epilepsia</MedlineTA>
        <NlmUniqueID>2983306R</NlmUniqueID>
        <ISSNLinking>0013-9580</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051658">KCNQ2 Potassium Channel</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001927" MajorTopicYN="N">Brain Diseases</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020936" MajorTopicYN="N">Epilepsy, Benign Neonatal</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051658" MajorTopicYN="N">KCNQ2 Potassium Channel</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020125" MajorTopicYN="N">Mutation, Missense</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010375" MajorTopicYN="N">Pedigree</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013036" MajorTopicYN="N">Spasms, Infantile</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">
KCNQ3
</Keyword>
        <Keyword MajorTopicYN="Y">Kv7.2</Keyword>
        <Keyword MajorTopicYN="Y">genotype</Keyword>
        <Keyword MajorTopicYN="Y">infant</Keyword>
        <Keyword MajorTopicYN="Y">self-limiting epilepsy</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>01</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418850</ArticleId>
        <ArticleId IdType="doi">10.1111/epi.16314</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Hirose S, Mitsudome A, Okada M, Kaneko S; Epilepsy Genetic Study Group, Japan. Genetics of idiopathic epilepsies. Epilepsia. 2005;46(Suppl 1):38-43.</Citation>
        </Reference>
        <Reference>
          <Citation>Ishii A, Fukuma G, Uehara A, Miyajima T, Makita Y, Hamachi A, et al. A de novo KCNQ2 mutation detected in non-familial benign neonatal convulsions. Brain Dev. 2009;31:27-33.</Citation>
        </Reference>
        <Reference>
          <Citation>Kato M, Yamagata T, Kubota M, Arai H, Yamashita S, Nakagawa T, et al. Clinical spectrum of early onset epileptic encephalopathies caused by KCNQ2 mutation. Epilepsia. 2013;54:1282-7.</Citation>
        </Reference>
        <Reference>
          <Citation>Dedek K, Fusco L, Teloy N, Steinlein OK. Neonatal convulsions and epileptic encephalopathy in an Italian family with a missense mutation in the fifth transmembrane region of KCNQ2. Epilepsy Res. 2003;54:21-7.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang HS, Pan Z, Shi W, Brown BS, Wymore RS, Cohen IS, et al. KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science. 1998;282:1890-3.</Citation>
        </Reference>
        <Reference>
          <Citation>Steinlein OK, Conrad C, Weidner B. Benign familial neonatal convulsions: always benign? Epilepsy Res. 2007;73:245-9.</Citation>
        </Reference>
        <Reference>
          <Citation>Greene DL, Hoshi N. Modulation of Kv7 channels and excitability in the brain. Cell Mol Life Sci. 2016;74:495-508.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhu G, Okada M, Murakami T, Kamata A, Kawata Y, Wada K, et al. Dysfunction of M-channel enhances propagation of neuronal excitability in rat hippocampus monitored by multielectrode dish and microdialysis systems. Neurosci Lett. 2000;294:53-7.</Citation>
        </Reference>
        <Reference>
          <Citation>Singh NA, Charlier C, Stuffer D, DuPont BR, Leach RJ, Melis R, et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited in an inherited epilepsy of newborns. Nat Genet. 1998;18:25-9.</Citation>
        </Reference>
        <Reference>
          <Citation>Soldovieri MV, Boutry-Kryza N, Milh M, Doummar D, Heron B, Bourel E, et al. Novel KCNQ2 and KCNQ3 mutations in a large cohort of families with benign neonatal epilepsy: first evidence for an altered channel regulation by syntaxin-1A. Hum Mutat. 2014;35:356-67.</Citation>
        </Reference>
        <Reference>
          <Citation>Soldovieri MV, Miceli F, Bellini G, Coppola G, Pascotto A, Taglialatela M. Correlating the Clinical and Genetic Features of Benign Familial Neonatal Seizures (BFNS) with the functional consequences of underlying mutations. Channels. 2014;1:228-33.</Citation>
        </Reference>
        <Reference>
          <Citation>Borgatti R, Zucca C, Cavallini A, Ferrario M, Panzeri C, Castaldo P, et al. A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation. Neurology. 2004;63:57-65.</Citation>
        </Reference>
        <Reference>
          <Citation>Miceli F, Soldovieri MV, Ambrosino P, Barrese V, Migliore M, Cilio MR, et al. Genotype-phenotype correlations in neonatal epilepsies caused by mutations in the voltage sensor of K(v)7.2 potassium channel subunits. Proc Natl Acad Sci USA. 2013;110:4386-91.</Citation>
        </Reference>
        <Reference>
          <Citation>Weckhuysen S, Mandelstam S, Suls A, Audenaert D, Deconinck T, Claes LR, et al. KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy. Ann Neurol. 2012;71:15-25.</Citation>
        </Reference>
        <Reference>
          <Citation>Orhan G, Bock M, Schepers D, Ilina EI, Reichel SN, Löffler H, et al. Dominant-negative effects of KCNQ2 mutations are associated with epileptic encephalopathy. Ann Neurol. 2014;75:382-94.</Citation>
        </Reference>
        <Reference>
          <Citation>Ishii A, Kang JQ, Schornak CC, Hernandez CC, Shen W, Watkins JC, et al. A de novo missense mutation of GABRB2 causes early myoclonic encephalopathy. J Med Genet. 2017;54:202-11.</Citation>
        </Reference>
        <Reference>
          <Citation>Ishii A, Watkins JC, Chen D, Hirose S, Hammer MF. Clinical implications of SCN1A missense and truncation variants in a large Japanese cohort with Dravet syndrome. Epilepsia. 2017;58:282-90.</Citation>
        </Reference>
        <Reference>
          <Citation>Kurahashi H, Wang JW, Ishii A, Kojima T, Wakai S, Kizawa T, et al. Deletions involving both KCNQ2 and CHRNA4 present with benign familial neonatal seizures. Neurology. 2009;73:1214-7.</Citation>
        </Reference>
        <Reference>
          <Citation>Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405-24.</Citation>
        </Reference>
        <Reference>
          <Citation>Ran X, Li J, Shao Q, Chen H, Lin Z, Sun ZS, et al. EpilepsyGene: a genetic resource for genes and mutations related to epilepsy. Nucleic Acids Res. 2015;43:D893-9.</Citation>
        </Reference>
        <Reference>
          <Citation>Dayhoff MO, Schwartz RM, Orcutt BC. A model of evolutionary change in proteins. In: Dayhoff MO, editor. Atlas of protein sequence and structure. Washington D. C: National Biomedical Research Foundation, 1978;5;p. 345-352.</Citation>
        </Reference>
        <Reference>
          <Citation>Mount DW. Comparison of the PAM and BLOSUM amino acid substitution matrices. Cold Spring Harb Protoc. 2008;2008:pdb.ip59.</Citation>
        </Reference>
        <Reference>
          <Citation>Gutierrez AH, Martin WD, Bailey-Kellogg C, Terry F, Moise L, De Groot AS. Development and validation of an epitope prediction tool for swine (PigMatrix) based on the pocket profile method. BMC Bioinformatics. 2015;16:290.</Citation>
        </Reference>
        <Reference>
          <Citation>Kuersten M, Tacke M, Gerstl L, Hoelz H, Stülpnagel CV, Borggraefe I. Antiepileptic therapy approaches in KCNQ2 related epilepsy: a systematic review. Eur J Med Genet. 2019. https://doi.org/10.1016/j.ejmg.2019.02.001.</Citation>
        </Reference>
        <Reference>
          <Citation>Miceli F, Soldovieri MV, Joshi N, Weckhuysen S, Cooper E, Taglialatela M. KCNQ2-related disorders. In: Adam MP, Ardinger HH, Pagon RA, et al. (eds). GeneReviews((R)). Seattle (WA): University of Washington; 1993.</Citation>
        </Reference>
        <Reference>
          <Citation>Millichap JJ, Park KL, Tsuchida T, Ben-Zeev B, Carmant L, Flamini R, et al. KCNQ2 encephalopathy: features, mutational hot spots, and ezogabine treatment of 11 patients. Neurol Genet. 2016;2:e96.</Citation>
        </Reference>
        <Reference>
          <Citation>Etxeberria A, Aivar P, Rodriguez-Alfaro JA, Alaimo A, Villacé P, Gómez-Posada JC, et al. Calmodulin regulates the trafficking of KCNQ2 potassium channels. FASEB J. 2008;22:1135-43.</Citation>
        </Reference>
        <Reference>
          <Citation>Regev N, Degani-Katzav N, Korngreen A, Etzioni A, Siloni S, Alaimo A, et al. Selective interaction of syntaxin 1A with KCNQ2: possible implications for specific modulation of presynaptic activity. PLoS ONE. 2009;4:e6586.</Citation>
        </Reference>
        <Reference>
          <Citation>Zaydman MA, Cui J. PIP2 regulation of KCNQ channels: biophysical and molecular mechanisms for lipid modulation of voltage-dependent gating. Front Physiol. 2014;5:195.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31418848</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>16</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1468-5922</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>64</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of analytical psychology</Title>
          <ISOAbbreviation>J Anal Psychol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>When culture fails: coping with cultural trauma.</ArticleTitle>
        <Pagination>
          <MedlinePgn>530-547</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/1468-5922.12519</ELocationID>
        <Abstract>
          <AbstractText>The research into the phenomenon of cultural trauma is growing as the effects of historical transformations are recognized and analysed. The concept of cultural trauma and the analytic concept of the cultural complex is a suitable theoretical approach for this research. The Lithuanian experience of cultural trauma after the historical shifts indicates the importance of the interplay between societal and individual factors in coping with trauma. Academic psychotraumatological studies carried out at Vilnius University indicate a stronger traumatic experience by people who are survivors of direct political repression and even intergenerational transmission of trauma, but this group also seems to demonstrate an intergenerational transmission of resilience. Paradoxically, from a long-term perspective, the victims of direct repression seem to have suffered less than the people who accommodated to the regime, and this applies also to their offspring. Analysis in terms of overcoming cultural trauma indicates that society is gradually integrating historic traumatic experiences, although a healthy cultural identity has not yet been restored.</AbstractText>
          <CopyrightInformation>© 2019, The Society of Analytical Psychology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Gailienė</LastName>
            <ForeName>Danutė</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Vilnius, Lithuania.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Anal Psychol</MedlineTA>
        <NlmUniqueID>0376573</NlmUniqueID>
        <ISSNLinking>0021-8774</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000223" MajorTopicYN="Y">Adaptation, Psychological</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003469" MajorTopicYN="Y">Culture</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008097" MajorTopicYN="N" Type="Geographic">Lithuania</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011057" MajorTopicYN="Y">Politics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000067073" MajorTopicYN="Y">Psychological Trauma</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055500" MajorTopicYN="Y">Resilience, Psychological</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <OtherAbstract Type="Publisher" Language="fre">
        <AbstractText>La recherche sur le phénomène du traumatisme culturel se développe alors que les effets des transformations historiques sont reconnues et analysées. Le concept de traumatisme culturel et le concept analytique du complexe culturel donnent un cadre théorique utile pour ce domaine d’études. L’expérience lithuanienne de traumatisme culturel après les changements historiques montre l’importance de l’interaction entre les facteurs sociétaux et individuels pour se débrouiller du traumatisme. Des études en psychotraumatologie faites à l’université de Vilnius montrent une expérience traumatique plus forte chez les personnes qui ont survécu à une répression politique directe, et même une transmission intergénérationnelle du traumatisme. Mais ces chercheurs semblent aussi pouvoir montrer une transmission intergénérationnelle de la résilience. De manière paradoxale, sur le long terme, les victimes d’une répression directe semblent avoir moins souffert que les personnes qui se sont adaptées au régime, et ceci s’applique également à leurs descendants. L’analyse s’occupant de surmonter le traumatisme culturel montre que la société procède peu à peu à l’intégration des expériences historiques traumatiques, bien qu’une identité culturelle saine n’ait pas encore été restaurée.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="ger">
        <AbstractText>Die Erforschung des Phänomens des kulturellen Traumas nimmt zu, je mehr die Auswirkungen historischer Veränderungen sichtbar und analysiert werden. Das Konzept des Kulturtraumas und das analytische Konzept des Kulturellen Komplexes bilden geeignete theoretische Ansätze für diese Forschung. Die litauische Erfahrung des kulturellen Traumas nach den historischen Verschiebungen zeigt, wie wichtig das Zusammenspiel von gesellschaftlichen und individuellen Faktoren bei der Bewältigung von Traumata ist. Akademische psychotraumatologische Studien der Universität Vilnius weisen auf eine stärkere traumatische Erfahrung von Menschen hin, die Überlebende direkter politischer Unterdrückung sind und sehen bei diesen gleichzeitig eine intergenerationale Weitergabe von Traumata. Diese Gruppe scheint jedoch auch eine Weitergabe von Resilienz zwischen den Generationen aufzuweisen. Paradoxerweise scheinen die Opfer der direkten Repression auf lange Sicht weniger gelitten zu haben als die Menschen, die sich mit dem Regime arrangiert hatten und dies gilt auch für ihre Nachkommen. Analysen mit dem Ziel der Überwindung kultureller Traumata zeigen, daß die Gesellschaft nach und nach historische traumatische Erlebnisse integriert, wenngleich eine gesunde kulturelle Identität noch nicht wiederhergestellt ist.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="ita">
        <AbstractText>La ricerca sul fenomeno del trauma culturale cresce man mano che gli effetti delle trasformazioni storiche vengono riconosciuti ed analizzati. Il concetto di trauma culturale ed il concetto analitico del complesso culturale sono degli adeguati approcci teorici per questa ricerca. L’esperienza lituana del trauma culturale dopo i cambiamenti storici indica l’importanza dell’interazione tra fattori sociali ed individuali nell’affrontare il trauma. Studi accademici di psicotraumatologia condotti all’Università di Vilnius indicano un’esperienza traumatica maggiore nelle persone che sono sopravvissute a dirette repressioni politiche ed addirittura trasmissioni intergenerazionali del trauma, ma questo gruppo sembra dimostrare anche trasmissioni intergenerazionali della resilienza. Paradossalmente, da una prospettiva a lungo termine, le vittime di repressioni dirette sembrano aver sofferto meno delle persone che si sono adattate al regime, e questo vale anche per i loro discendenti. L’analisi in termini di superamento del trauma culturale indica che la società sta gradualmente integrando esperienze traumatiche della storia, nonostante non sia stata ancora ripristinata una sana identità culturale.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="rus">
        <AbstractText>Область исследований феномена культурной травмы растет по мере того, как распознаются и анализируются эффекты исторических перемен. Понятие культурной травмы и аналитическое понятие культурного комплекса - подходящие для этого исследования теоретические концепции. Литовский опыт культурной травмы исторических перемен показывает важность взаимодействия между общественными и индивидуальными копинговыми стратегиями. Академические психотравматологические исследования, проведенный в Университете Вильнюса, свидетельствуют о более сильном травматическом опыте у людей, переживших политические репрессии и межпоколенческую травму. Однако у этой же группы наблюдается межпоколонеческая передача устойчивости. Парадоксально, что с точки зрения долгосрочной перспективы жертвы репрессий пострадали меньше, чем люди, которые приспособились к режиму. Это верно и для их потомков. В терминах преодоления культурной травмы анализ показывает, что общество постепенно интегрирует исторический травматический опыт, однако здоровая культурная идентичность еще не восстановлена.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="spa">
        <AbstractText>Mientras los efectos sobre las transformaciones históricas y sociales están siendo reconocidas y analizadas, la investigación sobre el fenómeno del trauma cultural está creciendo. El concepto de trauma cultural y el concepto analítico de complejo cultural es un abordaje teórico apropiado para dicha investigación. La experiencia Lituana de trauma cultural luego de los cambios históricos da cuenta de la importancia del inter-juego entre factores individuales y sociales para hacer frente al trauma. Estudios académicos psico-traumatológicos llevados a cabo e la Universidad de Vilnius indican la presencia de experiencias traumáticas más intensas en las personas sobrevivientes de una represión política directa, y también de la transmisión intergeneracional del trauma, pero este grupo, también pareciera demostrar la transmisión intergeneracional de resiliencia. Paradójicamente, desde una perspectiva a largo plazo, las víctimas de represión directa parecieran haber sufrido menos que quienes se acomodaron al régimen, y esto aplica también a los descendientes. El análisis, en términos de sobreponerse al trauma cultural indica que la sociedad está gradualmente integrando las experiencias traumáticas de la historia, aunque una identidad cultural saludable todavía no ha podido ser restaurada.</AbstractText>
      </OtherAbstract>
      <OtherAbstract Type="Publisher" Language="chi">
        <AbstractText>随着人们越多地对历史性转变效应的觉察和分析, 关于文化创伤现象的研究也越发增多。文化创伤的概念 和分析心理学关于文化情结的概念 是适合于这类研究的理论取向。立陶宛在历史性转变之后所经历的文化创伤, 呈现了在应付创伤时, 社会与个体因素相互作用的重要性。在维尔纽斯大学进行的关于心理创伤的学术研究显示, 经历过直接的政治性压迫的幸存者, 具有更强的创伤经验, 甚至会把创伤进行隔代的传递, 但这个群体似乎也在隔代之间传递了弹性。矛盾的是, 从长期的角度看, 受到直接压迫的受害者似乎比那些适应了这个制度的人更少地感受到痛苦, 对于他们的后代来说也是如此。关于文化创伤的克服的分析显示, 社会在逐步整合历史性的创伤经验, 尽管一个健康的文化身份尚未恢复。.</AbstractText>
      </OtherAbstract>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Coping</Keyword>
        <Keyword MajorTopicYN="N">Kultureller Komplex</Keyword>
        <Keyword MajorTopicYN="N">Kulturtrauma</Keyword>
        <Keyword MajorTopicYN="N">Resilienz</Keyword>
        <Keyword MajorTopicYN="N">Sovieterfahrung</Keyword>
        <Keyword MajorTopicYN="N">complejo cultural</Keyword>
        <Keyword MajorTopicYN="N">complesso culturale</Keyword>
        <Keyword MajorTopicYN="N">complexe culturel</Keyword>
        <Keyword MajorTopicYN="N">coping</Keyword>
        <Keyword MajorTopicYN="N">cultural complex</Keyword>
        <Keyword MajorTopicYN="N">cultural trauma</Keyword>
        <Keyword MajorTopicYN="N">enfrentar</Keyword>
        <Keyword MajorTopicYN="N">esperienza sovietica</Keyword>
        <Keyword MajorTopicYN="N">experiencia soviética</Keyword>
        <Keyword MajorTopicYN="N">expérience soviétique</Keyword>
        <Keyword MajorTopicYN="N">faire face</Keyword>
        <Keyword MajorTopicYN="N">intergenerational transmission of trauma</Keyword>
        <Keyword MajorTopicYN="N">intergenerationale Weitergabe von Traumata</Keyword>
        <Keyword MajorTopicYN="N">resilience</Keyword>
        <Keyword MajorTopicYN="N">resiliencia</Keyword>
        <Keyword MajorTopicYN="N">resilienza</Keyword>
        <Keyword MajorTopicYN="N">résilience</Keyword>
        <Keyword MajorTopicYN="N">sobrevivientes de represión política</Keyword>
        <Keyword MajorTopicYN="N">sopravvissuti a repressioni politiche</Keyword>
        <Keyword MajorTopicYN="N">soviet experience</Keyword>
        <Keyword MajorTopicYN="N">survivors of political repression</Keyword>
        <Keyword MajorTopicYN="N">transmisión intergeneracional del trauma</Keyword>
        <Keyword MajorTopicYN="N">transmission intergénérationnelle de traumatisme</Keyword>
        <Keyword MajorTopicYN="N">trasmissione intergenerazionale del trauma</Keyword>
        <Keyword MajorTopicYN="N">trauma cultural</Keyword>
        <Keyword MajorTopicYN="N">trauma culturale</Keyword>
        <Keyword MajorTopicYN="N">traumatisme culturel</Keyword>
        <Keyword MajorTopicYN="N">victime de répression politique</Keyword>
        <Keyword MajorTopicYN="N">Überlebende von politischer Repression</Keyword>
        <Keyword MajorTopicYN="N">выжившие в политических репрессиях</Keyword>
        <Keyword MajorTopicYN="N">копинг</Keyword>
        <Keyword MajorTopicYN="N">культурная травма</Keyword>
        <Keyword MajorTopicYN="N">культурный комплекс</Keyword>
        <Keyword MajorTopicYN="N">межпоколенческая передача травмы</Keyword>
        <Keyword MajorTopicYN="N">советский опыт</Keyword>
        <Keyword MajorTopicYN="N">创伤的代际传递</Keyword>
        <Keyword MajorTopicYN="N">应对</Keyword>
        <Keyword MajorTopicYN="N">弹性</Keyword>
        <Keyword MajorTopicYN="N">政治压迫幸存者</Keyword>
        <Keyword MajorTopicYN="N">文化创伤</Keyword>
        <Keyword MajorTopicYN="N">文化情结</Keyword>
        <Keyword MajorTopicYN="N">苏联经验</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418848</ArticleId>
        <ArticleId IdType="doi">10.1111/1468-5922.12519</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Aarelaid-Tart, A. (2006). Cultural Trauma and Life Stories. Helsinki: Kikimora Publications.</Citation>
        </Reference>
        <Reference>
          <Citation>Alexander, J.C. (2004). ‘Toward a Theory of Cultural Trauma’. In J.C. Alexander, R. Eyerman, B. Giesen, N.J. Smelser, P. Sztompka. (Eds.). Cultural Trauma and Collective Identity. Berkeley: University of California Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Alexander, J.C. (2012). Trauma: A Social Theory. Cambridge: Polity Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Anušauskas, A. (1996). Lietuvių tautos sovietinis naikinimas 1940-1958 metais. Vilnius: Mintis.</Citation>
        </Reference>
        <Reference>
          <Citation>Assmann, A. (2013). Das neue Unbehagen an der Errinnerungskultur: Eine Intervention. München: C.H. Beck Verlag.</Citation>
        </Reference>
        <Reference>
          <Citation>Bhugra, D., Bhui, K. (Eds.) (2007). Textbook of Cultural Psychiatry. Cambridge: Cambridge University Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Bieliauskaitė, R., Grigienė, D., Eimontas, J., Grigutytė, N. (2015). ‘Evaluation of Changes Brought About by Independence on Three Generations in Lithuania’. In D. Gailienė (Ed.) Lithuanian Faces after Transition: Psychological Consequencies of Cultural Trauma. Vilnius: Eugrimas, 48-85.</Citation>
        </Reference>
        <Reference>
          <Citation>Bieliauskienė, I., Gudaitė, G. (2016). ‘Lyties veiksnys asmens santykyje su autoritetais: kokybinė subjektyvaus patyrimo analizė’ [‘Gender issues in an individual’s relationship with authority: qualitative analysis of subjective experience’]. Psichologija, 53, 101-113.</Citation>
        </Reference>
        <Reference>
          <Citation>Bronfenbrenner, U. (1979). The Ecology of Human Development. Cambridge, MA: Harvard University Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Bronfenbrenner, U. (1994). ‘Ecological models of human development’. In T. Husen &amp; T.N. Postlethwaite (Ed.). The International Encyclopaedia of Education (2nd ed., pp. 1643-1647). New York: Elsevier.</Citation>
        </Reference>
        <Reference>
          <Citation>Danieli Y. (Ed.) (1998). International Handbook of Multigenerational Legacies of Trauma. New York: Plenum Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Daugirdas T. (2018). Ar turėsime Vilniuje Czesƚawo Miƚoszo oro uostą? Naujasis židinys-aidai, 8, p. 8.</Citation>
        </Reference>
        <Reference>
          <Citation>deVries, M.W. (2007). ‘Trauma in cultural perspective’. In B.A. van der Kolk, A.C. McFarlane, L. Weisaeth (Eds.) Traumatic Stress: The Effects of Overwhelming Experience on Mind, Body, and Society. New York, London: The Guilford Press, pgs. 398-413.</Citation>
        </Reference>
        <Reference>
          <Citation>Domanskaitė-Gota, V., Gailienė, D., Kazlauskas, E. (2006). ‘Life-threatening Experiences, Posttraumatic Stress Disorder, and Adaptation in Lithuanian Men 17 Years after Military Service in Afghanistan and the USSR’. Psichologija. Mokslo darbai. Vilnius: Vilniaus universiteto leidykla, 34, 57-68.</Citation>
        </Reference>
        <Reference>
          <Citation>Gailienė, D. (2001). Vienos diagnozės istorija. Naujasis židinys-aidai, 12, 675-683.</Citation>
        </Reference>
        <Reference>
          <Citation>Gailienė, D. (2008). Ką jie mums padarė: Lietuvos gyvenimas traumų psichologijos žvilgsniu. Vilnius: Tyto alba.</Citation>
        </Reference>
        <Reference>
          <Citation>Gailienė, D. (Ed.) (2015a). Lithuanian Faces after Transition: Psychological Consequences of Cultural Trauma. Vilnius: Eugrimas.</Citation>
        </Reference>
        <Reference>
          <Citation>Gailienė, D. (2015b). ‘Suicides in Lithuania. Sociocultural Context’. In D. Gailienė (Ed.). Lithuanian Faces after Transition: Psychological Consequences of Cultural Trauma. Vilnius: Eugrimas, 198-216.</Citation>
        </Reference>
        <Reference>
          <Citation>Gailienė, D. (2018). ‘Why are suicides so widespread in Catholic Lithuania?’ Religions, 9(3), 71; https://doi.org/10.3390/rel9030071</Citation>
        </Reference>
        <Reference>
          <Citation>Gailienė, D., Kazlauskas, E. (2005). ‘Fifty Years on: The Long-term Psychological Effects of Soviet Repression in Lithuania’. In D. Gailienė. (Ed.), The Psychology of Extreme Traumatisation: The Aftermath of PoliticalRepression. Vilnius: Akreta, 67-107.</Citation>
        </Reference>
        <Reference>
          <Citation>Gailius, B. (2006). Partizanai tada ir šiandien. Vilnius: Versus Aureus.</Citation>
        </Reference>
        <Reference>
          <Citation>Gudaitė, G. (2005). ‘Psychological aftereffects of the Soviet trauma’. In D. Gailienė. (Ed.) The Psychology of Extreme Traumatisation: The Aftermath of PoliticalRepression. Vilnius: Akreta, 108-126.</Citation>
        </Reference>
        <Reference>
          <Citation>Gudaitė, G. (2014). ‘Restoration of continuity: desperation or hope in facing the consequences of cultural trauma’. In G. Gudaitė, M. Stein (Eds.). Confronting cultural trauma: Jungian approaches to understanding and healing. Spring Journal Books.</Citation>
        </Reference>
        <Reference>
          <Citation>Gudaitė, G. (2016). Santykis su autoritetu ir asmeninės galios pajauta. Vilnius. Vilniaus universiteto leidykla.</Citation>
        </Reference>
        <Reference>
          <Citation>Gudaitė G., Stein M. (Eds.) (2014). Confronting Cultural Trauma: Jungian Approaches to Understanding and Healing. Spring Journal Books.</Citation>
        </Reference>
        <Reference>
          <Citation>Herman, J.L. (1992). Trauma and Recovery. New York: Basic Books.</Citation>
        </Reference>
        <Reference>
          <Citation>Ijzendoorn, M.H., Bakermans-Kranenburg, M.J., Sagi-Schwartz, A. (2003). Are children of Holocaust survivors less well-adapted? A meta-analytic investigations of secondary traumatization. Jornal of Traumatic Stress, 16, 459-469.</Citation>
        </Reference>
        <Reference>
          <Citation>Kazlauskas, E. (2006). Politinių represijų ilgalaikės psichologinės pasekmės. Daktaro disertacija. Vilnius: Vilniaus universitetas.</Citation>
        </Reference>
        <Reference>
          <Citation>Kazlauskas, E., Zelviene, P. (2015). ‘A history of political violence in the family as a resilience factor’. In D. Ajdukovic, S. Kimhi, M. Lahad (Eds.). Resiliency: Enhancing Coping with Crisis and Terrorism (Amsterdam: IOS Press) 141-148. https://doi.org/10.3233/978-1-61499-490-9-141.</Citation>
        </Reference>
        <Reference>
          <Citation>Kazlauskas, E., Zelviene, P. (2017). ‘Association between posttraumatic stress and acceptance of social changes: findings from a general population study and proposal of a new concept’. International Journal of Social Psychiatry 63 126-131. https://doi.org/10.1177/0020764016687788</Citation>
        </Reference>
        <Reference>
          <Citation>Kazlauskas, E., Gailiene, D., Vaskeliene, I., Skeryte-Kazlauskiene, M. (2017). ‘Intergenerational Transmission of Resilience? Sense of Coherence is Associated between Lithuanian Survivors of Political Violence and Their Adult Offspring’. Frontiers in Psychology 8. September 2017 https://doi.org/10.3389/fpsyg.2017.01677S.</Citation>
        </Reference>
        <Reference>
          <Citation>Lifton, R.J. (Eds.) (2001). ‘History as trauma’. In D. Lindy, R.J. Lifton (Eds.). Beyond Invisible Walls: Th Psychological Legacy of Soviet Trauma, Eastern European Therapists and Their Patients. Hove &amp; New York: Brunner-Routlege, 213-223.</Citation>
        </Reference>
        <Reference>
          <Citation>Maercker A. (Hrsg.) (2009). Posttraumatische Belastungsstörungen. 3., vollständig neu bearbeitete und erweiterte Auflage. Heidelberg: Springer.</Citation>
        </Reference>
        <Reference>
          <Citation>Maercker A., Horn, A.B. (2013). ‘A Socio-interpersonal perspective on PTSD: The case for environments and interpersonal processes’. Clinical Psychology and Psychotherapy. 20, 465-481.</Citation>
        </Reference>
        <Reference>
          <Citation>Major, E.F. (1996). War Stress in a Transgenerational Perspective. Oslo: Universitas Osloensis.</Citation>
        </Reference>
        <Reference>
          <Citation>Mažulytė-Rašytinė, E. (2017). Šeimos istorinių traumų ilgalaikiai padariniai: vėlesnių kartų psichologinio atsparumo tyrimas. Daktaro disertacija. Vilnius: Vilniaus universitetas.</Citation>
        </Reference>
        <Reference>
          <Citation>Neal, A.G. (1998). National Trauma and Collective Memory: Major Events in the American Century. New York and London: M.E. Shape Armonk.</Citation>
        </Reference>
        <Reference>
          <Citation>Norkus, Z. (2008). Kokia demokratija, koks kapitalizmas? Pokomunistinė transformacija Lietuvoje lyginamosios istorinės sociologijos požiūriu. Vilnius: Vilniaus universiteto leidykla.</Citation>
        </Reference>
        <Reference>
          <Citation>Petronytė-Kvedarauskienė, D., Gudaitė, G. (2018). Narcistinių asmenybių santykio su autoritetu patyrimas: kokybinė analizė. Sveikatos mokslai/Health Sciences in Eastern Europe, 28, 1, 40-46. https://doi.org/10.5200/sm-hs.2018.007</Citation>
        </Reference>
        <Reference>
          <Citation>Pūras, D., Šumskienė, E., Veniūtė, M., Šumskas, G., Juodkaitė, D., Murauskienė, L., Mataitytė-Diržienė, J., Šliužaitė, D. (2014). Iššūkiai įgyvendinant Lietuvos psichikos sveikatos politiką. Mokslo studija. http://www.fsf.vu.lt/dokumentai</Citation>
        </Reference>
        <Reference>
          <Citation>Putinaitė, N. (2007). Nenutrūkusi styga.Prisitaikymas ir pasipriešinimas sovietų Lietuvoje. Vilnius: Aidai.</Citation>
        </Reference>
        <Reference>
          <Citation>Putinaitė, N. (2015). Nugenėta pušis. Ateizmas kaip asmeninis apsisprendimas tarybų Lietuvoje. Vilnius: Naujasis židinys-aidai.</Citation>
        </Reference>
        <Reference>
          <Citation>Shephard B. A. (2014). War of Nerves: Soldiers and Psychiatrists. London: Jonathan Cape.</Citation>
        </Reference>
        <Reference>
          <Citation>Silbereisen, R.K., Pinquart, M., Tomasik, M.J. (2010). ‘Demands of social change and psychological adjustment: Results from the Jena study’. In R.K. Silbereisen, X. Chen (Eds.), Social Change and Human Development: Concepts and Results. London, UK: Sage, 125-147.</Citation>
        </Reference>
        <Reference>
          <Citation>Singer T., Kimbles S.L. (Eds.) (2004). The Cultural Complex: Contemporary Jungian Perspectives on Psyche and Society. Hove and New York: Brunner-Routledge.</Citation>
        </Reference>
        <Reference>
          <Citation>Smelser, N.J. (2004). ‘Psychological trauma and cultural trauma’. In J.C. Alexander, R. Eyerman, B. Giesen, N.J. Smelser, P. Sztompka (Eds.). Cultural Trauma and Collective Identity. Berkeley: University of California Press, 31-59.</Citation>
        </Reference>
        <Reference>
          <Citation>Staub E. (2006). ‘Reconciliation after genocide, mass killing or intractable conflict: Understanding the roots of violence, psychological recovery, and steps toward a general theory’. Political Psychology, 27, 867-893.</Citation>
        </Reference>
        <Reference>
          <Citation>Stein M. (2018). ‘Deepening the narrative of identity: “A Harsh and Bitter Drink”.’ Paper presented at the International Congress of Analytical Psychology. Vilnius, 11th-12th of May 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>Streikus, A. (2016). ‘Democracy and Catholicism in twentieth-century Lithuania’. In M.J. Schuck and J. Crowley-Buck (Eds.) Democracy, Culture, Catholicism: Voices from four Continents. New York: Fordham University Press, 17-28.</Citation>
        </Reference>
        <Reference>
          <Citation>Sztompka P. (2000). ‘Cultural trauma. The other face of social change’. European Journal of Social Theory 3(4): 449-466.</Citation>
        </Reference>
        <Reference>
          <Citation>Sztompka, P. (2004). The trauma of social change: A case of postcommunist societies. In J.C. Alexander, R. Eyman, B. Giesen, N.J. Smelser, &amp; P. Sztompka (Eds.). Cultural trauma and Collective Identity. University of California Press</Citation>
        </Reference>
        <Reference>
          <Citation>Tomasik, M. J., Silbereisen, R. K., Lechner, C. M., &amp; Wasilewski, J. (2013). ‘Negotiating demands of social change in young and middle-aged adults from Poland’. International Journal of Stress Management, 20(3), 222-253. https://doi.org/10.1037/a0033935</Citation>
        </Reference>
        <Reference>
          <Citation>Vaskelienė I. (2012). Politinių represijų Lietuvoje ilgalaikės psichologinės pasekmės antrajai kartai, Daktaro disertacija. Vilnius: Vilniaus universitetas.</Citation>
        </Reference>
        <Reference>
          <Citation>Weisaeth L. (2004). ‘Psychotraumatology: an overview from a European perspective’. In Gailienė D (Ed.) The Psychology of Extreme Traumatization: The Aftermath of Political Repression. Vilnius: LGGRTC, 26-66.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31418851</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>14</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>14</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1528-1167</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>60</Volume>
            <Issue>9</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>09</Month>
            </PubDate>
          </JournalIssue>
          <Title>Epilepsia</Title>
          <ISOAbbreviation>Epilepsia</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The underlying etiology of infantile spasms (West syndrome): Information from the International Collaborative Infantile Spasms Study (ICISS).</ArticleTitle>
        <Pagination>
          <MedlinePgn>1861-1869</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/epi.16305</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE">To determine the underlying etiologies in a contemporary cohort of infants with infantile spasms and to examine response to treatment.</AbstractText>
          <AbstractText Label="METHODS">Identification of the underlying etiology and response to treatment in 377 infants enrolled in a clinical trial of the treatment of infantile spasms between 2007 and 2014 using a systematic review of history, examination, and investigations. They were classified using the pediatric adaptation of International Classification of Diseases, Tenth Revision (ICD-10).</AbstractText>
          <AbstractText Label="RESULTS">A total of 219 of 377 (58%) had a proven etiology, of whom 128 (58%) responded, 58 of 108 (54%) were allocated hormonal treatment, and 70 of 111 (63%) had combination therapy. Fourteen of 17 (82%, 95% confidence interval [CI] 59% to 94%) infants with stroke and infarct responded (compared to 114 of 202 for the rest of the proven etiology group (56%, 95% CI 48% to 62%, chi-square 4.3, P = .037): the better response remains when treatment allocation and lead time are taken into account (odds ratio 5.1, 95% CI 1.1 to 23.6, P = .037). Twenty of 37 (54%, 95% CI 38% to 70%) infants with Down syndrome had cessation of spasms compared to 108 of 182 (59%, 95% CI 52% to 66%, chi-square 0.35, P = .55) for the rest of the proven etiology group. The lack of a significant difference remains after taking treatment modality and lead-time into account (odds ratio 0.8, 95% CI 0.4 to 1.7, P = .62). In Down syndrome infants, treatment modality did not appear to affect response: 11 of 20 (55%) allocated hormonal therapy responded, compared to 9 of 17 (53%) allocated combination therapy.</AbstractText>
          <AbstractText Label="SIGNIFICANCE">This classification allows easy comparison with other classifications and with our earlier reports. Stroke and infarct have a better outcome than other etiologies, whereas Down syndrome might not respond to the addition of vigabatrin to hormonal treatment.</AbstractText>
          <CopyrightInformation>Wiley Periodicals, Inc. © 2019 International League Against Epilepsy.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Osborne</LastName>
            <ForeName>John P</ForeName>
            <Initials>JP</Initials>
            <Identifier Source="ORCID">0000-0002-6602-0894</Identifier>
            <AffiliationInfo>
              <Affiliation>Department for Health, University of Bath, Bath, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Children's Department, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Edwards</LastName>
            <ForeName>Stuart W</ForeName>
            <Initials>SW</Initials>
            <AffiliationInfo>
              <Affiliation>Department for Health, University of Bath, Bath, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Children's Department, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dietrich Alber</LastName>
            <ForeName>Fabienne</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Neurology/Neuropsychology, University Children's Hospital, Zurich, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hancock</LastName>
            <ForeName>Eleanor</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Children's Department, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Johnson</LastName>
            <ForeName>Anthony L</ForeName>
            <Initials>AL</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Research Council Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kennedy</LastName>
            <ForeName>Colin R</ForeName>
            <Initials>CR</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical Neurosciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Likeman</LastName>
            <ForeName>Marcus</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Paediatric Radiology, Bristol Royal Hospital for Children, Bristol, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lux</LastName>
            <ForeName>Andrew L</ForeName>
            <Initials>AL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Paediatric Neurology, Bristol Royal Hospital for Children, Bristol, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mackay</LastName>
            <ForeName>Mark</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Neurology Department, The Royal Children's Hospital Melbourne, Parkville, Vic., Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mallick</LastName>
            <ForeName>Andrew</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Paediatric Neurology, Bristol Royal Hospital for Children, Bristol, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Newton</LastName>
            <ForeName>Richard W</ForeName>
            <Initials>RW</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Royal Manchester Children's Hospital, Manchester, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nolan</LastName>
            <ForeName>Melinda</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Starship Children's Health, Auckland, New Zealand.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pressler</LastName>
            <ForeName>Ronit</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>UCL Institute of Child Health, Clinical Neurosciences, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rating</LastName>
            <ForeName>Dietz</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>University of Heidelberg, Heidelberg, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schmitt</LastName>
            <ForeName>Bernhard</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Paediatric Neurology, University Children's Hospital, Zurich, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Verity</LastName>
            <ForeName>Christopher M</ForeName>
            <Initials>CM</Initials>
            <AffiliationInfo>
              <Affiliation>PIND research, Addenbrookes Hospital, Cambridge, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>O'Callaghan</LastName>
            <ForeName>Finbar J K</ForeName>
            <Initials>FJK</Initials>
            <AffiliationInfo>
              <Affiliation>Children's Department, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Child Health, University College London, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <CollectiveName>participating investigators</CollectiveName>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Epilepsia</MedlineTA>
        <NlmUniqueID>2983306R</NlmUniqueID>
        <ISSNLinking>0013-9580</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000927">Anticonvulsants</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>9PHQ9Y1OLM</RegistryNumber>
          <NameOfSubstance UI="D011239">Prednisolone</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>GR120KRT6K</RegistryNumber>
          <NameOfSubstance UI="D020888">Vigabatrin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000927" MajorTopicYN="N">Anticonvulsants</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054220" MajorTopicYN="N">Malformations of Cortical Development</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011239" MajorTopicYN="N">Prednisolone</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013036" MajorTopicYN="N">Spasms, Infantile</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020888" MajorTopicYN="N">Vigabatrin</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">West syndrome</Keyword>
        <Keyword MajorTopicYN="Y">etiology</Keyword>
        <Keyword MajorTopicYN="Y">infantile spasms</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>04</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>09</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>09</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418851</ArticleId>
        <ArticleId IdType="doi">10.1111/epi.16305</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Pavone P, Striano P, Falsaperla R, Pavone L, Ruggieri M. Infantile spasms syndrome, West syndrome and related phenotypes: What we know in 2013. Brain Dev. 2014;36:739-51.</Citation>
        </Reference>
        <Reference>
          <Citation>Illingworth RS. Sudden mental deterioration with convulsions in infancy. Arch Dis Child. 1955;39:529-37.</Citation>
        </Reference>
        <Reference>
          <Citation>Jr Engel J. International League Against E. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia. 2001;42:796-803.</Citation>
        </Reference>
        <Reference>
          <Citation>Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58:512-21.</Citation>
        </Reference>
        <Reference>
          <Citation>Riikonen R. Epidemiological data of West syndrome in Finland. Brain Dev. 2001;23:539-41.</Citation>
        </Reference>
        <Reference>
          <Citation>Osborne JP, Lux AL, Edwards SW, Hancock E, Johnson AL, Kennedy CR, et al. The underlying etiology of infantile spasms (West syndrome): information from the United Kingdom Infantile Spasms Study (UKISS) on contemporary causes and their classification. Epilepsia. 2010;51:2168-74.</Citation>
        </Reference>
        <Reference>
          <Citation>Karvelas G, Lortie A, Scantlebury MH, Duy PT, Cossette P, Carmant L. A retrospective study on aetiology based outcome of infantile spasms. Seizure. 2009;18:197-201.</Citation>
        </Reference>
        <Reference>
          <Citation>Ohtahara S, Ohtsuka Y, Yamatogi Y, Oka E, Yoshinaga H, Sato M. Prenatal etiologies of West syndrome. Epilepsia. 1993;34:716-22.</Citation>
        </Reference>
        <Reference>
          <Citation>Lux AL, Edwards SW, Hancock E, Johnson AL, Kennedy CR, Newton RW, et al. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol. 2005;4:712-7.</Citation>
        </Reference>
        <Reference>
          <Citation>O'Callaghan F, Edwards SW, Alber FD, Hancock E, Johnson AL, Kennedy CR, et al. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial. Lancet Neurol. 2017;16:33-42.</Citation>
        </Reference>
        <Reference>
          <Citation>Lux AL, Osborne JP. A proposal for case definitions and outcome measures in studies of infantile spasms and West syndrome: consensus statement of the West Delphi group. Epilepsia. 2004;45:1416-28.</Citation>
        </Reference>
        <Reference>
          <Citation>Crawshaw P. The new BPA classification. Arch Dis Child. 1995;73:563-7.</Citation>
        </Reference>
        <Reference>
          <Citation>O'Callaghan FJK, Edwards SW, Alber FD, Cortina Borja M, Hancock E, Johnson AL, et al. Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial. Lancet Child Adolesc Health. 2018;2:715-25.</Citation>
        </Reference>
        <Reference>
          <Citation>Paciorkowski AR, Thio LL, Dobyns WB. Genetic and biologic classification of infantile spasms. Pediatr Neurol. 2011;45:355-67.</Citation>
        </Reference>
        <Reference>
          <Citation>Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde BW, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. 2010;51:676-85.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">31418852</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1532-5415</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>67</Volume>
            <Issue>11</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>11</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of the American Geriatrics Society</Title>
          <ISOAbbreviation>J Am Geriatr Soc</ISOAbbreviation>
        </Journal>
        <ArticleTitle>From One Mother to Another.</ArticleTitle>
        <Pagination>
          <MedlinePgn>2420</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jgs.16140</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Colburn</LastName>
            <ForeName>Jessica L</ForeName>
            <Initials>JL</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Geriatric Medicine &amp; Gerontology, Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Am Geriatr Soc</MedlineTA>
        <NlmUniqueID>7503062</NlmUniqueID>
        <ISSNLinking>0002-8614</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>02</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>03</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418852</ArticleId>
        <ArticleId IdType="doi">10.1111/jgs.16140</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31418853</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>08</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1751-0813</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>97</Volume>
            <Issue>11</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Nov</Month>
            </PubDate>
          </JournalIssue>
          <Title>Australian veterinary journal</Title>
          <ISOAbbreviation>Aust Vet J</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A pilot study of Australian pet owners who engage in social media and their use, experience and views of online pet health information.</ArticleTitle>
        <Pagination>
          <MedlinePgn>433-439</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/avj.12870</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this study was to gain a better understanding of Australian pet owners' use of the internet for pet health; how trustworthy they rate various pet health information sources and the use of online information in subsequent veterinary consultations.</AbstractText>
          <AbstractText Label="METHOD" NlmCategory="METHODS">An anonymous questionnaire was developed, consisting of 30 questions, and distributed between March 2018 and May 2018 using convenience sampling through social media venues including Facebook and Twitter. All respondents were over the age of 18, lived in Australia and owned a pet animal.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 228 responses were received. The most common sources of pet health information were veterinarians (88.2%) and internet websites (81.1%). Most respondents reported using the internet 'many times per day' at either home or work. The majority of respondents used the internet to seek pet health information either 'not weekly but at least once a month' or 'less than once a month'. Nearly half of the respondents stated that they only 'sometimes' discuss their online findings with their veterinarian. Approximately one half of respondents agreed with the statement that online pet health information had affected their decision about whether to take their pet to the veterinarian.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study assesses how pet owners use the internet for pet health information and the role veterinarians can play in helping to facilitate these searches with tools such as information prescriptions. Further large-scale research is needed to help further understand this increasingly important aspect of pet health.</AbstractText>
          <CopyrightInformation>© 2019 Australian Veterinary Association.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kogan</LastName>
            <ForeName>L R</ForeName>
            <Initials>LR</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hazel</LastName>
            <ForeName>S J</ForeName>
            <Initials>SJ</Initials>
            <AffiliationInfo>
              <Affiliation>School of Animal and Veterinary Sciences, University of Adelaide, Adelaide, South Australia, 5005, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Oxley</LastName>
            <ForeName>J A</ForeName>
            <Initials>JA</Initials>
            <AffiliationInfo>
              <Affiliation>Independent Researcher, Measham, Swadlincote DE12 7LQ, Leicestershire, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Aust Vet J</MedlineTA>
        <NlmUniqueID>0370616</NlmUniqueID>
        <ISSNLinking>0005-0423</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007722" MajorTopicYN="N">Health Knowledge, Attitudes, Practice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057226" MajorTopicYN="Y">Information Seeking Behavior</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010067" MajorTopicYN="Y">Ownership</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057805" MajorTopicYN="Y">Pets</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D061108" MajorTopicYN="N">Social Media</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018634" MajorTopicYN="N">Veterinarians</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">health</Keyword>
        <Keyword MajorTopicYN="N">information</Keyword>
        <Keyword MajorTopicYN="N">online</Keyword>
        <Keyword MajorTopicYN="N">owners</Keyword>
        <Keyword MajorTopicYN="N">pets</Keyword>
        <Keyword MajorTopicYN="N">veterinarians</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>03</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>06</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418853</ArticleId>
        <ArticleId IdType="doi">10.1111/avj.12870</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Statista. Number of internet users worldwide from 2005 to 2017 (in millions). 2018. Available at: https://www.statista.com/statistics/273018/number-of-internet-users-worldwide/. Accessed 27 December 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>We Are Social. 2018 - digital report Australia. 2018. Available at: https://wearesocial.com/au/blog/2018/02/2018-digital-report-australia. Accessed 27 December 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>Animal Medicine Australia. Pet ownership in Australia 2016. 2016. Available at: https://animalmedicinesaustralia.org.au/wp-content/uploads/2016/11/AMA_Pet-Ownership-in-Australia-2016-Report_sml.pdf. Accessed 26 February 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Fox. The social life of health information. 2014. Available at: http://www.pewresearch.org/fact-tank/2014/01/15/the-social-life-of-health-information/. Accessed 26 February 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Lanon. How consumers find and use online health-related content in 2017. 2017. Available at: https://www.pm360online.com/how-consumers-find-and-use-online-health-related-content-in-2017/. Accessed 26 February 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>McDaid D, Park AL. Online health: untangling the web - evidence from the BUPA health pulse 2010 International Healthcare Survey. 2010. Available at: https://www.bupa.com.au/staticfiles/Bupa/HealthAndWellness/MediaFiles/PDF/LSE_Report_Online_Health.pdf. Accessed 28 December 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>Cheng C, Dunn M Health literacy and the Internet: a study on the readability of Australian online health information. Aust N Z J Public Health 2015;39:309-314.</Citation>
        </Reference>
        <Reference>
          <Citation>NIH (National Institute of Health). Finding and evaluating online resources. 2018. Available at: https://nccih.nih.gov/health/webresources. Accessed 30 December 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>Hazel SJ, Jenvey CJ, Tuke J Online relinquishments of dogs and cats in Australia. Animals 2018;8:25.</Citation>
        </Reference>
        <Reference>
          <Citation>Kogan L, Oxley JA, Hellyer P et al. UKpet owners' use of the internet for online pet health information. Vet Rec 2018;182:601-601.</Citation>
        </Reference>
        <Reference>
          <Citation>Kogan LR, Schoenfeld-Tacher R, Simon AA et al. The internet and pet health information: perceptions and behaviors of pet owners and veterinarians. Internet J Vet Med 2010;8:1.</Citation>
        </Reference>
        <Reference>
          <Citation>Jehn CT, Perzak DE, Cook JL et al. Usefulness, completeness, and accuracy of web sites providing information on osteoarthritis in dogs. J Am Vet Med Assoc 2003;223:1272-1275.</Citation>
        </Reference>
        <Reference>
          <Citation>Hofmeister EH, Watson V, Snyder LB et al. Validity and client use of information from the World Wide Web regarding veterinary anesthesia in dogs. J Am Vet Med Assoc 2008;233:1860-1864.</Citation>
        </Reference>
        <Reference>
          <Citation>Taggart R, Wardlaw J, Horstman CL et al. An analysis of the quality of canine cranial cruciate ligament disease information available on the internet. Vet Surg 2010;39:278-283.</Citation>
        </Reference>
        <Reference>
          <Citation>Weijs CA, Coe JB, Muise A et al. Reputation management on Facebook: awareness is key to protecting yourself, your practice, and the veterinary profession. J Am Anim Hosp Assoc 2014;50:227-236.</Citation>
        </Reference>
        <Reference>
          <Citation>Oxley JA, Eastwood B, Kogan LR Pet owners and the internet. Companion Anim 2017;22:358-358.</Citation>
        </Reference>
        <Reference>
          <Citation>Kogan LR, Oxley JA, Hazel SJ Pilot study of Australian veterinarians and their perceptions and experiences related to online pet health information. Aust Vet J 2019;97:10-13.</Citation>
        </Reference>
        <Reference>
          <Citation>Oxley JA, Kogan L A preliminary study investigating the use of rabbit-related Facebook groups in relation to rabbit health information. Vet Nurse 2018;9:382-387.</Citation>
        </Reference>
        <Reference>
          <Citation>Weijs CA, Coe JB, Christofides E et al. Facebook use among early-career veterinarians in Ontario, Canada (March to May 2010). J Am Vet Med Assoc 2013;242:1083-1090.</Citation>
        </Reference>
        <Reference>
          <Citation>van Veggel N “But it worked for my mother's cat”. Some common misconceptions about anecdotal evidence. Vet Nurs J 2017;32:239-240.</Citation>
        </Reference>
        <Reference>
          <Citation>Kogan LR, Schoenfeld-Tacher R, Gould L et al. Information prescriptions: A tool for veterinary practices. Open Vet J 2014;4:90-95.</Citation>
        </Reference>
        <Reference>
          <Citation>Belshaw Z, Robinson NJ, Dean RS et al. Owner and veterinary surgeon perspectives on the roles of veterinary nurses and receptionists in relation to small animal preventive healthcare consultations in the United Kingdom. Vet Rec 2018;183:296-296.</Citation>
        </Reference>
        <Reference>
          <Citation>Bethlehem J Selection bias in web surveys. Int Stat Rev 2010;78:161-188.</Citation>
        </Reference>
        <Reference>
          <Citation>Statista. Use of social networking sites in Australia as of March 2018, by age. 2019. Available at: https://www.statista.com/statistics/729928/australia-social-media-usage-by-age/. Accessed 26 May 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Greenacre ZA The importance of selection bias in internet surveys. Open J Stat 2016;8:397-404.</Citation>
        </Reference>
        <Reference>
          <Citation>Rohlf VI, Bennett PC, Toukhsati S, Coleman G. Why do even committed dog owners fail to comply with some responsible ownership practices? Anthrozoös 2010;23:143-155.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31418854</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>08</Month>
        <Day>05</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>12</Month>
        <Day>02</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-2141</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>188</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>01</Month>
            </PubDate>
          </JournalIssue>
          <Title>British journal of haematology</Title>
          <ISOAbbreviation>Br J Haematol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>GDF11 contributes to hepatic hepcidin (HAMP) inhibition through SMURF1-mediated BMP-SMAD signalling suppression.</ArticleTitle>
        <Pagination>
          <MedlinePgn>321-331</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/bjh.16156</ELocationID>
        <Abstract>
          <AbstractText>Hepcidin (HAMP) synthesis is suppressed by erythropoiesis to increase iron availability for red blood cell production. This effect is thought to result from factors secreted by erythroid precursors. Growth differentiation factor 11 (GDF11) expression was recently shown to increase in erythroid cells of β-thalassaemia, and decrease with improvement in anaemia. Whether GDF11 regulates hepatic HAMP production has never been experimentally studied. Here, we explore GDF11 function during erythropoiesis-triggered HAMP suppression. Our results confirm that exogenous erythropoietin significantly increases Gdf11 as well as Erfe (erythroferrone) expression, and Gdf11 is also increased, albeit at a lower degree than Erfe, in phlebotomized wild type and β-thalassaemic mice. GDF11 is expressed predominantly in erythroid burst forming unit- and erythroid colony-forming unit- cells during erythropoiesis. Exogeneous GDF11 administration results in HAMP suppression in vivo and in vitro. Furthermore, exogenous GDF11 decreases BMP-SMAD signalling, enhances SMAD ubiquitin regulatory factor 1 (SMURF1) expression and induces ERK1/2 (MAPK3/1) signalling. ERK1/2 signalling activation is required for GDF11 or SMURF1-mediated suppression in BMP-SMAD signalling and HAMP expression. This research newly characterizes GDF11 in erythropoiesis-mediated HAMP suppression, in addition to ERFE.</AbstractText>
          <CopyrightInformation>© 2019 British Society for Haematology and John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Fang</LastName>
            <ForeName>Zheng</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Molecular Biology Research Centre, School of Life Sciences, Central South University, Changsha, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhu</LastName>
            <ForeName>Zesen</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Molecular Biology Research Centre, School of Life Sciences, Central South University, Changsha, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Haihang</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Molecular Biology Research Centre, School of Life Sciences, Central South University, Changsha, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Peng</LastName>
            <ForeName>Yuanliang</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Molecular Biology Research Centre, School of Life Sciences, Central South University, Changsha, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Jin</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Molecular Biology Research Centre, School of Life Sciences, Central South University, Changsha, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lu</LastName>
            <ForeName>Hongyu</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Molecular Biology Research Centre, School of Life Sciences, Central South University, Changsha, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Jiang</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Laboratory, Hunan Provincial People's Hospital, Changsha, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liang</LastName>
            <ForeName>Long</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Molecular Biology Research Centre, School of Life Sciences, Central South University, Changsha, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xia</LastName>
            <ForeName>Shenghua</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Molecular Biology Research Centre, School of Life Sciences, Central South University, Changsha, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Qiguang</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Laboratory, Hunan Provincial People's Hospital, Changsha, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fu</LastName>
            <ForeName>Bin</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Haematology, Central South University Xiangya Hospital, Changsha, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Kunlu</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Molecular Biology Research Centre, School of Life Sciences, Central South University, Changsha, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Lingqiang</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Proteomics, National Centre of Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ginzburg</LastName>
            <ForeName>Yelena</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Haematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Jing</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Molecular Biology Research Centre, School of Life Sciences, Central South University, Changsha, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Huiyong</ForeName>
            <Initials>H</Initials>
            <Identifier Source="ORCID">0000-0001-8162-4381</Identifier>
            <AffiliationInfo>
              <Affiliation>Molecular Biology Research Centre, School of Life Sciences, Central South University, Changsha, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>81770107</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <GrantID>2017JJ3402</GrantID>
            <Agency>National Natural Science Foundation of Hunan Province</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <GrantID>31101686</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <GrantID>81270576</GrantID>
            <Agency>National Natural Science Foundation of China</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <GrantID>1053320170146</GrantID>
            <Agency>Central South University Graduate Research and Innovation Project</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DK095112</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DK107670</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>2018YFA0107800</GrantID>
            <Agency>National Key Research and Development Program of China</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <Agency>Central South University Teachers Foundation</Agency>
            <Country>International</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Br J Haematol</MedlineTA>
        <NlmUniqueID>0372544</NlmUniqueID>
        <ISSNLinking>0007-1048</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D019485">Bone Morphogenetic Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C000600298">Erfe protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C492266">GDF11 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C119153">Gdf11 protein, mouse</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D055412">Growth Differentiation Factors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C578702">HAMP protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C579599">Hamp protein, mouse</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D064451">Hepcidins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D036361">Peptide Hormones</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051785">Smad Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>11096-26-7</RegistryNumber>
          <NameOfSubstance UI="D004921">Erythropoietin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.3.2.26</RegistryNumber>
          <NameOfSubstance UI="C498342">SMURF1 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.3.2.26</RegistryNumber>
          <NameOfSubstance UI="C492381">Smurf1 protein, mouse</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.3.2.27</RegistryNumber>
          <NameOfSubstance UI="D044767">Ubiquitin-Protein Ligases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019485" MajorTopicYN="N">Bone Morphogenetic Proteins</DescriptorName>
          <QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004920" MajorTopicYN="N">Erythropoiesis</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004921" MajorTopicYN="N">Erythropoietin</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055412" MajorTopicYN="N">Growth Differentiation Factors</DescriptorName>
          <QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D056945" MajorTopicYN="N">Hep G2 Cells</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D022781" MajorTopicYN="N">Hepatocytes</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D064451" MajorTopicYN="N">Hepcidins</DescriptorName>
          <QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020935" MajorTopicYN="N">MAP Kinase Signaling System</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D036361" MajorTopicYN="N">Peptide Hormones</DescriptorName>
          <QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051785" MajorTopicYN="N">Smad Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D044767" MajorTopicYN="N">Ubiquitin-Protein Ligases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">GDF11</Keyword>
        <Keyword MajorTopicYN="Y">erythroid factor</Keyword>
        <Keyword MajorTopicYN="Y">erythropoiesis</Keyword>
        <Keyword MajorTopicYN="Y">hepcidin/HAMP</Keyword>
        <Keyword MajorTopicYN="Y">iron</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>01</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>06</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>8</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418854</ArticleId>
        <ArticleId IdType="doi">10.1111/bjh.16156</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Alarcon, C., Zaromytidou, A.I., Xi, Q., Gao, S., Yu, J., Fujisawa, S., Barlas, A., Miller, A.N., Manova-Todorova, K., Macias, M.J., Sapkota, G., Pan, D. &amp; Massague, J. (2009) Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. Cell, 139, 757-769.</Citation>
        </Reference>
        <Reference>
          <Citation>Alvarez, C., Aravena, A., Tapia, T., Rozenblum, E., Solis, L., Corvalan, A., Camus, M., Alvarez, M., Munroe, D., Maass, A. &amp; Carvallo, P. (2016) Different Array CGH profiles within hereditary breast cancer tumors associated to BRCA1 expression and overall survival. BMC Cancer, 16, 219.</Citation>
        </Reference>
        <Reference>
          <Citation>An, X.L., Schulz, V.P., Li, J., Wu, K.L., Liu, J., Xue, F.M., Hu, J.P., Mohandas, N. &amp; Gallagher, P.G. (2014) Global transcriptome analyses of human and murine terminal erythroid differentiation. Blood, 123, 3466-3477.</Citation>
        </Reference>
        <Reference>
          <Citation>Arezes, J., Foy, N., McHugh, K., Sawant, A., Quinkert, D., Terraube, V., Brinth, A., Tam, M., LaVallie, E.R., Taylor, S., Armitage, A.E., Pasricha, S.R., Cunningham, O., Lambert, M., Draper, S.J., Jasuja, R. &amp; Drakesmithm, H. (2018) Erythroferrone inhibits the induction of hepcidin by BMP6. Blood, 132, 1473-1477.</Citation>
        </Reference>
        <Reference>
          <Citation>Aschemeyer, S., Qiao, B., Stefanova, D., Valore, E.V., Sek, A.C., Ruwe, T.A., Vieth, K.R., Jung, G., Casu, C., Rivella, S., Jormakka, M., Mackenzie, B., Ganz, T. &amp; Nemeth, E. (2018) Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin. Blood, 131, 899-910.</Citation>
        </Reference>
        <Reference>
          <Citation>Augusciak-Duma, A. &amp; Sieron, A.L. (2008) Molecular characteristics of leiomyoma uteri based on selected compounds of the extracellular matrix. Postepy Higieny Medycyny Doswiasczalnej, 62, 148-165.</Citation>
        </Reference>
        <Reference>
          <Citation>Cao, Y. &amp; Zhang, L.Q. (2013) A Smurf1 tale: function and regulation of an ubiquitin ligase in multiple cellular networks. Cellular and Molecular Life Sciences, 70, 2305-2317.</Citation>
        </Reference>
        <Reference>
          <Citation>Carrancio, S., Markovics, J., Wong, P., Leisten, J., Castiglioni, P., Groza, M.C., Raymon, H.K., Heise, C., Daniel, T., Chopra, R. &amp; Sung, V. (2014) An activin receptor IIA ligand trap promotes erythropoiesis resulting in a rapid induction of red blood cells and haemoglobin. British Journal of Haematology, 165, 870-882.</Citation>
        </Reference>
        <Reference>
          <Citation>Casanovas, G., Spasic, M.V., Casu, C., Rivella, S., Strelau, J., Unsicker, K. &amp; Muckenthaler, M.U. (2013) The murine growth differentiation factor 15 is not essential for systemic iron homeostasis in phlebotomized mice. Haematologica, 98, 444-447.</Citation>
        </Reference>
        <Reference>
          <Citation>Casu, C., Oikonomidou, P.R., Chen, H.Y., Nandi, V., Ginzburg, Y., Prasad, P., Fleming, R.E., Shah, Y.M., Valore, E.V., Nemeth, E., Ganz, T., Macdonald, B. &amp; Rivella, S. (2016) Minihepcidin peptides as disease modifiers in mice affected by beta-thalassemia and polycythemia vera. Blood, 128, 265-276.</Citation>
        </Reference>
        <Reference>
          <Citation>Chen, H.Y., Choesang, T., Li, H.H., Sun, S.M., Pham, P., Bao, W.L., Feola, M., Westerman, M., Li, G.Y., Follenzi, A., Blanc, L., Rivella, S., Fleming, R.E. &amp; Ginzburg, Y.Z. (2016) Increased hepcidin in transferrin-treated thalassemic mice correlates with increased liver BMP2 expression and decreased hepatocyte ERK activation. Haematologica, 101, 297-308.</Citation>
        </Reference>
        <Reference>
          <Citation>Coffey, R., Sardo, U., Kautz, L., Gabayan, V., Nemeth, E. &amp; Ganz, T. (2018) Erythroferrone is not required for the glucoregulatory and hematologic effects of chronic erythropoietin treatment in mice. Physiological Reports, 6, e13890.</Citation>
        </Reference>
        <Reference>
          <Citation>Ding, Y., Li, X.R., Yang, K.Y., Huang, L.H., Hu, G. &amp; Gao, K. (2013) Proteomics analysis of gastric epithelial AGS cells infected with Epstein-Barr virus. Asian Pacific Journal of Cancer Prevention, 14, 367-372.</Citation>
        </Reference>
        <Reference>
          <Citation>Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S.J., Moynihan, J., Paw, B.H., Drejer, A., Barut, B., Zapata, A., Law, T.C., Brugnara, C., Lux, S.E., Pinkus, G.S., Pinkus, J.L., Kingsley, P.D., Palis, J., Fleming, M.D., Andrews, N.C. &amp; Zon, L.I. (2000) Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature, 403, 776-781.</Citation>
        </Reference>
        <Reference>
          <Citation>Dussiot, M., Maciel, T.T., Fricot, A., Chartier, C., Negre, O., Veiga, J., Grapton, D., Paubelle, E., Payen, E., Beuzard, Y., Leboulch, P., Ribeil, J.A., Arlet, J.B., Cote, F., Courtois, G., Ginzburg, Y.Z., Daniel, T.O., Chopra, R., Sung, V., Hermine, O. &amp; Moura, I.C. (2014) An activin receptor IIA ligand trap corrects ineffective erythropoiesis in beta-thalassemia. Nature Medicine, 20, 398-407.</Citation>
        </Reference>
        <Reference>
          <Citation>Flygare, J., Estrada, V.R., Shin, C., Gupta, S. &amp; Lodish, H.F. (2011) HIF1 alpha synergizes with glucocorticoids to promote BFU-E progenitor self-renewal. Blood, 117, 3435-3444.</Citation>
        </Reference>
        <Reference>
          <Citation>Fuentealba, L.C., Eivers, E., Ikeda, A., Hurtado, C., Kuroda, H., Pera, E.M. &amp; De Robertis, E.M. (2007) Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell, 131, 980-993.</Citation>
        </Reference>
        <Reference>
          <Citation>Ganz, T. (2019) Erythropoietic regulators of iron metabolism. Free Radical Biology Medicine, 133, 69-74.</Citation>
        </Reference>
        <Reference>
          <Citation>Ganz, T., Jung, G., Naeim, A., Ginzburg, Y., Pakbaz, Z., Walter, P.B., Kautz, L. &amp; Nemeth, E. (2017) Immunoassay for human serum erythroferrone. Blood, 130, 1243-1246.</Citation>
        </Reference>
        <Reference>
          <Citation>Gardenghi, S., Ramos, P., Marongiu, M.F., Melchiori, L., Breda, L., Guy, E., Muirhead, K., Rao, N., Roy, C.N., Andrews, N.C., Nemeth, E., Follenzi, A., An, X.L., Mohandas, N., Ginzburg, Y., Rachmilewitz, E.A., Giardina, P.J., Grady, R.W. &amp; Rivella, S. (2010) Hepcidin as a therapeutic tool to limit iron overload and improve anemia in beta-thalassemic mice. Journal of Clinical Investigation, 120, 4466-4477.</Citation>
        </Reference>
        <Reference>
          <Citation>Guerra, A., Oikonomidou, R., Gonzalez, S., Zhang, J., Lo Presti, V., Hamilton, C.R., Breda, L., Casu, C., Fleming, M.D., Martinez, P., Suragani, R., Kumar, R. &amp; Rivella, S. (2018) Lack of GDF11 does not ameliorate erythropoiesis in beta-thalassemia and does not prevent the activity of the trap-ligand RAP-536. Blood, 132, 165.</Citation>
        </Reference>
        <Reference>
          <Citation>Guo, S.L., Casu, C., Gardenghi, S., Booten, S., Aghajan, M., Peralta, R., Watt, A., Freier, S., Monia, B.P. &amp; Rivella, S. (2013) Reducing TMPRSS6 ameliorates hemochromatosis and beta-thalassemia in mice. Journal of Clinical Investigation, 123, 1531-1541.</Citation>
        </Reference>
        <Reference>
          <Citation>Hu, J.P., Liu, J., Xue, F.M., Halverson, G., Reid, M., Guo, A.Q., Chen, L.X., Raza, A., Galili, N., Jaffray, J., Lane, J., Chasis, J.A., Taylor, N., Mohandas, N. &amp; An, X.L. (2013) Isolation and functional characterization of human erythroblasts at distinct stages: implications for understanding of normal and disordered erythropoiesis in vivo. Blood, 121, 3246-3253.</Citation>
        </Reference>
        <Reference>
          <Citation>Iyengar, P.V. (2017) Regulation of ubiquitin enzymes in the TGF-beta pathway. International Journalof Molecular Science, 18, 877-886.</Citation>
        </Reference>
        <Reference>
          <Citation>Jamaiyar, A., Wan, W., Janota, D.M., Enrick, M.K., Chilian, W.M. &amp; Yin, L. (2017) The versatility and paradox of GDF11. Pharmacology &amp; Therapeutics, 175, 28-34.</Citation>
        </Reference>
        <Reference>
          <Citation>Kaiser, J. (2014) Aging 'rejuvenation factor' in blood turns back the clock in old mice. Science, 344, 570-571.</Citation>
        </Reference>
        <Reference>
          <Citation>Katsimpardi, L., Litterman, N.K., Schein, P.A., Miller, C.M., Loffredo, F.S., Wojtkiewicz, G.R., Chen, J.W., Lee, R.T., Wagers, A.J. &amp; Rubin, L.L. (2014) Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors. Science, 344, 630-634.</Citation>
        </Reference>
        <Reference>
          <Citation>Kautz, L., Jung, G., Valore, E.V., Rivella, S., Nemeth, E. &amp; Ganz, T. (2014) Identification of erythroferrone as an erythroid regulator of iron metabolism. Nature Genetics, 46, 678-684.</Citation>
        </Reference>
        <Reference>
          <Citation>Kautz, L., Jung, G., Du, X., Gabayan, V., Chapman, J., Nasoff, M., Nemeth, E. &amp; Ganz, T. (2015) Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of beta-thalassemia. Blood, 126, 2031-2037.</Citation>
        </Reference>
        <Reference>
          <Citation>Li, H.H., Rybicki, A.C., Suzuka, S.M., Von Bonsdorff, L., Breuer, W., Hall, C.B., Cabantchik, Z.I., Bouhassira, E.E., Fabry, M.E. &amp; Ginzburg, Y.Z. (2010) Transferrin therapy ameliorates disease in beta-thalassemic mice. Nature Medicine, 16, 177-182.</Citation>
        </Reference>
        <Reference>
          <Citation>Li, J., Hale, J., Bhagia, P., Xue, F.M., Chen, L.X., Jaffray, J., Yan, H.X., Lane, J., Gallagher, P.G., Mohandas, N., Liu, J. &amp; An, X.L. (2014) Isolation and transcriptome analyses of human erythroid progenitors: BFU-E and CFU-E. Blood, 124, 3636-3645.</Citation>
        </Reference>
        <Reference>
          <Citation>Loffredo, F.S., Steinhauser, M.L., Jay, S.M., Gannon, J., Pancoast, J.R., Yalamanchi, P., Sinha, M., Dall'osso, C., Khong, D., Shadrach, J.L., Miller, C.M., Singer, B.S., Stewart, A., Psychogios, N., Gerszten, R.E., Hartigan, A.J., Kim, M.J., Serwold, T., Wagers, A.J. &amp; Lee, R.T. (2013) Growth Differentiation factor 11 Is a circulating factor that reverses age-related cardiac hypertrophy. Cell, 153, 828-839.</Citation>
        </Reference>
        <Reference>
          <Citation>McPherron, A.C., Lawler, A.M. &amp; Lee, S.J. (1999) Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11. Nature Genetics, 22, 260-264.</Citation>
        </Reference>
        <Reference>
          <Citation>Nai, A., Rubio, A., Campanella, A., Gourbeyre, O., Artuso, I., Bordini, J., Gineste, A., Latour, C., Besson-Fournier, C., Lin, H.Y., Coppin, H., Roth, M.P., Camaschella, C., Silvestri, L. &amp; Meynard, D. (2016) Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice. Blood, 127, 2327-2336.</Citation>
        </Reference>
        <Reference>
          <Citation>Nakashima, M., Tachibana, K., Iohara, K., Ito, M., Ishikawa, M. &amp; Akamine, A. (2003) Induction of reparative dentin formation by ultrasound-mediated gene delivery of growth/differentiation factor 11. Human Gene Therapy, 14, 591-597.</Citation>
        </Reference>
        <Reference>
          <Citation>Nemeth, E. &amp; Ganz, T. (2006) Regulation of iron metabolism by hepcidin. Annual Review of Nutrition, 26, 323-242.</Citation>
        </Reference>
        <Reference>
          <Citation>Nemeth, E., Tuttle, M.S., Powelson, J., Vaughn, M.B., Donovan, A., Ward, D.M., Ganz, T. &amp; Kaplan, J. (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science, 306, 2090-2093.</Citation>
        </Reference>
        <Reference>
          <Citation>Ozdamar, B., Bose, R., Barrios-Rodiles, M., Wang, H.R., Zhang, Y. &amp; Wrana, J.L. (2005) Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science, 307, 1603-1609.</Citation>
        </Reference>
        <Reference>
          <Citation>Sanchez, N.S. &amp; Barnett, J.V. (2012) TGFbeta and BMP-2 regulate epicardial cell invasion via TGFbetaR3 activation of the Par6/Smurf1/RhoA pathway. Cellular Signalling, 24, 539-548.</Citation>
        </Reference>
        <Reference>
          <Citation>Sapkota, G., Alarcon, C., Spagnoli, F.M., Brivanlou, A.H. &amp; Massague, J. (2007) Balancing BMP signaling through integrated inputs into the Smad1 linker. Molecular Cell, 25, 441-454.</Citation>
        </Reference>
        <Reference>
          <Citation>Schmidt, P.J., Racie, T., Westerman, M., Fitzgerald, K., Butler, J.S. &amp; Fleming, M.D. (2015) Combination therapy with a Tmprss6 RNAi-therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of beta-thalassemia intermedia. American Journal of Hematology, 90, 310-313.</Citation>
        </Reference>
        <Reference>
          <Citation>Shenoy, N., Vallumsetla, N., Rachmilewitz, E., Verma, A. &amp; Ginzburg, Y. (2014) Impact of iron overload and potential benefit from iron chelation in low-risk myelodysplastic syndrome. Blood, 124, 873-881.</Citation>
        </Reference>
        <Reference>
          <Citation>Silvestri, L., Pagani, A., Nai, A., De Domenico, I., Kaplan, J. &amp; Camaschella, C. (2008) The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metabolism, 8, 502-511.</Citation>
        </Reference>
        <Reference>
          <Citation>Stumpf, M., Waskow, C., Krotschel, M., Van Essen, D., Rodriguez, P., Zhang, X.T., Guyot, B., Roeder, R.G. &amp; Borggrefe, T. (2006) The mediator complex functions as a coactivator for GATA-1 in erythropoiesis via subunit Med1/TRAP220. Proceedings of the National Academy of Sciences, USA, 104, 18504-18509.</Citation>
        </Reference>
        <Reference>
          <Citation>Sun, Z.W., Wang, Y., Han, X., Zhao, X.L., Peng, Y.L., Li, Y.S., Peng, M.Y., Song, J.H., Wu, K.L., Sun, S.M., Zhou, W.H., Qi, B.W., Zhou, C.F., Chen, H.Y., An, X.L. &amp; Liu, J. (2015) miR-150 inhibits terminal erythroid proliferation and differentiation. Oncotarget, 6, 43033-43047.</Citation>
        </Reference>
        <Reference>
          <Citation>Suragani, R.N.V.S., Cadena, S.M., Cawley, S.M., Sako, D., Mitchell, D., Li, R., Davies, M.V., Alexander, M.J., Devine, M., Loveday, K.S., Underwood, K.W., Grinberg, A.V., Quisel, J.D., Chopra, R., Pearsall, R.S., Seehra, J. &amp; Kumar, R. (2014a) Transforming growth factor-beta superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis. Nature Medicine, 20, 408-414.</Citation>
        </Reference>
        <Reference>
          <Citation>Suragani, R.N.V.S., Cawley, S.M., Li, R., Wallner, S., Alexander, M.J., Mulivor, A.W., Gardenghi, S., Rivella, S., Grinberg, A.V., Pearsall, R.S. &amp; Kumar, R. (2014b) Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine beta-thalassemia. Blood, 123, 3864-3872.</Citation>
        </Reference>
        <Reference>
          <Citation>Tanno, T., Bhanu, N.V., Oneal, P.A., Goh, S.H., Staker, P., Lee, Y.T., Moroney, J.W., Reed, C.H., Luban, N.L.C., Wang, R.H., Eling, T.E., Childs, R., Ganz, T., Leitman, S.F., Fucharoen, S. &amp; Miller, J.L. (2007) High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nature Medicine, 13, 1096-1101.</Citation>
        </Reference>
        <Reference>
          <Citation>Tanno, T., Porayette, P., Sripichai, O., Noh, S.J., Byrnes, C., Bhupatiraju, A., Lee, Y.T., Goodnough, J.B., Harandi, O., Ganz, T., Paulson, R.F. &amp; Miller, J.L. (2009) Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. Blood, 114, 181-186.</Citation>
        </Reference>
        <Reference>
          <Citation>Wallace, D.F. (2016) The regulation of iron absorption and homeostasis. Clinical Biochemist Reviews, 37, 51-62.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, C.Y., Fang, Z., Zhu, Z.S., Liu, J. &amp; Chen, H.Y. (2017a) Reciprocal regulation between hepcidin and erythropoiesis and its therapeutic application in erythroid disorders. Experimental Hematology, 52, 24-31.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, C.Y., Core, A.B., Canali, S., Zumbrennen-Bullough, K.B., Ozer, S., Umans, L., Zwijsen, A. &amp; Babitt, J.L. (2017b) Smad1/5 is required for erythropoietin-mediated suppression of hepcidin in mice. Blood, 130, 73-83.</Citation>
        </Reference>
        <Reference>
          <Citation>Xie, P., Zhang, M.H., He, S., Lu, K.F., Chen, Y.H., Xing, G.C., Lu, Y.M., Liu, P., Li, Y., Wang, S.X., Chai, N., Wu, J.W., Deng, H.T., Wang, H.R., Cao, Y., Zhao, F., Cui, Y., Wang, J., He, F.C. &amp; Zhang, L.Q. (2014) The covalent modifier Nedd8 is critical for the activation of Smurf1 ubiquitin ligase in tumorigenesis. Nature Communications, 5, 3733.</Citation>
        </Reference>
        <Reference>
          <Citation>Yamashita, M., Ying, S.X., Zhang, G.M., Li, C.L., Cheng, S.Y., Deng, C.X. &amp; Zhang, Y.E. (2005) Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation. Cell, 121, 101-113.</Citation>
        </Reference>
        <Reference>
          <Citation>Yokoe, T., Ohmachi, T., Inoue, H., Mimori, K., Tanaka, F., Kusunoki, M. &amp; Mori, M. (2007) Clinical significance of growth differentiation factor 11 in colorectal cancer. International Journal of Oncology, 31, 1097-1101.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang, D.L., Wu, J., Shah, B.N., Greutelaers, K.C., Ghosh, M.C., Ollivierre, H., Su, X.Z., Thuma, P.E., Bedu-Addo, G., Mockenhaupt, F.P., Gordeuk, V.R. &amp; Rouault, T.A. (2018) Erythrocytic ferroportin reduces intracellular iron accumulation, hemolysis, and malaria risk. Science, 359, 1520-1523.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang, Y.H., Wei, Y., Liu, D., Liu, F., Li, X.S., Pan, L.H., Pang, Y. &amp; Chen, D.L. (2017) Role of growth differentiation factor 11 in development, physiology and disease. Oncotarget, 8, 81604-81616.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhu, H.T., Kavsak, P., Abdollah, S., Wrana, J.L. &amp; Thomsen, G.H. (1999) A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature, 400, 687-693.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31418855</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>08</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1751-0813</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>97</Volume>
            <Issue>11</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Nov</Month>
            </PubDate>
          </JournalIssue>
          <Title>Australian veterinary journal</Title>
          <ISOAbbreviation>Aust Vet J</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Cobalt accumulation in horses following repeated administration of cobalt chloride.</ArticleTitle>
        <Pagination>
          <MedlinePgn>465-472</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/avj.12872</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To monitor cobalt concentrations in urine, red blood cells and plasma after chronic parenteral administration of cobalt chloride evaluate these results against the current International Federation of Horseracing Authorities thresholds for detecting cobalt misuse.</AbstractText>
          <AbstractText Label="DESIGN" NlmCategory="METHODS">Eight mares were randomly assigned to four treatment groups, with two mares in each group: Group 1 - control group, Group 2 - 25 milligrams cobalt intravenously as CoCl<sub>2</sub> weekly, Group 3 - 50 milligrams cobalt intravenously as CoCl<sub>2</sub> weekly, and Group 4 - 25 milligrams cobalt intravenously mid-week and at the end of the week. Urine and blood samples were collected before each weekly administration so that trough levels were assessed. In the group receiving two doses per week, urine and blood were collected prior to the dose given at the end of each week. Samples were initially collected at time zero then weekly for 10 weeks. Three further collections of urine and blood were made at days 81, 106 and 127.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Urine creatinine measurements to assess horse hydration status were performed by the Jaffe reaction method. Cobalt determinations in plasma, blood and urine were by inductively coupled plasma-mass spectrometry. Haematocrit concentrations, used to calculate red cell cobalt levels, were performed using a microhematocrit centrifuge. Statistical analyses were conducted in Genstat (v17, VSNi).</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Marked cobalt accumulation was evident with increasing cobalt concentrations for all sample matrices in specimens collected immediately prior to cobalt administration. Correlation between the sample matrices improved when urine cobalt concentration was adjusted for creatinine level. Red cell cobalt levels remained elevated for at least 12 weeks after cessation of administration, consistent with the lifespan of the red cell. There was no significant change in haematocrit concentrations for the duration of the study.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The current urine cobalt threshold was only effective at detecting acute cobalt exposure while the plasma cobalt threshold was able to consistently identify chronic high-level cobalt exposure and potential cobalt misuse. The threshold values legislated for urine cobalt do not correlate with those set for plasma. The acute nature of urinary cobalt excretion provides a relatively small window through which cobalt administration is detected. Plasma and red cell cobalt concentrations can provide a clearer picture of potential cobalt misuse.</AbstractText>
          <CopyrightInformation>© 2019 Australian Veterinary Association.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wenzel</LastName>
            <ForeName>R G</ForeName>
            <Initials>RG</Initials>
            <Identifier Source="ORCID">https://orcid.org/0000-0002-4395-0239</Identifier>
            <AffiliationInfo>
              <Affiliation>NSW Health Pathology, Trace Elements Laboratory, Royal North Shore Hospital, Level 5, Acute Services Building, Pacific Highway, St Leonards, New South Wales, 2065, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre for Forensic Science, University of Technology Sydney, Broadway, New South Wales, 2001, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Major</LastName>
            <ForeName>D</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Derek Major Consulting Pty Ltd, Richmond, New South Wales, 2753, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hesp</LastName>
            <ForeName>K F</ForeName>
            <Initials>KF</Initials>
            <AffiliationInfo>
              <Affiliation>NSW Health Pathology, Trace Elements Laboratory, Royal North Shore Hospital, Level 5, Acute Services Building, Pacific Highway, St Leonards, New South Wales, 2065, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hall</LastName>
            <ForeName>E</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Veterinary Biostatistics, University of Sydney, Camden, New South Wales, 2570, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Doble</LastName>
            <ForeName>P</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Forensic Science, University of Technology Sydney, Broadway, New South Wales, 2001, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D000081262">Randomized Controlled Trial, Veterinary</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Aust Vet J</MedlineTA>
        <NlmUniqueID>0370616</NlmUniqueID>
        <ISSNLinking>0005-0423</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>3G0H8C9362</RegistryNumber>
          <NameOfSubstance UI="D003035">Cobalt</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>AYI8EX34EU</RegistryNumber>
          <NameOfSubstance UI="D003404">Creatinine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EVS87XF13W</RegistryNumber>
          <NameOfSubstance UI="C018021">cobaltous chloride</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003035" MajorTopicYN="N">Cobalt</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
          <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
          <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
          <QualifierName UI="Q000652" MajorTopicYN="Y">urine</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName>
          <QualifierName UI="Q000652" MajorTopicYN="Y">urine</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006736" MajorTopicYN="N">Horses</DescriptorName>
          <QualifierName UI="Q000652" MajorTopicYN="Y">urine</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009517" MajorTopicYN="N" Type="Geographic">New South Wales</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010949" MajorTopicYN="N">Plasma</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013177" MajorTopicYN="N">Sports</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">accumulation</Keyword>
        <Keyword MajorTopicYN="N">blood</Keyword>
        <Keyword MajorTopicYN="N">cobalt</Keyword>
        <Keyword MajorTopicYN="N">haematocrit</Keyword>
        <Keyword MajorTopicYN="N">horse</Keyword>
        <Keyword MajorTopicYN="N">urine</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>11</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>06</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418855</ArticleId>
        <ArticleId IdType="doi">10.1111/avj.12872</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Harris P, Coenen M, Frape D et al. Equine nutrition and metabolic diseases. In: The equine manual. Saunders Ltd., Philadelphia, Pennsylvania, 2006;72.</Citation>
        </Reference>
        <Reference>
          <Citation>Simonsen LO, Harbak H, Bennekou P Cobalt metabolism and toxicology-a brief update. Sci Total Environ 2012;432:210-215.</Citation>
        </Reference>
        <Reference>
          <Citation>Tvermoes BE, Unice KM, Paustenbach DJ et al. Effects and blood concentrations of cobalt after ingestion of 1 mg/d by human volunteers for 90 d. Am J Clin Nutr 2014;99:632-646.</Citation>
        </Reference>
        <Reference>
          <Citation>Carter E, Valli V, McSherry B et al. The kinetics of hematopoiesis in the light horse I. The lifespan of peripheral blood cells in the normal horse. Can J Comp Med 1974;38:303.</Citation>
        </Reference>
        <Reference>
          <Citation>Kinobe RT Towards the elimination of excessive cobalt supplementation in racing horses: a pharmacological review. Res Vet Sci 2016;104:106-112.</Citation>
        </Reference>
        <Reference>
          <Citation>Estey MP, Diamandis EP, Van Der Straeten C et al. Cobalt and chromium measurement in patients with metal hip prostheses. Clin Chem 2013;59:880-886.</Citation>
        </Reference>
        <Reference>
          <Citation>Daniel J, Ziaee H, Pradhan C et al. Blood and urine metal ion levels in young and active patients after Birmingham hip resurfacing arthroplasty: four-year results of a prospective longitudinal study. J Bone Joint Surg Br 2007;89:169-173.</Citation>
        </Reference>
        <Reference>
          <Citation>Krug O, Kutscher D, Piper T et al. Quantifying cobalt in doping control urine samples-a pilot study. Drug Test Anal 2014;6:1186-1190.</Citation>
        </Reference>
        <Reference>
          <Citation>International Federation of Horseracing Authorities. International agreement on breeding, racing and wagering. 2017. Available at: http://www.ifhaonline.org/resources/2017Agreement.pdf. Accessed 2 November 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>Ho EN, Chan GH, Wan TS et al. Controlling the misuse of cobalt in horses. Drug Test Anal 2015;7:21-30.</Citation>
        </Reference>
        <Reference>
          <Citation>Knych HK, Arthur RM, Mitchell MM et al. Pharmacokinetics and selected pharmacodynamics of cobalt following a single intravenous administration to horses. Drug Test Anal 2015;7:619-625.</Citation>
        </Reference>
        <Reference>
          <Citation>Flora SJ, Pachauri V Chelation in metal intoxication. Int J Environ Res Public Health 2010;7:2745-2788.</Citation>
        </Reference>
        <Reference>
          <Citation>Llobet JM, Domingo JL, Corbella J Comparison of the effectiveness of several chelators after single administration on the toxicity, excretion and distribution of cobalt. Arch Toxicol 1986;58:278-281.</Citation>
        </Reference>
        <Reference>
          <Citation>Apple FS, Quist HE, Otto AP et al. Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race. Clin Chem 2002;48:1097-1100.</Citation>
        </Reference>
        <Reference>
          <Citation>Lippi G, Montagnana M, Guidi GC Albumin cobalt binding and ischemia modified albumin generation: an endogenous response to ischemia? Int J Cardiol 2006;108:410-411.</Citation>
        </Reference>
        <Reference>
          <Citation>Yaqub LS, Mshelia WP, Ayo JO Erythrocyte osmotic fragility and hematological responses of horses administered ascorbic acid and exposed to road transportation. J Equine Vet 2014;34:1324-1328.</Citation>
        </Reference>
        <Reference>
          <Citation>Hanzawa K, Watanabe S Changes in osmotic fragility of erythrocytes during exercise in athletic horses. J Equine Sci 2000;11:51-61.</Citation>
        </Reference>
        <Reference>
          <Citation>WADA Laboratory Committee. Decision limits for the confirmatory quantification of threshold substances. 2014. Available at: http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-ISLaboratories/Technical_Documents/WADA-TD2013DL-Decision-Limits-for-the-Confirmatory-Quantification-Threshold-Substances-2.0-EN.pdf. Accessed 19 April 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>Sauve JF, Levesque M, Huard M et al. Creatinine and specific gravity normalization in biological monitoring of occupational exposures. J Occup Environ Hyg 2015;12:123-129.</Citation>
        </Reference>
        <Reference>
          <Citation>Warrack BM, Hnatyshyn S, Ott KH et al. Normalization strategies for metabonomic analysis of urine samples. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877:547-552.</Citation>
        </Reference>
        <Reference>
          <Citation>Boeniger MF, Lowry LK, Rosenberg J Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: a review. Am Ind Hyg Assoc J 1993;54:615-627.</Citation>
        </Reference>
        <Reference>
          <Citation>Abbott Laboratories. Creatinine. 2006. Available at: http://www.ilexmedical.com/files/PDF/Creatinine_ARC_CHEM.pdf. Accessed 21 April 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>International Organization for Standardization. ISO 15189:2012 medical laboratories - requirements for quality and competence. 2012. Available at: http://www.iso.org/iso/catalogue_detail?csnumber=56115. Accessed 22 April 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>Burns T, Dembek K, Kamr A et al. Effect of intravenous administration of cobalt chloride to horses on clinical and hemodynamic variables. J Vet Intern Med 2018;32:441-449.</Citation>
        </Reference>
        <Reference>
          <Citation>Simonsen LO, Brown AM, Harbak H et al. Cobalt uptake and binding in human red blood cells. Blood Cells Mol Dis 2011;46:266-276.</Citation>
        </Reference>
        <Reference>
          <Citation>Mobasheri A, Proudman CJ Cobalt chloride doping in racehorses: concerns over a potentially lethal practice. Vet J 2015;205:335-338.</Citation>
        </Reference>
        <Reference>
          <Citation>Finley BL, Monnot AD, Gaffney SH et al. Dose-response relationships for blood cobalt concentrations and health effects: a review of the literature and application of a biokinetic model. J Toxicol Environ Health B Crit Rev 2012;15:493-523.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
      <PMID Version="1">31418856</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>27</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1469-1809</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>84</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>01</Month>
            </PubDate>
          </JournalIssue>
          <Title>Annals of human genetics</Title>
          <ISOAbbreviation>Ann Hum Genet</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Argentinian clinical genomics in a leukodystrophies and genetic leukoencephalopathies cohort: Diagnostic yield in our first 9 years.</ArticleTitle>
        <Pagination>
          <MedlinePgn>11-28</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/ahg.12345</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION AND OBJECTIVES">Leukodystrophies and genetic leukoencephalopathies constitute a vast group of pathologies of the cerebral white matter. The large number of etiopathogenic genes and the frequent unspecificity on the clinical-radiological presentation generate remarkable difficulties in the diagnosis approach. Despite recent and significant developments, molecular diagnostic yield is still less than 50%. Our objective was to develop and explore the usefulness of a new diagnostic procedure using standardized molecular diagnostic tools, and next-generation sequencing techniques.</AbstractText>
          <AbstractText Label="MATERIALS AND METHODS">A prospective, observational, analytical study was conducted in a cohort of 46 patients, evaluated between May 2008 and December 2016, with a suspected genetic leukoencephalopathy or leukodystrophy. A diagnostic procedure was set up using classical monogenic tools in patients with characteristic phenotypes, and next-generation techniques in nonspecific ones.</AbstractText>
          <AbstractText Label="RESULTS">Global diagnostic procedure yield was 57.9%, identifying the etiological pathogenesis in 22 of the 38 studied subjects. Analysis by subgroups, Sanger method, and next-generation sequencing showed a yield of 64%, and 46.1% respectively. The most common pathologies were adrenoleukodystrophy, cerebral autosomal-dominant arteriopathy with subcortical infarcts (CADASIL), and vanishing white matter disease.</AbstractText>
          <AbstractText Label="CONCLUSIONS">Our results confirm the usefulness of the proposed diagnostic procedure expressed in a high diagnostic yield and suggest a more optimal cost-effectiveness in an etiological analysis phase.</AbstractText>
          <CopyrightInformation>© 2019 John Wiley &amp; Sons Ltd/University College London.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Cohen</LastName>
            <ForeName>Leila</ForeName>
            <Initials>L</Initials>
            <Identifier Source="ORCID">0000-0002-9093-2834</Identifier>
            <AffiliationInfo>
              <Affiliation>Neurology Department, Hospital J.M. Ramos Mejía, CABA, Centro Universitario de Neurología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Manín</LastName>
            <ForeName>Analisa</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Neurology Department, Hospital J.M. Ramos Mejía, CABA, Centro Universitario de Neurología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Medina</LastName>
            <ForeName>Nancy</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Neurology Department, Hospital J.M. Ramos Mejía, CABA, Centro Universitario de Neurología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Neurogenetic Section, Neurology Department, Hospital J.M. Ramos Mejía, CABA, Centro Universitario de Neurología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rodríguez-Quiroga</LastName>
            <ForeName>Sergio</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Neurology Department, Hospital J.M. Ramos Mejía, CABA, Centro Universitario de Neurología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Neurogenetic Section, Neurology Department, Hospital J.M. Ramos Mejía, CABA, Centro Universitario de Neurología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Movements Disorders Section, Neurology Department, Hospital J.M. Ramos Mejía, CABA, Centro Universitario de Neurología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>González-Morón</LastName>
            <ForeName>Dolores</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Neurology Department, Hospital J.M. Ramos Mejía, CABA, Centro Universitario de Neurología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Neurogenetic Section, Neurology Department, Hospital J.M. Ramos Mejía, CABA, Centro Universitario de Neurología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Neuroophthalmology Section, Neurology Department, Hospital J.M. Ramos Mejía, CABA, Centro Universitario de Neurología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rosales</LastName>
            <ForeName>Julieta</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Neurology Department, Hospital J.M. Ramos Mejía, CABA, Centro Universitario de Neurología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Neurogenetic Section, Neurology Department, Hospital J.M. Ramos Mejía, CABA, Centro Universitario de Neurología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Amartino</LastName>
            <ForeName>Hernan</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Child Neurology Department, Hospital Universitario Austral, Buenos Aires, Argentina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Specola</LastName>
            <ForeName>Norma</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Metabolism Department, Hospital de Niños "Sor María Ludovica" de La Plata, Buenos Aires, Argentina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Córdoba</LastName>
            <ForeName>Marta</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Neurology Department, Hospital J.M. Ramos Mejía, CABA, Centro Universitario de Neurología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Neurogenetic Section, Neurology Department, Hospital J.M. Ramos Mejía, CABA, Centro Universitario de Neurología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kauffman</LastName>
            <ForeName>Marcelo</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Neurology Department, Hospital J.M. Ramos Mejía, CABA, Centro Universitario de Neurología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Neurogenetic Section, Neurology Department, Hospital J.M. Ramos Mejía, CABA, Centro Universitario de Neurología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Instituto de Investigaciones en Medicina Traslacional-CONICET y Facultad de Ciencias Biomédicas-Universidad Austral, Buenos Aires, Argentina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vega</LastName>
            <ForeName>Patricia</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Neurogenetic Section, Neurology Department, Hospital J.M. Ramos Mejía, CABA, Centro Universitario de Neurología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <Agency>"Lautaro te Necesita" Foundation</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <Agency>Ministry of Science and Technology of Argentina</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <Agency>Fund for Scientific and Technological Research</Agency>
            <Country>International</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Ann Hum Genet</MedlineTA>
        <NlmUniqueID>0416661</NlmUniqueID>
        <ISSNLinking>0003-4800</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">diagnostic procedure</Keyword>
        <Keyword MajorTopicYN="Y">genetic leukoencephalopathies</Keyword>
        <Keyword MajorTopicYN="Y">leukodystrophies</Keyword>
        <Keyword MajorTopicYN="Y">next-generation sequencing</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>12</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>02</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418856</ArticleId>
        <ArticleId IdType="doi">10.1111/ahg.12345</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Amorosi, C. A., Myskóva, H., Monti, M. R., Argaraña, C. E., Morita, M., Kemp, S., … Oller de Ramírez, A. M. (2012). X-linked adrenoleukodystrophy: Molecular and functional analysis of the ABCD1 gene in Argentinean patients. PloS One, 7(12), e52635. Retrieved from https://doi.org/10.1371/journal.pone.0052635</Citation>
        </Reference>
        <Reference>
          <Citation>Arroyo, H. A., Grippo, J., Taratuto, A., Duffau, J., &amp; Chamoles, N. (1991). Krabbe disease in monozygotic triplets. Developmental Medicine and Child Neurology, 33(12), 1101-1103.</Citation>
        </Reference>
        <Reference>
          <Citation>Boehm, C. D., Cutting, G. R., Lachtermacher, M. B., Moser, H. W., &amp; Chong, S. S. (1999). Accurate DNA-based diagnostic and carrier testing for X-linked adrenoleukodystrophy. Molecular Genetics and Metabolism, 66(2), 128-136. Retrieved from https://doi.org/10.1006/mgme.1998.2779</Citation>
        </Reference>
        <Reference>
          <Citation>Chen, S., Ni, W., Yin, X., Liu, H. Q., Lu, C., Zheng, Q. J., … Wu, Z. Y. (2017). Clinical features and mutation spectrum in Chinese patients with CADASIL: A multicenter retrospective study. CNS Neuroscience &amp; Therapeutics, 23, 707-716. Retrieved from https://doi.org/10.1111/cns.12719</Citation>
        </Reference>
        <Reference>
          <Citation>Córdoba, M., González Morón, D., Rodríguez-Quiroga, S. A., &amp; Kauffman, M. A. (2014). Neurología genómica personalizada: El futuro es ahora. Neurología Argentina, 6, 127-136.</Citation>
        </Reference>
        <Reference>
          <Citation>Córdoba, M., Rodriguez-Quiroga, S. A., Vega, P., Salinas, V., Perez/Maturo, J., Amartino, H., … Kauffman, M. A. (2018). Whole exome sequencing in neurogenetic diagnostic odysseys: An Argentinian experience. PloS One, 13(2), e0191228.</Citation>
        </Reference>
        <Reference>
          <Citation>Davous, P. (1998). CADASIL: A review with proposed diagnostic criteria. European Journal of Neurology, 5(3), 219-233.</Citation>
        </Reference>
        <Reference>
          <Citation>de Kremer, R. D., Latini, A., Suormala, T., Baumgartner, E. R., Laróvere, L., Civallero, G., … Mayor, C. Q. (2002). Leukodystrophy and CSF purine abnormalities associated with isolated 3-methylcrotonyl-CoA carboxylase deficiency. Metabolic Brain Disease, 17(1), 13-18.</Citation>
        </Reference>
        <Reference>
          <Citation>Gordon, H. B., Letsou, A., &amp; Bonkowsky, J. L. (2014). The leukodystrophies. Seminars in Neurology, 34(3), 312-320. Retrieved from https://doi.org/10.1055/s-0034-1386769</Citation>
        </Reference>
        <Reference>
          <Citation>Guarnaschelli, M., &amp; Sotelo, A. (2017). Hemorragia cerebral en CADASIL. Neurología Argentina, 9, 49-52.</Citation>
        </Reference>
        <Reference>
          <Citation>Kevelam, S., Steenweg, M., Srivastava, S., Helman, G., Naidu, S., Schiffman, R., … van der Knaap, M. (2016). Update on leukodystrophies: A historical perspective and adapted definition. Neuropediatrics, 47(6), 349-354. Retrieved from https://doi.org/10.1055/s-0036-1588020</Citation>
        </Reference>
        <Reference>
          <Citation>Korenke, G. C., Roth, C., Krasemann, E. W., Hufner, M., Hunneman, D. H., &amp; Hanefeld, F. (1997). Variability of endocrinological dysfunction in 55 patients with X-linked adrenoleukodystrophy: Clinical, laboratory and genetic findings. European Journal of Endocrinology, 137(1), 40-47.</Citation>
        </Reference>
        <Reference>
          <Citation>Krasemann, E. W., Meier, V., Korenke, G. C., Hunneman, D. H., &amp; Hanefeld, F. (1996). Identification of mutations in the ALD-gene of 20 families with adrenoleukodystrophy/adrenomyeloneuropathy. Human Genetics, 97(2), 194-197.</Citation>
        </Reference>
        <Reference>
          <Citation>Li, H., &amp; Durbin, R. (2009). Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics, 25(14), 1754-1760. Retrieved from https://doi.org/10.1093/bioinformatics/btp324</Citation>
        </Reference>
        <Reference>
          <Citation>Lynch, D. S., Rodrigues Brandão de Paiva, A., Zhang, W. J., Bugiardini, E., Freua, F., Tavares Lucato, L., … Houlden, H. (2017). Clinical and genetic characterization of leukoencephalopathies in adults. Brain, 140(5), 1204-1211. Retrieved from https://doi.org/10.1093/brain/awx045</Citation>
        </Reference>
        <Reference>
          <Citation>Parikh, S., Bernard, G., Leventer, R. J., van der Knaap, M. S., van Hove, J., Pizzino, A., … GLIA Consortium.(2015). A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephalopathies. Molecular Genetics and Metabolism, 114(4), 501-515. Retrieved from https://doi.org/10.1016/j.ymgme.2014.12.434</Citation>
        </Reference>
        <Reference>
          <Citation>Pescini, F., Nannucci, S., &amp; Pantoni, L. (2013). Response to letter regarding article, “The cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy scale. A screening tool to select patients for NOTCH3 gene analysis”. Stroke; A Journal of Cerebral Circulation, 44(3), e19.</Citation>
        </Reference>
        <Reference>
          <Citation>Richards, J., Korgenski, E. K., Taft, R. J., Vanderver, A., &amp; Bonkowsky, J. L. (2015). Targeted leukodystrophy diagnosis based on charges and yields for testing. American Journal of Medical Genetics. Part A, 167A(11), 2541-2543. Retrieved from https://doi.org/10.1002/ajmg.a.37215</Citation>
        </Reference>
        <Reference>
          <Citation>Rodríguez-Quiroga, S. A., Cordoba, M., González-Morón, D., Medina, N., Vega, P., Dusefante, C. V., … Kauffman, M. A. (2015). Neurogenetics in Argentina: Diagnostic yield in a personalized research based clinic. Genetic Research (Cambridge), 97, e10.</Citation>
        </Reference>
        <Reference>
          <Citation>Stellitano, L. A., Winstone, A. M., van der Knaap, M. S., &amp; Verity, C. M. (2016). Leukodystrophies and genetic leukoencephalopathies in childhood: A national epidemiological study. Developmental Medicine and Child Neurology, 58(7), 680-689. Retrieved from https://doi.org/10.1111/dmcn.13027</Citation>
        </Reference>
        <Reference>
          <Citation>Van der Auwera, G. A., Carneiro, M. O., Hartl, C., Poplin, R., Del Angel, G., Levy-Moonshine, A., … DePristo, M. A. (2013). From FastQ data to high confidence variant calls: The Genome Analysis Toolkit best practices pipeline. Current Protocols in Bioinformatics, 4(3), 11.10.1-11.10.33.</Citation>
        </Reference>
        <Reference>
          <Citation>van der Knaap, M. S., Leegwater, P. A., Könst, A. A., Visser, A., Naidu, S., Oudejans, C. B., … Pronk, J. C. (2002). Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter. Annals of Neurology, 51(2), 264-270.</Citation>
        </Reference>
        <Reference>
          <Citation>Vanderver, A., Prust, M., Tonduti, D., Mochel, F., Hussey, H. M., Helman, G., … GLIA Consortium.(2015). Case definition and classification of leukodystrophies and leukoencephalopathies. Molecular Genetics and Metabolism, 114(4), 494-500. Retrieved from https://doi.org/10.1016/j.ymgme.2015.01.006.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang, X., He, F., Yin, F., Chen, C., Wu, L., Yang, L., &amp; Peng, J. (2016). The use of targeted genomic capture and massively parallel sequencing in diagnosis of Chinese leukoencephalopathies. Scientific Reports, 6, 35936. Retrieved from https://doi.org/10.1038/srep35936</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31418857</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>06</Month>
        <Day>11</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>12</Month>
        <Day>01</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1471-4159</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>151</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>12</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of neurochemistry</Title>
          <ISOAbbreviation>J Neurochem</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Mutant huntingtin fails to directly impair brain mitochondria.</ArticleTitle>
        <Pagination>
          <MedlinePgn>716-731</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jnc.14852</ELocationID>
        <Abstract>
          <AbstractText>Although the mechanisms by which mutant huntingtin (mHtt) results in Huntington's disease (HD) remain unclear, mHtt-induced mitochondrial defects were implicated in HD pathogenesis. The effect of mHtt could be mediated by transcriptional alterations, by direct interaction with mitochondria, or by both. In the present study, we tested a hypothesis that mHtt directly damages mitochondria. To test this hypothesis, we applied brain cytosolic fraction from YAC128 mice, containing mHtt, to brain non-synaptic and synaptic mitochondria from wild-type mice and assessed mitochondrial respiration with a Clark-type oxygen electrode, membrane potential and Ca<sup>2+</sup> uptake capacity with tetraphenylphosphonium (TPP<sup>+</sup> )- and Ca<sup>2+</sup> -sensitive electrodes, respectively, and, reactive oxygen species production with Amplex Red assay. The amount of mHtt bound to mitochondria following incubation with mHtt-containing cytosolic fraction was greater than the amount of mHtt bound to brain mitochondria isolated from YAC128 mice. Despite mHtt binding to wild-type mitochondria, no abnormalities in mitochondrial functions were detected. This is consistent with our previous results demonstrating the lack of defects in brain mitochondria isolated from R6/2 and YAC128 mice. This, however, could be because of partial loss of mitochondrially bound mHtt during the isolation procedure. Consequently, we increased the amount of mitochondrially bound mHtt by incubating brain non-synaptic and synaptic mitochondria isolated from YAC128 mice with mHtt-containing cytosolic fraction. Despite the enrichment of YAC128 brain mitochondria with mHtt, mitochondrial functions (respiration, membrane potential, reactive oxygen species production, Ca<sup>2+</sup> uptake capacity) remained unchanged. Overall, our results suggest that mHtt does not directly impair mitochondrial functions, arguing against the involvement of this mechanism in HD pathogenesis. Open Science: This manuscript was awarded with the Open Materials Badge For more information see: https://cos.io/our-services/open-science-badges/.</AbstractText>
          <CopyrightInformation>© 2019 International Society for Neurochemistry.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hamilton</LastName>
            <ForeName>James</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brustovetsky</LastName>
            <ForeName>Tatiana</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brustovetsky</LastName>
            <ForeName>Nickolay</ForeName>
            <Initials>N</Initials>
            <Identifier Source="ORCID">0000-0002-6564-2560</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 NS098772</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Neurochem</MedlineTA>
        <NlmUniqueID>2985190R</NlmUniqueID>
        <ISSNLinking>0022-3042</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C506812">Htt protein, mouse</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000071058">Huntingtin Protein</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020013" MajorTopicYN="N">Calcium Signaling</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000071058" MajorTopicYN="N">Huntingtin Protein</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053078" MajorTopicYN="N">Membrane Potential, Mitochondrial</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Huntington's disease</Keyword>
        <Keyword MajorTopicYN="Y">calcium</Keyword>
        <Keyword MajorTopicYN="Y">mitochondria</Keyword>
        <Keyword MajorTopicYN="Y">mitochondrial membrane potential</Keyword>
        <Keyword MajorTopicYN="Y">reactive oxygen species</Keyword>
        <Keyword MajorTopicYN="Y">respiration</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>05</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>06</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418857</ArticleId>
        <ArticleId IdType="doi">10.1111/jnc.14852</ArticleId>
        <ArticleId IdType="pmc">PMC6917837</ArticleId>
        <ArticleId IdType="mid">NIHMS1046348</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Biochim Biophys Acta. 1969 Jan 14;172(1):52-65</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4387597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Neurol. 2000 Jan;47(1):80-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10632104</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Subcell Biochem. 2007;45:481-506</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18193649</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Biol Chem. 2008 Nov 7;283(45):30715-24</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18606820</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biochem Pharmacol. 1978;27(24):2835-44</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">153748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nat Neurosci. 2014 Jun;17(6):822-31</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24836077</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neurobiol Dis. 2012 Jan;45(1):322-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21907283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hum Mol Genet. 2012 Jan 15;21(2):406-20</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21997870</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Biol Chem. 2011 Dec 30;286(52):44512-20</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21984825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Biol Chem. 2003 May 23;278(21):19062-70</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12660243</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mol Cell Biol. 2004 Sep;24(18):8195-209</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15340079</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hum Mol Genet. 2013 Oct 1;22(19):3869-82</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23720495</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Neurosci. 2008 Mar 12;28(11):2783-92</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18337408</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Anesth. 1975;11(1):25-44</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">235376</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arch Biochem Biophys. 2003 Feb 1;410(1):1-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12559971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hum Mol Genet. 2014 Jan 1;23(1):129-44</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24021477</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Mol Sci. 2018 Nov 30;19(12):null</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30513656</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mol Neurobiol. 2016 Jul;53(5):2944-2953</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25941077</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>ASN Neuro. 2011 Jun 07;3(3):e00060</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21542802</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Physiol. 2005 Oct 1;568(Pt 1):47-59</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16051627</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Neurosci. 2000 Jan 1;20(1):103-13</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10627586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anesthesiology. 1973 Aug;39(2):153-64</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4146381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neurochem Int. 2017 Oct;109:24-33</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28062223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Membr Biol. 1979 Aug;49(2):105-21</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">490631</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>PLoS Curr. 2013 Apr 02;5:null</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23568011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cell Metab. 2019 Jun 4;29(6):1258-1273.e11</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30930170</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nat Neurosci. 2002 Aug;5(8):731-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12089530</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Neurochem. 2015 Aug;134(4):652-67</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25963273</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Neurochem. 1990 Aug;55(2):698-707</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2164576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Neurosci. 2007 Dec 12;27(50):13614-23</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18077673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Behav Res Methods. 2007 May;39(2):175-91</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17695343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hum Mol Genet. 2016 Jul 1;25(13):2762-2775</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27131346</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hum Mol Genet. 2004 Jul 15;13(14):1407-20</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15163634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hum Mol Genet. 2015 Sep 1;24(17):4862-78</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26041817</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Front Aging Neurosci. 2017 Dec 07;9:406</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29270123</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nat Neurosci. 2009 Jul;12(7):857-63</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19503084</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Neurochem. 2001 Oct;79(2):266-77</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11677254</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biochem Biophys Res Commun. 2006 Mar 10;341(2):607-13</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16427603</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nat Rev Dis Primers. 2015 Apr 23;1:15005</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27188817</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Annu Rev Med. 1975;26:391-401</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">167650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Biol Chem. 2008 Feb 29;283(9):5780-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18156184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Biol Chem. 2006 Nov 17;281(46):34785-95</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16973623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Neurochem. 1985 Jun;44(6):1948-50</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2985766</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31418858</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>04</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>05</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1471-4159</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>151</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>11</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of neurochemistry</Title>
          <ISOAbbreviation>J Neurochem</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The pathobiology of perturbed mutant huntingtin protein-protein interactions in Huntington's disease.</ArticleTitle>
        <Pagination>
          <MedlinePgn>507-519</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jnc.14853</ELocationID>
        <Abstract>
          <AbstractText>Mutations are at the root of many human diseases. Still, we largely do not exactly understand how they trigger pathogenesis. One, more recent, hypothesis has been that they comprehensively perturb protein-protein interaction (PPI) networks and significantly alter key biological processes. Under this premise, many rare genetic disorders with Mendelian inheritance, like Huntington's disease and several spinocerebellar ataxias, are likely to be caused by complex genotype-phenotype relationships involving abnormal PPIs. These altered PPI networks and their effects on cellular pathways are poorly understood at the molecular level. In this review, we focus on PPIs that are perturbed by the expanded pathogenic polyglutamine tract in huntingtin (HTT), the protein which, in its mutated form, leads to the autosomal dominant, neurodegenerative Huntington's disease. One aspect of perturbed mutant HTT interactions is the formation of abnormal protein species such as fibrils or large neuronal inclusions as a result of homotypic and heterotypic aberrant molecular interactions. This review focuses on abnormal PPIs that are associated with the assembly of mutant HTT aggregates in cells and their potential relevance in disease. Furthermore, the mechanisms and pathobiological processes that may contribute to phenotype development, neuronal dysfunction and toxicity in Huntington's disease brains are also discussed. This article is part of the Special Issue "Proteomics".</AbstractText>
          <CopyrightInformation>© 2019 The Authors. Journal of Neurochemistry published by John Wiley &amp; Sons Ltd on behalf of International Society for Neurochemistry.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wanker</LastName>
            <ForeName>Erich E</ForeName>
            <Initials>EE</Initials>
            <Identifier Source="ORCID">0000-0001-8072-1630</Identifier>
            <AffiliationInfo>
              <Affiliation>Neuroproteomics, Max Delbrueck Center for Molecular Medicine, Berlin, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ast</LastName>
            <ForeName>Anne</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Neuroproteomics, Max Delbrueck Center for Molecular Medicine, Berlin, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schindler</LastName>
            <ForeName>Franziska</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Neuroproteomics, Max Delbrueck Center for Molecular Medicine, Berlin, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Trepte</LastName>
            <ForeName>Philipp</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Neuroproteomics, Max Delbrueck Center for Molecular Medicine, Berlin, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schnoegl</LastName>
            <ForeName>Sigrid</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Neuroproteomics, Max Delbrueck Center for Molecular Medicine, Berlin, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Neurochem</MedlineTA>
        <NlmUniqueID>2985190R</NlmUniqueID>
        <ISSNLinking>0022-3042</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C086055">HTT protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000071058">Huntingtin Protein</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000071058" MajorTopicYN="N">Huntingtin Protein</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D066263" MajorTopicYN="N">Protein Aggregation, Pathological</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054730" MajorTopicYN="Y">Protein Interaction Domains and Motifs</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Huntington's disease</Keyword>
        <Keyword MajorTopicYN="Y">huntingtin</Keyword>
        <Keyword MajorTopicYN="Y">interactomics</Keyword>
        <Keyword MajorTopicYN="Y">pathobiology</Keyword>
        <Keyword MajorTopicYN="Y">perturbed protein-protein interactions</Keyword>
        <Keyword MajorTopicYN="Y">protein aggregation</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>04</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>07</Month>
          <Day>08</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>02</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31418858</ArticleId>
        <ArticleId IdType="doi">10.1111/jnc.14853</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Alanis-Lobato G., Andrade-Navarro M. A. and Schaefer M. H. (2017) HIPPIE v2.0: enhancing meaningfulness and reliability of protein-protein interaction networks. Nucleic Acids Res. 45, D408-D414.</Citation>
        </Reference>
        <Reference>
          <Citation>Amberger J. S., Bocchini C. A., Scott A. F. and Hamosh A. (2019) OMIM.org: leveraging knowledge across phenotype-gene relationships. Nucleic Acids Res. 47, D1038-D1043.</Citation>
        </Reference>
        <Reference>
          <Citation>Arrasate M., Mitra S., Schweitzer E. S., Segal M. R. and Finkbeiner S. (2004) Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431, 805-810.</Citation>
        </Reference>
        <Reference>
          <Citation>Ast A., Buntru A., Schindler F., et al. (2018) mHTT Seeding activity: a marker of disease progression and neurotoxicity in models of Huntington's disease. Mol. Cell 71, e676.</Citation>
        </Reference>
        <Reference>
          <Citation>Babcock D. T. and Ganetzky B. (2015) Transcellular spreading of huntingtin aggregates in the Drosophila brain. Proc. Natl Acad. Sci. USA 112, E5427-5433.</Citation>
        </Reference>
        <Reference>
          <Citation>Baias M., Smith P. E., Shen K., Joachimiak L. A., Zerko S., Kozminski W., Frydman J. and Frydman L. (2017) Structure and dynamics of the huntingtin exon-1 N-terminus: a solution NMR perspective. J. Am. Chem. Soc. 139, 1168-1176.</Citation>
        </Reference>
        <Reference>
          <Citation>Barabasi A. L., Gulbahce N. and Loscalzo J. (2011) Network medicine: a network-based approach to human disease. Nat. Rev. Genet. 12, 56-68.</Citation>
        </Reference>
        <Reference>
          <Citation>Bates G. P., Dorsey R., Gusella J. F., et al. (2015) Huntington disease. Nat. Rev. Dis. Primers 1, 15005.</Citation>
        </Reference>
        <Reference>
          <Citation>Bauerlein F. J. B., Saha I., Mishra A., et al. (2017) In Situ architecture and cellular interactions of PolyQ inclusions. Cell 171, e110.</Citation>
        </Reference>
        <Reference>
          <Citation>Berger J. and Moller D. E. (2002) The mechanisms of action of PPARs. Annu. Rev. Med. 53, 409-435.</Citation>
        </Reference>
        <Reference>
          <Citation>Bhattacharyya A. M., Thakur A. K. and Wetzel R. (2005) Polyglutamine aggregation nucleation: thermodynamics of a highly unfavorable protein folding reaction. Proc. Natl Acad. Sci. USA 102, 15400-15405.</Citation>
        </Reference>
        <Reference>
          <Citation>Bjorkoy G., Lamark T. and Johansen T. (2006) p62/SQSTM1: a missing link between protein aggregates and the autophagy machinery. Autophagy 2, 138-139.</Citation>
        </Reference>
        <Reference>
          <Citation>Brigidi G. S., Sun Y., Beccano-Kelly D., Pitman K., Mobasser M., Borgland S. L., Milnerwood A. J. and Bamji S. X. (2014) Palmitoylation of delta-catenin by DHHC5 mediates activity-induced synapse plasticity. Nat. Neurosci. 17, 522-532.</Citation>
        </Reference>
        <Reference>
          <Citation>Busch A., Engemann S., Lurz R., Okazawa H., Lehrach H. and Wanker E. E. (2003) Mutant huntingtin promotes the fibrillogenesis of wild-type huntingtin: a potential mechanism for loss of huntingtin function in Huntington's disease. J. Biol. Chem. 278, 41452-41461.</Citation>
        </Reference>
        <Reference>
          <Citation>Cariulo C., Azzollini L., Verani M., et al. (2017) Phosphorylation of huntingtin at residue T3 is decreased in Huntington's disease and modulates mutant huntingtin protein conformation. Proc. Natl Acad. Sci. USA 114, E10809-E10818.</Citation>
        </Reference>
        <Reference>
          <Citation>Chandra A., Sharma A., Calingasan N. Y., White J. M., Shurubor Y., Yang X. W., Beal M. F. and Johri A. (2016) Enhanced mitochondrial biogenesis ameliorates disease phenotype in a full-length mouse model of Huntington's disease. Hum. Mol. Genet. 25, 2269-2282.</Citation>
        </Reference>
        <Reference>
          <Citation>Chen S., Fragoza R., Klei L., Liu Y., Wang J., Roeder K., Devlin B. and Yu H. (2018) An interactome perturbation framework prioritizes damaging missense mutations for developmental disorders. Nat. Genet. 50, 1032-1040.</Citation>
        </Reference>
        <Reference>
          <Citation>Costa V., Giacomello M., Hudec R., et al. (2010) Mitochondrial fission and cristae disruption increase the response of cell models of Huntington's disease to apoptotic stimuli. EMBO Mol. Med. 2, 490-503.</Citation>
        </Reference>
        <Reference>
          <Citation>Costanzo M., Abounit S., Marzo L., Danckaert A., Chamoun Z., Roux P. and Zurzolo C. (2013) Transfer of polyglutamine aggregates in neuronal cells occurs in tunneling nanotubes. J. Cell Sci. 126, 3678-3685.</Citation>
        </Reference>
        <Reference>
          <Citation>Cui L., Jeong H., Borovecki F., Parkhurst C. N., Tanese N. and Krainc D. (2006) Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127, 59-69.</Citation>
        </Reference>
        <Reference>
          <Citation>Cunningham J. T., Rodgers J. T., Arlow D. H., Vazquez F., Mootha V. K. and Puigserver P. (2007) mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 450, 736-740.</Citation>
        </Reference>
        <Reference>
          <Citation>Davies S. W., Turmaine M., Cozens B. A., et al. (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537-548.</Citation>
        </Reference>
        <Reference>
          <Citation>Diaz-Hernandez M., Torres-Peraza J., Salvatori-Abarca A., Moran M. A., Gomez-Ramos P., Alberch J. and Lucas J. J. (2005) Full motor recovery despite striatal neuron loss and formation of irreversible amyloid-like inclusions in a conditional mouse model of Huntington's disease. J. Neurosci. 25, 9773-9781.</Citation>
        </Reference>
        <Reference>
          <Citation>Dickey A. S., Pineda V. V., Tsunemi T., et al. (2016) PPAR-delta is repressed in Huntington's disease, is required for normal neuronal function and can be targeted therapeutically. Nat. Med. 22, 37-45.</Citation>
        </Reference>
        <Reference>
          <Citation>Dickey A. S., Sanchez D. N., Arreola M., et al. (2017) PPARdelta activation by bexarotene promotes neuroprotection by restoring bioenergetic and quality control homeostasis. Sci. Transl. Med. 9, eaal2332.</Citation>
        </Reference>
        <Reference>
          <Citation>DiFiglia M., Sapp E., Chase K. O., Davies S. W., Bates G. P., Vonsattel J. P. and Aronin N. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993.</Citation>
        </Reference>
        <Reference>
          <Citation>Drombosky K. W., Rode S., Kodali R., Jacob T. C., Palladino M. J. and Wetzel R. (2018) Mutational analysis implicates the amyloid fibril as the toxic entity in Huntington's disease. Neurobiol. Dis. 120, 126-138.</Citation>
        </Reference>
        <Reference>
          <Citation>Duennwald M. L., Jagadish S., Giorgini F., Muchowski P. J. and Lindquist S. (2006) A network of protein interactions determines polyglutamine toxicity. Proc. Natl Acad. Sci. USA 103, 11051-11056.</Citation>
        </Reference>
        <Reference>
          <Citation>Dunah A. W., Jeong H., Griffin A., et al. (2002) Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science 296, 2238-2243.</Citation>
        </Reference>
        <Reference>
          <Citation>el-Husseini Ael D. and Bredt D. S. (2002) Protein palmitoylation: a regulator of neuronal development and function. Nat. Rev. Neurosci. 3, 791-802.</Citation>
        </Reference>
        <Reference>
          <Citation>Finck B. N. and Kelly D. P. (2006) PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J. Clin. Invest. 116, 615-622.</Citation>
        </Reference>
        <Reference>
          <Citation>Fu Y., Wu P., Pan Y., Sun X., Yang H., Difiglia M. and Lu B. (2017) A toxic mutant huntingtin species is resistant to selective autophagy. Nat. Chem. Biol. 13, 1152-1154.</Citation>
        </Reference>
        <Reference>
          <Citation>Garret M., Du Z., Chazalon M., Cho Y. H. and Baufreton J. (2018) Alteration of GABAergic neurotransmission in Huntington's disease. CNS Neurosci. Ther. 24, 292-300.</Citation>
        </Reference>
        <Reference>
          <Citation>Gauthier L. R., Charrin B. C., Borrell-Pages M., et al. (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118, 127-138.</Citation>
        </Reference>
        <Reference>
          <Citation>Giorgini F. (2013) A flexible polyglutamine hinge opens new doors for understanding huntingtin function. Proc. Natl Acad. Sci. USA 110, 14516-14517.</Citation>
        </Reference>
        <Reference>
          <Citation>Gromiha M. M., Yugandhar K. and Jemimah S. (2017) Protein-protein interactions: scoring schemes and binding affinity. Curr. Opin. Struct. Biol. 44, 31-38.</Citation>
        </Reference>
        <Reference>
          <Citation>Guo X., Sun X., Hu D., et al. (2016) VCP recruitment to mitochondria causes mitophagy impairment and neurodegeneration in models of Huntington's disease. Nat. Commun. 7, 12646.</Citation>
        </Reference>
        <Reference>
          <Citation>Guo Q., Bin H., Cheng J., et al. (2018) The cryo-electron microscopy structure of huntingtin. Nature 555, 117-120.</Citation>
        </Reference>
        <Reference>
          <Citation>Han T. W., Kato M., Xie S., et al. (2012) Cell-free formation of RNA granules: bound RNAs identify features and components of cellular assemblies. Cell 149, 768-779.</Citation>
        </Reference>
        <Reference>
          <Citation>Harding R. J., Loppnau P., Ackloo S., et al. (2019) Design and characterization of mutant and wild-type huntingtin proteins produced from a toolkit of scalable eukaryotic expression systems. J. Biol. Chem. 294, 6986-7001.</Citation>
        </Reference>
        <Reference>
          <Citation>Harjes P. and Wanker E. E. (2003) The hunt for huntingtin function: interaction partners tell many different stories. Trends Biochem. Sci. 28, 425-433.</Citation>
        </Reference>
        <Reference>
          <Citation>Hoffner G. and Djian P. (2014) Monomeric, oligomeric and polymeric proteins in huntington disease and other diseases of polyglutamine expansion. Brain Sci. 4, 91-122.</Citation>
        </Reference>
        <Reference>
          <Citation>Holmes B. B., DeVos S. L., Kfoury N., et al. (2013) Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds. Proc. Natl Acad. Sci. USA 110, E3138-3147.</Citation>
        </Reference>
        <Reference>
          <Citation>Hoop C. L., Lin H. K., Kar K., et al. (2016) Huntingtin exon 1 fibrils feature an interdigitated beta-hairpin-based polyglutamine core. Proc. Natl Acad. Sci. USA 113, 1546-1551.</Citation>
        </Reference>
        <Reference>
          <Citation>Hosp F., Gutierrez-Angel S., Schaefer M. H., et al. (2017) Spatiotemporal proteomic profiling of Huntington's disease inclusions reveals widespread loss of protein function. Cell Rep. 21, 2291-2303.</Citation>
        </Reference>
        <Reference>
          <Citation>Huang K. and El-Husseini A. (2005) Modulation of neuronal protein trafficking and function by palmitoylation. Curr. Opin. Neurobiol. 15, 527-535.</Citation>
        </Reference>
        <Reference>
          <Citation>Huang C. C., Faber P. W., Persichetti F., Mittal V., Vonsattel J. P., MacDonald M. E. and Gusella J. F. (1998) Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins. Somat. Cell Mol. Genet. 24, 217-233.</Citation>
        </Reference>
        <Reference>
          <Citation>Huang K., Yanai A., Kang R., et al. (2004) Huntingtin-interacting protein HIP14 is a palmitoyl transferase involved in palmitoylation and trafficking of multiple neuronal proteins. Neuron 44, 977-986.</Citation>
        </Reference>
        <Reference>
          <Citation>Huang K., Sanders S. S., Kang R., et al. (2011) Wild-type HTT modulates the enzymatic activity of the neuronal palmitoyl transferase HIP14. Hum. Mol. Genet. 20, 3356-3365.</Citation>
        </Reference>
        <Reference>
          <Citation>Intihar T. A., Martinez E. A. and Gomez-Pastor R. (2019) Mitochondrial dysfunction in Huntington's disease; interplay between HSF1, p53 and PGC-1alpha transcription factors. Front. Cell. Neurosci. 13, 103.</Citation>
        </Reference>
        <Reference>
          <Citation>Ivarsson Y. and Jemth P. (2018) Affinity and specificity of motif-based protein-protein interactions. Curr. Opin. Struct. Biol. 54, 26-33.</Citation>
        </Reference>
        <Reference>
          <Citation>Jayaraman M., Kodali R., Sahoo B., Thakur A. K., Mayasundari A., Mishra R., Peterson C. B. and Wetzel R. (2012) Slow amyloid nucleation via α-helix-rich oligomeric intermediates in short polyglutamine-containing huntingtin fragments. J. Mol. Biol. 415, 881-899.</Citation>
        </Reference>
        <Reference>
          <Citation>Jeon I., Cicchetti F., Cisbani G., et al. (2016) Human-to-mouse prion-like propagation of mutant huntingtin protein. Acta Neuropathol. 132, 577-592.</Citation>
        </Reference>
        <Reference>
          <Citation>Jin Y. N., Hwang W. Y., Jo C. and Johnson G. V. (2012) Metabolic state determines sensitivity to cellular stress in Huntington disease: normalization by activation of PPARgamma. PLoS ONE 7, e30406.</Citation>
        </Reference>
        <Reference>
          <Citation>Kang H., Vazquez F. X., Zhang L., Das P., Toledo-Sherman L., Luan B., Levitt M. and Zhou R. (2017a) Emerging beta-sheet rich conformations in supercompact huntingtin exon-1 mutant structures. J. Am. Chem. Soc. 139, 8820-8827.</Citation>
        </Reference>
        <Reference>
          <Citation>Kang H., Vázquez F. X., Zhang L., Das P., Toledo-Sherman L., Luan B., Levitt M. and Zhou R. (2017b) Emerging β-sheet rich conformations in supercompact huntingtin exon-1 mutant structures. J. Am. Chem. Soc. 139, 8820-8827.</Citation>
        </Reference>
        <Reference>
          <Citation>Kazantsev A., Preisinger E., Dranovsky A., Goldgaber D. and Housman D. (1999) Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells. Proc. Natl Acad. Sci. USA 96, 11404-11409.</Citation>
        </Reference>
        <Reference>
          <Citation>Kim M. W., Chelliah Y., Kim S. W., Otwinowski Z. and Bezprozvanny I. (2009) Secondary structure of Huntingtin amino-terminal region. Structure 17, 1205-1212.</Citation>
        </Reference>
        <Reference>
          <Citation>Kim S. R., Kareva T., Yarygina O., Kholodilov N. and Burke R. E. (2012) AAV transduction of dopamine neurons with constitutively active Rheb protects from neurodegeneration and mediates axon regrowth. Mol. Ther. 20, 275-286.</Citation>
        </Reference>
        <Reference>
          <Citation>Kim Y. E., Hosp F., Frottin F., Ge H., Mann M., Hayer-Hartl M. and Hartl F. U. (2016) Soluble oligomers of PolyQ-expanded huntingtin target a multiplicity of key cellular factors. Mol. Cell 63, 951-964.</Citation>
        </Reference>
        <Reference>
          <Citation>Knott A. B., Perkins G., Schwarzenbacher R. and Bossy-Wetzel E. (2008) Mitochondrial fragmentation in neurodegeneration. Nat. Rev. Neurosci. 9, 505-518.</Citation>
        </Reference>
        <Reference>
          <Citation>Kotler S. A., Tugarinov V., Schmidt T., Ceccon A., Libich D. S., Ghirlando R., Schwieters C. D. and Clore G. M. (2019) Probing initial transient oligomerization events facilitating Huntingtin fibril nucleation at atomic resolution by relaxation-based NMR. Proc. Natl Acad. Sci. USA 116, 3562-3571.</Citation>
        </Reference>
        <Reference>
          <Citation>Landles C., Sathasivam K., Weiss A., et al. (2010) Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease. J. Biol. Chem. 285, 8808-8823.</Citation>
        </Reference>
        <Reference>
          <Citation>Langfelder P., Cantle J. P., Chatzopoulou D., et al. (2016) Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice. Nat. Neurosci. 19, 623-633.</Citation>
        </Reference>
        <Reference>
          <Citation>Laplante M. and Sabatini D. M. (2012) mTOR signaling in growth control and disease. Cell 149, 274-293.</Citation>
        </Reference>
        <Reference>
          <Citation>Lee J. H., Tecedor L., Chen Y. H., Monteys A. M., Sowada M. J., Thompson L. M. and Davidson B. L. (2015) Reinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypes. Neuron 85, 303-315.</Citation>
        </Reference>
        <Reference>
          <Citation>Leitman J., Ulrich Hartl F. and Lederkremer G. Z. (2013) Soluble forms of polyQ-expanded huntingtin rather than large aggregates cause endoplasmic reticulum stress. Nat. Commun. 4, 2753.</Citation>
        </Reference>
        <Reference>
          <Citation>Li S. H. and Li X. J. (2004) Huntingtin-protein interactions and the pathogenesis of Huntington's disease. Trends Genet. 20, 146-154.</Citation>
        </Reference>
        <Reference>
          <Citation>Li X. J., Li S. H., Sharp A. H., Nucifora F. C., Jr, Schilling G., Lanahan A., Worley P., Snyder S. H. and Ross C. A. (1995) A huntingtin-associated protein enriched in brain with implications for pathology. Nature 378, 398-402.</Citation>
        </Reference>
        <Reference>
          <Citation>Li S. H., Cheng A. L., Zhou H., Lam S., Rao M., Li H. and Li X. J. (2002) Interaction of Huntington disease protein with transcriptional activator Sp1. Mol. Cell. Biol. 22, 1277-1287.</Citation>
        </Reference>
        <Reference>
          <Citation>Lin H. K., Boatz J. C., Krabbendam I. E., Kodali R., Hou Z., Wetzel R., Dolga A. M., Poirier M. A. and van der Wel P. C. A. (2017) Fibril polymorphism affects immobilized non-amyloid flanking domains of huntingtin exon1 rather than its polyglutamine core. Nat. Commun. 8, 15462.</Citation>
        </Reference>
        <Reference>
          <Citation>Lunkes A., Lindenberg K. S., Ben-Haiem L., Weber C., Devys D., Landwehrmeyer G. B., Mandel J. L. and Trottier Y. (2002) Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions. Mol. Cell 10, 259-269.</Citation>
        </Reference>
        <Reference>
          <Citation>Maday S. and Holzbaur E. L. (2012) Autophagosome assembly and cargo capture in the distal axon. Autophagy 8, 858-860.</Citation>
        </Reference>
        <Reference>
          <Citation>Marcora E., Gowan K. and Lee J. E. (2003) Stimulation of NeuroD activity by huntingtin and huntingtin-associated proteins HAP1 and MLK2. Proc. Natl Acad. Sci. USA 100, 9578-9583.</Citation>
        </Reference>
        <Reference>
          <Citation>Martinez-Vicente M., Talloczy Z., Wong E., et al. (2010) Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease. Nat. Neurosci. 13, 567-576.</Citation>
        </Reference>
        <Reference>
          <Citation>Masnata M., Sciacca G., Maxan A., et al. (2019) Demonstration of prion-like properties of mutant huntingtin fibrils in both in vitro and in vivo paradigms. Acta Neuropathol. 137, 981-1001.</Citation>
        </Reference>
        <Reference>
          <Citation>Mealer R. G., Murray A. J., Shahani N., Subramaniam S. and Snyder S. H. (2014) Rhes, a striatal-selective protein implicated in Huntington disease, binds beclin-1 and activates autophagy. J. Biol. Chem. 289, 3547-3554.</Citation>
        </Reference>
        <Reference>
          <Citation>Miller J., Arrasate M., Shaby B. A., Mitra S., Masliah E. and Finkbeiner S. (2010) Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington's disease molecular pathogenesis. J. Neurosci. 30, 10541-10550.</Citation>
        </Reference>
        <Reference>
          <Citation>Mompean M. and Laurents D. V. (2017) Intrinsically disordered domains, amyloids and protein liquid phases: evolving concepts and open questions. Protein Pept. Lett. 24, 281-293.</Citation>
        </Reference>
        <Reference>
          <Citation>Murakami T., Qamar S., Lin J. Q., et al. (2015) ALS/FTD Mutation-induced phase transition of FUS liquid droplets and reversible hydrogels into irreversible hydrogels impairs RNP granule function. Neuron 88, 678-690.</Citation>
        </Reference>
        <Reference>
          <Citation>Neueder A., Dumas A. A., Benjamin A. C. and Bates G. P. (2018) Regulatory mechanisms of incomplete huntingtin mRNA splicing. Nat. Commun. 9, 3955.</Citation>
        </Reference>
        <Reference>
          <Citation>Nucifora F. C., Jr, Sasaki M., Peters M. F., et al. (2001) Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291, 2423-2428.</Citation>
        </Reference>
        <Reference>
          <Citation>Ochaba J., Lukacsovich T., Csikos G., et al. (2014) Potential function for the Huntingtin protein as a scaffold for selective autophagy. Proc. Natl Acad. Sci. USA 111, 16889-16894.</Citation>
        </Reference>
        <Reference>
          <Citation>Paul B. D., Sbodio J. I., Xu R., Vandiver M. S., Cha J. Y., Snowman A. M. and Snyder S. H. (2014) Cystathionine gamma-lyase deficiency mediates neurodegeneration in Huntington's disease. Nature 509, 96-100.</Citation>
        </Reference>
        <Reference>
          <Citation>Peskett T. R., Rau F., O'Driscoll J., Patani R., Lowe A. R. and Saibil H. R. (2018) A liquid to solid phase transition underlying pathological huntingtin exon1 aggregation. Mol. Cell 70(588-601), e586.</Citation>
        </Reference>
        <Reference>
          <Citation>Peterson T. R., Sengupta S. S., Harris T. E., et al. (2011) mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell 146, 408-420.</Citation>
        </Reference>
        <Reference>
          <Citation>Pogue R. E., Cavalcanti D. P., Shanker S., Andrade R. V., Aguiar L. R., de Carvalho J. L. and Costa F. F. (2018) Rare genetic diseases: update on diagnosis, treatment and online resources. Drug Discov. Today 23, 187-195.</Citation>
        </Reference>
        <Reference>
          <Citation>Ren P. H., Lauckner J. E., Kachirskaia I., Heuser J. E., Melki R. and Kopito R. R. (2009) Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat. Cell Biol. 11, 219-225.</Citation>
        </Reference>
        <Reference>
          <Citation>Ripaud L., Chumakova V., Antonin M., et al. (2014) Overexpression of Q-rich prion-like proteins suppresses polyQ cytotoxicity and alters the polyQ interactome. Proc. Natl Acad. Sci. USA 111, 18219-18224.</Citation>
        </Reference>
        <Reference>
          <Citation>Ross C. A. and Tabrizi S. J. (2011) Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol. 10, 83-98.</Citation>
        </Reference>
        <Reference>
          <Citation>Rui Y. N., Xu Z., Patel B., et al. (2015) Huntingtin functions as a scaffold for selective macroautophagy. Nat. Cell Biol. 17, 262-275.</Citation>
        </Reference>
        <Reference>
          <Citation>Sahl S. J., Weiss L. E., Duim W. C., Frydman J. and Moerner W. E. (2012) Cellular inclusion bodies of mutant huntingtin exon 1 obscure small fibrillar aggregate species. Sci. Rep. 2, 895.</Citation>
        </Reference>
        <Reference>
          <Citation>Sahni N., Yi S., Zhong Q., Jailkhani N., Charloteaux B., Cusick M. E. and Vidal M. (2013) Edgotype: a fundamental link between genotype and phenotype. Curr. Opin. Genet. Dev. 23, 649-657.</Citation>
        </Reference>
        <Reference>
          <Citation>Sahni N., Yi S., Taipale M., et al. (2015) Widespread macromolecular interaction perturbations in human genetic disorders. Cell 161, 647-660.</Citation>
        </Reference>
        <Reference>
          <Citation>Sahoo B., Singer D., Kodali R., Zuchner T. and Wetzel R. (2014) Aggregation behavior of chemically synthesized, full-length huntingtin exon1. Biochemistry 53, 3897-3907.</Citation>
        </Reference>
        <Reference>
          <Citation>Sahoo B., Arduini I., Drombosky K. W., Kodali R., Sanders L. H., Greenamyre J. T. and Wetzel R. (2016) Folding landscape of mutant huntingtin exon1: diffusible multimers, oligomers and fibrils, and no detectable monomer. PLoS ONE 11, e0155747.</Citation>
        </Reference>
        <Reference>
          <Citation>Sanchez Mejia R. O. and Friedlander R. M. (2001) Caspases in Huntington's disease. Neuroscientist 7, 480-489.</Citation>
        </Reference>
        <Reference>
          <Citation>Sathasivam K., Lane A., Legleiter J., et al. (2010) Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease. Hum. Mol. Genet. 19, 65-78.</Citation>
        </Reference>
        <Reference>
          <Citation>Sathasivam K., Neueder A., Gipson T. A., et al. (2013) Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease. Proc. Natl Acad. Sci. USA 110, 2366-2370.</Citation>
        </Reference>
        <Reference>
          <Citation>Saudou F. and Humbert S. (2016) The biology of huntingtin. Neuron 89, 910-926.</Citation>
        </Reference>
        <Reference>
          <Citation>Saxton R. A. and Sabatini D. M. (2017) mTOR signaling in growth, metabolism, and disease. Cell 168, 960-976.</Citation>
        </Reference>
        <Reference>
          <Citation>Sbodio J. I., Paul B. D., Machamer C. E. and Snyder S. H. (2013) Golgi protein ACBD3 mediates neurotoxicity associated with Huntington's disease. Cell Rep. 4, 890-897.</Citation>
        </Reference>
        <Reference>
          <Citation>Sbodio J. I., Snyder S. H. and Paul B. D. (2016) Transcriptional control of amino acid homeostasis is disrupted in Huntington's disease. Proc. Natl Acad. Sci. USA 113, 8843-8848.</Citation>
        </Reference>
        <Reference>
          <Citation>Schaffar G., Breuer P., Boteva R., et al. (2004) Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation. Mol. Cell 15, 95-105.</Citation>
        </Reference>
        <Reference>
          <Citation>Scherzinger E., Lurz R., Turmaine M., et al. (1997) Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90, 549-558.</Citation>
        </Reference>
        <Reference>
          <Citation>Scherzinger E., Sittler A., Schweiger K., Heiser V., Lurz R., Hasenbank R., Bates G. P., Lehrach H. and Wanker E. E. (1999) Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology. Proc. Natl Acad. Sci. USA 96, 4604.</Citation>
        </Reference>
        <Reference>
          <Citation>Shirasaki D. I., Greiner E. R., Al-Ramahi I., et al. (2012) Network organization of the huntingtin proteomic interactome in mammalian brain. Neuron 75, 41-57.</Citation>
        </Reference>
        <Reference>
          <Citation>Shirendeb U., Reddy A. P., Manczak M., Calkins M. J., Mao P., Tagle D. A. and Reddy P. H. (2011) Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage. Hum. Mol. Genet. 20, 1438-1455.</Citation>
        </Reference>
        <Reference>
          <Citation>Shirendeb U. P., Calkins M. J., Manczak M., Anekonda V., Dufour B., McBride J. L., Mao P. and Reddy P. H. (2012) Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease. Hum. Mol. Genet. 21, 406-420.</Citation>
        </Reference>
        <Reference>
          <Citation>Singaraja R. R., Hadano S., Metzler M., et al. (2002) HIP14, a novel ankyrin domain-containing protein, links huntingtin to intracellular trafficking and endocytosis. Hum. Mol. Genet. 11, 2815-2828.</Citation>
        </Reference>
        <Reference>
          <Citation>Singaraja R. R., Huang K., Sanders S. S., et al. (2011) Altered palmitoylation and neuropathological deficits in mice lacking HIP14. Hum. Mol. Genet. 20, 3899-3909.</Citation>
        </Reference>
        <Reference>
          <Citation>Song W., Chen J., Petrilli A., et al. (2011) Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nat. Med. 17, 377-382.</Citation>
        </Reference>
        <Reference>
          <Citation>Steffan J. S., Kazantsev A., Spasic-Boskovic O., et al. (2000) The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc. Natl Acad. Sci. USA 97, 6763-6768.</Citation>
        </Reference>
        <Reference>
          <Citation>Subramaniam S., Sixt K. M., Barrow R. and Snyder S. H. (2009) Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity. Science 324, 1327-1330.</Citation>
        </Reference>
        <Reference>
          <Citation>Sutton L. M., Sanders S. S., Butland S. L., et al. (2013) Hip14l-deficient mice develop neuropathological and behavioural features of Huntington disease. Hum. Mol. Genet. 22, 452-465.</Citation>
        </Reference>
        <Reference>
          <Citation>Thakur A. K., Jayaraman M., Mishra R., et al. (2009) Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism. Nat. Struct. Mol. Biol. 16, 380.</Citation>
        </Reference>
        <Reference>
          <Citation>Trepte P., Strempel N. and Wanker E. E. (2014) Spontaneous self-assembly of pathogenic huntingtin exon 1 protein into amyloid structures. Essays Biochem. 56, 167-180.</Citation>
        </Reference>
        <Reference>
          <Citation>Twelvetrees A. E., Yuen E. Y., Arancibia-Carcamo I. L., et al. (2010) Delivery of GABAARs to synapses is mediated by HAP1-KIF5 and disrupted by mutant huntingtin. Neuron 65, 53-65.</Citation>
        </Reference>
        <Reference>
          <Citation>Valor L. M. (2015) Transcription, epigenetics and ameliorative strategies in Huntington's disease: a genome-wide perspective. Mol. Neurobiol. 51, 406-423.</Citation>
        </Reference>
        <Reference>
          <Citation>Vijayvargia R., Epand R., Leitner A., et al. (2016) Huntingtin's spherical solenoid structure enables polyglutamine tract-dependent modulation of its structure and function. eLife 5, e11184.</Citation>
        </Reference>
        <Reference>
          <Citation>Vonsattel J. P., Keller C. and Cortes Ramirez E. P. (2011) Huntington's disease - neuropathology. Handb. Clin. Neurol. 100, 83-100.</Citation>
        </Reference>
        <Reference>
          <Citation>Waelter S., Boeddrich A., Lurz R., Scherzinger E., Lueder G., Lehrach H. and Wanker E. E. (2001) Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation. Mol. Biol. Cell 12, 1393-1407.</Citation>
        </Reference>
        <Reference>
          <Citation>Wagner A. S., Politi A. Z., Ast A., et al. (2018) Self-assembly of mutant huntingtin exon-1 fragments into large complex fibrillar structures involves nucleated branching. J. Mol. Biol. 430, 1725-1744.</Citation>
        </Reference>
        <Reference>
          <Citation>Wanker E. E. (2000) Protein aggregation and pathogenesis of Huntington's disease: mechanisms and correlations. Biol. Chem. 381, 937-942.</Citation>
        </Reference>
        <Reference>
          <Citation>Wanker E. E., Scherzinger E., Heiser V., Sittler A., Eickhoff H. and Lehrach H. (1999) Membrane filter assay for detection of amyloid-like polyglutamine-containing protein aggregates. Methods Enzymol. 309, 375-386.</Citation>
        </Reference>
        <Reference>
          <Citation>Wear M. P., Kryndushkin D., O'Meally R., Sonnenberg J. L., Cole R. N. and Shewmaker F. P. (2015) Proteins with Intrinsically disordered domains are preferentially recruited to polyglutamine aggregates. PLoS ONE 10, e0136362.</Citation>
        </Reference>
        <Reference>
          <Citation>Wong Y. C. and Holzbaur E. L. (2014) The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation. J. Neurosci. 34, 1293-1305.</Citation>
        </Reference>
        <Reference>
          <Citation>Yanai A., Huang K., Kang R., et al. (2006) Palmitoylation of huntingtin by HIP14 is essential for its trafficking and function. Nat. Neurosci. 9, 824-831.</Citation>
        </Reference>
        <Reference>
          <Citation>Zala D., Hinckelmann M. V. and Saudou F. (2013) Huntingtin's function in axonal transport is conserved in Drosophila melanogaster. PLoS ONE 8, e60162.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhai W., Jeong H., Cui L., Krainc D. and Tjian R. (2005) In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets. Cell 123, 1241-1253.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhao Y., Sun X. and Qi X. (2018) Inhibition of Drp1 hyperactivation reduces neuropathology and behavioral deficits in zQ175 knock-in mouse model of Huntington's disease. Biochem. Biophys. Res. Comm. 507, 319-323.</Citation>
        </Reference>
        <Reference>
          <Citation>Zheng S., Clabough E. B., Sarkar S., Futter M., Rubinsztein D. C. and Zeitlin S. O. (2010) Deletion of the huntingtin polyglutamine stretch enhances neuronal autophagy and longevity in mice. PLoS Genet. 6, e1000838.</Citation>
        </Reference>
        <Reference>
          <Citation>Zuccato C., Tartari M., Crotti A., et al. (2003) Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat. Genet. 35, 76-83.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
